As
filed with the U.S. Securities and Exchange Commission on February 11, 2025
Registration
No. 333-
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
F-3
REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933
ADS-TEC
ENERGY PUBLIC LIMITED COMPANY
(Exact Name of Registrant as specified in its charter)
Ireland |
|
Not
Applicable |
(State or other jurisdiction
of
incorporation or organization) |
|
(I.R.S. Employer
Identification Number) |
10
Earlsfort Terrace
Dublin 2, D02 T380, Ireland
+353 1 920 1000
(Address and telephone number of Registrant’s principal executive offices)
Cogency
Global Inc.
122
East 42nd Street, 18th Floor
New
York, NY 10168
(800)
221-0102
(Name,
address and telephone number of agent for service)
Copies
to:
Michael
S. Lee, Esq. |
Connor
Manning, Esq. |
Lynwood
E. Reinhardt, Esq. |
Arthur
Cox LLP |
Reed
Smith LLP |
Ten
Earlsfort Terrace |
599
Lexington Avenue |
Dublin
2, D02 T380 |
New
York, New York 10022 |
Ireland |
(212)
521-5400 |
Telephone:
+353 1 920 1040 |
Approximate
date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement.
If
only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the
following box. ☐
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box. ☒
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.
Emerging
growth company ☒
If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards †
provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The
Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective
on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
† | The
term “new or revised financial accounting standard” refers to any update issued
by the Financial Accounting Standards Board to its Accounting Standards Codification after
April 5, 2012. |
EXPLANATORY
NOTE
This
registration statement contains two prospectuses:
| ● | a
base prospectus which covers the offering, issuance and sale by us of up to US$250,000,000
of our ordinary shares, preferred shares, debt securities, warrants, rights, purchase contracts
and/or units; and |
| ● | a
secondary offering prospectus which covers the offer and sale by the selling securityholders
described therein of up to 10,516,670 ordinary shares issuable upon the exercise of the May
Warrants, August Warrants, and 2024 Warrants acquired by certain selling securityholders
(each such term as defined herein). |
The
base prospectus immediately follows this explanatory note. The secondary offering prospectus immediately follows the base prospectus.
The 10,516,670 ordinary shares that may be offered and sold under the secondary offering prospectus are not included in the US$250,000,000
of securities that may be offered, issued and sold by us under the base prospectus.
The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not
soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT
TO COMPLETION, DATED February 11, 2025
PROSPECTUS
ADS-TEC
ENERGY PLC
$250,000,000
ORDINARY
SHARES
PREFERRED
SHARES
DEBT
SECURITIES
WARRANTS
RIGHTS
PURCHASE
CONTRACTS
UNITS
This
prospectus will allow us to issue, from time to time at prices and on terms to be determined at or prior to the time of the offering,
up to $250,000,000 of any combination of the securities described in this prospectus, either individually or in units. We may also offer
ordinary shares or preferred shares upon conversion of or exchange for the debt securities; ordinary shares or preferred shares or debt
securities upon the exercise of warrants, rights or performance of purchase contracts; or any combination of these securities upon the
performance of purchase contracts.
This
prospectus describes the general terms of these securities and the general manner in which these securities will be offered. We will
provide you with the specific terms of any offering in one or more supplements to this prospectus. The prospectus supplements will also
describe the specific manner in which these securities will be offered and may also supplement, update or amend information contained
in this document. You should read this prospectus and any prospectus supplement, as well as any documents incorporated by reference into
this prospectus or any prospectus supplement, carefully before you invest.
Our
securities may be sold directly by us to you, through agents designated from time to time or to or through underwriters or dealers. For
additional information on the methods of sale, you should refer to the section entitled "Plan of Distribution" in this prospectus
and in the applicable prospectus supplement. If any underwriters or agents are involved in the sale of our securities with respect to
which this prospectus is being delivered, the names of such underwriters or agents and any applicable fees, commissions or discounts
and over-allotment options will be set forth in a prospectus supplement. The price to the public of such securities and the net proceeds
that we expect to receive from such sale will also be set forth in a prospectus supplement.
Our
Ordinary Shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “ADSE.” On February 10, 2025,
the closing sale price as reported on Nasdaq of our Ordinary Shares was $14.54 per share.
We
may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this entire
prospectus and any amendments or supplements carefully before you make your investment decision.
We
are an “emerging growth company” and “foreign private issuer,” each as defined under the U.S. federal securities
laws, and, as such, are subject to reduced public company reporting requirements.
Our
principal executive offices are located at 10 Earlsfort Terrace Dublin 2, D02 T380, Ireland.
Investing
in our securities involves a high degree of risk. Before buying any of our securities, you should carefully read the discussion of material
risks of investing in our securities in “Risk Factors” beginning on page 3 of this prospectus, in any applicable
prospectus supplement and as described in certain of the documents we may incorporate by reference herein.
Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
The
date of this prospectus is ,
2025
TABLE
OF CONTENTS
ABOUT
THIS PROSPECTUS
This
prospectus is part of a registration statement that we filed with the Securities and Exchange Commission ("SEC"), utilizing
a "shelf" registration process. Under this shelf registration process, we may offer ordinary shares, preferred shares, various
series of debt securities and/or warrants, rights or purchase contracts to purchase any of such securities, either individually or in
units, in one or more offerings, with a total value of up to $250,000,000. This prospectus provides you with a general description of
the securities we may offer. Each time we offer a type or series of securities under this prospectus, we will provide a prospectus supplement
that will contain specific information about the terms of that offering.
The
prospectus supplement may also add, update or change information contained or incorporated by reference in this prospectus. However,
no prospectus supplement will offer a security that is not registered and described in this prospectus at the time of its effectiveness.
This prospectus, together with the applicable prospectus supplements and the documents incorporated by reference into this prospectus,
includes all material information relating to the offering of securities under this prospectus. You should carefully read this prospectus,
the applicable prospectus supplement, the information and documents incorporated herein by reference and the additional information under
the headings “Where You Can Find More Information” and “Documents Incorporated By Reference” before
making an investment decision.
You
should rely only on the information we have provided or incorporated by reference in this prospectus or any prospectus supplement. We
have not authorized anyone to provide you with information different from that contained or incorporated by reference in this prospectus.
No dealer, salesperson or other person is authorized to give any information or to represent anything not contained or incorporated by
reference in this prospectus. You must not rely on any unauthorized information or representation. This prospectus is an offer to sell
only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. You should assume
that the information in this prospectus or any prospectus supplement is accurate only as of the date on the front of the document and
that any information we have incorporated herein by reference is accurate only as of the date of the document incorporated by reference,
regardless of the time of delivery of this prospectus or any sale of a security.
We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document
that is incorporated by reference in the accompanying prospectus were made solely for the benefit of the parties to such agreement, including,
in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation,
warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly,
such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.
This
prospectus may not be used to consummate sales of our securities, unless it is accompanied by a prospectus supplement. To the extent
there are inconsistencies between any prospectus supplement, this prospectus and any documents incorporated by reference, the document
with the most recent date will control.
Other
than in the United States, no action has been taken by us or any underwriters that would permit a public offering of the securities offered
by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be
offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with
the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result
in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are
advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
any jurisdiction in which such an offer or a solicitation is unlawful.
FREQUENTLY
USED TERMS
Unless
otherwise stated in this prospectus, any prospectus supplement or the documents incorporated by reference herein or therein, or the context
otherwise requires, references to:
“ADSE”
means collectively, ads-tec Energy GmbH, ads-tec Energy, Inc., and ads-tec Energy PLC.
“ADSE
GM” means ads-tec Energy GmbH, a wholly-owned subsidiary of ADSE Holdco, based in Nürtingen, Germany and entered in the
commercial register of the Stuttgart Local Court under HRB 762810.
“ADSE
Holdco” or “Company” means ADS-TEC Energy PLC, an Irish public limited company duly incorporated under the
laws of Ireland.
“ADSE
US” means ads-tec Energy Inc., a Delaware corporation and wholly-owned subsidiary of the Company.
“ADSH”
means ads-tec Holding GmbH, based in Nürtingen, Germany and entered in the commercial register of the Stuttgart Local Court under
HRB 224527.
“Bosch”
means Bosch Thermotechnik GmbH, based in Wetzlar and entered in the commercial register of the Wetzlar Local Court under HRB 13.
“Business
Combination” means the transactions contemplated on December 22, 2021, pursuant to the Business Combination Agreement, in connection
with which EUSG ceased to exist and ADSE GM became a wholly-owned subsidiary of ADSE Holdco and the securityholders of ADSE GM and EUSG
became securityholders of ADSE Holdco.
“Business
Combination Agreement” means the Business Combination Agreement, dated August 10, 2021, by and among EUSG, ADSE Holdco, Merger
Sub, Bosch, ADSH and ADSE GM.
“Business
Combination Warrants” means collectively, the Public Warrants, the Private Warrants and the Lender Warrants issued in connection
with the Business Combination at an exercise price of $11.50 per Ordinary Share.
“EBC”
means EarlyBirdCapital, Inc.
“EUSG”
means European Sustainable Growth Acquisition Corp., a blank check company incorporated as a Cayman Islands exempted company.
“EUSG
Class A Ordinary Shares” means Class A ordinary shares, par value of $0.0001 per share, in the share capital of EUSG.
“EUSG
Private Warrants” means whole redeemable warrants to purchase EUSG Class A Ordinary Shares issued pursuant to (i) that certain
Private Placement Warrants Purchase Agreement, dated as of January 26, 2021, by and between EUSG and EUSG Sponsor, (ii) that certain
Private Placement Warrants Purchase Agreement, dated as of January 26, 2021 by and between EUSG and EBC, and (iii) that certain Private
Placement Warrants Purchase Agreement, dated as of January 26, 2021, by and between EUSG and ABN AMRO Securities (USA) LLC.
“EUSG
Public Warrants” means the warrants to purchase EUSG Class A Ordinary Shares issued as part of the EUSG units in the IPO.
“EUSG
Sponsor” means LRT Capital1 LLC, a Delaware limited liability company.
“Exchange
Act” means the U.S. Securities Exchange Act of 1934, as amended.
“IPO”
means EUSG’s initial public offering of EUSG units, consummated on January 26, 2021.
“JOBS
Act” means the Jumpstart Our Business Startups Act of 2012, as amended.
“Lender
Warrants” means the 100,000 Business Combination Warrants that came into existence on the automatic adjustment of the whole
redeemable warrants to purchase EUSG Class A Ordinary Shares issued to Jonathan Copplestone upon conversion of an outstanding unsecured
convertible promissory note in an aggregate principal amount of $100,000, dated October 30, 2021, between EUSG and Jonathan Copplestone
upon consummation of the business combination contemplated in the Business Combination Agreement.
“Merger
Sub” means EUSG II Corporation, an exempted company incorporated in the Cayman Islands with limited liability under company
number 379118 and a wholly-owned subsidiary of ADSE Holdco.
“Ordinary
Shares” means the ordinary shares, with US$0.0001 par value per share, of ADSE Holdco.
“Private
Warrants” means the Business Combination Warrants that came into existence on the automatic adjustment of the EUSG Private
Warrants upon consummation of the Business Combination.
“Public
Warrants” means the Business Combination Warrants that came into existence on
the automatic adjustment of the EUSG Public Warrants upon consummation of the Business Combination.
“Securities
Act” means the U.S. Securities Act of 1933, as amended.
“Share-for-Share
Exchange” means the transaction by which ADSH and Bosch transferred as contribution to ADSE Holdco, and ADSE Holdco assumed
from ADSH and Bosch, certain shares of ADSE GM in exchange for Ordinary Shares.
“$”,
“US$” and “U.S. dollar” means the United States dollar.
“€”,
“EUR” and “Euro” means the Euro.
PROSPECTUS
SUMMARY
This
summary highlights certain information about us, this offering and selected information contained elsewhere in this prospectus. This
summary is not complete and does not contain all of the information that you should consider before deciding whether to invest in the
securities covered by this prospectus. This summary is qualified in its entirety by the more detailed information included in or incorporated
by reference into this prospectus and any applicable prospectus supplement. For a more complete understanding of the Company and our
securities, we encourage you to read in their entirety and consider carefully the more detailed information in this prospectus and any
related prospectus supplement, including the documents referred to in “Where You Can Find More Information” and “Documents
Incorporated by Reference,” before making an investment decision. Some of the statements in this prospectus constitute, and certain
statements in any prospectus supplement or the documents incorporated by reference herein and therein may be, forward-looking statements
that involve assumptions, risks and uncertainties as further described in “Forward-Looking Statements.”
Unless
otherwise stated or the context otherwise indicates, references to the “Company” or “ADSE Holdco” refer to ads-tec
Energy plc and, “we”, “our”, “us” or “ADSE” refer to ads-tec Energy plc, together with
its subsidiaries.
Our
Company
We
are a supplier of integrated technology platforms (ecosystem platforms) that enable customers to run their EV charging and energy business
models on those decentralized platforms. Our ecosystem platforms consist of hardware, software and services and are designed to provide
key functions such as flexibility (energy storage with a battery), intelligent energy- and data management, as well as a wide range of
related and recurring digital and physical services. We believe that these decentralized ecosystem platforms will play a significant
role in the transition to a low carbon economy. These decentralized systems are getting more and more complex as the level of integration
increases. Development must follow continuous changes in regulatory requirements and component improvements. Batteries, power inverters
and all the software and security involved must be serviceable and maintained over a long period of time. For the leading players in
the future energy market such as utilities and operators, the question of which platforms to invest in and run their business on will,
in our opinion, be based on the quality and total cost of ownership of such platforms. Our core business is providing and servicing these
ecosystem platforms to, ideally, all of the future power companies, in principle, striving to reach a CO2 neutral world. Due to the depth
of our experience and capabilities across a wide range of technical disciplines, we have positioned ourselves as partner of choice for
customers running their business and serving their end-customers on these platforms. We strive to penetrate three main domains of the
decentralized energy market: (1) Ultra-fast Charging on power limited grids; (2) Residential sector coupling; and (3) Commercial &
Industrial applications.
Implications
of Being an Emerging Growth Company and a Foreign Private Issuer
We
qualify as an “emerging growth company” as defined in the JOBS Act. As an emerging growth company, we may take advantage
of certain exemptions from specified disclosure and other requirements that are otherwise generally applicable to public companies. These
exemptions include:
|
● |
an exemption from the provisions
of Section 404(b) of the Sarbanes-Oxley Act of 2002 requiring that our independent registered public accounting firm provide an attestation
report on the effectiveness of our internal control over financial reporting; |
|
● |
reduced disclosure obligations
regarding executive compensation; and |
|
● |
not being required to hold
a nonbinding advisory vote on executive compensation or to seek shareholder approval of any golden parachute payments not previously
approved. |
We
will remain an “emerging growth company” until the earliest to occur of (i) the last day of the fiscal year (a) following
the fifth anniversary of the closing of the Business Combination, (b) in which we have total annual gross revenue of at least $1.235
billion or (c) in which we are deemed to be a large accelerated filer, which means the market value of equity securities held by our
non-affiliates exceeds $700 million as of the last business day of our prior second fiscal quarter, and (ii) the date on which we have
issued more than $1.0 billion in non-convertible debt during the prior three-year period.
We
are also considered a “foreign private issuer” subject to reporting requirements under the Exchange Act, as a non-U.S. company
with foreign private issuer status. As a “foreign private issuer,” we will be subject to different U.S. securities laws than
domestic U.S. issuers. The rules governing the information that we must disclose differ from those governing U.S. corporations pursuant
to the Exchange Act. This means that, even after we no longer qualify as an emerging growth company, as long as we qualify as a foreign
private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic
public companies, including:
|
● |
the rules under the Exchange
Act prescribing the furnishing and content of proxy statements to shareholders and requirements that the proxy statements conform
to Schedule 14A of the proxy rules promulgated under the Exchange Act; |
|
● |
the sections of the Exchange
Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; |
|
● |
the sections of the Exchange
Act requiring insiders (i.e., officers, directors and holders of more than 10% of our issued and outstanding equity securities) to
file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short
period of time; |
|
● |
the rules under the Exchange
Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information,
or current reports on Form 8-K upon the occurrence of specified significant events; and |
|
● |
the SEC rules on disclosure
of compensation on an individual basis unless individual disclosure is required in our home country (Ireland) and is not otherwise
publicly disclosed by us. |
We
may take advantage of these exemptions until such time as we are no longer a foreign private issuer.
We
would cease to be a foreign private issuer at such time as more than 50% of our outstanding voting securities are held by U.S. residents
and any of the following three circumstances applies: (i) the majority of our executive officers or directors are U.S. citizens or residents,
(ii) more than 50% of our assets are located in the United States or (iii) our business is administered principally in the United States.
We
may choose to take advantage of some but not all of these reduced reporting requirements of which we have taken advantage of in this
prospectus. Accordingly, the information contained herein may be different from the information you receive from our competitors that
are U.S. domestic filers or other U.S. domestic public companies in which you have made an investment.
Risk
Factors
Investing
in our securities entails a high degree of risk as discussed in the “Risk Factors” section beginning on page 3
of this prospectus and in the documents incorporated by reference in this prospectus. You should carefully consider such risks before
deciding to invest in our securities.
Corporate
Information
We
were incorporated as an Irish public limited company on July 26, 2021 solely for the purpose of effectuating the Business Combination.
Prior to the Business Combination, we did not conduct any material activities other than those incident to our formation and certain
matters related to the Business Combination, such as the making of certain required securities law filings.
Our
principal executive offices are located at 10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland. Our telephone number at this address is
+353 1 920 1000.
We
have appointed Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY 10168 as our agent upon
whom process may be served in any action brought against us under the securities laws of the United States in connection with offerings
of securities registered by the registration statement of which this prospectus is a part.
We
maintain a website at www.ads-tec-energy.com, where we regularly post copies of our press releases as well as additional information
about us. Our filings with the SEC are available free of charge through the website as soon as reasonably practicable after being electronically
filed with or furnished to the SEC. Information contained in our website is not a part of, nor incorporated by reference into, this prospectus
or our other filings with the SEC, and should not be relied upon.
All
trademarks, service marks and trade names appearing in this prospectus are the property of their respective holders. Use or display by
us of other parties’ trademarks, trade dress, or products in this prospectus is not intended to, and does not, imply a relationship
with, or endorsements or sponsorship of, us by the trademark or trade dress owners.
RISK
FACTORS
An
investment in our securities carries a significant degree of risk. Before you decide to purchase our securities, you should carefully
consider all risk factors set forth in the applicable prospectus supplement and the documents incorporated by reference herein or therein.
See “Documents Incorporated by Reference.” These risk factors are not exhaustive, and investors are encouraged to
perform their own investigation with respect to our business, financial condition and prospects. You should carefully consider these
risk factors in addition to the other information included in this prospectus, including matters addressed in the section entitled “Forward-Looking
Statements.” We may face additional risks and uncertainties that are not presently known to us, or that we currently deem immaterial,
which may also impair our business or financial condition. The risk factors should be read in conjunction with our financial statements
and notes to the financial statements incorporated by reference herein. If any of these risks actually occur, our business, financial
condition, results of operations or prospects could be materially affected. As a result, the trading prices of our securities could decline
and you could lose part or all of your investment.
FORWARD-LOOKING
STATEMENTS
This
prospectus contains or may contain forward-looking statements as defined in Section 27A of the Securities Act, and Section 21E of the
Exchange Act that involve significant risks and uncertainties. All statements other than statements of historical facts are forward-looking
statements. These forward-looking statements include information about our possible or assumed future results of operations or our performance.
These statements involve known and unknown risks, uncertainties and other factors, including those listed under “Risk Factors,”
and elsewhere in this prospectus that may cause our actual results, performance or achievements to be materially different from those
expressed or implied by the forward-looking statements.
In
some cases, these forward-looking statements can be identified by words and phrases such as “may,” “should,”
“intend,” “predict,” “potential,” “continue,” “will,” “expect,”
“anticipate,” “estimate,” “plan,” “believe,” “is /are likely to” or the negative
form of these words and phrases or other comparable expressions. The forward-looking statements included in this prospectus relate to,
among other things:
| ● | our
ability to maintain the listing of the Ordinary Shares and the Business Combination Warrants on a national securities exchange; |
|
● |
changes adversely affecting
the businesses in which we are engaged; |
|
● |
general economic conditions,
including changes in the credit, debit, securities, financial or capital markets; |
|
● |
the impact of adverse public
health developments on ADSE’s business and operations; |
|
● |
increased costs, disruption
of supply, or shortage of materials, could harm our business; |
|
● |
our ability to implement
business plans, operating models, forecasts, and other expectations and identify and realize additional business opportunities; |
|
● |
the result of future financing
efforts; |
|
● |
product liability lawsuits,
civil or damages claims or regulatory proceedings relating to our technology, intellectual property or products; |
|
● |
the impact of the military
action in Ukraine may affect our current and future operations in the European Union; |
|
● |
identified material weaknesses
in our internal control over financial reporting, which failure to remediate such material weaknesses in the future or to maintain
an effective system of internal control could impair our ability to comply with the financial reporting and internal controls requirements
for publicly traded companies; |
|
● |
changes to fuel economy
standards or the success of alternative fuels may negatively impact the EV market and thus the demand for our products and services; |
|
● |
changes to battery energy
storage standards or the success of alternative energy storage technologies may negatively impact the battery-energy storage market
and thus the demand for our products and services; |
|
● |
existing and future environmental
health and safety laws and regulations could result in increased compliance costs or additional operating costs or construction costs
and restrictions. Failure to comply with such laws and regulations may result in substantial fines or other limitations that may
adversely impact our financial results or results of operation; and |
|
● |
other factors discussed
in “Item 3. Key Information — D. Risk Factors” in our Annual Report on Form 20-F, filed with the SEC on
April 30, 2024 (the “Annual Report on Form 20-F”) and incorporated by reference herein. |
These
forward-looking statements involve various risks, assumptions and uncertainties. Although we believe that our expectations expressed
in these forward-looking statements are reasonable, our expectations may turn out to be incorrect. Our actual results could be materially
different from or worse than our expectations. You should read this prospectus and the documents that we refer to in this prospectus
with the understanding that our actual future results may be materially different from and worse than what we expect. Other sections
of this prospectus include additional factors which could adversely impact our business and financial performance. Moreover, we operate
in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for our management to
predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor,
or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
You
should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this prospectus
relate only to events or information as of the date on which the statements are made in this prospectus. All forward-looking statements
included herein attributable to us or other parties or any person acting on our behalf are expressly qualified in their entirety by the
cautionary statements contained or referred to in this section. We undertake no obligation to update or revise any forward-looking statements
whether as a result of new information, future events or otherwise, after the date of this prospectus or to reflect the occurrence of
unanticipated events, except as otherwise required by the U.S. federal securities laws.
USE
OF PROCEEDS
We
cannot assure you that we will receive any proceeds in connection with securities which may be offered pursuant to this prospectus. Unless
otherwise indicated in the applicable prospectus supplement, we intend to use any net proceeds from the sale of securities under this
prospectus for our operations and for other general corporate purposes, including, but not limited to, our internal research and development
programs and the development of new programs, general working capital and possible future acquisitions. We have not determined the amounts
we plan to spend on any of the areas listed above or the timing of these expenditures. As a result, our management will have broad discretion
to allocate the net proceeds, if any, we receive in connection with securities offered pursuant to this prospectus for any purpose. Pending
application of the net proceeds as described above, we may initially invest the net proceeds in short-term, investment-grade, interest-bearing
securities or apply them to the reduction of short-term indebtedness.
DIVIDEND
POLICY
We
have not paid any cash dividends on our Ordinary Shares to date. Our board of directors will consider whether or not to institute a dividend
policy. It is presently intended that we will retain our earnings for use in business operations and, accordingly, it is not anticipated
that our board of directors will declare dividends in the foreseeable future.
DESCRIPTION
OF SHARE CAPITAL
The
following description of the material terms of the share capital of ADSE Holdco includes a summary of specified provisions of ADSE Holdco’s
Memorandum and Articles of Association (“M&A”). This description is qualified by reference to ADSE Holdco’s M&A
and form of warrant, each of which has been filed as an exhibit to the registration statement of which this prospectus forms a part.
General
We
are a public limited company organized and existing under the laws of Ireland. We were formed on 26 July 2021 as a public limited company
under the name ADS-TEC ENERGY PLC. Our affairs are governed by our M&A, the Irish Companies Act and the corporate law of Ireland.
Our authorized share capital is (a) US$60,000 divided into (i) 500,000,000 Ordinary Shares, with a nominal value of US$0.0001 per share,
and (ii) 100,000,000 preferred shares, with a nominal value of US$0.0001 per share and (b) €25,000 divided into 25,000 deferred
ordinary shares with a nominal value of €1.00 per share, which are held by ADSE Holdco as treasury shares.
Ordinary
Shares
General.
As of February 10, 2025, there were 53,206,322 Ordinary Shares issued and outstanding. In addition, ADSE Holdco holds €25,000
worth of deferred ordinary shares in ADSE Holdco as treasury shares.
Dividends.
The holders of Ordinary Shares are entitled to such dividends as may be declared by our board of directors. Dividends may be
declared and paid out of the funds legally available therefor. Dividends may also be declared and paid out of share premium account or
any other fund or account which can be authorized for this purpose in accordance with the Irish Companies Act.
Voting
Rights. Each Ordinary Share shall be entitled to one vote on all matters subject to the vote at general meetings of the Company.
Voting at any meeting of shareholders is by way of a poll, which shall be taken in such manner as the chairperson of the meeting directs.
An
ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching
to the Ordinary Shares cast at a meeting, while a special resolution requires the affirmative vote of no less than 75% of the votes cast
attaching to the outstanding ordinary shares at a meeting. Where the shareholders wish to act by way of written resolution in lieu of
holding a meeting, unanimous consent of the holders of the Ordinary Shares shall be required. A special resolution will be required for
important matters such as a change of name, reducing the share capital or making changes to the M&A to be in effect.
Transfer
of Ordinary Shares. Subject to the restrictions contained in the Business Combination Agreement with respect to the ADSE Holdco
securities issued to the ADSE GM Shareholders in the Share-for-Share Exchange, the provisions of the Lock-Up Agreement, and subject to
any further restrictions contained in the M&A, any ADSE Holdco shareholder may transfer all or any of his or her Ordinary Shares
by an instrument of transfer in the usual or common form or any other form approved by ADSE Holdco’s board of directors from time
to time.
Liquidation.
On a return of capital on winding-up or otherwise (other than on conversion, redemption or purchase of ordinary shares), assets
available for distribution among the holders of Ordinary Shares shall be distributed among the holders thereof on a pro rata basis. If
ADSE Holdco’s assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed
so that, as nearly as may be, the losses are borne by ADSE Holdco’s shareholders proportionately.
General
Meetings of Shareholders. Shareholders’ meetings may be convened by the board of directors, by the board of directors on
the requisition of the shareholders or, if the board of directors fails to so convene a meeting, such extraordinary general meeting may
be convened by the requisitioning shareholders where the requisitioning shareholders hold not less than 10% of the paid up share capital
of ADSE Holdco. Any action required or permitted to be taken at any annual or extraordinary general meetings may be taken only upon the
vote of the shareholders at an annual or extraordinary general meeting duly noticed and convened in accordance with the M&A and the
Irish Companies Act. Unanimous consent of the holders of the Ordinary Shares shall be required before the shareholders may act by way
of written resolution without a meeting.
Preferred
Shares
ADSE
Holdco is authorized to issue 100,000,000 preferred shares with a nominal value of US$0.0001 each. As of the date of this prospectus,
there are no preference shares issued or outstanding. If issued, the preference shares will have such rights and preferences as determined
by our board of directors in accordance with the Irish Companies Act, our M&A, and as set forth in the terms of issue for the shares.
The following outlines some of the general terms and provisions of preference shares that we may issue from time to time. Additional
or different terms of the preference shares will be set forth in the applicable prospectus supplement.
We
will file as an exhibit to the registration statement of which this prospectus forms a part, or will incorporate by reference from reports
that we file with the SEC, the form of any subscription agreement that describes the terms of the issue of preference shares we are offering
before the issuance of the preference shares. The summaries of material provisions of the preference shares are subject to, and qualified
in their entirety by reference to, the Irish Companies Act, all of the provisions of our M&A and the subscription agreement applicable
to a particular issue of preference shares. We urge you to read the applicable prospectus supplements, as well as the complete agreement
and M&A that contains the terms of the issue of preference shares.
General.
We may issue preference shares including preference shares which are, at the option of us or holder, liable to be redeemed or, at the
option of the holders of shares of such series, liable to be converted into shares of any other class or classes or of any one or more
series of the same class or of another class or classes. Each preference share may confer on the holder a number of rights, including
but not limited to (i) receive a preferential dividend, in priority to the payment of any dividend on the ordinary shares, at a rate
(which may be fixed or variable) and on the basis (including whether cumulative or not) decided by the directors at the time of issue;
(ii) in a winding up and on redemption, payment in priority to the ordinary shares of: (A) the amount of any dividend accrued but unpaid
on the share at the date of winding up or the date of redemption; and (B) any additional amount specified in the terms of issue; and
(iii) vote at any general meeting.
The
prospectus supplement relating to a particular issue of preference shares will describe the terms of that issue of preference shares
and the price or prices at which we will offer the shares of that issue of preference shares. The description may include:
| ● | the
title of the issue of preference shares and the number of shares offered; |
| ● | the
preferential dividend rate, the terms and conditions relating to the payment of dividends on the preference shares; |
| ● | whether
the preference shares are redeemable, and the terms and conditions relating to any such redemption; |
| ● | whether
the preference shares are convertible into ordinary shares, and the terms and conditions relating to any such conversion; and |
| ● | any
liquidation preference of the preference shares. |
Voting
Rights. Before issuance, the board of directors of ADSE Holdco can fix in the resolution(s) providing for the issue of the preference
shares of each particular series the voting rights, full or limited, if any, of the shares of such series; and whether or not and under
what conditions the shares of such series (alone or together with the shares of one or more other series having similar provisions) shall
be entitled to vote separately as a single class, for the election of one or more additional directors of ADSE Holdco in case of dividend
arrears or other specified events, or upon other matters. On each matter on which holders of preference shares are entitled to vote,
each preference share will be entitled to one vote, or will be entitled to the number of votes specified in the terms of issue for the
share.
Dividend
Rights. Holders of our preference shares may be entitled to receive a preferential dividend, in priority to the payment of any
dividend on the ordinary shares, at a rate (which may be fixed or variable) and on the basis (including whether cumulative or not) decided
by our board of directors at the time of issue.
Indemnification
of Directors and Officers
Pursuant
to ADSE Holdco’s M&A, subject to the provisions of and so far as may be permitted by the Irish Companies Act, every director,
officer or employee of ADSE Holdco, and each person who is or was serving at the request of ADSE Holdco as a director, officer or employee
of another company, or of a partnership, joint venture, trust or other enterprise, shall be entitled to be indemnified by ADSE Holdco
against all costs, charges, losses, expenses and liabilities incurred by him or her in the execution and discharge of his or her duties
or in relation thereto, including any liability incurred by him or her in defending any proceedings, civil or criminal, which relate
to anything done or omitted or alleged to have been done or omitted by him or her as a director, officer or employee of ADSE Holdco or
such other company, partnership, joint venture, trust or other enterprise, and in which judgment is given in his or her favor (or the
proceedings are otherwise disposed of without any finding or admission of any material breach of duty on his or her part) or in which
he or she is acquitted or in connection with any application under any statute for relief from liability in respect of any such act or
omission in which relief is granted to him or her by the court.
The
Irish Companies Act prescribes that such an indemnity only permits a company to pay the costs or discharge the liability of a director
or the secretary where judgment is given in any civil or criminal action in respect of such costs or liability, or where an Irish court
grants relief because the director or secretary acted honestly and reasonably and ought fairly to be excused.
ADSE
Holdco is permitted under its M&A and the Irish Companies Act to purchase directors’ and officers’ liability insurance,
as well as other types of insurance, for its directors, officers and employees.
ADSE
Holdco has entered into deeds of indemnity with its directors and ADSE GM executive officers. Given the director indemnification limitations
arising under Irish law, ADSE Holdco’s subsidiary, ADSE GM and ADSE GM’s subsidiary, ads-tec Energy, Inc. have also entered
into such deeds of indemnity. These agreements, among other things, require ADSE to jointly and severally indemnify ADSE Holdco’s
directors and ADSE directors and executive officers for certain expenses, including attorneys’ fees, judgments, fines and settlement
amounts incurred by any such director or executive officer in any action or proceeding arising out of their services as one of ADSE directors
or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services
at ADSE’s request. We believe that these indemnification deeds are necessary to attract and retain qualified persons as directors
and officers.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the
registrant pursuant to the foregoing provisions, the registrant has been informed that in the opinion of the SEC such indemnification
is against public policy as expressed in the Securities Act and is therefore unenforceable.
Transfer
Agent, Warrant Agent and Registrar
ADSE
Holdco’s transfer agent and warrant agent for the Business Combination Warrants is Continental Stock Transfer & Trust Company.
ADSE Holdco’s registrar is Link Group.
Listing
of Securities
Our
Ordinary Shares and the Business Combination Warrants are listed on Nasdaq under the symbols “ADSE” and “ADSEW,”
respectively. Holders of our securities should obtain current market quotations for their securities. There can be no assurance that
our Ordinary Shares will remain listed on Nasdaq. If we fail to comply with the Nasdaq listing requirements, our Ordinary Shares and/or
warrants could be delisted from Nasdaq. A delisting of our Ordinary Shares and warrants will likely affect the liquidity of our Ordinary
Shares and warrants and could inhibit or restrict our ability to raise additional financing.
DESCRIPTION
OF DEBT SECURITIES
The
following description, together with the additional information we include in any applicable prospectus supplements, summarizes the material
terms and provisions of the debt securities that we may offer under this prospectus. While the terms we have summarized below will apply
generally to any future debt securities we may offer pursuant to this prospectus, we will describe the particular terms of any debt securities
that we may offer in more detail in the applicable prospectus supplement. If we so indicate in a prospectus supplement, the terms of
any debt securities offered under such prospectus supplement may differ from the terms we describe below, and to the extent the terms
set forth in a prospectus supplement differ from the terms described below, the terms set forth in the prospectus supplement shall control.
We
may sell from time to time, in one or more offerings under this prospectus, debt securities, which may be senior or subordinated. We
will issue any such senior debt securities under a senior indenture that we will enter into with a trustee to be named in the senior
indenture. We will issue any such subordinated debt securities under a subordinated indenture, which we will enter into with a trustee
to be named in the subordinated indenture. We use the term "indentures" to refer to either the senior indenture or the subordinated
indenture, as applicable. The indentures will be qualified under the Trust Indenture Act of 1939, as in effect on the date of the indenture.
We use the term "debenture trustee" to refer to either the trustee under the senior indenture or the trustee under the subordinated
indenture, as applicable.
Certain
of our subsidiaries may guarantee the debt securities we offer. Those guarantees may or may not be secured by liens, mortgages, and security
interests in the assets of those subsidiaries. The terms and conditions of any such subsidiary guarantees, and a description of any such
liens, mortgages or security interests, will be set forth in the prospectus supplement that will accompany this prospectus.
The
following summaries of material provisions of the senior debt securities, the subordinated debt securities and the indentures are subject
to, and qualified in their entirety by reference to, all the provisions of the indenture applicable to a particular series of debt securities.
General
Each
indenture will provide that debt securities may be issued from time to time in one or more series and may be denominated and payable
in foreign currencies or units based on or relating to foreign currencies. Neither indenture will limit the amount of debt securities
that may be issued thereunder, and each indenture will provide that the specific terms of any series of debt securities shall be set
forth in, or determined pursuant to, an authorizing resolution and/or a supplemental indenture, if any, relating to such series.
We
will describe in each prospectus supplement the following terms relating to a series of debt securities:
| ● | the
title or designation; |
| ● | the
aggregate principal amount and any limit on the amount that may be issued; |
| ● | the
currency or units based on or relating to currencies in which debt securities of such series
are denominated and the currency or units in which principal or interest or both will or
may be payable; |
| ● | whether
we will issue the series of debt securities in global form, the terms of any global securities
and who the depositary will be; |
| ● | the
maturity date and the date or dates on which principal will be payable; |
| ● | the
interest rate, which may be fixed or variable, or the method for determining the rate and
the date interest will begin to accrue, the date or dates interest will be payable and the
record dates for interest payment dates or the method for determining such dates; |
| ● | whether
or not the debt securities will be secured or unsecured, and the terms of any secured debt; |
| ● | the
terms of the subordination of any series of subordinated debt; |
| ● | the
place or places where payments will be payable; |
| ● | our
right, if any, to defer payment of interest and the maximum length of any such deferral period; |
| ● | the
date, if any, after which, and the price at which, we may, at our option, redeem the series
of debt securities pursuant to any optional redemption provisions; |
| ● | the
date, if any, on which, and the price at which we are obligated, pursuant to any mandatory
sinking fund provisions or otherwise, to redeem, or at the holder's option to purchase, the
series of debt securities; |
| ● | whether
the indenture will restrict our ability to pay dividends, or will require us to maintain
any asset ratios or reserves; |
| ● | whether
we will be restricted from incurring any additional indebtedness; |
| ● | a
discussion on any material or special U.S. federal income tax considerations applicable to
a series of debt securities; |
| ● | the
denominations in which we will issue the series of debt securities, if other than denominations
of $1,000 and any integral multiple thereof; and |
| ● | any
other specific terms, preferences, rights or limitations of, or restrictions on, the debt
securities. |
We
may issue debt securities that provide for an amount less than their stated principal amount to be due and payable upon declaration of
acceleration of their maturity pursuant to the terms of the indenture. We will provide you with information on the federal income tax
considerations and other special considerations applicable to any of these debt securities in the applicable prospectus supplement.
Conversion
or Exchange Rights
We
will set forth in the prospectus supplement the terms, if any, on which a series of debt securities may be convertible into or exchangeable
for our ordinary shares or our other securities. We will include provisions as to whether conversion or exchange is mandatory, at the
option of the holder or at our option. We may include provisions pursuant to which the number of ordinary shares or our other securities
that the holders of the series of debt securities receive would be subject to adjustment.
Information
Concerning the Debenture Trustee
The
debenture trustee, other than during the occurrence and continuance of an event of default under the applicable indenture, undertakes
to perform only those duties as are specifically set forth in the applicable indenture. Upon an event of default under an indenture,
the debenture trustee under such indenture must use the same degree of care as a prudent person would exercise or use in the conduct
of his or her own affairs. Subject to this provision, the debenture trustee is under no obligation to exercise any of the powers given
it by the indentures at the request of any holder of debt securities unless it is offered reasonable security and indemnity against the
costs, expenses and liabilities that it might incur.
Payment
and Paying Agents
Unless
we otherwise indicate in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest
payment date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business
on the regular record date for the interest.
We
will pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agents designated
by us, except that unless we otherwise indicate in the applicable prospectus supplement, we will make interest payments by check which
we will mail to the holder. Unless we otherwise indicate in a prospectus supplement, we will designate the corporate trust office of
the debenture trustee in the City of New York as our sole paying agent for payments with respect to debt securities of each series. We
will name in the applicable prospectus supplement any other paying agents that we initially designate for the debt securities of a particular
series. We will maintain a paying agent in each place of payment for the debt securities of a particular series.
All
money we pay to a paying agent or the debenture trustee for the payment of the principal of or any premium or interest on any debt securities
which remains unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to
us, and the holder of the security thereafter may look only to us for payment thereof.
Governing
Law
The
indentures and the debt securities will be governed by and construed in accordance with the laws of the State of New York, except to
the extent that the Trust Indenture Act is applicable.
Subordination
of Subordinated Debt Securities
Our
obligations pursuant to any subordinated debt securities will be unsecured and will be subordinate and junior in priority of payment
to certain of our other indebtedness to the extent described in a prospectus supplement. The subordinated indenture does not limit the
amount of senior indebtedness we may incur. It also does not limit us from issuing any other secured or unsecured debt.
DESCRIPTION
OF WARRANTS
General
We
may issue warrants to purchase ordinary shares, preferred shares and/or debt securities. We may offer warrants separately or together
with one or more additional warrants, debt securities, ordinary shares, preferred shares, rights or purchase contracts, or any combination
of those securities in the form of units, as described in the applicable prospectus supplement. Each series of warrants will be issued
under a separate warrant agreement to be entered into between us and a bank or trust company, as warrant agent. The warrant agent will
act solely as our agent in connection with the certificates relating to the rights of the series of certificates and will not assume
any obligation or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights. The
following description sets forth certain general terms and provisions of the rights to which any prospectus supplement may relate. The
particular terms of the warrant to which any prospectus supplement may relate and the extent, if any, to which the general provisions
may apply to the rights so offered will be described in the applicable prospectus supplement. To the extent that any particular terms
of the warrant, warrant agreement or warrant certificates described in a prospectus supplement differ from any of the terms described
below, then the terms described below will be deemed to have been superseded by that prospectus supplement. We encourage you to read
the applicable warrant agreement and warrant certificate for additional information before you decide whether to purchase any of our
rights.
We
will provide in a prospectus supplement the following terms of the warrants being issued:
| ● | the
specific designation and aggregate number of, and the price at which we will issue, the warrants; |
| ● | the
currency or currency units in which the offering price, if any, and the exercise price are
payable; |
| ● | the
designation, amount and terms of the securities purchasable upon exercise of the warrants; |
| ● | if
applicable, the exercise price for ordinary shares and the number of ordinary shares to be
received upon exercise of the warrants; |
| ● | if
applicable, the exercise price for preferred shares, the number of preferred shares to be
received upon exercise, and a description of that series of our preferred shares; |
| ● | if
applicable, the exercise price for our debt securities, the amount of debt securities to
be received upon exercise, and a description of that series of debt securities; |
| ● | the
date on which the right to exercise the warrants will begin and the date on which that right
will expire or, if you may not continuously exercise the warrants throughout that period,
the specific date or dates on which you may exercise the warrants; |
| ● | whether
the warrants will be issued in fully registered form or bearer form, in definitive or global
form or in any combination of these forms, although, in any case, the form of a warrant included
in a unit will correspond to the form of the unit and of any security included in that unit; |
| ● | any
applicable material U.S. federal income tax consequences; |
| ● | the
identity of the warrant agent for the warrants and of any other depositaries, execution or
paying agents, transfer agents, registrars or other agents; |
| ● | the
proposed listing, if any, of the warrants or any securities purchasable upon exercise of
the warrants on any securities exchange; |
| ● | if
applicable, the date from and after which the warrants and the ordinary shares, preferred
shares and/or debt securities will be separately transferable; |
| ● | if
applicable, the minimum or maximum amount of the warrants that may be exercised at any one
time; |
| ● | information
with respect to book-entry procedures, if any; |
| ● | the
anti-dilution provisions of the warrants, if any; |
| ● | any
redemption or call provisions; |
| ● | whether
the warrants may be sold separately or with other securities as parts of units; and |
| ● | any
additional terms of the warrants, including terms, procedures and limitations relating to
the exchange and exercise of the warrants. |
Each
warrant will entitle the holder of rights to purchase for cash the principal amount of ordinary shares or other securities at the exercise
price provided in the applicable prospectus supplement. Warrants may be exercised at any time up to the close of business on the expiration
date for the rights provided in the applicable prospectus supplement.
Holders
may exercise warrants as described in the applicable prospectus supplement. Upon receipt of payment and the warrant certificate properly
completed and duly executed at the corporate trust office of the rights agent or any other office indicated in the prospectus supplement,
we will, as soon as practicable, forward the ordinary shares, preferred shares or other securities, as applicable, purchasable upon exercise
of the rights. If less than all of the warrants issued in any rights offering are exercised, we may offer any unsubscribed securities
directly to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods,
including pursuant to standby arrangements, as described in the applicable prospectus supplement.
Warrant
Agent
The
warrant agent for any warrants we offer will be set forth in the applicable prospectus supplement.
DESCRIPTION
OF RIGHTS
General
We
may issue rights to purchase ordinary shares, preferred shares, and/or debt securities described in this prospectus. We may offer rights
separately or together with one or more additional rights, ordinary shares, preferred shares, debt securities, warrants or purchase contracts,
or any combination of those securities in the form of units, as described in the applicable prospectus supplement. Each series of rights
will be issued under a separate rights agreement to be entered into between us and a bank or trust company, as rights agent. The rights
agent will act solely as our agent in connection with the certificates relating to the rights of the series of certificates and will
not assume any obligation or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights.
The following description sets forth certain general terms and provisions of the rights to which any prospectus supplement may relate.
The particular terms of the rights to which any prospectus supplement may relate and the extent, if any, to which the general provisions
may apply to the rights so offered will be described in the applicable prospectus supplement. To the extent that any particular terms
of the rights, rights agreement or rights certificates described in a prospectus supplement differ from any of the terms described below,
then the terms described below will be deemed to have been superseded by that prospectus supplement. We encourage you to read the applicable
rights agreement and rights certificate for additional information before you decide whether to purchase any of our rights.
We
will provide in a prospectus supplement the following terms of the rights being issued:
| ● | the
date of determining the shareholders entitled to the rights distribution; |
| ● | the
aggregate number of ordinary shares or other securities purchasable upon exercise of the rights; |
| ● | the
aggregate number of rights issued; |
| ● | whether
the rights are transferrable and the date, if any, on and after which the rights may be separately transferred; |
| ● | the
date on which the right to exercise the rights will commence, and the date on which the right to exercise the rights will expire; |
| ● | the
method by which holders of rights will be entitled to exercise; |
| ● | the
conditions to the completion of the offering, if any; |
| ● | the
withdrawal, termination and cancellation rights, if any; |
| ● | whether
there are any backstop or standby purchaser or purchasers and the terms of their commitment, if any; |
| ● | whether
shareholders are entitled to oversubscription rights, if any; |
| ● | any
applicable U.S. federal income tax considerations; and |
| ● | any
other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the rights,
as applicable. |
Each
right will entitle the holder of rights to purchase for cash the principal amount of ordinary shares or other securities at the exercise
price provided in the applicable prospectus supplement. Rights may be exercised at any time up to the close of business on the expiration
date for the rights provided in the applicable prospectus supplement.
Holders
may exercise rights as described in the applicable prospectus supplement. Upon receipt of payment and the rights certificate properly
completed and duly executed at the corporate trust office of the rights agent or any other office indicated in the prospectus supplement,
we will, as soon as practicable, forward the ordinary shares or other securities, as applicable, purchasable upon exercise of the rights.
If less than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons
other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to
standby arrangements, as described in the applicable prospectus supplement.
Rights
Agent
The
rights agent for any rights we offer will be set forth in the applicable prospectus supplement.
DESCRIPTION
OF PURCHASE CONTRACTS
We
may issue purchase contracts, including contracts obligating holders to purchase from us, and for us to sell to holders, a specific or
variable number of our ordinary shares, preferred shares, debt securities, warrants or rights, or securities of an entity unaffiliated
with us, or any combination of the above, as described in the applicable prospectus supplement. Alternatively, the purchase contracts
may obligate us to purchase from holders, and obligate holders to sell to us, a specific or variable number of our ordinary shares, preferred
shares, debt securities, warrants, rights or other property, or any combination of the above. The price of the securities or other property
subject to the purchase contracts may be fixed at the time the purchase contracts are issued or may be determined by reference to a specific
formula described in the purchase contracts. We may issue purchase contracts separately or as a part of units each consisting of a purchase
contract and one or more of our other securities described in this prospectus or securities of third parties, securing the holder's obligations
under the purchase contract. The purchase contracts may require us to make periodic payments to holders or vice versa and the payments
may be unsecured or pre-funded on some basis. The purchase contracts may require holders to secure the holder's obligations in a manner
specified in the applicable prospectus supplement.
The
applicable prospectus supplement will describe the terms of any purchase contracts in respect of which this prospectus is being delivered,
including, to the extent applicable, the following:
| ● | whether
the purchase contracts obligate the holder or us to purchase or sell, or both purchase and sell, the securities subject to purchase under
the purchase contract, and the nature and amount of each of those securities, or the method of determining those amounts; |
| ● | whether
the purchase contracts are to be prepaid; |
| ● | whether
the purchase contracts are to be settled by delivery, or by reference or linkage to the value, performance or level of the securities
subject to purchase under the purchase contract; |
| ● | any
acceleration, cancellation, termination or other provisions relating to the settlement of the purchase contracts; |
| ● | any
applicable U.S. federal income tax considerations; and |
| ● | whether
the purchase contracts will be issued in fully registered or global form. |
The
preceding description sets forth certain general terms and provisions of the purchase contracts to which any prospectus supplement may
relate. The particular terms of the purchase contracts to which any prospectus supplement may relate and the extent, if any, to which
the general provisions may apply to the purchase contracts so offered will be described in the applicable prospectus supplement. To the
extent that any particular terms of the purchase contracts described in a prospectus supplement differ from any of the terms described
above, then the terms described above will be deemed to have been superseded by that prospectus supplement. We encourage you to read
the applicable purchase contract for additional information before you decide whether to purchase any of our purchase contracts.
DESCRIPTION
OF UNITS
The
following description, together with the additional information that we include in any applicable prospectus supplements summarizes the
material terms and provisions of the units that we may offer under this prospectus. While the terms we have summarized below will apply
generally to any units that we may offer under this prospectus, we will describe the particular terms of any series of units in more
detail in the applicable prospectus supplement. The terms of any units offered under a prospectus supplement may differ from the terms
described below.
We
will incorporate by reference from reports that we file with the SEC, the form of unit agreement that describes the terms of the series
of units we are offering, and any supplemental agreements, before the issuance of the related series of units. The following summaries
of material terms and provisions of the units are subject to, and qualified in their entirety by reference to, all the provisions of
the unit agreement and any supplemental agreements applicable to a particular series of units. We urge you to read the applicable prospectus
supplements related to the particular series of units that we may offer under this prospectus, as well as any related free writing prospectuses
and the complete unit agreement and any supplemental agreements that contain the terms of the units.
General
We
may issue units consisting of ordinary shares, preferred shares, one or more debt securities, warrants, rights or purchase contracts
for the purchase of ordinary shares, preferred shares and/or debt securities in one or more series, in any combination. Each unit will
be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have
the rights and obligations of a holder of each security included in the unit. The unit agreement under which a unit is issued may provide
that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date.
We
will describe in the applicable prospectus supplement the terms of the series of units being offered, including:
| ● | the
designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities
may be held or transferred separately; |
| ● | any
provisions of the governing unit agreement that differ from those described below; and |
| ● | any
provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units. |
The
provisions described in this section, as well as those set forth in any prospectus supplement or as described under "Description
of Capital Stock," "Description of Debt Securities," "Description of Warrants," "Description of Rights"
and "Description of Purchase Contracts" will apply to each unit, as applicable, and to any ordinary shares, preferred shares,
debt security, warrant, right or purchase contract included in each unit, as applicable.
Unit
Agent
The
name and address of the unit agent for any units we offer will be set forth in the applicable prospectus supplement.
Issuance
in Series
We
may issue units in such amounts and in such numerous distinct series as we determine.
Enforceability
of Rights by Holders of Units
Each
unit agent will act solely as our agent under the applicable unit agreement and will not assume any obligation or relationship of agency
or trust with any holder of any unit. A single bank or trust company may act as unit agent for more than one series of units. A unit
agent will have no duty or responsibility in case of any default by us under the applicable unit agreement or unit, including any duty
or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a unit may, without the
consent of the related unit agent or the holder of any other unit, enforce by appropriate legal action its rights as holder under any
security included in the unit.
PLAN
OF DISTRIBUTION
General
Plan of Distribution
We
may offer securities under this prospectus from time to time pursuant to underwritten public offerings, negotiated transactions, block
trades or a combination of these methods. We may sell the securities (1) through underwriters or dealers, (2) through agents, including
"at the market" offerings within the meaning of Rule 415(a)(4) under the Securities Act, or (3) directly to one or more purchasers,
or through a combination of such methods. We may distribute the securities from time to time in one or more transactions at:
| ● | a
fixed price or prices, which may be changed from time to time; |
| ● | market
prices prevailing at the time of sale; |
| ● | prices
related to the prevailing market prices; or |
We
may directly solicit offers to purchase the securities being offered by this prospectus. We may also designate agents to solicit offers
to purchase the securities from time to time. We will name in a prospectus supplement any underwriter or agent involved in the offer
or sale of the securities.
If
we utilize a dealer in the sale of the securities being offered by this prospectus, we will sell the securities to the dealer, as principal.
The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.
If
we utilize an underwriter in the sale of the securities being offered by this prospectus, we will execute an underwriting agreement with
the underwriter at the time of sale, and we will provide the name of any underwriter in the prospectus supplement which the underwriter
will use to make re-sales of the securities to the public. In connection with the sale of the securities, we, or the purchasers of the
securities for whom the underwriter may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions.
The underwriter may sell the securities to or through dealers, and the underwriter may compensate those dealers in the form of discounts,
concessions or commissions.
With
respect to underwritten public offerings, negotiated transactions and block trades, we will provide in the applicable prospectus supplement
information regarding any compensation we pay to underwriters, dealers or agents in connection with the offering of the securities, and
any discounts, concessions or commissions allowed by underwriters to participating dealers. Underwriters, dealers and agents participating
in the distribution of the securities may be deemed to be underwriters within the meaning of the Securities Act, and any discounts and
commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and
commissions. We may enter into agreements to indemnify underwriters, dealers and agents against civil liabilities, including liabilities
under the Securities Act, or to contribute to payments they may be required to make in respect thereof.
If
so indicated in the applicable prospectus supplement, we will authorize underwriters or other persons acting as our agents to solicit
offers by certain institutions to purchase securities from us pursuant to delayed delivery contracts providing for payment and delivery
on the date stated in the prospectus supplement. Each contract will be for an amount not less than, and the aggregate amount of securities
sold pursuant to such contracts shall not be less nor more than, the respective amounts stated in the prospectus supplement. Institutions
with whom the contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment
companies, educational and charitable institutions and other institutions, but shall in all cases be subject to our approval. Delayed
delivery contracts will not be subject to any conditions except that:
| ● | the
purchase by an institution of the securities covered under that contract shall not at the
time of delivery be prohibited under the laws of the jurisdiction to which that institution
is subject; and |
| ● | if
the securities are also being sold to underwriters acting as principals for their own account,
the underwriters shall have purchased such securities not sold for delayed delivery. The
underwriters and other persons acting as our agents will not have any responsibility in respect
of the validity or performance of delayed delivery contracts. |
Ordinary
shares sold pursuant to the registration statement of which this prospectus is a part will be authorized for quotation and trading on
the Nasdaq, the over-the-counter market or on any other national securities exchange on which our ordinary shares are then listed or
traded. The applicable prospectus supplement will contain information, where applicable, as to any other listing, if any, on the Nasdaq
or any securities market or other securities exchange of the securities covered by the prospectus supplement. We can make no assurance
as to the liquidity of or the existence of trading markets for any of the securities.
In
order to facilitate the offering of the securities, certain persons participating in the offering may engage in transactions that stabilize,
maintain or otherwise affect the price of the securities. This may include over-allotments or short sales of the securities, which involve
the sale by persons participating in the offering of more securities than we sold to them. In these circumstances, these persons would
cover such over-allotments or short positions by making purchases in the open market or by exercising their over-allotment option. In
addition, these persons may stabilize or maintain the price of the securities by bidding for or purchasing the applicable security in
the open market or by imposing penalty bids, whereby selling concessions allowed to dealers participating in the offering may be reclaimed
if the securities sold by them are repurchased in connection with stabilization transactions. The effect of these transactions may be
to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market. These
transactions may be discontinued at any time.
The
underwriters, dealers and agents may engage in other transactions with us, or perform other services for us, in the ordinary course of
their business. Underwriters, dealers, agents and other persons may be entitled under agreements which may be entered into with us to
indemnification against and contribution toward certain civil liabilities, including liabilities under the Securities Act, and to be
reimbursed by us for certain expenses.
Any
securities initially sold outside the U.S. may be resold in the U.S. through underwriters, dealers or otherwise.
Any
underwriters to which offered securities are sold by us for public offering and sale may make a market in such securities, but those
underwriters will not be obligated to do so and may discontinue any market making at any time.
The
anticipated date of delivery of the securities offered by this prospectus will be described in the applicable prospectus supplement relating
to the offering.
In
compliance with the guidelines of the Financial Industry Regulatory Authority (“FINRA”), the aggregate maximum discount,
commission, agency fees or other items constituting underwriting compensation to be received by any FINRA member or independent broker-dealer
will not exceed 8% of the offering proceeds from any offering pursuant to this prospectus and any applicable prospectus supplement.
No
FINRA member may participate in any offering of securities made under this prospectus if such member has a conflict of interest under
FINRA Rule 5121, including if 5% or more of the net proceeds, not including underwriting compensation, of any offering of securities
made under this prospectus will be received by a FINRA member participating in the offering or affiliates or associated persons of such
FINRA members, unless a qualified independent underwriter has participated in the offering or the offering otherwise complies with FINRA
Rule 5121.
To
comply with the securities laws of some states, if applicable, the securities may be sold in these jurisdictions only through registered
or licensed brokers or dealers. In addition, in some states the securities may not be sold unless they have been registered or qualified
for sale or an exemption from registration or qualification requirements is available and is complied with.
TAXATION
The
material Irish and U.S. federal income tax consequences relating to the purchase, ownership and disposition of any shelf securities offered
by the prospectus will be set forth in the applicable prospectus supplement.
LEGAL
MATTERS
The
validity of the ordinary shares to be offered by this prospectus and certain other legal matters relating to Irish law have been passed
upon by Arthur Cox, LLP, Dublin, Ireland. Certain matters of U.S. federal and New York State law will be passed upon for us by Reed Smith
LLP, New York, New York. Any underwriters or agents will be advised about other issues relating to the offering by counsel to be named
in the applicable prospectus supplement.
EXPERTS
The
consolidated financial statements of ADSE as of December 31, 2023 and 2022 and for each of the three years in the period ended December
31, 2023 incorporated by reference in this Prospectus and in the Registration Statement have been so included in reliance on the report
of BDO AG Wirtschaftsprüfungsgesellschaft, an independent registered public accounting firm, given on the authority of said firm
as experts in auditing and accounting. The report on the consolidated financial statements contains an explanatory paragraph regarding
the Company’s ability to continue as a going concern.
ENFORCEMENT
OF CIVIL LIABILITIES
Certain
of our directors and executive officers may be nonresidents of the United States. All or a substantial portion of the assets of such
nonresident persons and of our company are located outside the United States. As a result, it may not be possible to effect service of
process within the United States upon such persons or our company, or to enforce against such persons or us in U.S. Courts judgments
obtained in such courts predicated upon the civil liability provisions of the federal securities laws of the United States. We have been
advised by our Irish counsel that there is doubt as to the enforceability in Ireland against our company and our executive officers and
directors who are non-residents of the United States, in original actions or in actions for enforcement of judgments of U.S. Courts,
of liabilities predicated solely upon the securities laws of the United States.
WHERE
YOU CAN FIND MORE INFORMATION
We
have filed with the SEC a registration statement (including exhibits to the registration statement) on Form F-3 under the Securities
Act. This prospectus, which is part of the registration statement, does not contain all of the information set forth in the registration
statement and the exhibits and schedules to the registration statement. For further information, we refer you to the registration statement
and the exhibits and schedules filed as part of the registration statement. If a document has been filed as an exhibit to the registration
statement, we refer you to the copy of the document that has been filed. Each statement in this prospectus relating to a document filed
as an exhibit is qualified in all respects by the filed exhibit. We are subject to the informational requirements of the Exchange Act
that are applicable to foreign private issuers. Accordingly, we are required to file or furnish reports and other information with the
SEC, including annual reports on Form 20-F and reports on Form 6-K. The SEC maintains an Internet website that contains reports and other
information regarding issuers that file electronically with the SEC. Our filings with the SEC are available to the public through the
SEC’s website at http://www.sec.gov. As a foreign private issuer, we are exempt under the Exchange Act from, among other things,
the rules prescribing the furnishing and content of proxy statements, and our executive officers, directors and principal and selling
securityholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.
In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently
or as promptly as U.S. companies whose securities are registered under the Exchange Act. We maintain a corporate website at https://adstec-energy.com/.
Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus. We have included
our website address in this prospectus solely for informational purposes.
DOCUMENTS
INCORPORATED BY REFERENCE
The
SEC allows the Company to “incorporate by reference” into this prospectus the information we file with or furnish to the
SEC, which means that the Company can disclose important information to you by referring you to those documents. The Company hereby incorporates
by reference in this prospectus the documents listed below and all amendments or supplements we may file to such documents:
|
● |
the Company’s Annual
Report on Form 20-F filed
with the SEC on April 30, 2024; |
|
● |
any future filings on Form
20-F made with the SEC under the Exchange Act after the date of this prospectus and prior to the termination of the offering of the
securities offered by this prospectus; |
|
● |
the Company’s reports
of foreign private issuer on Form 6-K or Form 6-K/A (each, a “Form 6-K”) furnished to the SEC on February
8, 2024, March 14,
2024, April 29, 2024,
April 30, 2024, May
14, 2024, August 30, 2024,
September 4, 2024, September
13, 2024, and October 18
2024; |
|
● |
any future reports on Form
6-K that we furnish to the SEC after the date of this prospectus that are identified in such reports as being incorporated by reference
in this prospectus; and |
|
● |
the description of the
securities contained in our registration statement on Form
8-A filed on December 22, 2021 pursuant to Section 12 of the Exchange Act, together with all amendments and reports filed for
the purpose of updating that description. |
All
documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act and, to the extent
specifically designated therein, Form 6-K’s, in each case, after the date of the initial registration statement of which this prospectus
is a part and prior to the effectiveness of the registration statement, as well as prior to the completion or termination of the offering
of securities under this prospectus, shall be deemed to be incorporated by reference in this prospectus and to be a part hereof from
the date of filing or furnishing of such documents.
Any
statement contained herein or in a document, all or a portion of which is incorporated or deemed to be incorporated by reference herein,
shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in any
other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.
Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.
Notwithstanding
the foregoing, no information is incorporated by reference in this prospectus or any prospectus supplement hereto where such information
under applicable forms and regulations of the SEC is not deemed to be “filed” under Section 18 of the Exchange Act or otherwise
subject to the liabilities of that section, unless the report or filing containing such information indicates that the information therein
is to be considered “filed” under the Exchange Act or is to be incorporated by reference in this prospectus or any prospectus
supplement hereto.
We
will provide to each person, including any beneficial owner, to whom this prospectus is delivered, a copy of any or all the reports or
documents incorporated by reference in this prospectus, at no cost to the requester, upon written or oral request to us at the following
address: ADS-TEC Energy PLC, 10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland.
ADS-TEC
ENERGY PUBLIC LIMITED COMPANY
$250,000,000
ORDINARY
SHARES
PREFERRED SHARES
DEBT SECURITIES
WARRANTS
RIGHTS
PURCHASE CONTRACTS
UNITS
PROSPECTUS
,
2025
The
information in this prospectus is not complete and may be changed. Neither we nor the selling securityholders may sell these securities
until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell
these securities and we are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT
TO COMPLETION, DATED February 11, 2025
PROSPECTUS
ADS-TEC
ENERGY PLC
Up
to 10,516,670 Ordinary Shares Issuable Upon Exercise of Warrants
This
prospectus relates to the offer and sale from time to time by the selling securityholders identified in this prospectus or their permitted
transferees (the “selling securityholders”), of up to 10,516,670 of our ordinary shares, nominal value US$0.0001 per share
(“Ordinary Shares”), which consists of up to (i) 1,716,667 Ordinary Shares issuable upon exercise of the warrants to purchase
Ordinary Shares, dated May 5, 2023, with an exercise price of $3.00 per share (the “May Warrants”), (ii) 4,000,001 Ordinary
Shares issuable upon exercise of the warrants to purchase Ordinary Shares, dated August 18, 2023 and amended on August 26, 2024, with
an exercise price of $6.20 per share (the “August Warrants”) and (iii) 4,800,002 Ordinary Shares issuable upon exercise of
those warrants to purchase Ordinary Shares, dated August 26, 2024, with an exercise price of $6.20 per share (the “2024 Warrants”
and together with the May Warrants and the August Warrants, the “Warrants” and such Ordinary Shares issuable upon exercise
of the Warrants, collectively the “Warrant Shares”). The May Warrants, August Warrants and 2024 Warrants were acquired by
the selling securityholders pursuant to the warrant agreements dated May 5, 2023, August 18, 2023 and August 26, 2024, respectively,
in transactions more fully described in the section titled “Debt Financings.” This prospectus also covers any additional
securities that may become issuable by means of share splits, share dividends or other similar transactions.
This
prospectus provides you with a general description of such securities and the general manner in which the selling securityholders may
offer or sell the securities. More specific terms of any securities that the selling securityholders may offer or sell may be provided
in a prospectus supplement that describes, among other things, the specific amounts and prices of the securities being offered and the
terms of the offering. The prospectus supplement may also add, update or change information contained in this prospectus.
All
of the Warrant Shares offered by the selling securityholders pursuant to this prospectus will be sold by each selling securityholder
for its own account. We will not receive any proceeds from the sale by the selling securityholders of the Warrant Shares offered by this
prospectus, except with respect to amounts received by us upon exercise of any of the Warrants for cash.
Our
registration of the securities covered by this prospectus does not mean that the selling securityholders will issue, offer or sell, as
applicable, any of the securities. The selling securityholders may offer and sell the securities covered by this prospectus in a number
of different ways and at varying prices. We provide more information about how the selling securityholders may sell the securities offered
hereby in the section entitled “Plan of Distribution.”
We
will pay certain expenses associated with the registration of the securities covered by this prospectus, as described in the section
entitled “Plan of Distribution.”
Our
Ordinary Shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “ADSE.” On February 10, 2025,
the closing sale price as reported on Nasdaq of our Ordinary Shares was $14.54 per share.
We
may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this entire
prospectus and any amendments or supplements carefully before you make your investment decision.
We
are an “emerging growth company” and “foreign private issuer,” each as defined under the U.S. federal securities
laws, and, as such, are subject to reduced public company reporting requirements.
Our
principal executive offices are located at 10 Earlsfort Terrace Dublin 2, D02 T380, Ireland.
Investing
in our securities involves a high degree of risk. Before buying any of our securities, you should carefully read the discussion of material
risks of investing in our securities in “Risk Factors” beginning on page 6 of this prospectus, in any applicable
prospectus supplement and as described in certain of the documents we may incorporate by reference herein.
Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
The
date of this prospectus is ,
2025
TABLE
OF CONTENTS
You
should rely only on the information contained in this prospectus and any amendment or supplement to this prospectus, as well as any information
incorporated by reference herein or therein. Neither we, nor the selling securityholder, have authorized any other person to provide
you with different or additional information. Neither we, nor the selling securityholder, take responsibility for, nor can we provide
assurance as to the reliability of, any other information that others may provide. The selling securityholders are not making an offer
to sell these securities in any jurisdiction where the offer or sale is not permitted. The information contained in this prospectus,
any applicable prospectus supplement or any documents incorporated by reference herein or therein is accurate only as of the date hereof
or thereof or such other date expressly stated herein or therein, and our business, financial condition, results of operations or prospects
may have changed since those dates.
Except
as otherwise set forth in this prospectus, neither we nor the selling securityholders have taken any action to permit a public offering
of these securities outside the United States or to permit the possession or distribution of this prospectus outside the United States.
Persons outside the United States who come into possession of this prospectus must inform themselves about and observe any restrictions
relating to the offering of these securities and the distribution of this prospectus outside the United States.
ABOUT
THIS PROSPECTUS
This
prospectus is part of a registration statement on Form F-3 that we filed with the United States Securities and Exchange Commission (the
“SEC”) using a “shelf” registration process. Under this shelf registration process, the selling securityholders
may, from time to time, offer and sell the securities described in this prospectus in one or more offerings.
We
will not receive any proceeds from the sale of securities offered by the selling securityholders described in this prospectus, but we
will receive proceeds upon exercise of the Warrants. To the extent required, we and the selling securityholders, as applicable, will
deliver a prospectus supplement with this prospectus to update the information contained in this prospectus. The prospectus supplement
may also add, update or change information included in this prospectus. You should read both this prospectus and any applicable prospectus
supplement, together with additional information described below under the captions “Where You Can Find More Information”
and “Documents Incorporated by Reference.” We have not, and the selling securityholders have not, authorized anyone
to provide you with information different from that contained in this prospectus. The information contained in this prospectus is accurate
only as of the date on the front cover of the prospectus. You should not assume that the information contained in this prospectus is
accurate as of any other date.
No
offer of these securities will be made in any jurisdiction where the offer is not permitted.
FREQUENTLY
USED TERMS
Unless
otherwise stated in this prospectus, any prospectus supplement or the documents incorporated by reference herein or therein, or the context
otherwise requires, references to:
“Debt
Financings” means the May Debt Financing, the August Debt Financing and the 2024 Debt Financing.
“2023
PIPE” means the subscription for and purchase by the selling securityholder of 1,666,667 Ordinary Shares and the Warrants to
purchase up to 1,339,285 Ordinary Shares.
“2024
Debt Financing” means that certain transaction consummated on August 26, 2024, whereby (i) ADSE US issued secured promissory
notes with an aggregate principal amount of $15,000,000 to certain lenders with such promissory notes having a maturity date of August
31, 2025, (ii) ADSE GM issued a secured promissory note with an principal amount of $3,000,000 to ADSH with such promissory note having
a maturity date of August 31, 2025, (iii) the Company issued the 2024 Warrants, (iv) the Company entered into a guarantee agreement with
the lenders, (v) ADSE US amended a security agreement with The Lucerne Capital Master Fund L.P., (vi) ADSE GM amended a guarantee agreement
with The Lucerne Capital Master Fund, L.P., and (vii) ADSE GM entered into a security agreement with ADSH.
“2024
Warrants” means those warrants, dated as of August 26, 2024, by and between the Company and the selling securityholders, to
purchase 4,800,002 Ordinary Shares at an exercise price of $6.20 per share.
“ADSE”
means collectively, ads-tec Energy GmbH, ads-tec Energy, Inc., and ads-tec Energy PLC.
“ADSE
GM” means ads-tec Energy GmbH, a wholly-owned subsidiary of ADSE Holdco, based in Nürtingen, Germany and entered in the
commercial register of the Stuttgart Local Court under HRB 762810.
“ADSE
Holdco” or “Company” means ADS-TEC Energy PLC, an Irish public limited company duly incorporated under the
laws of Ireland.
“ADSE
US” means ads-tec Energy Inc., a Delaware corporation and wholly-owned subsidiary of the Company.
“ADSH”
means ads-tec Holding GmbH, based in Nürtingen, Germany and entered in the commercial register of the Stuttgart Local Court under
HRB 224527.
“August
Debt Financing” means that certain transaction consummated on August 18, 2023, whereby (i) ADSE US issued secured promissory
notes with an aggregate principal amount of $15,000,000 to certain lenders with such promissory notes having a maturity date of July
31, 2024, (ii) the Company issued the August Warrants, (iii) the Company and ADSE GM entered into guarantee agreements with the lenders,
and (iv) ADSE US entered into a security agreement with The Lucerne Capital Master Fund L.P.
“August
Warrants” means those warrants, dated as of August 18, 2023, by and between the Company and the selling securityholders, to
purchase 1,500,000 Ordinary Shares at an exercise price of $6.20 per share.
“Bosch”
means Bosch Thermotechnik GmbH, based in Wetzlar and entered in the commercial register of the Wetzlar Local Court under HRB 13.
“Bosch
Acquisition” means ADSE Holdco’s acquisition from Bosch of certain shares of ADSE GM in exchange for the Cash Consideration.
“Business
Combination” means the transactions contemplated on December 22, 2021, pursuant to the Business Combination Agreement, in connection
with which EUSG ceased to exist and ADSE GM became a wholly-owned subsidiary of ADSE Holdco and the securityholders of ADSE GM and EUSG
became securityholders of ADSE Holdco.
“Business
Combination Agreement” means the Business Combination Agreement, dated August 10, 2021, by and among EUSG, ADSE Holdco, Merger
Sub, Bosch, ADSH and ADSE GM.
“Business
Combination Warrants” means collectively, the Public Warrants, the Private Warrants and the Lender Warrants issued in connection
with the Business Combination at an exercise price of $11.50 per Ordinary Share.
“Cash
Consideration” means €20,000,000, multiplied by the applicable currency exchange rate.
“EBC”
means EarlyBirdCapital, Inc.
“EUSG”
means European Sustainable Growth Acquisition Corp., a blank check company incorporated as a Cayman Islands exempted company.
“EUSG
Class A Ordinary Shares” means Class A ordinary shares, par value of $0.0001 per share, in the share capital of EUSG.
“EUSG
Private Warrants” means whole redeemable warrants to purchase EUSG Class A Ordinary Shares issued pursuant to (i) that certain
Private Placement Warrants Purchase Agreement, dated as of January 26, 2021, by and between EUSG and EUSG Sponsor, (ii) that certain
Private Placement Warrants Purchase Agreement, dated as of January 26, 2021 by and between EUSG and EBC, and (iii) that certain Private
Placement Warrants Purchase Agreement, dated as of January 26, 2021, by and between EUSG and ABN AMRO Securities (USA) LLC.
“EUSG
Public Warrants” means the warrants to purchase EUSG Class A Ordinary Shares issued as part of the EUSG units in the IPO.
“EUSG
Sponsor” means LRT Capital1 LLC, a Delaware limited liability company.
“Exchange
Act” means the U.S. Securities Exchange Act of 1934, as amended.
“IPO”
means EUSG’s initial public offering of EUSG units, consummated on January 26, 2021.
“JOBS
Act” means the Jumpstart Our Business Startups Act of 2012, as amended.
“Lender
Warrants” means the 100,000 Business Combination Warrants that came into existence on the automatic adjustment of the whole
redeemable warrants to purchase EUSG Class A Ordinary Shares issued to Jonathan Copplestone upon conversion of an outstanding unsecured
convertible promissory note in an aggregate principal amount of $100,000, dated October 30, 2021, between EUSG and Jonathan Copplestone
upon consummation of the business combination contemplated in the Business Combination Agreement.
“May
Debt Financing” means that certain transaction consummated on May 5, 2023, whereby (i) ADSE US issued secured promissory notes
with an aggregate principal amount of $12,875,000 to certain lenders, with (a) $7,1000,000 of such promissory notes having a maturity
date of June 30, 2023 and (b) $5,775,000 of such promissory notes having a maturity date of December 22, 2023, (ii) the Company issued
the May Warrants, and (iii) the Company and ADSE GM entered into guarantee agreements with the lenders.
“May
Warrants” means those warrants, dated as of May 5, 2023, by and between the Company and the selling securityholders, to purchase
1,716,667 Ordinary Shares at an exercise price of $6.20 per share.
“Merger”
means the merger of EUSG with and into Merger Sub, as a result of which the separate corporate existence of EUSG ceased and Merger Sub
continued as the surviving company and as a wholly-owned subsidiary of ADSE Holdco, and the security holders of EUSG (other than shareholders
of EUSG that elected to redeem their EUSG ordinary shares) became security holders of ADSE Holdco.
“Merger
Sub” means EUSG II Corporation, an exempted company incorporated in the Cayman Islands with limited liability under company
number 379118 and a wholly-owned subsidiary of ADSE Holdco.
“Ordinary
Shares” means the ordinary shares, with US$0.0001 par value per share, of ADSE Holdco.
“Private
Warrants” means the Business Combination Warrants that came into existence on the automatic adjustment of the EUSG Private
Warrants upon consummation of the Business Combination.
“Public
Warrants” means the Business Combination Warrants that came into existence on
the automatic adjustment of the EUSG Public Warrants upon consummation of the Business Combination.
“Securities
Act” means the U.S. Securities Act of 1933, as amended.
“Share-for-Share
Exchange” means the transaction by which ADSH and Bosch transferred as contribution to ADSE Holdco, and ADSE Holdco assumed
from ADSH and Bosch, certain shares of ADSE GM in exchange for Ordinary Shares.
“Transactions”
means the transactions contemplated by the Business Combination Agreement which, among other things, provides for the Merger, the Bosch
Acquisition and the Share-for-Share Exchange.
“IPO
Underwriters” means EarlyBirdCapital, Inc. and ABN AMRO Securities (USA) LLC, the underwriters in the IPO.
“Warrants”
means the May Warrants and the August Warrants, which were issued in connection with the 2023 Debt Financings.
“$”,
“US$” and “U.S. dollar” means the United States dollar.
“€”,
“EUR” and “Euro” means the Euro.
PROSPECTUS
SUMMARY
This
summary highlights certain information about us, this offering and selected information contained elsewhere in this prospectus. This
summary is not complete and does not contain all of the information that you should consider before deciding whether to invest in the
securities covered by this prospectus. This summary is qualified in its entirety by the more detailed information included in or incorporated
by reference into this prospectus and any applicable prospectus supplement. For a more complete understanding of the Company and our
securities, we encourage you to read in their entirety and consider carefully the more detailed information in this prospectus and any
related prospectus supplement, including the documents referred to in “Where You Can Find More Information” and “Documents
Incorporated by Reference,” before making an investment decision. Some of the statements in this prospectus constitute, and certain
statements in any prospectus supplement or the documents incorporated by reference herein and therein may be, forward-looking statements
that involve assumptions, risks and uncertainties as further described in “Forward-Looking Statements.”
Unless
otherwise stated or the context otherwise indicates, references to the “Company” or “ADSE Holdco” refer to ads-tec
Energy plc and, “we”, “our”, “us”, or “ADSE” refer to ads-tec Energy plc, together with
its subsidiaries.
Our
Company
We
are a supplier of integrated technology platforms (ecosystem platforms) that enable customers to run their EV charging and energy business
models on those decentralized platforms. Our ecosystem platforms consist of hardware, software and services and are designed to provide
key functions such as flexibility (energy storage with a battery), intelligent energy- and data management, as well as a wide range of
related and recurring digital and physical services. We believe that these decentralized ecosystem platforms will play a significant
role in the transition to a low carbon economy. These decentralized systems are getting more and more complex as the level of integration
increases. Development must follow continuous changes in regulatory requirements and component improvements. Batteries, power inverters
and all the software and security involved must be serviceable and maintained over a long period of time. For the leading players in
the future energy market such as utilities and operators, the question of which platforms to invest in and run their business on will,
in our opinion, be based on the quality and total cost of ownership of such platforms. Our core business is providing and servicing these
ecosystem platforms to, ideally, all of the future power companies, in principle, striving to reach a CO2 neutral world. Due to the depth
of our experience and capabilities across a wide range of technical disciplines, we have positioned ourselves as partner of choice for
customers running their business and serving their end-customers on these platforms. We strive to penetrate three main domains of the
decentralized energy market: (1) Ultra-fast Charging on power limited grids; (2) Residential sector coupling; and (3) Commercial &
Industrial applications.
Debt
Financings
May
Debt Financing
On
May 5, 2023, ADSE US issued unsecured promissory notes with an aggregate principal amount of $12,875,000 to certain lenders (the “May
Lenders”), with (i) $7,100,000 of such promissory notes having a maturity date of June 30, 2023 and (ii) $5,775,000 of such
promissory notes having a maturity date of December 22, 2023 (collectively, the “May Promissory Notes”). The May Lenders
include entities and individuals affiliated with Lucerne Capital, entities affiliated with UFO HOLDING AS, an entity formed under the
laws of Norway, and the following parties related to the Company: Thomas Speidel, the Chief Executive Officer of the Company, Wolfgang
Breme, the previous Chief Financial Officer of the Company, and ADSE GM.
In
connection with ADSE US’ entry into the Promissory Notes, on May 5, 2023, the Company entered into warrant agreements with the
May Lenders, pursuant to which the May Lenders subscribed to purchase 1,716,667 duly authorized, fully paid, and nonassessable ordinary
shares, nominal value $0.0001 per share of the Company, at a purchase price of $3.00 per Warrant Share (the “May Warrants,”
and such shares, the “May Warrant Shares”). Each May Warrant is exercisable, in whole or in part, from May 5, 2024
until 5:00 p.m., Eastern Time, on May 5, 2025. Regardless of either the amount ADSE US actually drew under the May Promissory Notes or
the amount each May Lender actually funded pursuant to their respective May Promissory Notes, each May Lender may exercise its respective
May Warrant for such May Lender’s total pro rata amount of May Warrant Shares, calculated by multiplying the quotient of such May
Lender’s respective commitment amount over the aggregate principal amount by the
total number of May Warrant Shares.
August
Debt Financing
On
August 18, 2023, ADSE US issued a series of secured promissory notes with an aggregate principal amount of $15,000,000 to certain lenders
(the “August Lenders”), with the promissory notes having a maturity date of July 31, 2024 (the “August Promissory Notes”).
The August Lenders include entities and individuals affiliated with Lucerne Capital.
In
connection with ADSE US’ entry into the August Promissory Notes, on August 18, 2023, the Company entered into warrant agreements
with the August Lenders (the “August Warrants”)), pursuant to which the August Lenders subscribed to purchase a total of
3,500,001 duly authorized, fully paid, and nonassessable ordinary shares, nominal value $0.0001 per share (the “August Warrant
Shares”) of the Company, at a purchase price of $6.20 per August Warrant Share. Each August Warrant is exercisable, in whole or
in part, from August 18, 2024 until 5:00 p.m., Eastern Time, on August 18, 2025. Each August Lender may exercise its respective August
Warrant for such August Lender’s total pro rata amount of August Warrant Shares, calculated by multiplying the quotient of such
Lender’s respective commitment amount over the aggregate principal amount by the total number of August Warrant
Shares when the Company draws down on such August Lender’s August Promissory Note.
On August
26, 2024, in connection with the 2024 Debt Financing, ADSE US, the Company and the August Lenders agreed to amend and restate the August
Promissory Notes and the August Warrants, pursuant to which (i) the maturity date of the August Promissory Notes was extended to August
31, 2025, (ii) the exercise period of the August Warrants was extended to August 26, 2026, and (iii) certain of the August Lenders received
warrants to purchase an additional 500,000 Warrant Shares. As of February 10, 2025, ADSE US has drawn down $8,000,000 on the August Promissory
Notes, and 4,000,001 August Warrants are exercisable.
In
connection with the May Debt Financing and August Debt Financing, the Company and ADSE GM entered into guarantee agreements with the
Lenders, dated as of May 5, 2023 and August 18, 2023, respectively (the “2023 Guarantee Agreements”). Pursuant to the 2023
Guarantee Agreements, the Company and ADSE GM agreed to provide guarantees for ADSE US’ obligations, including all monies, obligations
and liabilities thereafter due, owing or incurred by ADSE US to the Lenders under the Promissory Notes, including interest (including
interest capitalized or rolled up and default interest) at such rates and upon such terms as may from time to time be payable by ADSE
US to the Lenders.
Additionally,
in connection with the August Debt Financing, ADSE US entered into a security agreement (the “2023 Security Agreement”),
dated as of August 18, 2023, with The Lucerne Capital Master Fund, L.P. (the “2023 Secured Party”), pursuant to which ADSE
US assigned and granted to the 2023 Secured Party, for the benefit of the August Lenders, a security interest in all of its right, title
and interest in and to all of the personal property of ADSE US as collateral security for the prompt payment in full when due (whether
at stated maturity, by acceleration or otherwise) of all obligations and liabilities of ADSE US arising out of or in connection with
the August Promissory Notes.
2024
Debt Financing
On
August 26, 2024, ADSE US issued a series of secured promissory notes with an aggregate principal amount of $15,000,000 to certain lenders
(the “2024 Lenders,” and together with the May Lenders and the August Lenders, the “Lenders”), with the promissory
notes having a maturity date of August 31, 2025 (the “2024 Promissory Notes,” and together with the May Promissory Notes
and the August Promissory Notes, the “Promissory Notes”). The 2024 Lenders include entities affiliated with Lucerne Capital
and ADSH.
In connection
with ADSE US’ entry into the 2024 Promissory Notes, on August 26, 2024, the Company entered into warrant agreements with the 2024
Lenders (the “2024 Warrants,” and together with the May Warrants and the August Warrants, the “Warrants”), pursuant
to which the 2024 Lenders subscribed to purchase a total of 4,800,002 duly authorized, fully paid, and nonassessable ordinary shares,
nominal value $0.0001 per share (the “2024 Warrant Shares”) of the Company, at a purchase price of $6.20 per 2024 Warrant
Share. Each 2024 Warrant is exercisable, in whole or in part, from August 26, 2025 until 5:00 p.m., Eastern Time, on August 26, 2026.
Each 2024 Lender may exercise its respective 2024 Warrant for such 2024 Lender’s total pro rata amount of 2024 Warrant Shares, calculated
by multiplying the quotient of such 2024 Lender’s respective commitment amount over the aggregate principal amount by the
total number of 2024 Warrant Shares when the Company draws down on such 2024 Lender’s 2024 Promissory Note. As of February 10, 2025,
ADSE US has drawn down $8,000,000 on the 2024 Promissory Notes, and none of the 2024 Warrants are exercisable.
In connection with the 2024 Debt Financing, the
Company, ADSE GM and the 2024 Lenders amended the 2023 Guarantee Agreements and the 2023 Security Agreement, to incorporate the terms
and conditions of the 2024 Promissory Notes. The Company also entered into a guarantee agreement with certain of the 2024 Lenders (the
“2024 Guarantee Agreement” and together with the 2023 Guarantee Agreements, the “Guarantee Agreements”). Pursuant
to the 2024 Guarantee Agreement, the Company agreed to provide guarantees for ADSE US’ obligations, including all monies, obligations
and liabilities thereafter due, owing or incurred by ADSE US to the 2024 Lenders under the 2024 Promissory Notes, including interest (including
interest capitalized or rolled up and default interest) at such rates and upon such terms as may from time to time be payable by ADSE
US to the 2024 Lenders. Additionally, pursuant to the 2024 Guarantee Agreement, the Company agreed to liability as the sole and primary
guarantor for ADSE US’ obligations.
Additionally,
in connection with the 2024 Debt Financing, on August 26, 2024, ADSE GM entered into a security agreement with ADSH, as secured party
(the “2024 Security Agreement” and together with the 2023 Security Agreement, the “Security Agreements”). Pursuant
to the 2024 Security Agreement, ADSE GM assigned and granted to the ADSH a security interest in all of its right, title and interest
in and to all of the personal property of ADSE GM as collateral security for the prompt payment in full when due (whether at stated maturity,
by acceleration or otherwise) of all obligations and liabilities of ADSE GM arising out of or in connection with the 2024 Promissory
Notes.
This
summary of certain terms and provisions of the Warrants, Promissory Notes, Guarantee Agreements, and Security Agreements is not complete
and is subject to, and qualified in its entirety by, the provisions of the forms of the Warrants, Promissory Notes, Guarantee Agreements,
and Security Agreement which were filed with the SEC as exhibits to the Current Reports on Form 6-K filed on May 11, 2023, August 25,
2023 and August 30, 2024.
Implications
of Being an Emerging Growth Company and a Foreign Private Issuer
We
qualify as an “emerging growth company” as defined in the JOBS Act. As an emerging growth company, we may take advantage
of certain exemptions from specified disclosure and other requirements that are otherwise generally applicable to public companies. These
exemptions include:
|
● |
an exemption from the provisions
of Section 404(b) of the Sarbanes-Oxley Act of 2002 requiring that our independent registered public accounting firm provide an attestation
report on the effectiveness of our internal control over financial reporting; |
|
● |
reduced disclosure obligations
regarding executive compensation; and |
|
● |
not being required to hold
a nonbinding advisory vote on executive compensation or to seek shareholder approval of any golden parachute payments not previously
approved. |
We
will remain an “emerging growth company” until the earliest to occur of (i) the last day of the fiscal year (a) following
the fifth anniversary of the closing of the Business Combination, (b) in which we have total annual gross revenue of at least $1.235
billion or (c) in which we are deemed to be a large accelerated filer, which means the market value of equity securities held by our
non-affiliates exceeds $700 million as of the last business day of our prior second fiscal quarter, and (ii) the date on which we have
issued more than $1.0 billion in non-convertible debt during the prior three-year period.
We
are also considered a “foreign private issuer” subject to reporting requirements under the Exchange Act, as a non-U.S. company
with foreign private issuer status. As a “foreign private issuer,” we will be subject to different U.S. securities laws than
domestic U.S. issuers. The rules governing the information that we must disclose differ from those governing U.S. corporations pursuant
to the Exchange Act. This means that, even after we no longer qualify as an emerging growth company, as long as we qualify as a foreign
private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic
public companies, including:
|
● |
the rules under the Exchange
Act prescribing the furnishing and content of proxy statements to shareholders and requirements that the proxy statements conform
to Schedule 14A of the proxy rules promulgated under the Exchange Act; |
|
● |
the sections of the Exchange
Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; |
|
● |
the sections of the Exchange
Act requiring insiders (i.e., officers, directors and holders of more than 10% of our issued and outstanding equity securities) to
file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short
period of time; |
|
● |
the rules under the Exchange
Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information,
or current reports on Form 8-K upon the occurrence of specified significant events; and |
|
● |
the SEC rules on disclosure
of compensation on an individual basis unless individual disclosure is required in our home country (Ireland) and is not otherwise
publicly disclosed by us. |
We
may take advantage of these exemptions until such time as we are no longer a foreign private issuer.
We
would cease to be a foreign private issuer at such time as more than 50% of our outstanding voting securities are held by U.S. residents
and any of the following three circumstances applies: (i) the majority of our executive officers or directors are U.S. citizens or residents,
(ii) more than 50% of our assets are located in the United States or (iii) our business is administered principally in the United States.
We
may choose to take advantage of some but not all of these reduced reporting requirements of which we have taken advantage of in this
prospectus. Accordingly, the information contained herein may be different from the information you receive from our competitors that
are U.S. domestic filers or other U.S. domestic public companies in which you have made an investment.
Risk
Factors
Investing
in our securities entails a high degree of risk as discussed in the “Risk Factors” section beginning on page 6
of this prospectus and in the documents incorporated by reference in this prospectus. You should carefully consider such risks before
deciding to invest in our securities.
Corporate
Information
We
were incorporated as an Irish public limited company on July 26, 2021 solely for the purpose of effectuating the Business Combination.
Prior to the Business Combination, we did not conduct any material activities other than those incident to our formation and certain
matters related to the Business Combination, such as the making of certain required securities law filings.
Our
principal executive offices are located at 10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland. Our telephone number at this address is
+353 1 920 1000.
We
have appointed Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY 10168 as our agent upon
whom process may be served in any action brought against us under the securities laws of the United States in connection with offerings
of securities registered by the registration statement of which this prospectus is a part.
We
maintain a website at www.ads-tec-energy.com, where we regularly post copies of our press releases as well as additional information
about us. Our filings with the SEC are available free of charge through the website as soon as reasonably practicable after being electronically
filed with or furnished to the SEC. Information contained in our website is not a part of, nor incorporated by reference into, this prospectus
or our other filings with the SEC, and should not be relied upon.
All
trademarks, service marks and trade names appearing in this prospectus are the property of their respective holders. Use or display by
us of other parties’ trademarks, trade dress, or products in this prospectus is not intended to, and does not, imply a relationship
with, or endorsements or sponsorship of, us by the trademark or trade dress owners.
THE
OFFERING
Securities Offered by the
Selling Securityholders |
Up to 10,516,670
Ordinary Shares, issuable upon exercise of the Warrants. |
|
|
Use of Proceeds |
We will not receive any
proceeds from the sale of the Warrant Shares by the selling securityholders. See “Use of Proceeds.” |
RISK
FACTORS
An
investment in our securities carries a significant degree of risk. Before you decide to purchase our securities, you should carefully
consider all risk factors set forth in the applicable prospectus supplement and the documents incorporated by reference herein or therein.
See “Documents Incorporated by Reference.” These risk factors are not exhaustive, and investors are encouraged to
perform their own investigation with respect to our business, financial condition and prospects. You should carefully consider these
risk factors in addition to the other information included in this prospectus, including matters addressed in the section entitled “Forward-Looking
Statements.” We may face additional risks and uncertainties that are not presently known to us, or that we currently deem immaterial,
which may also impair our business or financial condition. The risk factors should be read in conjunction with our financial statements
and notes to the financial statements incorporated by reference herein. If any of these risks actually occur, our business, financial
condition, results of operations or prospects could be materially affected. As a result, the trading prices of our securities could decline
and you could lose part or all of your investment.
FORWARD-LOOKING
STATEMENTS
This
prospectus contains or may contain forward-looking statements as defined in Section 27A of the Securities Act, and Section 21E of the
Exchange Act that involve significant risks and uncertainties. All statements other than statements of historical facts are forward-looking
statements. These forward-looking statements include information about our possible or assumed future results of operations or our performance.
These statements involve known and unknown risks, uncertainties and other factors, including those listed under “Risk Factors,”
and elsewhere in this prospectus that may cause our actual results, performance or achievements to be materially different from those
expressed or implied by the forward-looking statements.
In
some cases, these forward-looking statements can be identified by words and phrases such as “may,” “should,”
“intend,” “predict,” “potential,” “continue,” “will,” “expect,”
“anticipate,” “estimate,” “plan,” “believe,” “is /are likely to” or the negative
form of these words and phrases or other comparable expressions. The forward-looking statements included in this prospectus relate to,
among other things:
|
● |
our ability to maintain
the listing of the Ordinary Shares and the Business Combination Warrants on a national securities exchange; |
|
● |
changes adversely affecting
the businesses in which we are engaged; |
|
● |
general economic conditions,
including changes in the credit, debit, securities, financial or capital markets; |
|
● |
the impact of adverse public
health developments on ADSE’s business and operations; |
|
● |
increased costs, disruption
of supply, or shortage of materials, could harm our business; |
|
● |
our ability to implement
business plans, operating models, forecasts, and other expectations and identify and realize additional business opportunities; |
|
● |
the result of future financing
efforts; |
|
● |
product liability lawsuits,
civil or damages claims or regulatory proceedings relating to our technology, intellectual property or products; |
|
● |
the impact of the military
action in Ukraine may affect our current and future operations in the European Union; |
|
● |
identified material weaknesses
in our internal control over financial reporting, which failure to remediate such material weaknesses in the future or to maintain
an effective system of internal control could impair our ability to comply with the financial reporting and internal controls requirements
for publicly traded companies; |
|
● |
changes to fuel economy
standards or the success of alternative fuels may negatively impact the EV market and thus the demand for our products and services; |
|
● |
changes to battery energy
storage standards or the success of alternative energy storage technologies may negatively impact the battery-energy storage market
and thus the demand for our products and services; |
|
● |
existing and future environmental
health and safety laws and regulations could result in increased compliance costs or additional operating costs or construction costs
and restrictions. Failure to comply with such laws and regulations may result in substantial fines or other limitations that may
adversely impact our financial results or results of operation; and |
|
● |
other factors discussed
in “Item 3. Key Information — D. Risk Factors” in our Annual Report on Form 20-F, filed with the SEC on
April 30, 2024 (the “Annual Report on Form 20-F”) and incorporated by reference herein. |
These
forward-looking statements involve various risks, assumptions and uncertainties. Although we believe that our expectations expressed
in these forward-looking statements are reasonable, our expectations may turn out to be incorrect. Our actual results could be materially
different from or worse than our expectations. You should read this prospectus and the documents that we refer to in this prospectus
with the understanding that our actual future results may be materially different from and worse than what we expect. Other sections
of this prospectus include additional factors which could adversely impact our business and financial performance. Moreover, we operate
in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for our management to
predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor,
or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
You
should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this prospectus
relate only to events or information as of the date on which the statements are made in this prospectus. All forward-looking statements
included herein attributable to us or other parties or any person acting on our behalf are expressly qualified in their entirety by the
cautionary statements contained or referred to in this section. We undertake no obligation to update or revise any forward-looking statements
whether as a result of new information, future events or otherwise, after the date of this prospectus or to reflect the occurrence of
unanticipated events, except as otherwise required by the U.S. federal securities laws.
USE
OF PROCEEDS
We
will not receive any of the proceeds from the sale by the selling securityholders of the Warrant Shares in this offering. The selling
securityholders will receive all of the proceeds from the sale of the Warrant Shares hereunder.
DIVIDEND
POLICY
We
have not paid any cash dividends on our Ordinary Shares to date. Our board of directors will consider whether or not to institute a dividend
policy. It is presently intended that we will retain our earnings for use in business operations and, accordingly, it is not anticipated
that our board of directors will declare dividends in the foreseeable future.
DESCRIPTION
OF SECURITIES
The
following description of the material terms of the share capital of ADSE Holdco includes a summary of specified provisions of ADSE Holdco’s
Memorandum and Articles of Association (“M&A”), and the description also includes a description of the Warrants. This
description is qualified by reference to ADSE Holdco’s M&A and form of warrant, each of which has been filed as an exhibit
to the registration statement of which this prospectus forms a part.
General
We
are a public limited company organized and existing under the laws of Ireland. We were formed on 26 July 2021 as a public limited company
under the name ADS-TEC ENERGY PLC. Our affairs are governed by our M&A, the Irish Companies Act and the corporate law of Ireland.
Our authorized share capital is (a) US $60,000 divided into (i) 500,000,000 Ordinary Shares, with a nominal value of US$0.0001 per share,
and (ii) 100,000,000 preferred shares, with a nominal value of US$0.0001 per share and (b) €25,000 divided into 25,000 deferred
ordinary shares with a nominal value of €1.00 per share, which are held by ADSE Holdco as treasury shares.
Ordinary
Shares
General.
As of February 10, 2025, there were 53,206,322 Ordinary Shares issued and outstanding. In addition, ADSE Holdco holds €25,000
worth of deferred ordinary shares in ADSE Holdco as treasury shares.
Dividends.
The holders of Ordinary Shares are entitled to such dividends as may be declared by our board of directors. Dividends may be
declared and paid out of the funds legally available therefor. Dividends may also be declared and paid out of share premium account or
any other fund or account which can be authorized for this purpose in accordance with the Irish Companies Act.
Voting
Rights. Each Ordinary Share shall be entitled to one vote on all matters subject to the vote at general meetings of the Company.
Voting at any meeting of shareholders is by way of a poll, which shall be taken in such manner as the chairperson of the meeting directs.
An
ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching
to the Ordinary Shares cast at a meeting, while a special resolution requires the affirmative vote of no less than 75% of the votes cast
attaching to the outstanding ordinary shares at a meeting. Where the shareholders wish to act by way of written resolution in lieu of
holding a meeting, unanimous consent of the holders of the Ordinary Shares shall be required. A special resolution will be required for
important matters such as a change of name, reducing the share capital or making changes to the M&A to be in effect.
Transfer
of Ordinary Shares. Subject to the restrictions contained in the Business Combination Agreement with respect to the ADSE Holdco
securities issued to the ADSE GM Shareholders in the Share-for-Share Exchange, the provisions of the Lock-Up Agreement, and subject to
any further restrictions contained in the M&A, any ADSE Holdco shareholder may transfer all or any of his or her Ordinary Shares
by an instrument of transfer in the usual or common form or any other form approved by ADSE Holdco’s board of directors from time
to time.
Liquidation.
On a return of capital on winding-up or otherwise (other than on conversion, redemption or purchase of ordinary shares), assets
available for distribution among the holders of Ordinary Shares shall be distributed among the holders thereof on a pro rata basis. If
ADSE Holdco’s assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed
so that, as nearly as may be, the losses are borne by ADSE Holdco’s shareholders proportionately.
General
Meetings of Shareholders. Shareholders’ meetings may be convened by the board of directors, by the board of directors on
the requisition of the shareholders or, if the board of directors fails to so convene a meeting, such extraordinary general meeting may
be convened by the requisitioning shareholders where the requisitioning shareholders hold not less than 10% of the paid up share capital
of ADSE Holdco. Any action required or permitted to be taken at any annual or extraordinary general meetings may be taken only upon the
vote of the shareholders at an annual or extraordinary general meeting duly noticed and convened in accordance with the M&A and the
Irish Companies Act. Unanimous consent of the holders of the Ordinary Shares shall be required before the shareholders may act by way
of written resolution without a meeting.
Business
Combination Warrants
General.
As of February 10, 2025, there were an aggregate of 11,662,486 Business Combination Warrants issued and outstanding. Certain
“private warrants”, being warrants initially issued by EUSG to EUSG Sponsor and the IPO Underwriters rather than those issued
to the public, (i) will not be redeemable by ADSE Holdco, (ii) may be exercised for cash or on a cashless basis at the holder’s
option as long as such warrants are held by the initial holders or their affiliates or permitted transferees, and (iii) were subject
to a lockup for a period of 30 days from the closing of the Transactions.
Exercisability.
Each Business Combination Warrant entitles the registered holder to purchase one Ordinary Share.
Exercise
Price. $11.50 per share, subject to adjustment.
The
exercise price and number of Ordinary Shares issuable on exercise of the Business Combination Warrants may be adjusted in certain circumstances
including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However,
the Business Combination Warrants will not be adjusted for issuances of Ordinary Shares at a price below the Business Combination Warrant
exercise price.
Exercise
Period. The Business Combination Warrants are exercisable at any time and from time to time until 5:00 p.m., New York City time
on December 22, 2026, or earlier upon their redemption.
No
Business Combination Warrants will be exercisable for cash unless ADSE Holdco has an effective and current registration statement covering
the offer and sale of the Ordinary Shares issuable upon exercise of the Business Combination Warrants and a current prospectus relating
to such Ordinary Shares. Notwithstanding the foregoing, if a registration statement covering the offer and sale of Ordinary Shares issuable
upon exercise of the Business Combination Warrants is not effective within a specified period following the consummation of the Transactions,
warrant holders may, until such time as there is an effective registration statement and during any period when ADSE Holdco shall have
failed to maintain an effective registration statement, exercise Business Combination Warrants on a cashless basis pursuant to the exemption
provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption,
is not available, holders will not be able to exercise their Business Combination Warrants on a cashless basis. In such event, each holder
would pay the exercise price by surrendering the Business Combination Warrants for that number of Ordinary Shares equal to the quotient
obtained by dividing (x) the product of the number of Ordinary Shares underlying the Business Combination Warrants, multiplied by the
difference between the exercise price of the Business Combination Warrants and the “fair market value” (defined below) by
(y) the fair market value. The “fair market value” for this purpose will mean the average reported last sale price of the
Ordinary Shares for the five trading days ending on the trading day prior to the date of exercise.
ADSE
Holdco has agreed to use its best efforts to file and have an effective registration statement covering the offer and sale of the Ordinary
Shares issuable upon exercise of the Business Combination Warrants, to maintain a current prospectus relating to those Ordinary Shares
until the earlier of the date the Business Combination Warrants expire or are redeemed and the date on which all of the Business Combination
Warrants have been exercised, and to qualify the resale of such shares under U.S. state blue sky laws, to the extent an exemption is
not available. However, there is no assurance that ADSE Holdco will be able to do so and, if ADSE Holdco does not maintain a current
prospectus relating to the offer and sale of the Ordinary Shares issuable upon exercise of the Business Combination Warrants, holders
will be unable to exercise their Business Combination Warrants for cash and ADSE Holdco will not be required to net cash settle or cash
settle the Business Combination Warrant exercise.
Redemption
of Business Combination Warrants. ADSE Holdco may call the Business Combination Warrants for redemption (excluding certain Business
Combination Warrants initially issued to EUSG’s initial shareholders, so long as such Business Combination Warrants are held by
the EUSG initial shareholders or their respective affiliates and certain permitted transferees), in whole and not in part, at a price
of $0.01 per Business Combination Warrant:
|
● |
at any time after the Business
Combination Warrants become exercisable, |
|
● |
upon not less than 30 days’
prior written notice of redemption to each Business Combination Warrant holder, |
|
● |
if, and only if, the reported
last sale price of the Ordinary Shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends,
reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing after the ADSE Holdco Business
Combination Warrants become exercisable and ending three business days prior to the date the notice of redemption was sent to ADSE
Holdco Business Combination Warrant holders; and |
|
● |
if,
and only if, there is a current registration statement in effect with respect to offer and sale of the Ordinary Shares underlying
such Business Combination Warrants. |
The
right to exercise will be forfeited unless the Business Combination Warrants are exercised prior to the date specified in the notice
of redemption. On and after the redemption date, a record holder of a Business Combination Warrant will have no further rights except
to receive the redemption price for such holder’s Business Combination Warrant upon surrender of such Business Combination Warrant.
The
redemption criteria for the Business Combination Warrants have been established at a price which is intended to provide Business Combination
Warrant holders a reasonable premium to the initial exercise price and provide a sufficient differential between the then-prevailing
share price and the Business Combination Warrant exercise price so that if the share price declines as a result of the redemption call,
the redemption will not cause the share price to drop below the exercise price of the Business Combination Warrants.
If
ADSE Holdco calls the Business Combination Warrants for redemption as described above, ADSE Holdco’s management will have the option
to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such event, each holder would pay
the exercise price by surrendering the Business Combination Warrants for that number of Ordinary Shares equal to the quotient obtained
by dividing (x) the product of the number of Ordinary Shares underlying the Business Combination Warrants, multiplied by the difference
between the exercise price of the Business Combination Warrants and the “fair market value” (defined below) by (y) the fair
market value. The “fair market value” shall mean the average reported last sale price of the Ordinary Shares for the five
trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of Business Combination
Warrants.
Registered
Form. The Business Combination Warrants will be held in registered form pursuant to the Amended and Restated Warrant Agreement
among ADSE Holdco, EUSG, and Continental Stock Transfer & Trust Company, as warrant agent. The Amended and Restated Warrant Agreement
provides that the terms of the Business Combination Warrants may be amended without the consent of any holder to cure any ambiguity or
correct or supplement any defective provision, but requires the approval, by written consent or vote, of the holders of at least a majority
of the then outstanding Business Combination Warrants in order to make any change that adversely affects the interests of the registered
holders.
Manner
of Exercise. The Business Combination Warrants may be exercised upon surrender of the holder’s Business Combination
Warrant certificate on or prior to the expiration date at the offices or agency of the warrant agent, with the exercise form on the reverse
side of the Business Combination Warrant certificate completed and executed as indicated, accompanied by full payment of the exercise
price, by certified or official bank check payable to ADSE Holdco or by wire transfer, for the number of Business Combination Warrants
being exercised.
Business
Combination Warrant holders may elect to be subject to a restriction on the exercise of their Business Combination Warrants such that
an electing Business Combination Warrant holders would not be able to exercise their Business Combination Warrants to the extent that,
after giving effect to such exercise, such holder would beneficially own in excess of 9.8% of the Ordinary Shares outstanding.
No
Rights as a Shareholder. The Business Combination Warrant holders have neither the rights nor the privileges of holders
of Ordinary Shares, nor do they have any voting rights until they exercise their Business Combination Warrants and receive Ordinary Shares.
After the issuance of Ordinary Shares upon exercise of the Business Combination Warrants, each holder will be entitled to one vote for
each Ordinary Share held of record on all matters to be voted on by holders of Ordinary Shares.
No
Fractional Shares. No fractional shares will be issued upon exercise of the Business Combination Warrants. If, upon exercise
of the Business Combination Warrants, a holder would be entitled to receive a fractional interest in a share, ADSE Holdco will, upon
exercise, round up to the nearest whole number the number of Ordinary Shares to be issued to the warrant holder.
2023
PIPE Warrants
General.
The following description of the Warrants issued in connection with the 2023 PIPE is qualified in its entirety by reference to the
full text of the Six-Month Warrant Agreement (“Six-Month Warrant Agreement”) and One-Year Warrant Agreement (“One-Year
Warrant Agreement”) by and between the Company and Mirabella Financial Services LLP, dated as of December 28, 2023.
Exercisability.
Each Warrant entitles the registered holder to purchase one Ordinary Share.
Exercise
Price. 714,285 of the Warrants are exercisable at an exercise price of $7.00 per Ordinary Share (“Six-Month Warrants”).
625,000 of the Warrants are exercisable at an exercise price of $8.00 per Ordinary Share (“One-Year Warrants”).
Exercise
Period. The Six-Month Warrants were exercisable at any time and from time to time until 5:00 p.m., Eastern Time on June 28, 2024.
The One-Year Warrants were exercisable at any time and from time to time until 5:00 p.m., Eastern Time on December 28, 2024.
No
Rights as a Shareholder. The Warrant holder has neither the rights nor the privileges of holders of Ordinary Shares, nor does
it have any voting rights until it exercises its Warrants and receive Ordinary Shares. After the issuance of Ordinary Shares upon exercise
of the Warrants, the holder will be entitled to one vote for each Ordinary Share held of record on all matters to be voted on by holders
of Ordinary Shares.
No
Fractional Shares. No fractional shares will be issued upon exercise of the Warrants. If, upon exercise of the Warrants, a holder
would be entitled to receive a fractional interest in a share, ADSE Holdco will, upon exercise, pay the holder an amount in cash in lieu
of a fractional share.
Warrants
General.
The following description of the Warrants issued in connection with the 2023 Debt Financings and 2024 Debt Financing is qualified
in its entirety by reference to the full text of the May Warrants, August Warrants and 2024 Warrants, dated as of May 5, 2023, August
18, 2023 and August 26, 2024, which are attached to the registration statement of which this prospectus forms a part as Exhibit 4.1,
Exhibit 4.2 and 4.3, respectively.
Exercisability.
Each Warrant entitles the registered holder to purchase one Ordinary Share.
Exercise
Price. The May Warrants are exercisable at an exercise price of $3.00 per Ordinary Share. The August Warrants and the 2024 Warrants
are exercisable at an exercise price of $6.20 per Ordinary Share.
Exercise
Period. The May Warrants are exercisable at any time and from time to time until 5:00 p.m., Eastern Time on May 5, 2025. The
August Warrants and the 2024 Warrants are exercisable at any time and from time to time until 5:00 p.m., Eastern Time on August 26, 2026.
No
Rights as a Shareholder. The Warrant holder has neither the rights nor the privileges of holders of Ordinary Shares, nor does
it have any voting rights until it exercises its Warrants and receive Ordinary Shares. After the issuance of Ordinary Shares upon exercise
of the Warrants, the holder will be entitled to one vote for each Ordinary Share held of record on all matters to be voted on by holders
of Ordinary Shares.
No
Fractional Shares. No fractional shares will be issued upon exercise of the Warrants. If, upon exercise of the Warrants, a holder
would be entitled to receive a fractional interest in a share, ADSE Holdco will, upon exercise, pay the holder an amount in cash in lieu
of a fractional share.
Indemnification
of Directors and Officers
Pursuant
to ADSE Holdco’s M&A, subject to the provisions of and so far as may be permitted by the Irish Companies Act, every director,
officer or employee of ADSE Holdco, and each person who is or was serving at the request of ADSE Holdco as a director, officer or employee
of another company, or of a partnership, joint venture, trust or other enterprise, shall be entitled to be indemnified by ADSE Holdco
against all costs, charges, losses, expenses and liabilities incurred by him or her in the execution and discharge of his or her duties
or in relation thereto, including any liability incurred by him or her in defending any proceedings, civil or criminal, which relate
to anything done or omitted or alleged to have been done or omitted by him or her as a director, officer or employee of ADSE Holdco or
such other company, partnership, joint venture, trust or other enterprise, and in which judgment is given in his or her favor (or the
proceedings are otherwise disposed of without any finding or admission of any material breach of duty on his or her part) or in which
he or she is acquitted or in connection with any application under any statute for relief from liability in respect of any such act or
omission in which relief is granted to him or her by the court.
The
Irish Companies Act prescribes that such an indemnity only permits a company to pay the costs or discharge the liability of a director
or the secretary where judgment is given in any civil or criminal action in respect of such costs or liability, or where an Irish court
grants relief because the director or secretary acted honestly and reasonably and ought fairly to be excused.
ADSE
Holdco is permitted under its M&A and the Irish Companies Act to purchase directors’ and officers’ liability insurance,
as well as other types of insurance, for its directors, officers and employees.
ADSE
Holdco has entered into deeds of indemnity with its directors and ADSE GM executive officers. Given the director indemnification limitations
arising under Irish law, ADSE Holdco’s subsidiary, ADSE GM and ADSE GM’s subsidiary, ads-tec Energy, Inc. have also entered
into such deeds of indemnity. These agreements, among other things, require ADSE to jointly and severally indemnify ADSE Holdco’s
directors and ADSE directors and executive officers for certain expenses, including attorneys’ fees, judgments, fines and settlement
amounts incurred by any such director or executive officer in any action or proceeding arising out of their services as one of ADSE directors
or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services
at ADSE’s request. We believe that these indemnification deeds are necessary to attract and retain qualified persons as directors
and officers.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the
registrant pursuant to the foregoing provisions, the registrant has been informed that in the opinion of the SEC such indemnification
is against public policy as expressed in the Securities Act and is therefore unenforceable.
Transfer
Agent, Warrant Agent and Registrar
ADSE
Holdco’s transfer agent and warrant agent for the Business Combination Warrants is Continental Stock Transfer & Trust Company.
ADSE Holdco’s registrar is Link Group.
Listing
of Securities
Our
Ordinary Shares and the Business Combination Warrants are listed on Nasdaq under the symbols “ADSE” and “ADSEW,”
respectively. Holders of our securities should obtain current market quotations for their securities. There can be no assurance that
our Ordinary Shares will remain listed on Nasdaq. If we fail to comply with the Nasdaq listing requirements, our Ordinary Shares and/or
warrants could be delisted from Nasdaq. A delisting of our Ordinary Shares and warrants will likely affect the liquidity of our Ordinary
Shares and warrants and could inhibit or restrict our ability to raise additional financing.
There
is no trading market available for the Warrants on any securities exchange or nationally recognized trading system. We do not intend
to list the Warrants on Nasdaq or any securities exchange or nationally recognized trading system.
SELLING
SECURITYHOLDERS
This
prospectus and any supplement hereto relate to the possible offer and sale from time to time of up to 10,516,670 Ordinary Shares issuable
upon exercise of the Warrants by the selling securityholders. The selling securityholders acquired the securities offered hereby in the
Debt Financings. See “Prospectus Summary - Debt Financings” for more information.
The
selling securityholders may from time to time offer and sell any or all of the Warrant Shares set forth below pursuant to this prospectus.
When we refer to the “selling securityholders” in this prospectus, we mean the selling securityholders named under
this section “Selling Securityholders” and the
pledgees, donees, transferees, assignees, successors and others who later come to hold any of the selling securityholder’s interest
in our securities after the date of this prospectus.
The following table is prepared based on information
provided to us by the selling securityholders. It sets forth the name and address of the selling securityholders, the aggregate number
of Warrant Shares that the selling securityholders may offer pursuant to this prospectus and the beneficial ownership of the selling securityholders
both before and after the offering. We have based percentage ownership on 53,206,322 Ordinary Shares outstanding as of February 10, 2025.
In calculating the denominator used to determine percentages of Ordinary Shares owned after the offering described herein is consummated
by the selling securityholders, we did not give effect to the exercise of any other outstanding warrants issued by the Company that may
be held by the selling securityholders.
The SEC has defined “beneficial ownership”
of a security to mean the possession, directly or indirectly, of voting power and/or investment power over such security. A securityholder
is also deemed to be, as of any date, the beneficial owner of all securities that such securityholder has the right to acquire within
60 days after that date through (i) the exercise of any option, warrant or right, (ii) the conversion of a security, (iii) the power to
revoke a trust, discretionary account or similar arrangement, or (iv) the automatic termination of a trust, discretionary account or similar
arrangement. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, ordinary shares
subject to options or other rights (as set forth above) held by that person that are currently exercisable, or will become exercisable
within 60 days of February 10, 2025, are deemed outstanding, while such shares are not deemed outstanding for purposes of computing percentage
ownership of any other person.
We
cannot advise you as to whether the selling securityholders will in fact sell any or all of such Warrant Shares. In addition, the selling
securityholders may sell, transfer or otherwise dispose of, at any time and from time to time, and without our prior consent, the Warrant
Shares in transactions exempt from the registration requirements of the Securities Act after the date of this prospectus, subject to
applicable law.
Relevant
information for each additional selling securityholders, if any, will be set forth in a prospectus supplement to the extent required
prior to the time of any offer or sale of a selling securityholder’s securities pursuant to this prospectus. Any prospectus supplement
may add, update, substitute or change the information contained in this prospectus, including the identity of each selling securityholder
and the number of Warrant Shares registered on its behalf. The selling securityholders may sell all, some or none of such securities
in this offering. See “Plan of Distribution.”
The holdings of the selling securityholders are
stated as of February 10, 2025.
Name of Selling Securityholder | |
Ordinary Shares Beneficially Owned Prior to the Offering | | |
Number of Ordinary Shares Being Offered | | |
Ordinary Shares Beneficially Owned After the Offering | |
| |
| | |
| | |
Shares | | |
Percent | |
ads-tec Holding GmbH(1) | |
| 18,820,882 | | |
| 1,200,000 | | |
| 17,620,882 | | |
| 33.1 | % |
Lani Invest AS(2) | |
| 33,333 | | |
| 33,333 | | |
| — | | |
| — | |
Matheus Hovers(3) | |
| 719,085 | | |
| 26,667 | | |
| 692,419 | | |
| 1.3 | % |
Patrick Moroney(4) | |
| 25,000 | | |
| 10,000 | | |
| 15,000 | | |
| * | |
Pieter Taselaar(5) | |
| 508,563 | | |
| 26,667 | | |
| 481,896 | | |
| * | |
The Lucerne Capital Master Fund, L.P. (6) | |
| 11,315,304 | | |
| 6,946,669 | | |
| 4,368,635 | | |
| 8.2 | % |
The Lucerne Capital Nordic Master Fund, Ltd. (7) | |
| 290,315 | | |
| 66,667 | | |
| 223,648 | | |
| * | |
The Lucerne Capital Special Opportunity Fund, Ltd. (8) | |
| 803,846 | | |
| 133,333 | | |
| 670,513 | | |
| 1.3 | % |
Thomas Speidel(9) | |
| 599,141 | | |
| 26,667 | | |
| 572,474 | | |
| 1.1 | % |
UFI CAPITAL AS(10) | |
| 33,333 | | |
| 33,333 | | |
| — | | |
| — | |
Wolfgang Breme(11) | |
| 75,441 | | |
| 13,333 | | |
| 62,108 | | |
| * | |
* |
Represents less than 1%. |
(1) |
Consists of (i)17,620 Ordinary Shares, (ii) 400,000 Ordinary Shares issuable upon exercise of the May Warrants, and (iii) 800,000 Ordinary Shares issuable upon exercise of the 2024 Warrants. The business address for ads-tec Holding GmbH is Heinrich-Hertz-Str. 1, Germany 72622 Nürtingen. |
(2) |
Consists of 33,333 Ordinary
Shares issuable upon exercise of the Warrants. The business address for Lani Invest AS is Nedre Storgate 46, 3015 Drammen, Norway. |
(3) |
Consists of (i) 692,419
Ordinary Shares and (ii) 26,667 Ordinary Shares issuable upon exercise of the Warrants. The business address for Matheus Hovers is
169 Milton Road, Rye, New York 10580. |
(4) |
Consists of (i) 25,000
Ordinary Shares and (ii) 10,000 Ordinary Shares issuable upon exercise of the Warrants. The business address for Patrick Moroney
is 92 Ridgewood Rd., Ridgefield, CT 06877. |
(5) |
Consists of (i) 481,896
Ordinary Shares and (ii) 26,667 Ordinary Shares issuable upon exercise of the Warrants. The business address for Pieter Taselaar
is 158 Dunbar Road, Palm Beach, FL 33480. |
(6) |
Consists of 11,315,304
Ordinary Shares, consisting of (i) 4,368,635 Ordinary Shares held by the selling securityholder, (ii) 946,667 Ordinary Shares issuable
upon exercise of the May Warrants, (ii) 2,000,000 Ordinary Shares issuable upon exercise of the August Warrants and (iii) 4,000,002
Ordinary Shares issuable upon exercise of the 2024 Warrants. The business address for The Lucerne Capital Master Fund, L.P. is 73
Arch Street, Greenwich, CT 06830. |
(7) |
Consists of 290,315 Ordinary
Shares, consisting of (223,648 Ordinary Shares held by the selling securityholder and (ii) 66,667 Ordinary Shares issuable upon exercise
of the Warrants. The business address for The Lucerne Capital Nordic Master Fund, Ltd. is 73 Arch Street, Greenwich, CT 06830. |
(8) |
Consists of 803,846 Ordinary
Shares, consisting of (i) 670,513 Ordinary Shares held by the selling securityholder and (ii) 133,333 Ordinary Shares issuable upon
exercise of the Warrants. The business address for The Lucerne Capital Special Opportunity Fund, Ltd. is 73 Arch Street, Greenwich,
CT 06830. |
(9) |
Consists of (i) 572,474
Ordinary Shares and (ii) 26,667 Ordinary Shares issuable upon exercise of the Warrants. The business address for Thomas Speidel is
10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland. |
(10) |
Consists of 33,333 Ordinary
Shares issuable upon exercise of the Warrants. The business address for UFI CAPITAL AS is Bolette Brygge 1, 0121 Oslo, Norway. |
(11) |
Consists of (i) 62,108
Ordinary Shares and (ii) 13,333 Ordinary Shares issuable upon exercise of the Warrants. The business address for Wolfgang Breme is
10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland. |
TAXATION
References
in this “Taxation” section to “Warrants” refer only to the Warrants sold in the 2023 Debt Financings and
not to any of the Company’s other outstanding warrants.
Material
U.S. Federal Income Tax Considerations
The
following discussion is a general summary of certain material U.S. federal income tax considerations to U.S. Holders (as defined below)
of the acquisition, ownership and disposition of the Warrant Shares pursuant to this offering. The information set forth in this section
is based on the Internal Revenue Code of 1986, as amended (the “Code”), its legislative history, final, temporary and proposed
U.S. Treasury regulations promulgated thereunder (“Treasury Regulations”), published rulings and administrative pronouncements
of the U.S. Internal Revenue Service (the “IRS”) and court decisions, all as in effect as of the date hereof. These authorities
are subject to change or differing interpretations, possibly on a retroactive basis, in a manner that could adversely affect the tax
considerations discussed below.
For
purposes of this summary, a “U.S. Holder” means a beneficial owner of Warrant Shares that is for U.S. federal income tax
purposes:
|
● |
an individual citizen or
resident of the United States; |
|
● |
a corporation (or other
entity treated as a corporation) that is created or organized in or under the laws of the United States, any state thereof or the
District of Columbia; |
|
● |
an estate whose income
is includible in gross income for U.S. federal income tax purposes regardless of its source; or |
|
● |
a trust if (i) a U.S. court
can exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all
substantial decisions of the trust, or (ii) it has a valid election in effect under applicable Treasury Regulations to be treated
as a U.S. person. |
This
discussion does not address all aspects of U.S. federal income taxation that may be relevant to any particular U.S. Holder based on such
U.S. Holder’s individual circumstances. In particular, this discussion considers only U.S. Holders that hold Warrant Shares as
“capital assets” within the meaning of Section 1221 of the Code (generally, property held for investment). This discussion
does not address the alternative minimum tax, the Medicare tax on net investment income or the U.S. federal income tax consequences to
holders that are subject to special rules, including, without limitation:
|
● |
banks or certain other
financial institutions or financial services entities; |
|
● |
brokers, dealers or traders
in securities; |
|
● |
persons that are subject
to the mark-to-market accounting rules under Section 475 of the Code; |
|
● |
governments or agencies
or instrumentalities thereof; |
|
● |
tax-qualified retirement
plans; |
|
● |
regulated investment companies; |
|
● |
real estate investment
trusts; |
|
● |
certain expatriates or
former long-term residents of the United States; |
|
● |
persons that acquired Warrant
Shares pursuant to an exercise of employee options, in connection with employee incentive plans or otherwise as compensation; |
|
● |
persons that hold Warrant
Shares, or who will hold Warrant Shares, as part of a straddle, constructive sale, hedging, redemption or other risk reduction strategy
or as part of a conversion transaction or other integrated transaction; |
|
● |
persons whose functional
currency is not the U.S. dollar; |
|
● |
corporations that accumulate
earnings to avoid U.S. federal income tax (and their shareholders); |
|
● |
S corporations, partnerships
or entities or arrangements treated as partnerships or other pass-through entities for U.S. federal income tax purposes, or shareholders,
partners or members of such S corporations, partnerships or other pass-through entities; |
|
● |
persons required to accelerate
the recognition of any item of gross income with respect to Warrant Shares as a result of such income being recognized on an applicable
financial statement; |
|
● |
persons who actually or
constructively own 5% (measured by vote or value) or more of Ordinary Shares; and |
|
● |
holders that are not U.S.
Holders. |
This
discussion does not address any tax laws other than the U.S. federal income tax law, such as U.S. federal gift or estate tax laws, state,
local or non-U.S. tax laws.
If
a partnership (or other entity or arrangement classified as a partnership for U.S. federal income tax purposes) is the beneficial owner
of Warrant Shares, the U.S. federal income tax treatment of a partner in the partnership will generally depend on the status of the partner
and the activities of the partnership. A holder that is a partnership and the partners in such partnership should consult their tax advisors
with regard to the U.S. federal income tax consequences of the acquisition, ownership and disposition of Warrant Shares.
No
ruling has been requested or will be obtained from the IRS regarding the U.S. federal income tax consequences of acquiring, owning or
disposing Warrant Shares or any other related matter or other matter discussed herein. There can be no assurance that the IRS will not
challenge the U.S. federal income tax treatment described below or that, if challenged, such treatment will be sustained by a court.
EACH
HOLDER OF WARRANT SHARES SHOULD CONSULT ITS TAX ADVISORS WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES TO SUCH HOLDERS OF THE ACQUISITION,
OWNERSHIP AND DISPOSITION OF WARRANT SHARES, INCLUDING THE EFFECTS OF U.S. FEDERAL, STATE, AND LOCAL AND NON-U.S. TAX LAWS.
Distributions
on Warrant Shares
Subject
to the PFIC rules discussed in the section below titled “— Passive Foreign Investment Company Status,” if ADSE
Holdco makes a distribution of cash or other property to a U.S. Holder of Warrant Shares, such distribution generally will be treated
as a dividend for U.S. federal income tax purposes to the extent the distribution is paid out of ADSE Holdco’s current or accumulated
earnings and profits (as determined under U.S. federal income tax principles). Distributions in excess of such earnings and profits generally
will be applied against and reduce (but not below zero) a U.S. Holder’s basis in its Warrant Shares, and any remaining excess will
be treated as gain from the sale or exchange of such Warrant Shares (see “— Sale, Exchange, Redemption or Other Taxable
Disposition of Warrant Shares” below).
With
respect to corporate U.S. Holders, dividends with respect to Warrant Shares generally will not be eligible for the dividends-received
deduction generally allowed to U.S. corporations in respect of dividends received from other U.S. corporations. With respect to non-corporate
U.S. Holders, ADSE Holdco dividends generally will be taxed as “qualified dividend income” at preferential long-term capital
gains rates if (i) Warrant Shares are readily tradable on an established securities market in the United States or ADSE Holdco is eligible
for the benefits of an approved qualifying income tax treaty with the United States that includes an exchange of information program,
(ii) certain holding period and at-risk requirements are met, (iii) ADSE Holdco is not treated as a PFIC in the taxable year in which
the dividend is paid or the preceding taxable year, and (iv) certain other requirements are met. U.S. Holders should consult their tax
advisors regarding the availability of the preferential rate for any dividends paid with respect to Warrant Shares.
Subject
to certain conditions and limitations, withholding taxes, if any, on dividends paid by ADSE Holdco may be treated as foreign taxes eligible
for credit against a U.S. Holder’s U.S. federal income tax liability under the U.S. foreign tax credit rules. For purposes of calculating
the U.S. foreign tax credit, dividends paid on Warrant Shares will generally be treated as non-U.S. source income and will generally
constitute passive category income. The rules governing the U.S. foreign tax credit are complex. U.S. Holders should consult their tax
advisors regarding the availability of the U.S. foreign tax credit under particular circumstances.
Sale,
Exchange, Redemption or Other Taxable Disposition of Warrant Shares
Subject
to the PFIC rules discussed in the section below titled “— Passive Foreign Investment Company Status,” upon
a sale, exchange, redemption or other taxable disposition of Warrant Shares, a U.S. Holder will generally recognize capital gain or loss.
The amount of gain or loss recognized generally will be equal to the difference between (i) the sum of the amount of cash and the fair
market value of any property received in such sale, exchange, redemption or other taxable disposition, and (ii) such U.S. Holder’s
adjusted tax basis in the Warrant Shares sold.
Capital
gain or loss will generally constitute long-term capital gain or loss if a U.S. Holder’s holding period for the Warrant Shares
exceeds one year. Long-term capital gains recognized by non-corporate U.S. Holders may be taxable at preferential rates. The deductibility
of capital losses is subject to limitations. For purposes of calculating the U.S. foreign tax credit, gain or loss recognized by a U.S.
Holder upon the sale, exchange, redemption or other taxable disposition of Warrant Shares will generally be treated as U.S. source gain
or loss. The rules governing the U.S. foreign tax credit are complex. U.S. Holders should consult their tax advisors regarding the availability
of the U.S. foreign tax credit under particular circumstances.
Passive
Foreign Investment Company Status
A
non-U.S. corporation, such as ADSE Holdco, will be classified as a PFIC if either: (a) at least 75% of its gross income is “passive
income” for purposes of the PFIC rules, or (b) at least 50% of the value of its gross assets (determined on the basis of a quarterly
average) is attributable to assets that produce or are held for the production of passive income. Passive income for this purpose generally
includes dividends, interest, royalties, rents, gains from commodities and securities transactions, and net gains from the disposition
of assets which produce passive income. A corporation will be treated as owning a proportionate share of the assets and earning a proportionate
share of the income of another corporation if the first-mentioned corporation owns, directly or indirectly, 25% or more (by value) of
the stock of the other corporation.
ADSE
Holdco does not believe that it was a PFIC for its most recently completed taxable year and, based on the composition of our current
gross assets and income and the manner in which it expects to operate its business in the current taxable year and future taxable years,
does not currently expect to be classified as a PFIC for the current taxable year or foreseeable future taxable years. However,
this is a factual determination that must be made annually at the close of each taxable year and depends, among other things, upon the
composition of ADSE Holdco’s gross income and assets. Additionally, the value of ADSE Holdco’s assets for purposes of the
PFIC determination will generally be determined by reference to its market capitalization, which is likely to fluctuate. Accordingly,
there can be no assurance that ADSE Holdco will not be a PFIC for the current taxable year or in future taxable years.
If
ADSE Holdco is determined to be a PFIC for any taxable year (or any portion thereof) that is included in the holding period of a U.S.
Holder and, in the case of Warrant Shares, such U.S. Holder did not make a timely and effective qualified electing fund (“QEF”)
election or a mark-to-market election (each described below) for ADSE Holdco’s first taxable year as a PFIC in which such U.S.
Holder held (or was deemed to hold) Warrant Shares, then such U.S. Holder will generally be subject to special and adverse rules with
respect to (i) any gain recognized by such U.S. Holder on the sale or other disposition of its Warrant Shares and (ii) any “excess
distribution” made to a U.S. Holder (generally, any distributions to a U.S. Holder during a taxable year of such U.S. Holder that
are greater than 125% of the average annual distributions received by such U.S. Holder in respect of Warrant Shares during the three
preceding taxable years of such U.S. Holder or, if shorter, such U.S. Holder’s holding period for such Warrant Shares). Under these
default PFIC rules:
|
● |
a U.S. Holder’s gain
or excess distribution will be allocated ratably over such U.S. Holder’s holding period for its Warrant Shares; |
|
● |
the amount of gain allocated
to such U.S. Holder’s taxable year in which such U.S. Holder recognized the gain or received the excess distribution, or to
the period in such U.S. Holder’s holding period before the first day of ADSE Holdco’s taxable year in which it was a
PFIC, will be taxed as ordinary income; and |
|
● |
the amount of gain allocated
to other taxable years (or portions thereof) of such U.S. Holder and included in such U.S. Holder’s holding period will be
taxed at the highest marginal tax rate in effect for that year and applicable to such U.S. Holder, and an additional amount equal
to the interest charge generally applicable to underpayments of tax will be imposed in respect of the tax attributable to each such
other taxable year (or portion thereof) of such U.S. Holder’s holding period. |
In
general, a U.S. Holder may avoid the adverse PFIC tax consequences described above in respect of the Warrant Shares by making and maintaining
a timely and valid QEF election (if eligible to do so) to include in income its pro rata share of ADSE Holdco’s net capital gains
(as long-term capital gain) and other earnings and profits (as ordinary income), on a current basis, in each case whether or not distributed,
in the taxable year of the U.S. Holder in which or with which ADSE Holdco’s taxable year ends. In order to comply with the requirements
of a QEF election, a U.S. Holder must receive certain information from ADSE Holdco. ADSE Holdco has not determined whether it will provide
U.S. Holders with this information if it determines that it is a PFIC.
Alternatively,
if ADSE Holdco is a PFIC and the Warrant Shares are treated as “marketable stock,” a U.S. Holder may also be to avoid the
adverse PFIC tax consequences described above if such U.S. Holder, at the close of the first taxable year in which it holds (or is deemed
to hold) the Warrant Shares, makes an election to mark such shares to their market value for such taxable year (a “mark-to-market
election”). Such U.S. Holder generally will include as ordinary income for each year that ADSE Holdco is treated as a PFIC the
excess, if any, of the fair market value of its Warrant Shares at the end of its taxable year over such U.S. Holder’s adjusted
basis in its Warrant Shares. Such U.S. Holder also will be allowed to take an ordinary loss in respect of the excess, if any, of its
adjusted basis of its Warrant Shares over the fair market value of its Warrant Shares at the end of its taxable year (but only to the
extent of the net amount of previously included income as a result of the mark-to-market election). Such U.S. Holder’s basis in
its Warrant Shares will be adjusted to reflect any such income or loss recognized. Gain recognized on a sale or other taxable disposition
of the Warrant Shares in a taxable year in which ADSE Holdco is a PFIC will be treated as ordinary income, and any loss will be ordinary
to the extent of the net amount of previously included income as a result of the mark-to-market election (and thereafter will be capital
loss, the deductibility of which is subject to limitations).
The
mark-to-market election is available for “marketable stock,” which generally is stock that is regularly traded on a national
securities exchange that is registered with the Securities and Exchange Commission, including NASDAQ, or on a foreign exchange or market
that the IRS determines has rules sufficient to ensure that the market price represents a legitimate and sound fair market value. U.S.
Holders should consult their tax advisors regarding the availability and tax consequences of a mark-to-market election in their particular
circumstances.
If
ADSE Holdco is a PFIC and, at any time, any subsidiary is classified as a PFIC, U.S. Holders would generally be deemed to own a portion
of the shares of such lower-tier PFIC, and generally could incur liability under the default PFIC rules described above if ADSE Holdco
receives a distribution from, or disposes of all or part of ADSE Holdco’s interest in, the lower-tier PFIC or if such U.S. Holders
otherwise are deemed to have disposed of an interest in the lower-tier PFIC. A mark-to-market election generally would not be available
with respect to such lower-tier PFIC. U.S. Holders are urged to consult their tax advisors regarding the tax issues raised by lower-tier
PFICs.
A
U.S. Holder that owns (or is deemed to own) shares in a PFIC during any taxable year of such U.S. Holder may be required to file IRS
Form 8621 with such U.S. Holder’s U.S. federal income tax return and provide such other information as may be required by the Treasury
Regulations or other IRS guidance.
The
rules dealing with PFICs are very complex and affected by various factors in addition to those described above. Accordingly, U.S. Holders
should consult their tax advisors concerning the application of the PFIC rules to the Warrant Shares under their particular circumstances.
Information
Reporting and Backup Withholding
Certain
U.S. Holders are required to report information to the IRS relating to an interest in “specified foreign financial assets,”
including shares issued by a non-U.S. corporation, for any year in which the aggregate value of all specified foreign financial assets
exceeds an applicable threshold based on whether the U.S. Holder is an entity or an individual (and in the case of an individual, the
threshold depends upon such individual’s filing status and whether the individual resides in the United States), subject to certain
exceptions (including an exception for shares held in custodial accounts maintained with a U.S. financial institution). Generally, ADSE
Holdco securities would constitute “specified foreign financial assets.” Penalties may apply if a U.S. Holder is required
to submit such information to the IRS and fails to do so.
Distributions
with respect to Warrant Shares and proceeds from the sale, exchange, redemption or other taxable disposition of Warrant Shares may be
subject to information reporting to the IRS and possible U.S. backup withholding at a current rate of 24%. Backup withholding will not
apply, however, to a U.S. Holder who furnishes a correct taxpayer identification number and makes any other required certification on
IRS Form W-9 or who is otherwise exempt from backup withholding. U.S. Holders who are required to establish their exempt status generally
must provide such certification on IRS Form W-9.
U.S.
backup withholding is not an additional tax. Amounts withheld as U.S. backup withholding may be credited against a U.S. Holder’s
U.S. federal income tax liability, and a U.S. Holder may obtain a refund of any excess amounts withheld under the backup withholding
rules, if the required information is timely furnished to the IRS. Transactions effected through certain brokers or other intermediaries
may be subject to U.S. backup withholding, and such brokers or intermediaries may be required by law to do U.S. backup withholding.
U.S.
Holders are urged to consult their tax advisors regarding the application of the U.S. information reporting and backup withholding rules.
Anticipated
Material Irish Tax Consequences to Non-Irish Holders of Warrant Shares
Scope
The
following is a summary of the anticipated material Irish tax consequences for certain beneficial holders of the acquisition, ownership
and disposal of Warrant Shares. The summary is based upon Irish tax laws and the practice of the Irish Revenue Commissioners in effect
on the date of this prospectus and stamp duty and withholding tax clearances which have been granted by the Irish Revenue Commissioners.
Changes in law and/or administrative practice may result in a change in the tax consequences described below, possibly with retrospective
effect.
A
“Non-Irish Holder” is an individual who beneficially owns their Warrant Shares, that is neither a resident nor ordinarily
resident in Ireland for Irish tax purposes and does not hold their Warrant Shares, in connection with a trade carried on by such person
through an Irish branch or agency.
This
summary does not constitute tax advice and is intended only as a general guide. The summary is not exhaustive and securityholders should
consult their tax advisors about the Irish tax consequences (and tax consequences under the laws of other relevant jurisdictions) of
the acquisition, ownership and disposal of Warrant Shares. The summary applies only to Non-Irish Holders who hold their Warrant Shares
as capital assets and does not apply to other categories of Non-Irish Holders, such as dealers in securities, trustees, insurance companies,
collective investment schemes and Non-Irish Holders who acquired, or are deemed to have acquired, their Warrant Shares by virtue of an
Irish office or employment (performed or carried on to any extent in Ireland).
The
summary does not, except where expressly stated, consider the position of Non-Irish Holders who hold their Warrant Shares directly (and
not beneficially through a broker or custodian (through DTC)). The Irish tax consequences of transactions in Ordinary Shares and/or Warrants
held directly are generally negative when compared with Warrant Shares held through DTC. Any Non-Irish Holder contemplating holding their
Warrant Shares directly should consult their personal tax advisors as to the Irish tax consequences of acquiring, owning and disposing
of such Warrant Shares.
Irish
Tax on Chargeable Gains (Irish CGT)
The
current rate of tax on chargeable gains (where applicable) in Ireland is 33%. Non-Irish Holders will not be within the territorial scope
of a charge to Irish CGT on a disposal of their Warrant Shares unless such Warrant Shares are used in or for the purposes of a trade
carried on by such Non-Irish Holder through an Irish branch or agency, are used, held or acquired for use by or for the purposes of an
Irish branch or agency, or the shares derive the greater part of their value from Irish land.
A
Non-Irish Holder of Warrant Shares who is an individual and who is temporarily non-resident in Ireland may, under Irish anti-avoidance
legislation, be liable to Irish tax on any chargeable gain realized on a disposal of Warrant Shares during the period in which such individual
is non-resident.
Stamp
Duty
The
rate of stamp duty (where applicable) on transfers of shares of Irish incorporated companies is 1% of the greater of the price paid or
market value of the shares acquired. Where Irish stamp duty arises it is generally a liability of the transferee. However, in the case
of a gift or transfer at less than fair market value, all parties to the transfer are jointly and severally liable.
Irish
stamp duty may be payable in respect of transfers of Warrant Shares, depending on the manner in which the Warrant Shares are held. ADSE
Holdco has entered into arrangements with DTC to allow the Warrant Shares to be settled through the facilities of DTC. As such, the discussion
below discusses separately the securityholders who hold their shares through DTC and those who do not.
Warrant
Shares Held Through DTC
The
Irish Revenue Commissioners have confirmed to ADSE Holdco that transfers of Warrant Shares effected by means of the transfer of book
entry interests in DTC will not be subject to Irish stamp duty.
Warrant
Shares Held Outside of DTC or Transferred Into or Out of DTC
A
transfer of Warrant Shares where any party to the transfer holds such Warrant Shares outside of DTC may be subject to Irish stamp duty.
Holders
of Warrant Shares wishing to transfer their Warrant Shares into (or out of) DTC may do so without giving rise to Irish stamp duty provided
that:
|
● |
there is no change in the
beneficial ownership of such shares as a result of the transfer; and |
|
● |
the transfer into (or out
of) DTC is not effected in contemplation of a sale of such shares or warrants by a beneficial owner to a third party. |
Due
to the potential Irish stamp charge on transfers of Warrant Shares held outside of DTC, it is strongly recommended that those securityholders
who do not hold their ADSE Holdco securities through DTC (or through a broker who in turn holds such shares through DTC) should arrange
for the transfer of their ADSE Holdco securities as into DTC as soon as possible.
Withholding
Tax on Dividends (DWT)
Distributions
made by ADSE Holdco will, in the absence of one of many exemptions, be subject to DWT, currently at a rate of 25%.
For
DWT and Irish income tax purposes, a distribution includes any distribution that may be made by ADSE Holdco to holders of Ordinary Shares,
including cash dividends, non-cash dividends and additional stock taken in lieu of a cash dividend. Where an exemption from DWT does
not apply in respect of a distribution made to a holder of Ordinary Shares, ADSE Holdco is responsible for withholding DWT prior to making
such distribution.
General
Exemptions
Irish
domestic law provides that a non-Irish resident holder of Ordinary Shares is not subject to DWT on distributions received from ADSE Holdco
if such holder of Ordinary Shares is beneficially entitled to the distribution and is either:
|
● |
a person (not being a company)
resident for tax purposes in a Relevant Territory (including the United States) and is neither resident nor ordinarily resident in
Ireland (for a list of Relevant Territories for DWT purposes, please see Annex A to this prospectus); |
|
● |
a company resident for
tax purposes in a Relevant Territory, provided such company is not under the control, whether directly or indirectly, of a person
or persons who is or are resident in Ireland; |
|
● |
a company that is controlled,
directly or indirectly, by persons resident in a Relevant Territory and who is or are (as the case may be) not controlled by, directly
or indirectly, persons who are not resident in a Relevant Territory; |
|
● |
a company whose principal
class of shares (or those of its 75% direct or indirect parent) is substantially and regularly traded on a stock exchange in Ireland,
on a recognized stock exchange either in a Relevant Territory or on such other stock exchange approved by the Irish Minister for
Finance; or |
|
● |
a company that is wholly
owned, directly or indirectly, by two or more companies where the principal class of shares of each of such companies is substantially
and regularly traded on a stock exchange in Ireland, a recognized stock exchange in a Relevant Territory or on such other stock exchange
approved by the Irish Minister for Finance |
and
provided, in all cases noted above (but subject to “Ordinary—Shares Held by U.S. Resident Shareholders” below),
ADSE Holdco or, in respect of Ordinary Shares held through DTC, any qualifying intermediary appointed by ADSE Holdco, has received from
the holder of such Ordinary Shares, where required, the relevant DWT Forms prior to the payment of the distribution. In practice, in
order to ensure sufficient time to process the receipt of relevant DWT Forms, the holders of Ordinary Shares, where required, should
furnish the relevant DWT Form to:
|
● |
its broker (and the relevant
information is further transmitted to any qualifying intermediary appointed by ADSE Holdco) before the record date for the distribution
(or such later date before the distribution payment date as may be notified to the holder of Ordinary Shares by the broker) if its
Ordinary Shares are held through DTC; or |
|
● |
ADSE Holdco’s transfer
agent before the record date for the distribution if its Ordinary Shares are held outside of DTC. |
Links
to the various DWT Forms are available at: https://www.revenue.ie/en/companies-and-charities/dividend-withholding-tax/exemptions-for-non-residents.aspx.
The information on such website does not constitute a part of, and is not incorporated by reference into, this prospectus.
For
non-Irish resident holders of Ordinary Shares that cannot avail themselves of one of Ireland’s domestic law exemptions from DWT,
it may be possible for such holder of Ordinary Shares to rely on the provisions of a double tax treaty to which Ireland is party to reduce
the rate of DWT.
Ordinary
Shares Held by U.S. Resident Shareholders
Distributions
paid in respect of Ordinary Shares that are owned by a U.S. resident and held through DTC will not be subject to DWT provided the address
of the beneficial owner of such Ordinary Shares in the records of the broker holding such Ordinary Shares is in the United States (and
such broker has further transmitted the relevant information to a qualifying intermediary appointed by ADSE Holdco). It is strongly recommended
that such holders of Ordinary Shares ensure that their information is properly recorded by their brokers (so that such brokers can further
transmit the relevant information to a qualifying intermediary appointed by ADSE Holdco).
Distributions
paid in respect of Ordinary Shares that are held outside of DTC and are owned by a resident of the United States will not be subject
to DWT if such holder of Ordinary Shares provides a completed IRS Form 6166 or a valid DWT Form to ADSE Holdco’s transfer agent
to confirm its U.S. residence and claim an exemption. It is strongly recommended that holders of Ordinary Shares (which are to be held
outside of DTC) who are U.S. residents provide the appropriate completed IRS Form 6166 or DWT Form to ADSE Holdco’s transfer agent
as soon as possible after receiving their Ordinary Shares.
If
any holder of Ordinary Shares that is resident in the United States receives a distribution from which DWT has been withheld, the holder
Ordinary Shares should generally be entitled to apply for a refund of such DWT from the Irish Revenue Commissioners, provided the holder
of ordinary shares is beneficially entitled to the distribution.
Ordinary
Shares Held by Residents of Relevant Territories Other Than the United States
Holders
of Ordinary Shares who are residents of Relevant Territories, other than the United States, must satisfy the conditions of one of the
exemptions referred to above under the heading “—General Exemptions”, including the requirement to furnish valid
DWT Forms, in order to receive distributions without suffering DWT. If such holders of Ordinary Shares hold their Ordinary Shares through
DTC, they must provide the appropriate DWT Forms to their brokers (so that such brokers can further transmit the relevant information
to a qualifying intermediary appointed by ADSE Holdco) before the record date for the distribution (or such later date before the distribution
payment date as may be notified to holder of Ordinary Shares by the broker). If such holders of Ordinary Shares hold their Ordinary Shares
outside of DTC, they must provide the appropriate DWT Forms to ADSE Holdco’s transfer agent before the record date for the distribution.
It is strongly recommended that such holders of Ordinary Shares complete the appropriate DWT Forms and provide them to their brokers
or ADSE Holdco’s transfer agent, as the case may be, as soon as possible after receiving their Ordinary Shares.
If
any holder of Ordinary Shares who is resident in a Relevant Territory receives a distribution from which DWT has been withheld, the holder
of Ordinary Shares may be entitled to a refund of DWT from the Irish Revenue Commissioners provided the holder of Ordinary Shares is
beneficially entitled to the distribution.
Shares
Held by Other Persons
Holders
of Ordinary Shares that do not fall within any of the categories specifically referred to above may nonetheless fall within other exemptions
from DWT. If any holders of Ordinary Shares are exempt from DWT, but receive distributions subject to DWT, such holders of Ordinary Shares
may apply for refunds of such DWT from the Irish Revenue Commissioners.
Distributions
paid in respect of Ordinary Shares held through DTC that are owned by a partnership formed under the laws of a Relevant Territory and
where all the underlying partners are resident in a Relevant Territory will be entitled to exemption from DWT if all of the partners
complete the appropriate DWT Forms and provide them to their brokers (so that such brokers can further transmit the relevant information
to a qualifying intermediary appointed by ADSE Holdco) before the record date for the distribution (or such later date before the distribution
payment date as may be notified to the holder of Ordinary Shares by the broker). If any partner is not a resident of a Relevant Territory,
no part of the partnership’s position is entitled to exemption from DWT.
Qualifying
Intermediary
Prior
to paying any distribution, ADSE Holdco will put in place an agreement with an entity that is recognized by the Irish Revenue Commissioners
as a “qualifying intermediary,” which will provide for certain arrangements relating to distributions in respect of Ordinary
Shares that are held through DTC, which are referred to as the “Deposited Securities.” The agreement will provide that the
qualifying intermediary shall distribute or otherwise make available to Cede & Co., as nominee for DTC, any cash dividend or other
cash distribution with respect to the Deposited Securities after ADSE Holdco delivers or causes to be delivered to the qualifying intermediary
the cash to be distributed.
ADSE
Holdco will rely on information received directly or indirectly from its qualifying intermediary, brokers and its transfer agent in determining
where holders of Ordinary Shares reside, whether they have provided the required U.S. tax information and whether they have provided
the required DWT Forms. Holders of Ordinary Shares that are required to file DWT Forms in order to receive distributions free of DWT
should note that such forms are generally valid, subject to a change in circumstances, until December 31 of the fifth year after the
year in which such forms were completed.
Additional
Anti-avoidance Measures
Notwithstanding
the above stated exemptions, payments of distributions to associated entities in jurisdictions that are on the EU list of non-cooperative
jurisdictions or zero-tax jurisdictions may be subject to DWT on payment. Association for these purposes generally means a 50% ownership
connection (assessed on the basis of share ownership, voting power or entitlement to profits on a distribution) or the ability to participate
in the board of directors in a manner that causes, or could cause, the affairs of the company to be conducted in accordance with that
person’s wishes.
Income
Tax on Dividends Paid on Ordinary Shares
Irish
income tax may arise for certain persons in respect of distributions received from Irish resident companies.
A
Non-Irish Holder that is entitled to an exemption from DWT will generally have no Irish income tax or universal social charge liability
on a distribution from ADSE Holdco. A Non-Irish Holder that is not entitled to an exemption from DWT, and therefore is subject to DWT,
generally will have no additional Irish income tax liability or liability to universal social charge. The DWT deducted by ADSE Holdco
discharges the Irish income tax liability.
Capital
Acquisitions Tax (CAT)
CAT
comprises principally gift tax and inheritance tax on property situated in Ireland for CAT purposes or otherwise within the territorial
scope of CAT. CAT could apply to a gift or inheritance of Ordinary Shares and Warrants because Ordinary Shares and Warrants are regarded
as property situated in Ireland for CAT purposes. The person who receives the gift or inheritance has primary liability for CAT.
CAT
is currently levied at a rate of 33% on the value of any taxable gift or inheritance above certain tax-free thresholds. The appropriate
tax-free threshold depends upon (1) the relationship between the donor and the donee and (2) the aggregation of the values of previous
taxable gifts and inheritances received by the donee from persons within the same group threshold. Gifts and inheritances passing between
spouses are exempt from CAT, as are gifts to certain charities. Children have a lifetime tax-free threshold of €400,000 in respect
of taxable gifts or inheritances received from their parents. There is also a “small gift exemption” from CAT whereby the
first €3,000 of the taxable value of all taxable gifts taken by a donee from any one donor, in each calendar year, is exempt from
CAT and is also excluded from any future aggregation. This exemption does not apply to an inheritance.
THE
IRISH TAX CONSIDERATIONS SUMMARIZED ABOVE ARE FOR GENERAL INFORMATION ONLY AND ARE NOT INTENDED TO PROVIDE ANY DEFINITIVE TAX REPRESENTATIONS
TO HOLDERS. EACH SECURITYHOLDER SHOULD CONSULT HIS OR HER TAX ADVISOR AS TO THE PARTICULAR CONSEQUENCES THAT MAY APPLY TO SUCH SECURITYHOLDER.
PLAN
OF DISTRIBUTION
We
are registering the resale from time to time by the selling securityholders of up to 10,516,670 Ordinary Shares issuable upon exercise
of the Warrants. We are also registering any additional securities that may become issuable by reason of share splits, share dividends
or other similar transactions. All of the Warrant Shares offered by the selling securityholders pursuant to this prospectus will be sold
by each selling securityholder for its own account. We will not receive any proceeds from the sale of the Warrant Shares by the selling
securityholders.
The
selling securityholders will pay any underwriting discounts and commissions and expenses incurred by the selling securityholders for
brokerage, accounting, tax or legal services or any other expenses incurred by the selling securityholders in disposing of the securities.
We will bear all other costs, fees and expenses incurred in effecting the registration of the securities covered by this prospectus,
including, without limitation, all registration and filing fees, Nasdaq listing fees and fees and expenses of our counsel and our independent
registered public accountants.
The
securities beneficially owned by the selling securityholders covered by this prospectus may be offered and sold from time to time by
the selling securityholders. The term “selling securityholders” includes donees, pledgees, transferees or other successors
in interest selling securities received after the date of this prospectus from the selling securityholders as a gift, pledge, partnership
distribution or other transfer. The selling securityholders will act independently of us in making decisions with respect to the timing,
manner and size of each sale. Such sales may be made on one or more exchanges or in the over-the-counter market or otherwise, at prices
and under terms then prevailing or at prices related to our then current market price or in negotiated transactions. The selling securityholders
reserve the right to accept and, together with its agent, to reject, any proposed purchase of securities to be made directly or through
its agent. The selling securityholders and any of their permitted transferees may sell their securities offered by this prospectus on
any stock exchange, market or trading facility on which the securities are traded or in private transactions. If underwriters are used
in the sale, such underwriters will acquire the shares for their own account. These sales may be at a fixed price or varying prices,
which may be changed, or at market prices prevailing at the time of sale, at prices relating to prevailing market prices or at negotiated
prices. The securities may be offered to the public through underwriting syndicates represented by managing underwriters or by underwriters
without a syndicate. The obligations of the underwriters to purchase the securities will be subject to certain conditions. The underwriters
will be obligated to purchase all the securities offered if any of the securities are purchased.
The
selling securityholders may use any one or more of the following methods when selling the securities offered by this prospectus:
|
● |
purchases by a broker-dealer
as principal and resale by such broker-dealer for its own account pursuant to this prospectus; |
|
● |
ordinary brokerage transactions
and transactions in which the broker solicits purchasers; |
|
● |
block trades in which the
broker-dealer so engaged will attempt to sell the securities as agent but may position and resell a portion of the block as principal
to facilitate the transaction; |
|
● |
an over-the-counter distribution
in accordance with the rules of Nasdaq; |
|
● |
through trading plans entered
into by the selling securityholders pursuant to Rule 10b5-1 under the Exchange Act that are in place at the time of an offering pursuant
to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of its securities on the basis
of parameters described in such trading plans; |
|
● |
distribution to employees,
members, limited partners or stockholders of the selling securityholders; |
|
● |
through the writing or
settlement of options or other hedging transaction, whether through an options exchange or otherwise; |
|
● |
by pledge to secured debt
and other obligations; |
|
● |
delayed delivery arrangement; |
|
● |
to or through underwriters
or broker-dealers; |
|
● |
in “at the market”
offerings, as defined in Rule 415 under the Securities Act, at negotiated prices; |
|
● |
at prices prevailing at
the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange
or sales made through a market maker other than on an exchange or other similar offerings through sales agents; |
|
● |
directly to purchasers,
including through a specific bidding, auction or other process or in privately negotiated transactions; |
|
● |
in options transactions; |
|
● |
through a combination of
any of the above methods of sale; or |
|
● |
any other method permitted
pursuant to applicable law. |
In
addition, the selling securityholders may elect to make a pro rata in-kind distribution of securities to its members, partners
or shareholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus or prospectus supplement
with a plan of distribution. Such members, partners or shareholders would thereby receive freely tradeable securities pursuant to the
distribution through a registration statement. To the extent a distributee is an affiliate of ours (or to the extent otherwise required
by law), we may file a prospectus supplement in order to permit the distributees to use the prospectus to resell the securities acquired
in the distribution.
There
can be no assurance that the selling securityholders will sell all or any of the securities offered by this prospectus. In addition,
the selling securityholders may also sell securities under Rule 144 under the Securities Act, if available, or in other transactions
exempt from registration, rather than under this prospectus. The selling securityholders have the sole and absolute discretion not to
accept any purchase offer or make any sale of securities if it deems the purchase price to be unsatisfactory at any particular time.
The
selling securityholders also may transfer the securities in other circumstances, in which case the transferees, pledgees or other successors-in-interest
will be the selling beneficial owners for purposes of this prospectus. Upon being notified by a selling securityholder that a donee,
pledgee, transferee or other successor-in-interest intends to sell our securities, we will, to the extent required, promptly file a supplement
to this prospectus to name specifically such person as a selling securityholder.
With
respect to a particular offering of the securities held by the selling securityholders, to the extent required, an accompanying prospectus
supplement or, if appropriate, a post-effective amendment to the registration statement of which this prospectus is part, will be prepared
and will set forth the following information:
|
● |
the specific securities
to be offered and sold; |
|
● |
the name of the applicable
selling securityholder; |
|
● |
the respective purchase
prices and public offering prices, the proceeds to be received from the sale, if any, and other material terms of the offering; |
|
● |
settlement of short sales
entered into after the date of this prospectus; |
|
● |
the names of any participating
agents, broker-dealers or underwriters; and |
|
● |
any applicable commissions,
discounts, concessions and other items constituting compensation from the selling securityholder. |
In
connection with distributions of the securities or otherwise, the selling securityholders may enter into hedging transactions with broker-dealers
or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short
sales of the securities in the course of hedging the positions they assume with the selling securityholders. The selling securityholders
may also sell the securities short and redeliver the securities to close out such short positions. The selling securityholders may also
enter into option or other transactions with broker-dealers or other financial institutions that require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). The selling securityholders may also
pledge securities to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution
may effect sales of the pledged securities pursuant to this prospectus (as supplemented or amended to reflect such transaction).
In
order to facilitate the offering of the securities, any underwriters or agents, as the case may be, involved in the offering of such
securities may engage in transactions that stabilize, maintain or otherwise affect the price of our securities. Specifically, the underwriters
or agents, as the case may be, may overallot in connection with the offering, creating a short position in our securities for their own
account. In addition, to cover overallotments or to stabilize the price of our securities, the underwriters or agents, as the case may
be, may bid for, and purchase, such securities in the open market. Finally, in any offering of securities through a syndicate of underwriters,
the underwriting syndicate may reclaim selling concessions allotted to an underwriter or a broker-dealer for distributing such securities
in the offering if the syndicate repurchases previously distributed securities in transactions to cover syndicate short positions, in
stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent
market levels. The underwriters or agents, as the case may be, are not required to engage in these activities, and may end any of these
activities at any time.
The
selling securityholders may solicit offers to purchase the securities directly from, and they may sell such securities directly to, institutional
investors or others. In this case, no underwriters or agents would be involved. The terms of any of those sales, including the terms
of any bidding or auction process, if utilized, will be described in the applicable prospectus supplement.
It
is possible that one or more underwriters may make a market in our securities, but such underwriters will not be obligated to do so and
may discontinue any market making at any time without notice. We cannot give any assurance as to the liquidity of the trading market
for our securities.
The
selling securityholders may authorize underwriters, broker-dealers or agents to solicit offers by certain purchasers to purchase the
securities at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment
and delivery on a specified date in the future. The contracts will be subject only to those conditions set forth in the prospectus supplement,
and the prospectus supplement will set forth any commissions we pay or the selling securityholders pay for solicitation of these contracts.
The
selling securityholders may enter into derivative transactions with third parties or sell securities not covered by this prospectus to
third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives,
the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions.
If so, the third party may use securities pledged by the selling securityholders or borrowed from the selling securityholders or others
to settle those sales or to close out any related open borrowings of stock and may use securities received from the selling securityholders
in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will
be an underwriter and will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, the selling
securityholders may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities
short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in
our securities or in connection with a concurrent offering of other securities.
In
effecting sales, broker-dealers or agents engaged by the selling securityholders may arrange for other broker-dealers to participate.
Broker-dealers or agents may receive commissions, discounts or concessions from the selling securityholders in amounts to be negotiated
immediately prior to the sale.
To
our knowledge, there are currently no plans, arrangements or understandings between the selling securityholders and any broker-dealer
or agent regarding the sale of the securities by the selling securityholder. Upon our notification by the selling securityholders that
any material arrangement has been entered into with an underwriter or broker-dealer for the sale of securities through a block trade,
special offering, exchange distribution, secondary distribution or a purchase by an underwriter or broker-dealer, we will file, if required
by applicable law or regulation, a supplement to this prospectus pursuant to Rule 424(b) under the Securities Act disclosing certain
material information relating to such underwriter or broker-dealer and such offering.
In
compliance with the guidelines of the Financial Industry Regulatory Authority (“FINRA”), the aggregate maximum discount,
commission, fees or other items constituting underwriting compensation to be received by any FINRA member or independent broker-dealer
will not exceed 8% of the gross proceeds of any offering pursuant to this prospectus and any applicable prospectus supplement.
If
at the time of any offering made under this prospectus a member of FINRA participating in the offering has a “conflict of interest”
as defined in FINRA Rule 5121 (“Rule 5121”), that offering will be conducted in accordance with the relevant provisions of
Rule 5121.
We
have agreed to indemnify the selling securityholders against certain liabilities, including certain liabilities under the Securities
Act, the Exchange Act or other federal or state law.
LEGAL
MATTERS
The
validity of the Warrant Shares to be offered by this prospectus and certain legal matters relating to Irish law have been passed upon
by Arthur Cox, LLP, Dublin, Ireland. Any underwriters or agents will be advised about other issues relating to the offering by counsel
to be named in the applicable prospectus supplement.
EXPERTS
The
consolidated financial statements of ADSE as of December 31, 2023 and 2022 and for each of the three years in the period ended December
31, 2023 incorporated by reference in this Prospectus and in the Registration Statement have been so included in reliance on the report
of BDO AG Wirtschaftsprüfungsgesellschaft, an independent registered public accounting firm, given on the authority of said firm
as experts in auditing and accounting. The report on the consolidated financial statements contains an explanatory paragraph regarding
the Company’s ability to continue as a going concern.
ENFORCEMENT
OF CIVIL LIABILITIES
Certain
of our directors and executive officers may be nonresidents of the United States. All or a substantial portion of the assets of such
nonresident persons and of our company are located outside the United States. As a result, it may not be possible to effect service of
process within the United States upon such persons or our company, or to enforce against such persons or us in U.S. Courts judgments
obtained in such courts predicated upon the civil liability provisions of the federal securities laws of the United States. We have been
advised by our Irish counsel that there is doubt as to the enforceability in Ireland against our company and our executive officers and
directors who are non-residents of the United States, in original actions or in actions for enforcement of judgments of U.S. Courts,
of liabilities predicated solely upon the securities laws of the United States.
WHERE
YOU CAN FIND MORE INFORMATION
We
have filed with the SEC a registration statement (including exhibits to the registration statement) on Form F-3 under the Securities
Act. This prospectus, which is part of the registration statement, does not contain all of the information set forth in the registration
statement and the exhibits and schedules to the registration statement. For further information, we refer you to the registration statement
and the exhibits and schedules filed as part of the registration statement. If a document has been filed as an exhibit to the registration
statement, we refer you to the copy of the document that has been filed. Each statement in this prospectus relating to a document filed
as an exhibit is qualified in all respects by the filed exhibit. We are subject to the informational requirements of the Exchange Act
that are applicable to foreign private issuers. Accordingly, we are required to file or furnish reports and other information with the
SEC, including annual reports on Form 20-F and reports on Form 6-K. The SEC maintains an Internet website that contains reports and other
information regarding issuers that file electronically with the SEC. Our filings with the SEC are available to the public through the
SEC’s website at http://www.sec.gov. As a foreign private issuer, we are exempt under the Exchange Act from, among other things,
the rules prescribing the furnishing and content of proxy statements, and our executive officers, directors and principal and selling
securityholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.
In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently
or as promptly as U.S. companies whose securities are registered under the Exchange Act. We maintain a corporate website at https://adstec-energy.com/.
Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus. We have included
our website address in this prospectus solely for informational purposes.
DOCUMENTS
INCORPORATED BY REFERENCE
The
SEC allows the Company to “incorporate by reference” into this prospectus the information we file with or furnish to the
SEC, which means that the Company can disclose important information to you by referring you to those documents. The Company hereby incorporates
by reference in this prospectus the documents listed below and all amendments or supplements we may file to such documents:
|
● |
the Company’s Annual
Report on Form 20-F filed
with the SEC on April 30, 2024; |
|
● |
any future filings on Form
20-F made with the SEC under the Exchange Act after the date of this prospectus and prior to the termination of the offering of the
securities offered by this prospectus; |
|
● |
the Company’s reports
of foreign private issuer on Form 6-K or Form 6-K/A (each, a “Form 6-K”) furnished to the SEC on February
8, 2024, March 14,
2024, April 29, 2024,
April 30, 2024, May
14, 2024, August 30, 2024,
September 4, 2024, September
13, 2024, and October 18
2024; |
|
● |
any future reports on Form
6-K that we furnish to the SEC after the date of this prospectus that are identified in such reports as being incorporated by reference
in this prospectus; and |
|
● |
the description of the
securities contained in our registration statement on Form
8-A filed on December 22, 2021 pursuant to Section 12 of the Exchange Act, together with all amendments and reports filed for
the purpose of updating that description. |
All
documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act and, to the extent
specifically designated therein, Form 6-K’s, in each case, after the date of the initial registration statement of which this prospectus
is a part and prior to the effectiveness of the registration statement, as well as prior to the completion or termination of the offering
of securities under this prospectus, shall be deemed to be incorporated by reference in this prospectus and to be a part hereof from
the date of filing or furnishing of such documents.
Any
statement contained herein or in a document, all or a portion of which is incorporated or deemed to be incorporated by reference herein,
shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in any
other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.
Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.
Notwithstanding
the foregoing, no information is incorporated by reference in this prospectus or any prospectus supplement hereto where such information
under applicable forms and regulations of the SEC is not deemed to be “filed” under Section 18 of the Exchange Act or otherwise
subject to the liabilities of that section, unless the report or filing containing such information indicates that the information therein
is to be considered “filed” under the Exchange Act or is to be incorporated by reference in this prospectus or any prospectus
supplement hereto.
We
will provide to each person, including any beneficial owner, to whom this prospectus is delivered, a copy of any or all the reports or
documents incorporated by reference in this prospectus, at no cost to the requester, upon written or oral request to us at the following
address: ADS-TEC Energy PLC, 10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland.
ANNEX
A – LIST OF RELEVANT TERRITORIES FOR THE PURPOSES OF IRISH DIVIDEND
WITHHOLDING TAX
List
of Relevant Territories: |
|
|
|
|
1. |
The Republic of Albania |
|
2. |
The Republic of Armenia |
|
3. |
Australia |
|
4. |
The Republic of Austria |
|
5. |
The Kingdom of Bahrain |
|
6. |
The Republic of Belarus |
|
7. |
Belgium |
|
8. |
Bosnia and Herzegovina |
|
9. |
The Republic of Botswana |
|
10. |
The Republic of Bulgaria |
|
11. |
Canada |
|
12. |
The Republic of Chile |
|
13. |
The People’s Republic of China |
|
14. |
The Republic of Croatia |
|
15. |
Cyprus |
|
16. |
Czech Republic |
|
17. |
The Kingdom of Denmark |
|
18. |
The Arab Republic of Egypt |
|
19. |
The Republic of Estonia |
|
20. |
The Federal Democratic Republic of Ethiopia |
|
21. |
Finland |
|
22. |
France |
|
23. |
Georgia |
|
24. |
The Federal Republic of Germany |
|
25. |
The Republic of Ghana |
|
26. |
The Hellenic Republic (Greece) |
|
27. |
Hong Kong |
|
28. |
The Republic of Hungary |
|
29. |
The Republic of Iceland |
|
30. |
The Republic of India |
|
31. |
The State of Israel |
|
32. |
Italy |
|
33. |
Japan |
|
34. |
The Republic of Kazakhstan |
|
35. |
Kenya |
|
36. |
The Republic of Korea |
|
37. |
Kosovo |
|
38. |
The State of Kuwait |
|
39. |
The Republic of Latvia |
|
40. |
The Republic of Lithuania |
|
41. |
The Principality of Liechtenstein |
|
42. |
The Grand Duchy of Luxembourg |
|
43. |
The Republic of Macedonia (now the Republic of North
Macedonia) |
|
44. |
Malaysia |
|
45. |
Malta |
|
46. |
The United Mexican States (Mexico) |
|
47. |
The Republic of Moldova |
|
48. |
Montenegro |
|
49. |
The Kingdom of Morocco |
|
50. |
The Kingdom of the Netherlands |
|
51. |
New Zealand |
|
52. |
The Kingdom of Norway |
|
53. |
Oman |
|
54. |
The Islamic Republic of Pakistan |
|
55. |
The Republic of Panama |
|
56. |
The Republic of Poland |
|
57. |
Portuguese Republic |
|
58. |
State of Qatar |
|
59. |
Romania |
|
60. |
Russian Federation |
|
61. |
Kingdom of Saudi Arabia |
|
62. |
The Republic of Serbia |
|
63. |
The Republic of Singapore |
|
64. |
Slovak Republic |
|
65. |
The Republic of Slovenia |
|
66. |
The Republic of South Africa |
|
67. |
Kingdom of Spain |
|
68. |
Sweden |
|
69. |
Switzerland |
|
70. |
Kingdom of Thailand |
|
71. |
The Republic of Turkey |
|
72. |
United Kingdom |
|
73. |
Ukraine |
|
74. |
United Arab Emirates |
|
75. |
The Republic of Uzbekistan |
|
76. |
United States of America |
|
77. |
The Socialist Republic of Vietnam |
|
78. |
The Republic of Zambia |
|
ADS-TEC
ENERGY PUBLIC LIMITED COMPANY
Up
to 10,516,670
ORDINARY SHARES
PROSPECTUS
,
2025
PART
II
Information Not Required in Prospectus
Item
8. Indemnification of Directors and Officers
Pursuant
to ADSE Holdco’s M&A, subject to the provisions of and so far as may be permitted by the Irish Companies Act, every director,
officer or employee of ADSE Holdco, and each person who is or was serving at the request of ADSE Holdco as a director, officer or employee
of another company, or of a partnership, joint venture, trust or other enterprise, shall be entitled to be indemnified by ADSE Holdco
against all costs, charges, losses, expenses and liabilities incurred by him or her in the execution and discharge of his or her duties
or in relation thereto, including any liability incurred by him or her in defending any proceedings, civil or criminal, which relate
to anything done or omitted or alleged to have been done or omitted by him or her as a director, officer or employee of ADSE Holdco or
such other company, partnership, joint venture, trust or other enterprise, and in which judgment is given in his or her favor (or the
proceedings are otherwise disposed of without any finding or admission of any material breach of duty on his or her part) or in which
he or she is acquitted or in connection with any application under any statute for relief from liability in respect of any such act or
omission in which relief is granted to him or her by the court.
The
Irish Companies Act prescribes that such an indemnity only permits a company to pay the costs or discharge the liability of a director
or the secretary where judgment is given in any civil or criminal action in respect of such costs or liability, or where an Irish court
grants relief because the director or secretary acted honestly and reasonably and ought fairly to be excused.
ADSE
Holdco is permitted under its M&A and the Irish Companies Act to purchase directors’ and officers’ liability insurance,
as well as other types of insurance, for its directors, officers and employees.
ADSE
Holdco has entered into deeds of indemnity with its directors and ADSE GM executive officers. Given the director indemnification limitations
arising under Irish law, ADSE Holdco’s subsidiary, ADSE GM and ADSE GM’s subsidiary, ads-tec Energy, Inc. have also entered
into such deeds of indemnity. These agreements, among other things, require ADSE to jointly and severally indemnify ADSE Holdco’s
directors and ADSE directors and executive officers for certain expenses, including attorneys’ fees, judgments, fines and settlement
amounts incurred by any such director or executive officer in any action or proceeding arising out of their services as one of ADSE directors
or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services
at ADSE’s request. We believe that these indemnification deeds are necessary to attract and retain qualified persons as directors
and officers.
Item
9. Exhibits
The
following exhibits are included or incorporated by reference in this registration statement on Form F-3:
Exhibit
Index
Exhibit
No. |
|
Description |
1.1** |
|
Form of Underwriting Agreement |
|
|
|
2.1 |
|
Business
Combination Agreement, dated as of August 10, 2021, by and among European Sustainable Growth Acquisition Corp., ADS-TEC ENERGY PLC,
EUSG II Corporation, Bosch Thermotechnik GmbH, ads-tec Holding GmbH and ads-tec Energy GmbH (incorporated by reference to Exhibit
2.1 to the Registration Statement on Form F-4 (File No. 333-260312)). |
|
|
|
3.1 |
|
Memorandum
and Articles of Association of ADS-TEC ENERGY PLC, incorporated by reference to Exhibit 1.1 to the Registrant’s Shell Company
Report on Form 20-F filed with the SEC on December 29, 2021. |
|
|
|
4.1 |
|
Form
of Promissory Note, dated as of May 5, 2023, by and between ads-tec Energy Inc. and certain investors thereto (incorporated by reference
to Exhibit 10.1 to the Report on Form 6-K furnished to the SEC on May 11, 2023). |
|
|
|
4.2 |
|
Form
of May Warrant, dated as of May 5, 2023, by and between ADS-TEC Energy PLC and certain investors thereto (incorporated by reference
to Exhibit 10.2 to the Report on Form 6-K furnished to the SEC on May 11, 2023). |
|
|
|
4.3 |
|
Form
of August Warrant, dated as of August 18, 2023, by and between ADS-TEC Energy PLC and certain investors thereto (incorporated by
reference to Exhibit 10.2 to the Report on Form 6-K furnished to the SEC on August 25, 2023) |
4.4 |
|
Form
of Secured Promissory Note, dated August 18, 2023, by and between ads-tec Energy Inc. and certain lenders thereto (incorporated by
reference to Exhibit 10.1 to the Report on Form 6-K furnished to the SEC on August 25, 2023). |
|
|
|
4.5 |
|
Form
of Guarantee Agreement, dated as of May 5, 2023, by and between ADS-TEC Energy GMBH and certain lenders thereto (incorporated by
reference to Exhibit 10.3 to the Report on Form 6-K furnished to the SEC on May 11, 2023). |
|
|
|
4.6 |
|
Form
of Guarantee Agreement, dated as of May 5, 2023, by and between ADS-TEC Energy PLC and certain lenders thereto (incorporated by reference
to Exhibit 10.4 to the Report on Form 6-K furnished to the SEC on May 11, 2023). |
|
|
|
4.7 |
|
Form
of Guarantee Agreement, dated as of August 18, 2023, by and between ADS-TEC Energy PLC and certain lenders thereto (incorporated
by reference to Exhibit 10.3 to the Report on Form 6-K furnished to the SEC on August 25, 2023). |
|
|
|
4.8 |
|
Form
of Guarantee Agreement, dated as of August 18, 2023, by and between ADS-TEC Energy GMBH and certain lenders thereto (incorporated
by reference to Exhibit 10.4 to the Report on Form 6-K furnished to the SEC on August 25, 2023). |
|
|
|
4.9 |
|
Security
Agreement, dated August 18, 2023, by and between ads-tec Energy Inc. and The Lucerne Capital Master Fund, L.P. (incorporated by reference
to Exhibit 10.5 to the Report on Form 6-K furnished to the SEC on August 25, 2023). |
|
|
|
4.10 |
|
Form
of Amended and Restated August Promissory Note, dated August 26, 2024, by and between the Company and the August Lenders (incorporated
by reference to Exhibit 10.1 to the Report on Form 6-K furnished to the SEC on August 30, 2024). |
|
|
|
4.11 |
|
Form
of Amended and Restated August Warrant, dated August 26, 2024, by and between the Company and the August Lenders (incorporated by
reference to Exhibit 10.2 to the Report on Form 6-K furnished to the SEC on August 30, 2024). |
|
|
|
4,12 |
|
Form
of 2024 Promissory Note, dated August 26, 2024, by and between the Company and the Lenders (incorporated by reference to Exhibit
10.3 to the Report on Form 6-K furnished to the SEC on August 30, 2024). |
|
|
|
4.13 |
|
Form
of Intercompany 2024 Promissory Note, dated August 26, 2024, by and between the Company and ADSH (incorporated by reference to Exhibit
10.4 to the Report on Form 6-K furnished to the SEC on August 30, 2024). |
|
|
|
4.14 |
|
Form
of 2024 Warrant, dated August 26, 2024, by and between the Company and the Lenders (incorporated by reference to Exhibit 10.5 to
the Report on Form 6-K furnished to the SEC on August 30, 2024). |
|
|
|
4.15 |
|
Amended
2023 Guarantee Agreement, dated August 26, 2024, by and between ADSE GM and the 2024 Lenders (incorporated by reference to Exhibit
10.6 to the Report on Form 6-K furnished to the SEC on August 30, 2024). |
|
|
|
4.16 |
|
Amended
2023 Security Agreement, dated August 26, 2024, by and between ADSE GM and The Lucerne Capital Master Fund, L.P. (incorporated by
reference to Exhibit 10.7 to the Report on Form 6-K furnished to the SEC on August 30, 2024). |
|
|
|
4.17 |
|
Guarantee
Agreement, dated August 26, 2024, by and between the Company and the 2024 Lenders (incorporated by reference to Exhibit 10.8 to the
Report on Form 6-K furnished to the SEC on August 30, 2024). |
|
|
|
4.18 |
|
2024
Security Agreement, dated August 26, 2024, by and between ADSE GM and ADSH (incorporated by reference to Exhibit 10.9 to the Report
on Form 6-K furnished to the SEC on August 30, 2024). |
* |
Filed herewith. |
** |
To be filed either as an
amendment or as an exhibit to a report filed pursuant to the Securities Exchange Act of 1934 of the Registrant and incorporated by
reference into this registration statement. |
All
schedules have been omitted because they are not required, are not applicable or the information is otherwise set forth in the financial
statements or notes thereto.
Item
10. Undertakings
|
a. |
The undersigned registrant
hereby undertakes: |
| (1) | To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
|
(i) |
To include any prospectus
required by Section 10(a)(3) of the Securities Act of 1933 (the “Securities Act”); |
|
(ii) |
To reflect in the prospectus
any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering
range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in
volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of
Registration Fee” table in the effective registration statement; |
|
(iii) |
To include any material
information with respect to the plan of distribution not previously disclosed in the registration statement or any material change
to such information in the registration statement. |
provided,
however, that paragraphs (1)(i), (1)(ii) and (1)(iii) of this section do not apply if the information required to be included in
a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant
to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained
in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
|
(2) |
That, for the purpose of
determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof. |
|
(3) |
To remove from registration
by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
|
(4) |
To file a post-effective
amendment to the registration statement to include any financial statements required by “Item 8.A. of Form 20-F” at the
start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section
10(a)(3) of the Securities Act need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective
amendment, financial statements required pursuant to this paragraph and other information necessary to ensure that all other information
in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, a post-effective
amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Securities Act or
Item 8.A of Form 20-F if such financial statements and information are contained in periodic reports filed with or furnished to the
SEC by the Registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference in the registration
statement. |
|
(5) |
That, for the purpose of
determining liability of the undersigned registrant under the Securities Act to any purchaser, |
|
(i) |
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) (§ 230.424(b)(3) of this chapter) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) (§ 230.424(b)(2), (b)(5), or (b)(7) of this chapter) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) (§ 230.415(a)(1)(i), (vii), or (x) of this chapter) for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or |
|
(6) |
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
|
(i) |
Any preliminary prospectus
or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
|
(ii) |
Any free writing prospectus
relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
|
(iii) |
The portion of any other
free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities
provided by or on behalf of the undersigned registrant; and |
|
(iv) |
Any other communication
that is an offer in the offering made by the undersigned registrant to the purchaser. |
The
undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where
applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to
the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
|
b. |
Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In
the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will,
unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
by the final adjudication of such issue. |
|
c. |
The undersigned registrant
hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a)
of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the SEC under Section 305(b)(2)
of the Trust Indenture Act. |
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the city of Nürtingen, Germany on the 11th day of February, 2025.
|
ADS-TEC ENERGY PLC |
|
|
|
By: |
/s/
Thomas Speidel |
|
Name: |
Thomas Speidel |
|
Title: |
Chief Executive Officer and Director |
Power
of Attorney
KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Thomas Speidel and Stefan
Berndt-von Bülow, and each of them singly, as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution
and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments
(including post-effective amendments) to this registration statement, and any subsequent registration statement filed by the registrant
pursuant to Rule 462(b) of the Securities Act of 1933, as amended, and to file or cause to be filed the same, with all exhibits thereto,
and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, and each of them, full power
and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the
premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitutes, may lawfully do or cause to be done
by virtue hereof.
Pursuant
to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in
the capacities and on the dates indicated.
Signature |
|
Capacity |
|
Date |
|
|
|
|
|
/s/ Thomas Speidel |
|
Chief Executive Officer and Director |
|
February 11, 2025 |
Thomas Speidel |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/ Stefan Berndt-von Bülow |
|
Chief Financial Officer |
|
February 11, 2025 |
Stefan Berndt-von Bülow |
|
(Principal Financial and Accounting Officer) |
|
|
|
|
|
|
|
|
|
Director |
|
February 11, 2025 |
Joseph Brancato |
|
|
|
|
|
|
|
|
|
|
|
Director |
|
February 11, 2025 |
Kurt Lauk, PhD |
|
|
|
|
|
|
|
|
|
/s/ Sonja Harms |
|
Director |
|
February 11, 2025 |
Dr. Sonja Harms |
|
|
|
|
|
|
|
|
|
/s/ Alwin Epple |
|
Director |
|
February 11, 2025 |
Alwin Epple |
|
|
|
|
|
|
|
|
|
/s/ Dr. Andreas Fabritius |
|
Director |
|
February 11, 2025 |
Dr. Andreas Fabritius |
|
|
|
|
AUTHORIZED
REPRESENTATIVE
Pursuant to the requirements of the Securities
Act of 1933, as amended, the undersigned, the duly authorized undersigned representative in the United States of ADS-TEC Energy PLC,
has signed this registration statement on the 11th day of February, 2025.
|
AUTHORIZED U.S. REPRESENTATIVE |
|
|
|
COGENCY GLOBAL INC. |
|
|
|
By: |
/s/ Colleen
A. De Vries |
|
Name: |
Colleen A. De Vries |
|
Title: |
Senior Vice President |
II-7
Exhibit 4.20
ADS-TEC ENERGY PLC,
As Issuer,
AND
[_______________],
As Trustee
INDENTURE
DATED AS OF [__________] [___], 20[__]
SENIOR DEBT SECURITIES
CROSS-REFERENCE TABLE1
Section of Trust Indenture Act of 1939, as Amended |
|
Indenture |
310(a) |
|
7.10 |
310(b) |
|
7.09; 7.11 |
310(c) |
|
Inapplicable |
311(a) |
|
7.14 |
311(b) |
|
7.14 |
311(c) |
|
Inapplicable |
312(a) |
|
5.02(a) |
312(b) |
|
5.02(c) |
312(c) |
|
Inapplicable |
313(a) |
|
5.04(a) |
313(b) |
|
5.04(b) |
313(c) |
|
5.04(a); 5.04(b) |
313(d) |
|
5.04(c) |
314(a) |
|
5.03; 4.06 |
314(b) |
|
Inapplicable |
314(c) |
|
13.07 |
314(d) |
|
Inapplicable |
314(e) |
|
13.07 |
314(f) |
|
Inapplicable |
315(a) |
|
7.01(a); 7.03 |
315(b) |
|
7.02 |
315(c) |
|
7.01 |
315(d) |
|
7.01(b) |
315(e) |
|
6.07; 7.07 |
316(a) |
|
6.06; 8.04 |
316(b) |
|
6.04 |
316(c) |
|
8.01 |
317(a) |
|
6.02 |
317(b) |
|
4.03 |
318(a) |
|
13.09 |
1 | This Cross-Reference Table does not constitute part of the
Indenture and shall not have any bearing on the interpretation of any of its terms or provisions |
TABLE OF CONTENTS2
ARTICLE I DEFINITIONS |
1 |
SECTION 1.01 DEFINITIONS OF TERMS |
1 |
ARTICLE II ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES |
4 |
SECTION 2.01 DESIGNATION AND TERMS OF SECURITIES |
4 |
SECTION 2.02 FORM OF SECURITIES AND TRUSTEE’S CERTIFICATE |
6 |
SECTION 2.03 DENOMINATIONS: PROVISIONS FOR PAYMENT |
6 |
SECTION 2.04 EXECUTION AND AUTHENTICATION |
7 |
SECTION 2.05 REGISTRATION OF TRANSFER AND EXCHANGE |
8 |
SECTION 2.06 TEMPORARY SECURITIES |
8 |
SECTION 2.07 MUTILATED, DESTROYED, LOST OR STOLEN SECURITIES |
9 |
SECTION 2.08 CANCELLATION |
9 |
SECTION 2.09 BENEFITS OF INDENTURE |
9 |
SECTION 2.10 AUTHENTICATING AGENT |
10 |
SECTION 2.11 GLOBAL SECURITIES |
10 |
ARTICLE III REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS |
11 |
SECTION 3.01 REDEMPTION |
11 |
SECTION 3.02 NOTICE OF REDEMPTION |
11 |
SECTION 3.03 PAYMENT UPON REDEMPTION |
12 |
SECTION 3.04 SINKING FUND |
12 |
SECTION 3.05 SATISFACTION OF SINKING FUND PAYMENTS WITH SECURITIES |
13 |
SECTION 3.06 REDEMPTION OF SECURITIES FOR SINKING FUND |
13 |
ARTICLE IV COVENANTS |
13 |
SECTION 4.01 PAYMENT OF PRINCIPAL, PREMIUM AND INTEREST |
13 |
SECTION 4.02 MAINTENANCE OF OFFICE OR AGENCY |
13 |
SECTION 4.03 PAYING AGENTS |
14 |
SECTION 4.04 APPOINTMENT TO FILL VACANCY IN OFFICE OF TRUSTEE |
14 |
SECTION 4.05 COMPLIANCE WITH CONSOLIDATION PROVISIONS |
15 |
SECTION 4.06 STATEMENT BY OFFICERS AS TO DEFAULT |
15 |
ARTICLE V SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE |
15 |
SECTION 5.01 COMPANY TO FURNISH TRUSTEE NAMES AND ADDRESSES OF SECURITYHOLDERS |
15 |
SECTION 5.02 PRESERVATION OF INFORMATION; COMMUNICATIONS WITH SECURITYHOLDERS |
15 |
SECTION 5.03 REPORTS BY THE COMPANY |
15 |
SECTION 5.04 REPORTS BY THE TRUSTEE |
16 |
ARTICLE VI REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT |
16 |
SECTION 6.01 EVENTS OF DEFAULT |
16 |
SECTION 6.02 COLLECTION OF INDEBTEDNESS AND SUITS FOR ENFORCEMENT BY TRUSTEE |
18 |
SECTION 6.03 APPLICATION OF MONEYS COLLECTED |
19 |
SECTION 6.04 LIMITATION ON SUITS |
19 |
SECTION 6.05 RIGHTS AND REMEDIES CUMULATIVE; DELAY OR OMISSION NOT WAIVER |
20 |
SECTION 6.06 CONTROL BY SECURITYHOLDERS |
20 |
SECTION 6.07 UNDERTAKING TO PAY COSTS |
20 |
ARTICLE VII CONCERNING THE TRUSTEE |
21 |
SECTION 7.01 CERTAIN DUTIES AND RESPONSIBILITIES OF TRUSTEE |
21 |
SECTION 7.02 NOTICE OF DEFAULTS |
22 |
SECTION 7.03 CERTAIN RIGHTS OF TRUSTEE |
22 |
SECTION 7.04 TRUSTEE NOT RESPONSIBLE FOR RECITALS OR ISSUANCE OR SECURITIES |
23 |
SECTION 7.05 MAY HOLD SECURITIES |
23 |
SECTION 7.06 MONEYS HELD IN TRUST |
23 |
2 | This Table of Contents does not constitute part of the Indenture
and shall not have any bearing on the interpretation of any of its terms or provisions. |
SECTION 7.07 COMPENSATION AND REIMBURSEMENT |
23 |
SECTION 7.08 RELIANCE ON OFFICERS’ CERTIFICATE |
24 |
SECTION 7.09 DISQUALIFICATION; CONFLICTING INTERESTS |
24 |
SECTION 7.10 CORPORATE TRUSTEE REQUIRED; ELIGIBILITY |
24 |
SECTION 7.11 RESIGNATION AND REMOVAL; APPOINTMENT OF SUCCESSOR |
25 |
SECTION 7.12 ACCEPTANCE OF APPOINTMENT BY SUCCESSOR |
25 |
SECTION 7.13 MERGER, CONVERSION, CONSOLIDATION OR SUCCESSION TO BUSINESS |
26 |
SECTION 7.14 PREFERENTIAL COLLECTION OF CLAIMS AGAINST THE COMPANY |
27 |
ARTICLE VIII CONCERNING THE SECURITYHOLDERS |
27 |
SECTION 8.01 EVIDENCE OF ACTION BY SECURITYHOLDERS |
27 |
SECTION 8.02 PROOF OF EXECUTION BY SECURITYHOLDERS |
27 |
SECTION 8.03 WHO MAY BE DEEMED OWNERS |
27 |
SECTION 8.04 CERTAIN SECURITIES OWNED BY COMPANY DISREGARDED |
28 |
SECTION 8.05 ACTIONS BINDING ON FUTURE SECURITYHOLDERS |
28 |
ARTICLE IX SUPPLEMENTAL INDENTURES |
28 |
SECTION 9.01 SUPPLEMENTAL INDENTURES WITHOUT THE CONSENT OF SECURITYHOLDERS |
28 |
SECTION 9.02 SUPPLEMENTAL INDENTURES WITH CONSENT OF SECURITYHOLDERS |
29 |
SECTION 9.03 EFFECT OF SUPPLEMENTAL INDENTURES |
30 |
SECTION 9.04 SECURITIES AFFECTED BY SUPPLEMENTAL INDENTURES |
30 |
SECTION 9.05 EXECUTION OF SUPPLEMENTAL INDENTURES |
30 |
ARTICLE X SUCCESSOR ENTITY |
31 |
SECTION 10.01 COMPANY MAY CONSOLIDATE, ETC |
31 |
SECTION 10.02 SUCCESSOR ENTITY SUBSTITUTED |
31 |
SECTION 10.03 EVIDENCE OF CONSOLIDATION, ETC. TO TRUSTEE |
31 |
ARTICLE XI SATISFACTION AND DISCHARGE; DEFEASANCE |
32 |
SECTION 11.01 SATISFACTION AND DISCHARGE |
32 |
SECTION 11.02 DEFEASANCE |
32 |
SECTION 11.03 DEPOSITED MONEYS TO BE HELD IN TRUST |
33 |
SECTION 11.04 PAYMENT OF MONEYS HELD BY PAYING AGENTS |
33 |
SECTION 11.05 REPAYMENT TO COMPANY |
33 |
ARTICLE XII IMMUNITY OF INCORPORATORS, SHAREHOLDERS, OFFICERS AND DIRECTORS |
34 |
SECTION 12.01 NO RECOURSE |
34 |
ARTICLE XIII MISCELLANEOUS PROVISIONS |
34 |
SECTION 13.01 EFFECT ON SUCCESSORS AND ASSIGNS |
34 |
SECTION 13.02 ACTIONS BY SUCCESSOR. |
34 |
SECTION 13.03 SURRENDER OF COMPANY POWERS |
34 |
SECTION 13.04 NOTICES |
34 |
SECTION 13.05 GOVERNING LAW; WAIVER OF TRIAL BY JURY |
34 |
SECTION 13.06 TREATMENT OF SECURITIES AS DEBT |
35 |
SECTION 13.07 COMPLIANCE CERTIFICATES AND OPINIONS |
35 |
SECTION 13.08 PAYMENTS ON BUSINESS DAYS |
35 |
SECTION 13.09 CONFLICT WITH TRUST INDENTURE ACT |
35 |
SECTION 13.10 COUNTERPARTS |
35 |
SECTION 13.11 SEPARABILITY |
35 |
SECTION 13.12 ASSIGNMENT |
35 |
INDENTURE, dated as of [__________]
[___], 20[_], between ADS-TEC Energy PLC, a public company incorporated in Ireland (the “Company”), and [_____________], a
[______________], as trustee (the “Trustee”):
RECITALS OF THE COMPANY
WHEREAS, for its lawful corporate
purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities
(hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in
one or more series as provided in this Indenture, as registered Securities without coupons, to be authenticated by the certificate of
the Trustee;
WHEREAS, to provide the terms
and conditions upon which the Securities are to be authenticated, issued, and delivered, the Company has duly authorized the execution
of this Indenture; and
WHEREAS, all things necessary
to make this Indenture a valid agreement of the Company, in accordance with its terms, have been done.
NOW, THEREFORE, in consideration
of the premises and the purchase of the Securities by the Holders thereof, it is mutually covenanted and agreed as follows for the equal
and ratable benefit of the Holders of Securities or of series thereof.
ARTICLE I
DEFINITIONS
SECTION 1.01 DEFINITIONS OF TERMS.
The terms defined in this
Section (except as in this Indenture otherwise expressly provided or unless the context otherwise requires) for all purposes of this Indenture
and of any indenture supplemental hereto shall have the respective meanings specified in this Section and shall include the plural as
well as the singular. All other terms used in this Indenture that are defined in the Trust Indenture Act, or that are by reference in
said Trust Indenture Act defined in the Securities Act (except as herein otherwise expressly provided or unless the context otherwise
requires), shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date
of the execution of this instrument.
“ARTICLE”, “SECTION”
or other subdivisions refer to Articles, Sections or other subdivisions of this Indenture.
“AUTHENTICATING AGENT”
means an authenticating agent with respect to all or any of the series of Securities appointed with respect to all or any series of the
Securities by the Trustee pursuant to Section 2.10.
“BANKRUPTCY LAW”
means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.
“BOARD OF DIRECTORS”
means the Board of Directors of the Company or any duly authorized committee of such Board.
“BOARD RESOLUTION”
means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board
of Directors and to be in full force and effect on the date of such certification.
“BUSINESS DAY”
means, with respect to any series of Securities, any day other than a Saturday or Sunday, or a day on which federal or state banking institutions
in [________], are authorized or obligated by law, executive order or regulation to close.
“CERTIFICATE”
means a certificate signed by the principal executive officer, the principal financial officer or the principal accounting officer of
the Company. The Certificate need not comply with the provisions of Section 13.07.
“COMMISSION” means
the Securities and Exchange Commission.
“COMPANY” means
ADS-TEC Energy PLC, a public company incorporated in Ireland, and its subsidiaries, and, subject to the provisions of Article X, shall
also include its successors and assigns.
“CORPORATE TRUST OFFICE”
means the office of the Trustee at which, at any particular time, its corporate trust business shall be principally administered, which
office at the date hereof is located at [____________________________].
“COVENANT DEFEASANCE” has the meaning
given in Section 11.02.
“CUSTODIAN” means
any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.
“DEFAULT” means
any event, act or condition that with notice or lapse of time, or both, would constitute an Event of Default.
“DEFAULTED INTEREST” has the meaning
given in Section 2.03.
“DEPOSITARY” means,
with respect to Securities of any series, for which the Company shall determine that such Securities will be issued as a Global Security,
[_________], another clearing agency, or any successor registered as a clearing agency under the Exchange Act, or other applicable statute
or regulation, which, in each case, shall be designated by the Company pursuant to either Section 2.01 or 2.11.
“EVENT OF DEFAULT”
means, with respect to Securities of a particular series any event specified in Section 6.01, continued for the period of time, if any,
therein designated.
“EXCHANGE ACT”
means the Securities Exchange Act of 1934, as amended, or any successor statute or statutes thereto.
“GLOBAL SECURITY”
means, with respect to any series of Securities, a Security executed by the Company and delivered by the Trustee to the Depositary or
pursuant to the Depositary’s instruction, all in accordance with the Indenture, which shall be registered in the name of the Depositary
or its nominee.
“GOVERNMENTAL OBLIGATIONS”
means securities that are (i) direct obligations of the United States of America for the payment of which its full faith and credit is
pledged or (ii) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of
America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America that,
in either case, are not callable or redeemable at the option of the issuer thereof, and shall also include a depositary receipt issued
by a bank (as defined in Section 3(a)(2) of the Securities Act) as custodian with respect to any such Governmental Obligation or a specific
payment of principal of or interest on any such Governmental Obligation held by such custodian for the account of the Holder of such depositary
receipt; provided, however, that (except as required by law) such custodian is not authorized to make any deduction from the amount payable
to the Holder of such depositary receipt from any amount received by the custodian in respect of the Governmental Obligation or the specific
payment of principal of or interest on the Governmental Obligation evidenced by such depositary receipt.
“HEREIN”, “HEREOF”
and “HEREUNDER”, and other words of similar import, refer to this Indenture as a whole and not to any particular Article,
Section, or other subdivision.
“INCLUDING”, unless
the context requires otherwise, means including without limitation.
“INDENTURE” means
this instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental
hereto entered into in accordance with the terms hereof, including, for all purposes of this instrument and any such supplemental indenture,
the provisions of the Trust Indenture Act that are deemed to be a part of and govern this instrument and any such supplemental indenture,
respectively. The term “Indenture” shall also include the terms of particular series of Securities established as contemplated
by Section 2.01.
“INTEREST PAYMENT DATE”,
when used with respect to any installment of interest on a Security of a particular series, means the date specified in such Security
or in a Board Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment
of interest with respect to Securities of that series is due and payable.
“LEGAL DEFEASANCE” has the meaning
given in Section 11.02.
“OFFICERS’ CERTIFICATE”
means a certificate signed by the Executive Chairman, Chief Executive Officer, President or a Vice President and by the Chief Financial
Officer, Treasurer or an Assistant Treasurer or the Controller or an Assistant Controller or the Secretary or an Assistant Secretary of
the Company that is delivered to the Trustee in accordance with the terms hereof. Each such certificate shall include the statements provided
for in Section 13.07, if and to the extent required by the provisions thereof.
“OPINION OF COUNSEL”
means an opinion in writing of legal counsel acceptable to the Trustee, who may be an employee of or counsel for the Company that is delivered
to the Trustee in accordance with the terms hereof. Each such opinion shall include the statements provided for in Section 13.07, if and
to the extent required by the provisions thereof.
“ORIGINAL ISSUE DISCOUNT
SECURITY” means any Security which provides for an amount less than the principal amount thereof to be due and payable upon a declaration
of acceleration of the maturity thereof pursuant to Section 6.01.
“OUTSTANDING”,
when used with reference to Securities of any series, means, subject to the provisions of Section 8.04, as of any particular time, all
Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except (a) Securities theretofore
canceled by the Trustee or any paying agent, or delivered to the Trustee or any paying agent for cancellation or that have previously
been canceled; (b) Securities or portions thereof for the payment or redemption of which moneys or Governmental Obligations in the necessary
amount shall have been deposited in trust with the Trustee or with any paying agent (other than the Company) or shall have been set aside
and segregated in trust by the Company (if the Company shall act as its own paying agent); provided, however, that if such Securities
or portions of such Securities are to be redeemed prior to the maturity thereof, notice of such redemption shall have been given as in
Article III; or provision satisfactory to the Trustee shall have been made for giving such notice; and (c) Securities in lieu of or in
substitution for which other Securities shall have been authenticated and delivered pursuant to the terms of Section 2.07; provided, however,
that in determining whether the Holders of the requisite principal amount of the Outstanding Securities have given, made or taken any
request, demand, authorization, direction, notice, consent, waiver or other action hereunder as of any date, the principal amount of an
Original Issue Discount Security which shall be deemed to be Outstanding shall be the amount of the principal thereof which would be due
and payable as of such date upon acceleration of the maturity thereof to such date pursuant to Section 6.01.
“PERSON” means
any individual, corporation, limited liability company, partnership, joint-venture, joint-stock company, unincorporated organization or
government or any agency or political subdivision thereof.
“PREDECESSOR SECURITY”
of any particular Security means every previous Security evidencing all or a portion of the same debt as that evidenced by such particular
Security; and, for the purposes of this definition, any Security authenticated and delivered under Section 2.07 in lieu of a lost, destroyed
or stolen Security shall be deemed to evidence the same debt as the lost, destroyed or stolen Security.
“RESPONSIBLE OFFICER”,
when used with respect to the Trustee, means any officer assigned to the [______________] [Division / Unit] (or any successor division
or unit) of the Trustee located at the Corporate Trust Office of the Trustee, who shall have direct responsibility for the administration
of this Indenture, and for the purposes of Section 7.01(b)(ii) and Section 315(b) of the Trust Indenture Act shall also include any other
officer of the Trustee to whom any corporate trust matter is referred because of his or her knowledge of and familiarity with the particular
subject.
“SECURITIES” means
the debt securities authenticated and delivered under this Indenture.
“SECURITIES ACT”
means the Securities Act of 1933, as amended, or any successor statute or statutes thereto.
“SECURITYHOLDER”,
“HOLDER of SECURITIES”, “REGISTERED HOLDER”, “HOLDER”, or other similar term, means the Person or
Persons in whose name or names a particular Security shall be registered on the books of the Company kept for that purpose in accordance
with the terms of this Indenture.
“SECURITY REGISTER” has the meaning
given in Section 2.05.
“SECURITY REGISTRAR” has the meaning
given in Section 2.05.
“SUBSIDIARY” means,
with respect to any Person, (i) any corporation at least a majority of whose outstanding Voting Shares shall at the time be owned, directly
or indirectly, by such Person or by one or more of its Subsidiaries or by such Person and one or more of its Subsidiaries, (ii) any general
partnership, limited liability company, joint venture or similar entity, at least a majority of whose outstanding partnership or similar
interests shall at the time be owned by such Person, or by one or more of its Subsidiaries, or by such Person and one or more of its Subsidiaries
and (iii) any limited partnership of which such Person or any of its Subsidiaries is a general partner.
“TRUSTEE” means
[_______________] and, subject to the provisions of Article VII, shall also include its successors and assigns, and, if at any time there
is more than one Person acting in such capacity hereunder, “Trustee” shall mean each such Person. The term “Trustee”
as used with respect to a particular series of the Securities shall mean the trustee with respect to that series.
“TRUST INDENTURE ACT”
means the Trust Indenture Act of 1939, as amended, subject to the provisions of Sections 9.01, 9.02, and 10.01, as in effect at the date
of execution of this instrument.
“VOTING SHARES”,
as applied to shares of any Person, means shares, interests, participations or other equivalents in the equity interest (however designated)
in such Person having ordinary voting power for the election of a majority of the directors (or the equivalent) of such Person, other
than shares, interests, participations or other equivalents having such power only by reason of the occurrence of a contingency.
ARTICLE II
ISSUE, DESCRIPTION, TERMS, EXECUTION,
REGISTRATION AND EXCHANGE OF SECURITIES
SECTION 2.01 DESIGNATION AND TERMS OF SECURITIES.
The aggregate principal amount
of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or more series
up to the aggregate principal amount, if any, of Securities of that series from time to time authorized by or pursuant to a Board Resolution
or pursuant to one or more indentures supplemental hereto. Prior to the initial issuance of Securities of any series, there shall be established
in or pursuant to a Board Resolution, and set forth in an Officers’ Certificate, or established in one or more indentures supplemental
hereto:
(1) the title of the Security
of the series (which shall distinguish the Securities of the series from all other Securities);
(2) any limit upon the aggregate
principal amount of the Securities of that series that may be authenticated and delivered under this Indenture (except for Securities
authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of that series);
(3) the date or dates on which
the principal of the Securities of the series is payable, any original issue discount that may apply to the Securities of that series
upon their issuance, the principal amount due at maturity and the place(s) of payment;
(4) the rate or rates at which
the Securities of the series shall bear interest or the manner of calculation of such rate or rates, if any;
(5) the date or dates from
which such interest shall accrue, the Interest Payment Dates on which such interest will be payable or the manner of determination of
such Interest Payment Dates, the place(s) of payment, and the record date or other method for the determination of Holders to whom interest
is payable on any such Interest Payment Dates;
(6) the right, if any, to
extend the interest payment periods and the duration of such extension;
(7) the period or periods
within which, the price or prices at which and the terms and conditions upon which, Securities of the series may be redeemed, in whole
or in part, at the option of the Company;
(8) the obligation, if any,
of the Company to redeem or purchase Securities of the series pursuant to any sinking fund or analogous provisions (including payments
made in cash in satisfaction of future sinking fund obligations) or at the option of a Holder thereof and the period or periods within
which, the price or prices at which, and the terms and conditions upon which, Securities of the series shall be redeemed or purchased,
in whole or in part, pursuant to such obligation;
(9) the form of the Securities
of the series, including the form of the Trustee’s certificate of authentication for such series;
(10) if other than denominations
of one thousand U.S. dollars ($1,000) or any integral multiple thereof, the denominations in which the Securities of the series shall
be issuable (including denominations of foreign currency);
(11) any and all other terms
with respect to such series (which terms shall not be inconsistent with the terms of this Indenture);
(12) whether the Securities
of the series are issuable as a Global Security and, in such case, the identity of the Depositary for such series and any other or different
terms in respect of such Global Security;
(13) whether the Securities
of the series will be convertible into ordinary shares or other securities of the Company and, if so, the terms and conditions upon which
such Securities will be so convertible, including the conversion price and the conversion period;
(14) if other than the principal
amount thereof, the portion of the principal amount of Securities of the series which shall be payable upon declaration of acceleration
of the maturity thereof pursuant to Section 6.01;
(15) any additional or different
Events of Default or restrictive covenants provided for with respect to the Securities of the series;
(16) if applicable, that the
Securities of the series, in whole or in specified part, shall be defeasible pursuant to Section 11.02 and, if other than by a Board Resolution,
the manner in which any election by the Company to defease such Securities shall be evidenced;
(17) if other than the currency
of the United States of America, the currency, currencies or currency units in which the principal of or any premium or interest on any
Securities of the series shall be payable and the manner of determining the equivalent thereof in the currency of the United States of
America for any purpose, including for purposes of the definition of “Outstanding” in Section 1.01, and/or the property, including
securities of the Company, in which the principal of or any premium or interest on any Securities of the series may be payable and the
terms and conditions of such payment in property, including whether at the option of the Company or the Securityholder; and
(18) the terms and conditions,
if any, upon which the Company shall pay amounts in addition to the stated interest, premium, if any and principal amounts of the Securities
of the series to any Securityholder that is not a “United States person” for federal tax purposes.
All Securities of any one
series shall be substantially identical except as to denomination and except as may otherwise be provided in or pursuant to any such Board
Resolution or in any indentures supplemental hereto. If any of the terms of the series are established by action taken pursuant to a Board
Resolution, a copy of an appropriate record of such action shall be certified by the Secretary or an Assistant Secretary of the Company
and delivered to the Trustee at or prior to the delivery of the Officers’ Certificate setting forth the terms of the series. Securities
of any particular series may be issued at various times, with different dates on which the principal or any installment of principal is
payable, with different rates of interest, if any, or different methods by which rates of interest may be determined, with different dates
on which such interest may be payable and with different redemption dates. Notwithstanding Section 2.01(2) and unless otherwise expressly
provided with respect to a series of Securities, the aggregate principal amount of a series of Securities may be increased and additional
Securities of such series may be issued up to the maximum aggregate principal amount authorized with respect to such series as increased.
SECTION 2.02 FORM OF SECURITIES AND TRUSTEE’S CERTIFICATE.
The Securities of any series
and the Trustee’s certificate of authentication to be borne by such Securities shall be substantially of the tenor and purport as
set forth in one or more indentures supplemental hereto or as provided in or pursuant to a Board Resolution and as set forth in an Officers’
Certificate. The Securities may have such letters, numbers or other marks of identification or designation and such legends or endorsements
printed, lithographed or engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this
Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation
of any stock exchange on which Securities of that series may be listed, or to conform to usage.
SECTION 2.03 DENOMINATIONS: PROVISIONS FOR PAYMENT.
The Securities shall be issuable
as registered Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, subject to Section
2.01(10). The Securities of a particular series shall bear interest payable on the dates and at the rates specified or provided for with
respect to that series. Except as contemplated by Section 2.01(17), the principal of and the interest on the Securities of any series,
as well as any premium thereon in case of redemption thereof prior to maturity, shall be payable in the coin or currency of the United
States of America that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for
that purpose in [________________]; provided, however, that at the option of the Company payment of interest may be made by check mailed
to the address of the Person entitled thereto as such address shall appear in the Security Register. Each Security shall be dated the
date of its authentication by the Trustee. Except as contemplated by Section 2.01(4), interest on the Securities shall be computed on
the basis of a 360-day year composed of twelve 30-day months. Except as contemplated by Section 2.01(5), the interest installment on any
Security that is payable, and is punctually paid or duly provided for, on any Interest Payment Date for Securities of that series shall
be paid to the Person in whose name said Security (or one or more Predecessor Securities) is registered at the close of business on the
regular record date for such interest installment. In the event that any Security of a particular series or portion thereof is called
for redemption and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such
Interest Payment Date, interest on such Security will be paid upon presentation and surrender of such Security as provided in Section
3.03. Any interest on any Security that is payable, but is not punctually paid or duly provided for, on any Interest Payment Date for
Securities of the same series (herein called “Defaulted Interest”) shall forthwith cease to be payable to the registered Holder
on the relevant regular record date by virtue of having been such Holder; and such Defaulted Interest shall be paid by the Company, at
its election, as provided in clause (1) or clause (2) below:
(1) The Company may make payment
of any Defaulted Interest on Securities to the Persons in whose names such Securities (or their respective Predecessor Securities) are
registered at the close of business on a special record date for the payment of such Defaulted Interest, which shall be fixed in the following
manner: the Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such Security
and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the
aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for
such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled
to such Defaulted Interest as in this clause provided. Thereupon the Trustee shall fix a special record date for the payment of such Defaulted
Interest which shall not be more than 15 nor less than 10 days prior to the date of the proposed payment and not less than 10 days after
the receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the Company of such special record
date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Interest and the
special record date therefor to be mailed, first class postage prepaid, to each Securityholder at his or her address as it appears in
the Security Register (as hereinafter defined), not less than 10 days prior to such special record date. Notice of the proposed payment
of such Defaulted Interest and the special record date therefor having been mailed as aforesaid, such Defaulted Interest shall be paid
to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered on such special record date.
(2) The Company may make payment
of any Defaulted Interest on any Securities in any other lawful manner not inconsistent with the requirements of any securities exchange
on which such Securities may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company
to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee. Unless
otherwise set forth in a Board Resolution or one or more indentures supplemental hereto establishing the terms of any series of Securities
pursuant to Section 2.01 hereof, the term “regular record date” as used in this Section with respect to a series of Securities
with respect to any Interest Payment Date for such series shall mean either the fifteenth day of the month immediately preceding the month
in which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date
is the first day of a month, or the last day of the month immediately preceding the month in which an Interest Payment Date established
for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or
not such date is a Business Day. Subject to the foregoing provisions of this Section, each Security of a series delivered under this Indenture
upon transfer of or in exchange for or in lieu of any other Security of such series shall carry the rights to interest accrued and unpaid,
and to accrue, that were carried by such other Security.
SECTION 2.04 EXECUTION AND AUTHENTICATION.
The Securities shall be signed
on behalf of the Company by its President, or one of its Vice Presidents, or its Treasurer, or one of its Assistant Treasurers, attested
by its Secretary or one of its Assistant Secretaries. Signatures may be in the form of a manual or facsimile signature. The Company may
use the facsimile signature of any Person who shall have been a President or Vice President thereof, or of any Person who shall have been
the Treasurer, an Assistant Treasurer, the Secretary or an Assistant Secretary thereof, notwithstanding the fact that at the time the
Securities shall be authenticated and delivered or disposed of such Person shall have ceased to be the President or a Vice President,
or the Treasurer, an Assistant Treasurer, the Secretary or an Assistant Secretary, of the Company. The Securities may contain such notations,
legends or endorsements required by law, stock exchange rule or usage. A Security shall not be valid until authenticated manually by an
authorized signatory of the Trustee, or by an Authenticating Agent. Such signature shall be conclusive evidence and the only evidence
that the Security so authenticated has been duly authenticated and delivered hereunder and that the Holder is entitled to the benefits
of this Indenture. At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities
of any series executed by the Company to the Trustee for authentication, together with a written order of the Company for the authentication
and delivery of such Securities, signed by its President or any Vice President and its Secretary or any Assistant Secretary, and the Trustee
in accordance with such written order shall authenticate and deliver such Securities. In authenticating such Securities and accepting
the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive, and (subject
to Section 7.01) shall be fully protected in relying upon, an Opinion of Counsel stating that the form and terms thereof have been established
in conformity with the provisions of this Indenture and that such Securities, when authenticated and delivered by the Trustee and issued
by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute valid and legally binding
obligations of the Company enforceable in accordance with their terms, subject to any Bankruptcy Law or other insolvency, fraudulent transfer,
reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity
principles and to other customary exceptions. The Trustee shall not be required to authenticate such Securities if the issue of such Securities
pursuant to this Indenture will affect the Trustee’s own rights, duties or immunities under the Securities and this Indenture or
otherwise in a manner that is not reasonably acceptable to the Trustee.
SECTION 2.05 REGISTRATION OF TRANSFER AND EXCHANGE.
(a) Securities of any series
may be exchanged upon presentation thereof at the office or agency of the Company designated for such purpose in [____________], for other
Securities of such series of authorized denominations, and for a like aggregate principal amount, upon payment of a sum sufficient to
cover any tax or other governmental charge in relation thereto, all as provided in this Section. In respect of any Securities so surrendered
for exchange, the Company shall execute, the Trustee shall authenticate and such office or agency shall deliver in exchange therefor the
Security or Securities of the same series that the Securityholder making the exchange shall be entitled to receive, bearing numbers not
contemporaneously outstanding.
(b) The Company shall keep,
or cause to be kept, at its office or agency designated for such purpose in [_____________], or such other location designated by the
Company a register or registers (herein referred to as the “Security Register”) in which, subject to such reasonable regulations
as it may prescribe, the Company shall register the Securities and the transfers of Securities as in this Article provided and which at
all reasonable times shall be open for inspection by the Trustee. The registrar for the purpose of registering Securities and transfer
of Securities as herein provided shall be appointed as authorized by Board Resolution (the “Security Registrar”). Upon surrender
for transfer of any Security at the office or agency of the Company designated for such purpose, the Company shall execute, the Trustee
shall authenticate and such office or agency shall deliver in the name of the transferee or transferees a new Security or Securities of
the same series as the Security presented for a like aggregate principal amount. All Securities presented or surrendered for exchange
or registration of transfer, as provided in this Section, shall be accompanied (if so required by the Company or the Security Registrar)
by a written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly executed by the
registered Holder or by such Holder’s duly authorized attorney in writing.
(c) No service charge shall
be made for any exchange or registration of transfer of Securities, or issue of new Securities in case of partial redemption of any series,
but the Company may require payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, other than
exchanges pursuant to Section 2.06, Section 3.03(b) and Section 9.04 not involving any transfer. The Company shall not be required (i)
to issue, exchange or register the transfer of any Securities during a period beginning at the opening of business 15 days before the
day of the mailing of a notice of redemption of less than all the Outstanding Securities of the same series and ending at the close of
business on the day of such mailing, nor (ii) to register the transfer of or exchange any Securities of any series or portions thereof
called for redemption. The provisions of this Section 2.05 are, with respect to any Global Security, subject to Section 2.11 hereof.
SECTION 2.06 TEMPORARY SECURITIES.
Pending the preparation of
definitive Securities of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities (printed,
lithographed or typewritten) of any authorized denomination. Such temporary Securities shall be substantially in the form of the definitive
Securities in lieu of which they are issued, but with such omissions, insertions and variations as may be appropriate for temporary Securities,
all as may be determined by the Company. Every temporary Security of any series shall be executed by the Company and be authenticated
by the Trustee upon the same conditions and in substantially the same manner, and with like effect, as the definitive Securities of such
series. Without unnecessary delay the Company will execute and will furnish definitive Securities of such series and thereupon any or
all temporary Securities of such series may be surrendered in exchange therefor (without charge to the Holders), at the office or agency
of the Company designated for the purpose in [______________], and the Trustee shall authenticate and such office or agency shall deliver
in exchange for such temporary Securities an equal aggregate principal amount of definitive Securities of such series, unless the Company
advises the Trustee to the effect that definitive Securities need not be executed and furnished until further notice from the Company.
Until so exchanged, the temporary Securities of such series shall be entitled to the same benefits under this Indenture as definitive
Securities of such series authenticated and delivered hereunder.
SECTION 2.07 MUTILATED, DESTROYED, LOST OR STOLEN SECURITIES.
In case any temporary or definitive
Security shall become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence) shall execute,
and upon the Company’s request the Trustee (subject as aforesaid) shall authenticate and deliver, a new Security of the same series,
bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated Security, or in lieu of and in substitution
for the Security so destroyed, lost or stolen. In every case the applicant for a substituted Security shall furnish to the Company and
the Trustee such security or indemnity as may be required by them to save each of them harmless, and, in every case of destruction, loss
or theft, the applicant shall also furnish to the Company and the Trustee evidence to their satisfaction of the destruction, loss or theft
of the applicant’s Security and of the ownership thereof. The Trustee may authenticate any such substituted Security and deliver
the same upon the written request or authorization of any officer of the Company. Upon the issuance of any substituted Security, the Company
may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and
any other expenses (including the fees and expenses of the Trustee) connected therewith. In case any Security that has matured or is about
to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security, pay or authorize
the payment of the same (without surrender thereof except in the case of a mutilated Security) if the applicant for such payment shall
furnish to the Company and the Trustee such security or indemnity as they may require to save them harmless, and, in case of destruction,
loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss or theft of such Security and of the
ownership thereof. Every replacement Security issued pursuant to the provisions of this Section shall constitute an additional contractual
obligation of the Company whether or not the mutilated, destroyed, lost or stolen Security shall be found at any time, or be enforceable
by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of
the same series duly issued hereunder. All Securities shall be held and owned upon the express condition that the foregoing provisions
are exclusive with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities, and shall preclude (to the
extent lawful) any and all other rights or remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary
with respect to the replacement or payment of negotiable instruments or other securities without their surrender.
SECTION 2.08 CANCELLATION.
All Securities surrendered
for the purpose of payment, redemption, exchange or registration of transfer shall, if surrendered to the Company or any paying agent,
be delivered to the Trustee for cancellation, or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be
issued in lieu thereof except as expressly required or permitted by any of the provisions of this Indenture. On request of the Company
at the time of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee. In the absence of such
request the Trustee may dispose of canceled Securities in accordance with its standard procedures and deliver a certificate of disposition
to the Company. If the Company shall otherwise acquire any of the Securities, however, such acquisition shall not operate as a redemption
or satisfaction of the indebtedness represented by such Securities unless and until the same are delivered to the Trustee for cancellation.
SECTION 2.09 BENEFITS OF INDENTURE.
Nothing in this Indenture
or in the Securities, express or implied, shall give or be construed to give to any Person, other than the parties hereto and the Holders
of the Securities any legal or equitable right, remedy or claim under or in respect of this Indenture, or under any covenant, condition
or provision herein contained; all such covenants, conditions and provisions being for the sole benefit of the parties hereto and of the
Holders of the Securities.
SECTION 2.10 AUTHENTICATING AGENT.
So long as any of the Securities
of any series remain Outstanding there may be an Authenticating Agent for any or all such series of Securities which the Trustee shall
have the right to appoint. Said Authenticating Agent shall be authorized to act on behalf of the Trustee to authenticate Securities of
such series issued upon exchange, transfer or partial redemption thereof, and Securities so authenticated shall be entitled to the benefits
of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder. All references in this
Indenture to the authentication of Securities by the Trustee shall be deemed to include authentication by an Authenticating Agent for
such series. Each Authenticating Agent shall be acceptable to the Company and shall be a corporation that has a combined capital and surplus,
as most recently reported or determined by it, sufficient under the laws of any jurisdiction under which it is organized or in which it
is doing business to conduct a trust business, and that is otherwise authorized under such laws to conduct such business and is subject
to supervision or examination by federal or state authorities. If at any time any Authenticating Agent shall cease to be eligible in accordance
with these provisions, it shall resign immediately. Any Authenticating Agent may at any time resign by giving written notice of resignation
to the Trustee and to the Company. The Trustee may at any time (and upon request by the Company shall) terminate the agency of any Authenticating
Agent by giving written notice of termination to such Authenticating Agent and to the Company. Upon resignation, termination or cessation
of eligibility of any Authenticating Agent, the Trustee may appoint an eligible successor Authenticating Agent acceptable to the Company.
Any successor Authenticating Agent, upon acceptance of its appointment hereunder, shall become vested with all the rights, powers and
duties of its predecessor hereunder as if originally named as an Authenticating Agent pursuant hereto. Any corporation into which an Authenticating
Agent may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation
to which such Authenticating Agent shall be a party, or any corporation succeeding to the corporate agency or corporate trust business
of an Authenticating Agent, shall continue to be an Authenticating Agent, provided that such corporation shall be otherwise eligible under
this Section, without the execution or filing of any paper or any further act on the part of the Trustee or the Authenticating Agent.
SECTION 2.11 GLOBAL SECURITIES.
(a) If the Company shall establish
pursuant to Section 2.01 that the Securities of a particular series are to be issued as a Global Security, then the Company shall execute
and the Trustee shall, in accordance with Section 2.04, authenticate and deliver, a Global Security that
(1) shall represent, and
shall be denominated in an amount equal to the aggregate principal amount of, all or a portion of the Outstanding Securities of such series,
(2) shall be registered in
the name of the Depositary or its nominee,
(3) shall be delivered by
the Trustee to the Depositary or pursuant to the Depositary’s instruction, and
(4) shall bear a legend substantially
to the following effect: “Except as otherwise provided in Section 2.11 of the Indenture, this Security may be transferred, in whole
but not in part, only to the Depositary, another nominee of the Depositary or to a successor Depositary or to a nominee of such successor
Depositary.”
(b) Notwithstanding the provisions
of Section 2.05, the Global Security of a series may be transferred, in whole but not in part and in the manner provided in Section 2.05,
only to the Depositary for such series, another nominee of the Depositary for such series, or to a successor Depositary for such series
selected or approved by the Company or to a nominee of such successor Depositary.
(c) If at any time the Depositary
for a series of the Securities notifies the Company that it is unwilling or unable to continue as Depositary for such series or if at
any time the Depositary for such series shall no longer be registered or in good standing under the Exchange Act, or other applicable
statute or regulation, and a successor Depositary for such series is not appointed by the Company within 90 days after the Company receives
such notice or becomes aware of such condition, as the case may be, this Section 2.11 shall no longer be applicable to the Securities
of such series and the Company will execute, and subject to Section 2.05, the Trustee will authenticate and deliver the Securities of
such series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal amount equal to
the principal amount of the Global Security of such series in exchange for such Global Security. In addition, the Company may at any time
determine that the Securities of any series shall no longer be represented by a Global Security and that the provisions of this Section
2.11 shall no longer apply to the Securities of such series. In such event the Company will execute and subject to Section 2.05, the Trustee,
upon receipt of an Officers’ Certificate evidencing such determination by the Company, will authenticate and deliver the Securities
of such series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal amount equal
to the principal amount of the Global Security of such series in exchange for such Global Security. Upon the exchange of the Global Security
for such Securities in definitive registered form without coupons, in authorized denominations, the Global Security shall be canceled
by the Trustee. Such Securities in definitive registered form issued in exchange for the Global Security pursuant to this Section 2.11(c)
shall be registered in such names and in such authorized denominations as the Depositary, pursuant to instructions from its direct or
indirect participants or otherwise, shall instruct the Trustee. The Trustee shall deliver such Securities to the Depositary for delivery
to the Persons in whose names such Securities are so registered.
(d) None of the Trustee, the
Security Registrar or any paying agent shall have any responsibility or obligation to any beneficial owner in a Global Security, a member
of, or a participant in the Depositary or other Person with respect to the accuracy of the records of the Depositary or its nominee or
of any participant or member thereof, with respect to any ownership interest in the Securities or with respect to the delivery to any
participant, member, beneficial owner or other Person (other than the Depositary) of any notice (including any notice of redemption) or
the payment of any amount, under or with respect to such Securities. All notices and communications to be given to the Securityholders
and all payments to be made to Securityholders under the Securities and this Indenture shall be given or made only to or upon the order
of the registered holders (which shall be the Depositary or its nominee in the case of the Global Security). The rights of beneficial
owners in the Global Security shall be exercised only through the Depositary subject to the applicable procedures. The Trustee, the Security
Registrar and any paying agent shall be entitled to rely and shall be fully protected in relying upon information furnished by the Depositary
with respect to its members, participants and any beneficial owners. The Trustee, the Security Registrar and any paying agent shall be
entitled to deal with any depositary (including the Depositary), and any nominee thereof, that is the registered holder of any Global
Security for all purposes of this Indenture relating to such Global Security (including the payment of principal, premium, if any, and
interest and additional amounts, if any, and the giving of instructions or directions by or to the owner or holder of a beneficial ownership
interest in such Global Security) as the sole holder of such Global Security and shall have no obligations to the beneficial owners thereof.
None of the Trustee, the Security Registrar or any paying agent shall have any responsibility or liability for any acts or omissions of
any such depositary with respect to such Global Security, for the records of any such depositary, including records in respect of beneficial
ownership interests in respect of any such Global Security, for any transactions between such depositary and any participant in such depositary
or between or among any such depositary, any such participant and/or any holder or owner of a beneficial interest in such Global Security,
or for any transfers of beneficial interests in any such Global Security.
Notwithstanding the foregoing,
with respect to any Global Security, nothing herein shall prevent the Company, the Trustee, the Security Registrar, any paying agent,
or any other agent of the Company or any agent of the Trustee, from giving effect to any written certification, proxy or other authorization
furnished by any depositary (including the Depositary), as a Securityholder, with respect to such Global Security or impair, as between
such depositary and owners of beneficial interests in such Global Security, the operation of customary practices governing the exercise
of the rights of such depositary (or its nominee) as Holder of such Global Security.
ARTICLE III
REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS
SECTION 3.01 REDEMPTION.
The Company may redeem the
Securities of any series issued hereunder on and after the dates and in accordance with the terms established for such series pursuant
to Section 2.01 hereof.
SECTION 3.02 NOTICE OF REDEMPTION.
(a) In case the Company shall
desire to exercise such right to redeem all or, as the case may be, a portion of the Securities of any series in accordance with the right
reserved so to do, the Company shall (upon five Business Days prior notice to the Trustee, unless a shorter notice period shall be acceptable
to the Trustee), or shall cause the Trustee to, give notice of such redemption to Holders of the Securities of such series to be redeemed
by mailing, first class postage prepaid, a notice of such redemption not less than 30 days and not more than 90 days before the date fixed
for redemption of that series to such Holders at their last addresses as they shall appear upon the Security Register unless a shorter
period is specified in the Securities to be redeemed. Any notice that is mailed in the manner herein provided shall be conclusively presumed
to have been duly given, whether or not the registered Holder receives the notice. In any case, failure duly to give such notice to the
Holder of any Security of any series designated for redemption in whole or in part, or any defect in the notice, shall not affect the
validity of the proceedings for the redemption of any other Securities of such series or any other series. In the case of any redemption
of Securities prior to the expiration of any restriction on such redemption provided in the terms of such Securities or elsewhere in this
Indenture, the Company shall furnish the Trustee with an Officers’ Certificate evidencing compliance with any such restriction.
Each such notice of redemption shall specify the date fixed for redemption and the redemption price at which Securities of that series
are to be redeemed, and shall state that payment of the redemption price of such Securities to be redeemed will be made at the office
or agency of the Company in [_____________], upon presentation and surrender of such Securities, that interest accrued to the date fixed
for redemption will be paid as specified in said notice, that from and after said date interest will cease to accrue and that the redemption
is for a sinking fund, if such is the case. If less than all the Securities of a series are to be redeemed, the notice to the Holders
of Securities of that series to be redeemed in whole or in part shall specify the particular Securities to be so redeemed. In case any
Security is to be redeemed in part only, the notice that relates to such Security shall state the portion of the principal amount thereof
to be redeemed, and shall state that on and after the redemption date, upon surrender of such Security, a new Security or Securities of
such series in principal amount equal to the unredeemed portion thereof will be issued.
(b) If less than all the Securities
of a series are to be redeemed, the Company shall give the Trustee at least 45 days’ notice in advance of the date fixed for redemption
as to the aggregate principal amount of Securities of the series to be redeemed, and thereupon the Trustee shall select, by lot or in
such other manner as it shall deem appropriate and fair in its discretion and that may provide for the selection of a portion or portions
(equal to one thousand U.S. dollars ($1,000) or any integral multiple thereof) of the principal amount of such Securities of a denomination
larger than $1,000, the Securities to be redeemed and shall thereafter promptly notify the Company in writing of the numbers of the Securities
to be redeemed, in whole or in part. The Company may, if and whenever it shall so elect, by delivery of instructions signed on its behalf
by its President or any Vice President, instruct the Trustee or any paying agent to call all or any part of the Securities of a particular
series for redemption and to give notice of redemption in the manner set forth in this Section, such notice to be in the name of the Company
or its own name as the Trustee or such paying agent as it may deem advisable. In any case in which notice of redemption is to be given
by the Trustee or any such paying agent, the Company shall deliver or cause to be delivered to, or permit to remain with, the Trustee
or such paying agent, as the case may be, such Security Register, transfer books or other records, or suitable copies or extracts therefrom,
sufficient to enable the Trustee or such paying agent to give any notice by mail that may be required under the provisions of this Section.
SECTION 3.03 PAYMENT UPON REDEMPTION.
(a) If the giving of notice
of redemption shall have been completed as above provided, the Securities or portions of Securities of the series to be redeemed specified
in such notice shall become due and payable on the date and at the place stated in such notice at the applicable redemption price, together
with interest accrued to the date fixed for redemption and interest on such Securities or portions of Securities shall cease to accrue
on and after the date fixed for redemption, unless the Company shall default in the payment of such redemption price and accrued interest
with respect to any such Security or portion thereof. On presentation and surrender of such Securities on or after the date fixed for
redemption at the place of payment specified in the notice, said Securities shall be paid and redeemed at the applicable redemption price
for such series, together with interest accrued thereon to the date fixed for redemption (but if the date fixed for redemption is an Interest
Payment Date, the interest installment payable on such date shall be payable to the registered Holder at the close of business on the
applicable record date pursuant to Section 2.03).
(b) Upon presentation of any
Security of such series that is to be redeemed in part only, the Company shall execute and the Trustee shall authenticate and the office
or agency where the Security is presented shall deliver to the Holder thereof, at the expense of the Company, a new Security of the same
series of authorized denominations in principal amount equal to the unredeemed portion of the Security so presented.
SECTION 3.04 SINKING FUND.
The provisions of Sections
3.04, 3.05 and 3.06 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified
as contemplated by Section 2.01 for Securities of such series. The minimum amount of any sinking fund payment provided for by the terms
of Securities of any series is herein referred to as a “mandatory sinking fund payment,” and any payment in excess of such
minimum amount provided for by the terms of Securities of any series is herein referred to as an “optional sinking fund payment”.
If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided
in Section 3.05. Each sinking fund payment shall be applied to the redemption of Securities of any series as provided for by the terms
of Securities of such series.
SECTION 3.05 SATISFACTION OF SINKING FUND PAYMENTS WITH SECURITIES.
The Company,
(1) may deliver Outstanding
Securities of a series (other than any Securities previously called for redemption) and
(2) may apply as a credit
Securities of a series that have been redeemed either at the election of the Company pursuant to the terms of such Securities or through
the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of
all or any part of any sinking fund payment with respect to the Securities of such series required to be made pursuant to the terms of
such Securities as provided for by the terms of such series, provided that such Securities have not been previously so credited. Such
Securities shall be received and credited for such purpose by the Trustee at the redemption price specified in such Securities for redemption
through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly.
SECTION 3.06 REDEMPTION OF SECURITIES FOR SINKING FUND.
Not less than 45 days prior
to each sinking fund payment date for any series of Securities, the Company will deliver to the Trustee an Officers’ Certificate
specifying the amount of the next ensuing sinking fund payment for that series pursuant to the terms of the series, the portion thereof,
if any, that is to be satisfied by delivering and crediting Securities of that series pursuant to Section 3.05 and the basis for such
credit and will, together with such Officers’ Certificate, deliver to the Trustee any Securities to be so delivered. Not less than
30 days before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund payment
date in the manner specified in Section 3.02 and cause notice of the redemption thereof to be given in the name of and at the expense
of the Company in the manner provided in Section 3.02. Such notice having been duly given, the redemption of such Securities shall be
made upon the terms and in the manner stated in Section 3.03.
ARTICLE IV
COVENANTS
SECTION 4.01 PAYMENT OF PRINCIPAL, PREMIUM AND INTEREST.
The Company will duly and
punctually pay or cause to be paid the principal of (and premium, if any) and interest on the Securities of each series at the time and
place and in the manner provided herein and established with respect to such Securities.
SECTION 4.02 MAINTENANCE OF OFFICE OR AGENCY.
So long as any series of the
Securities remain Outstanding, the Company agrees to maintain an office or agency in [____________], with respect to each such series
and at such other location or locations as may be designated as provided in this Section 4.02, where (i) Securities of that series may
be presented for payment, (ii) Securities of that series may be presented as herein above authorized for registration of transfer and
exchange, and (iii) notices and demands to or upon the Company in respect of the Securities of that series and this Indenture may be given
or served, such designation to continue with respect to such office or agency until the Company shall, by written notice signed by its
President or a Vice President and delivered to the Trustee, designate some other office or agency in [_____________] for such purposes
or any of them. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee
with the address thereof, such presentations, notices and demands may be made or served at the Corporate Trust Office of the Trustee,
and the Company hereby appoints the Trustee as its agent to receive all such presentations, notices and demands.
The Company may also from
time to time designate one or more other offices or agencies where the Securities of one or more series may be presented or surrendered
for any or all such purposes and may from time to time rescind such designations; provided, however, that no such designation or rescission
shall in any manner relieve the Company of its obligation to maintain an office or agency in [____________] for Securities of any series
for such purposes. The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change
in the location of any such other office or agency.
SECTION 4.03 PAYING AGENTS.
(a) If the Company shall appoint
one or more paying agents for all or any series of the Securities, other than the Trustee, the Company will cause each such paying agent
to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this
Section:
(1) that it will hold all
sums held by it as such agent for the payment of the principal of (and premium, if any) or interest on the Securities of that series (whether
such sums have been paid to it by the Company or by any other obligor of such Securities) in trust for the benefit of the Persons entitled
thereto;
(2) that it will give the
Trustee notice of any failure by the Company (or by any other obligor of such Securities) to make any payment of the principal of (and
premium, if any) or interest on the Securities of that series when the same shall be due and payable;
(3) that it will, at any
time during the continuance of any failure referred to in the preceding paragraph (a)(2) above, upon the written request of the Trustee,
forthwith pay to the Trustee all sums so held in trust by such paying agent; and
(4) that it will perform
all other duties of paying agent as set forth in this Indenture.
(b) If the Company shall act
as its own paying agent with respect to any series of the Securities, it will on or before each due date of the principal of (and premium,
if any) or interest on Securities of that series, set aside, segregate and hold in trust for the benefit of the Persons entitled thereto
a sum sufficient to pay such principal (and premium, if any) or interest so becoming due on Securities of that series until such sums
shall be paid to such Persons or otherwise disposed of as herein provided and will promptly notify the Trustee of such action, or any
failure (by it or any other obligor on such Securities) to take such action. Whenever the Company shall have one or more paying agents
for any series of Securities, it will, prior to each due date of the principal of (and premium, if any) or interest on any Securities
of that series, deposit with the paying agent a sum sufficient to pay the principal (and premium, if any) or interest so becoming due,
such sum to be held in trust for the benefit of the Persons entitled to such principal, premium or interest, and (unless such paying agent
is the Trustee) the Company will promptly notify the Trustee of this action or failure so to act.
(c) Notwithstanding anything in this Section to
the contrary,
(1) the agreement to hold
sums in trust as provided in this Section is subject to the provisions of Section 11.05, and
(2) the Company may at any
time, for the purpose of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or direct any paying
agent to pay, to the Trustee all sums held in trust by the Company or such paying agent, such sums to be held by the Trustee upon the
same terms and conditions as those upon which such sums were held by the Company or such paying agent; and, upon such payment by any paying
agent to the Trustee, such paying agent shall be released from all further liability with respect to such money.
SECTION 4.04 APPOINTMENT TO FILL VACANCY IN OFFICE OF TRUSTEE.
The Company, whenever necessary
to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 7.11, a Trustee, so that there shall
at all times be a Trustee hereunder.
SECTION 4.05 COMPLIANCE WITH CONSOLIDATION PROVISIONS.
The Company will not, while
any of the Securities remain Outstanding, consolidate with or merge into any other Person, in either case where the Company is not the
survivor of such transaction, or sell, convey, transfer or otherwise dispose of its property as an entirety or substantially as an entirety
to any other Person unless the provisions of Article X hereof are complied with.
SECTION 4.06 STATEMENT BY OFFICERS AS TO DEFAULT.
The Company will deliver to
the Trustee, within 120 days after the end of each fiscal year of the Company, an Officers’ Certificate, stating whether or not
to the best knowledge of the signer thereof the Company is in default in the performance and observance of any of the terms, provisions
and conditions of this Indenture (without regard to any period of grace or requirement of notice provided hereunder) and, if the Company
shall be in default, specifying all such defaults and the nature and status thereof of which such signer may have knowledge.
ARTICLE V
SECURITYHOLDERS’ LISTS AND REPORTS BY
THE COMPANY AND THE TRUSTEE
SECTION 5.01 COMPANY TO FURNISH TRUSTEE NAMES AND ADDRESSES OF SECURITYHOLDERS.
The Company will furnish or cause to be furnished
to the Trustee:
(1) not more than 15 days
after each regular record date (as defined in Section 2.03) a list, in such form as the Trustee may reasonably require, of the names and
addresses of the Holders of each series of Securities as of such regular record date, provided that the Company shall not be obligated
to furnish or cause to furnish such list at any time that the list shall not differ in any respect from the most recent list furnished
to the Trustee by the Company; and
(2) at such other times as
the Trustee may request in writing within 30 days after the receipt by the Company of any such request, a list of similar form and content
as of a date not more than 15 days prior to the time such list is furnished; provided, however, that, in either case, no such list need
be furnished for any series for which the Trustee shall be the Security Registrar.
SECTION 5.02 PRESERVATION OF INFORMATION; COMMUNICATIONS WITH SECURITYHOLDERS.
(a) The Trustee shall preserve,
in as current a form as is reasonably practicable, all information as to the names and addresses of the Holders of Securities contained
in the most recent list furnished to it as provided in Section 5.01 and as to the names and addresses of Holders of Securities received
by the Trustee in its capacity as Security Registrar (if acting in such capacity).
(b) The Trustee may destroy
any list furnished to it as provided in Section 5.01 upon receipt of a new list so furnished.
(c) Securityholders may communicate
as provided in Section 312(b) of the Trust Indenture Act with other Securityholders with respect to their rights under this Indenture
or under the Securities.
SECTION 5.03 REPORTS BY THE COMPANY.
(a) The Company covenants
and agrees to file with the Trustee, within 15 days after the Company has filed the same with the Commission, copies of the annual reports
and of the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time
to time by rules and regulations prescribe) that the Company may be required to file with the Commission pursuant to Section 13 or Section
15(d) of the Exchange Act; or, if the Company is not required to file information, documents or reports pursuant to either of such sections,
then to file with the Trustee and the Commission, in accordance with the rules and regulations prescribed from time to time by the Commission,
such of the supplementary and periodic information, documents and reports that may be required pursuant to Section 13 of the Exchange
Act, in respect of a security listed and registered on a national securities exchange as may be prescribed from time to time in such rules
and regulations.
(b) The Company covenants
and agrees to file with the Trustee and the Commission, in accordance with the rules and regulations prescribed from to time by the Commission,
such additional information, documents and reports with respect to compliance by the Company with the conditions and covenants provided
for in this Indenture as may be required from time to time by such rules and regulations.
(c) The Company covenants
and agrees to transmit by mail, first class postage prepaid, or reputable overnight delivery service that provides for evidence of receipt,
to the Securityholders, as their names and addresses appear upon the Security Register, within 30 days after the filing thereof with the
Trustee, such summaries of any information, documents and reports required to be filed by the Company pursuant to subsections (a) and
(b) of this Section as may be required by rules and regulations prescribed from time to time by the Commission.
(d) Delivery of reports, information
and documents to the Trustee under this Section 5.03 is for informational purposes only and the Trustee’s receipt of the foregoing
shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including
the Company’s compliance with any of its respective covenants hereunder (as to which the Trustee is entitled to rely exclusively
on Officers’ Certificates, except as otherwise provided herein).
SECTION 5.04 REPORTS BY THE TRUSTEE.
(a) On or before July 15 in
each year in which any of the Securities are Outstanding, the Trustee shall transmit by mail, first class postage prepaid, to the Securityholders,
as their names and addresses appear upon the Security Register, a brief report dated as of the preceding May 15, if and to the extent
required under Section 313(a) of the Trust Indenture Act.
(b) The Trustee shall comply
with Section 313(b) and 313(c) of the Trust Indenture Act.
(c) A copy of each such report
shall, at the time of such transmission to Securityholders, be filed by the Trustee with the Company, with each stock exchange upon which
any Securities are listed (if so listed) and also with the Commission. The Company agrees to notify the Trustee when any Securities become
listed on any stock exchange.
ARTICLE VI
REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS
ON EVENT OF DEFAULT
SECTION 6.01 EVENTS OF DEFAULT.
(a) Whenever used herein with
respect to Securities of a particular series, “Event of Default” means any one or more of the following events that has occurred
and is continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation
of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental
body):
(1) the Company defaults
in the payment of any installment of interest upon any of the Securities of that series, as and when the same shall become due and payable,
and continuance of such default for a period of 90 days; provided, however, that a valid extension of an interest payment period by the
Company in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment of interest for
this purpose;
(2) the Company defaults
in the payment of the principal of (or premium, if any, on) any of the Securities of that series as and when the same shall become due
and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by any sinking or analogous
fund established with respect to that series; provided, however, that a valid extension of the maturity of such Securities in accordance
with the terms of any indenture supplemental hereto shall not constitute a default in the payment of principal or premium, if any;
(3) the Company fails to
observe or perform any other of its covenants or agreements with respect to that series contained in this Indenture or otherwise established
with respect to that series of Securities pursuant to Section 2.01 hereof (other than a covenant or agreement that has been expressly
included in this Indenture solely for the benefit of one or more series of Securities other than such series) for a period of 90 days
after the date on which written notice of such failure, requiring the same to be remedied and stating that such notice is a “Notice
of Default” hereunder, shall have been given to the Company by the Trustee, by registered or certified mail, or to the Company and
the Trustee by the Holders of at least 25% in principal amount of the Securities of that series at the time Outstanding;
(4) the Company pursuant to or within the meaning
of any Bankruptcy Law
|
(i) |
commences a voluntary case, |
|
(ii) |
consents to the entry of an order for relief against it in an involuntary case, |
|
(iii) |
consents to the appointment of a Custodian of it or for all or substantially all of its property, or |
|
(iv) |
makes a general assignment for the benefit of its creditors; or |
(5) a court of competent jurisdiction enters an
order under any Bankruptcy Law that
|
(i) |
is for relief against the Company in an involuntary case, |
|
(ii) |
appoints a Custodian of the Company for all or substantially all of its property, or |
|
(iii) |
orders the liquidation of the Company, and the order remains unstayed and in effect for 90 days. |
(b) In each and every such
case, unless the principal of all the Securities of that series shall have already become due and payable, either the Trustee or the Holders
of not less than 25% in aggregate principal amount of the Securities of that series then Outstanding hereunder, by notice in writing to
the Company (and to the Trustee if given by such Securityholders), may declare the principal of all the Securities of that series to be
due and payable immediately, and upon any such declaration the same shall become and shall be immediately due and payable, notwithstanding
anything contained in this Indenture or in the Securities of that series or established with respect to that series pursuant to Section
2.01 to the contrary.
(c) At any time after the
principal of the Securities of that series shall have been so declared due and payable, and before any judgment or decree for the payment
of the moneys due shall have been obtained or entered as hereinafter provided, the Holders of a majority in aggregate principal amount
of the Securities of that series then Outstanding hereunder, by written notice to the Company and the Trustee, may rescind and annul such
declaration and its consequences if:
(1) the Company has paid
or deposited with the Trustee a sum sufficient to pay all matured installments of interest upon all the Securities of that series and
the principal of (and premium, if any, on) any and all Securities of that series that shall have become due otherwise than by acceleration
(with interest upon such principal and premium, if any, and, to the extent that such payment is enforceable under applicable law, upon
overdue installments of interest, at the rate per annum expressed in the Securities of that series to the date of such payment or deposit)
and the amount payable to the Trustee under Section 7.07, and
(2) any and all Events of
Default under the Indenture with respect to such series, other than the nonpayment of principal on Securities of that series that shall
not have become due by their terms, shall have been remedied or waived as provided in Section 6.06. No such rescission and annulment shall
extend to or shall affect any subsequent default or impair any right consequent thereon.
(d) In case the Trustee shall
have proceeded to enforce any right with respect to Securities of that series under this Indenture and such proceedings shall have been
discontinued or abandoned because of such rescission or annulment or for any other reason or shall have been determined adversely to the
Trustee, then and in every such case, subject to any determination in such proceedings, the Company, and the Trustee shall be restored
respectively to their former positions and rights hereunder, and all rights, remedies and powers of the Company and the Trustee shall
continue as though no such proceedings had been taken.
SECTION 6.02 COLLECTION OF INDEBTEDNESS AND SUITS FOR ENFORCEMENT
BY TRUSTEE.
(a) The Company covenants that
(1) in case it shall default
in the payment of any installment of interest on any of the Securities of a series, as and when the same shall have become due and payable,
and such default shall have continued for a period of 90 days, or
(2) in case it shall default
in the payment of the principal of (or premium, if any, on) any of the Securities of a series when the same shall have become due and
payable, whether upon maturity of the Securities of a series or upon redemption or upon declaration, pursuant to any sinking or analogous
fund established with respect to that series or otherwise, then, upon demand of the Trustee, the Company will pay to the Trustee, for
the benefit of the Holders of the Securities of that series, the whole amount that then shall have been become due and payable on all
such Securities for principal (and premium, if any) or interest, or both, as the case may be, with interest upon the overdue principal
(and premium, if any) and (to the extent that payment of such interest is enforceable under applicable law) upon overdue installments
of interest at the rate per annum expressed in the Securities of that series; and, in addition thereto, such further amount as shall be
sufficient to cover the costs and expenses of collection, and the amount payable to the Trustee under Section 7.07.
(b) If the Company shall fail
to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be entitled and
empowered to institute any action or proceedings at law or in equity for the collection of the sums so due and unpaid, and may prosecute
any such action or proceeding to judgment or final decree, and may enforce any such judgment or final decree against the Company or other
obligor upon the Securities of that series and collect the moneys adjudged or decreed to be payable in the manner provided by law out
of the property of the Company or other obligor upon the Securities of that series, wherever situated.
(c) In case of any receivership,
insolvency, liquidation, bankruptcy, reorganization, readjustment, arrangement, composition or judicial proceedings affecting the Company,
or its creditors or property, the Trustee shall have power to intervene in such proceedings and take any action therein that may be permitted
by the court and shall (except as may be otherwise provided by law) be entitled to file such proofs of claim and other papers and documents
as may be necessary or advisable in order to have the claims of the Trustee and of the Holders of Securities of such series allowed for
the entire amount due and payable by the Company under the Indenture at the date of institution of such proceedings and for any additional
amount that may become due and payable by the Company after such date, and to collect and receive any moneys or other property payable
or deliverable on any such claim, and to distribute the same after the deduction of the amount payable to the Trustee under Section 7.07;
and any receiver, assignee or trustee in bankruptcy or reorganization is hereby authorized by each of the Holders of Securities of such
series to make such payments to the Trustee, and, in the event that the Trustee shall consent to the making of such payments directly
to such Securityholders, to pay to the Trustee any amount due it under Section 7.07.
(d) All rights of action and
of asserting claims under this Indenture, or under any of the terms established with respect to Securities of that series, may be enforced
by the Trustee without the possession of any of such Securities, or the production thereof at any trial or other proceeding relative thereto,
and any such suit or proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery
of judgment shall, after provision for payment to the Trustee of any amounts due under Section 7.07, be for the ratable benefit of the
Holders of the Securities of such series. In case of an Event of Default hereunder, the Trustee may in its discretion proceed to protect
and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as the Trustee shall deem most effectual
to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise, whether for the specific enforcement
of any covenant or agreement contained in the Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce
any other legal or equitable right vested in the Trustee by this Indenture or by law. Nothing contained herein shall be deemed to authorize
the Trustee to authorize or consent to or accept or adopt on behalf of any Securityholder any plan of reorganization, arrangement, adjustment
or composition affecting the Securities of that series or the rights of any Holder thereof or to authorize the Trustee to vote in respect
of the claim of any Securityholder in any such proceeding.
SECTION 6.03 APPLICATION OF MONEYS COLLECTED.
Any moneys collected by the
Trustee pursuant to this Article with respect to a particular series of Securities and any money or other property distributable in respect
of the company’s obligations under this Indenture after an Event of Default shall be applied in the following order, at the date
or dates fixed by the Trustee and, in case of the distribution of such moneys on account of principal (or premium, if any) or interest,
upon presentation of the Securities of that series, and notation thereon of the payment, if only partially paid, and upon surrender thereof
if fully paid:
FIRST: To the payment of costs
and expenses of collection and of all amounts payable to the Trustee (including any predecessor Trustee) under Section 7.07; and
SECOND: To the payment of
the amounts then due and unpaid upon Securities of such series for principal (and premium, if any) and interest, in respect of which or
for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts
due and payable on such Securities for principal (and premium, if any) and interest, respectively.
SECTION 6.04 LIMITATION ON SUITS.
No Holder of any Security
of any series shall have any right by virtue or by availing of any provision of this Indenture to institute any suit, action or proceeding
in equity or at law upon or under or with respect to this Indenture or for the appointment of a receiver or trustee, or for any other
remedy hereunder, unless
(1) such Holder previously
shall have given to the Trustee written notice of an Event of Default and of the continuance thereof with respect to the Securities of
such series specifying such Event of Default, as hereinbefore provided;
(2) the Holders of not less
than 25% in aggregate principal amount of the Securities of such series then Outstanding shall have made written request upon the Trustee
to institute such action, suit or proceeding in its own name as trustee hereunder;
(3) such Holder or Holders
shall have offered to the Trustee such reasonable indemnity as it may require against the costs, expenses and liabilities to be incurred
therein or thereby; and
(4) the Trustee for 60 days
after its receipt of such notice, request and offer of indemnity, shall have failed to institute any such action, suit or proceeding and
(5) during such 60-day period,
the Holders of a majority in principal amount of the Securities of that series do not give the Trustee a direction inconsistent with the
request.
Notwithstanding anything contained
herein to the contrary, the right of any Holder of any Security to receive payment of the principal of (and premium, if any) and interest
on such Security, as therein provided, on the respective due dates expressed in such Security (or in the case of redemption, on the redemption
date), or to institute suit for the enforcement of any such payment on or after such respective dates or redemption date, shall not be
impaired or affected without the consent of such Holder and by accepting a Security hereunder it is expressly understood, intended and
covenanted by the taker and Holder of every Security of such series with every other such taker and Holder and the Trustee, that no one
or more Holders of Securities of such series shall have any right in any manner whatsoever by virtue or by availing of any provision of
this Indenture to affect, disturb or prejudice the rights of the Holders of any other of such Securities, or to obtain or seek to obtain
priority over or preference to any other such Holder, or to enforce any right under this Indenture, except in the manner herein provided
and for the equal, ratable and common benefit of all Holders of Securities of such series. For the protection and enforcement of the provisions
of this Section, each and every Securityholder and the Trustee shall be entitled to such relief as can be given either at law or in equity.
SECTION 6.05 RIGHTS AND REMEDIES CUMULATIVE; DELAY OR OMISSION NOT
WAIVER.
(a) Except as otherwise provided
in Section 2.07, all powers and remedies given by this Article to the Trustee or to the Securityholders shall, to the extent permitted
by law, be deemed cumulative and not exclusive of any other powers and remedies available to the Trustee or the Holders of the Securities,
by judicial proceedings or otherwise, to enforce the performance or observance of the covenants and agreements contained in this Indenture
or otherwise established with respect to such Securities.
(b) No delay or omission of
the Trustee or of any Holder of any of the Securities to exercise any right or power accruing upon any Event of Default occurring and
continuing as aforesaid shall impair any such right or power, or shall be construed to be a waiver of any such default or on acquiescence
therein; and, subject to the provisions of Section 6.04, every power and remedy given by this Article or by law to the Trustee or the
Securityholders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Securityholders.
SECTION 6.06 CONTROL BY SECURITYHOLDERS.
The Holders of a majority
in aggregate principal amount of the Securities of any series at the time Outstanding, determined in accordance with Section 8.01, shall
have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising
any trust or power conferred on the Trustee with respect to such series; provided, however, that such direction shall not be in conflict
with any rule of law or with this Indenture or be unduly prejudicial to the rights of Holders of Securities of any other series at the
time Outstanding determined in accordance with Section 8.01. Subject to the provisions of Section 7.01, the Trustee shall have the right
to decline to follow any such direction if the Trustee in good faith shall, by a Responsible Officer or Officers of the Trustee, determine
that the proceeding so directed would involve the Trustee in personal liability. The Holders of a majority in aggregate principal amount
of the Securities of any series at the time Outstanding affected thereby, determined in accordance with Section 8.01, may on behalf of
the holders of all of the Securities of such series waive any past default in the performance of any of the covenants contained herein
or established pursuant to Section 2.01 with respect to such series and its consequences, except a default in the payment of the principal
of (or premium, if any) or interest on, any of the Securities of that series as and when the same shall become due by the terms of such
Securities otherwise than by acceleration (unless such default has been cured and a sum sufficient to pay all matured installments of
interest and principal and any premium has been deposited with the Trustee (in accordance with Section 6.01(c)) or in respect of a covenant
or provision hereof which under Article IX cannot be modified or amended without the consent of the Holder of each Outstanding Security
affected. Upon any such waiver, the default covered thereby shall be deemed to be cured for all purposes of this Indenture and the Company,
the Trustee and the Holders of the Securities of such series shall be restored to their former positions and rights hereunder, respectively;
but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon.
SECTION 6.07 UNDERTAKING TO PAY COSTS.
All parties to this Indenture
agree, and each Holder of any Securities by such Holder’s acceptance thereof shall be deemed to have agreed, that any court may
in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee
for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of
such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees, against any
party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but
the provisions of this Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder, or
group of Securityholders, holding more than 10% in aggregate principal amount of the Outstanding Securities of any series, or to any suit
instituted by any Securityholder for the enforcement of the payment of the principal of (or premium, if any) or interest on any Security
of such series, on or after the respective due dates expressed in such Security or established pursuant to this Indenture.
ARTICLE VII
CONCERNING THE TRUSTEE
SECTION 7.01 CERTAIN DUTIES AND RESPONSIBILITIES OF TRUSTEE.
(a) The Trustee, prior to
the occurrence of an Event of Default with respect to the Securities of a series and after the curing of all Events of Default with respect
to the Securities of that series that may have occurred, shall undertake to perform with respect to the Securities of such series such
duties and only such duties as are specifically set forth in this Indenture, and no implied covenants shall be read into this Indenture
against the Trustee. In case an Event of Default with respect to the Securities of a series has occurred (that has not been cured or waived),
the Trustee shall exercise with respect to Securities of that series such of the rights and powers vested in it by this Indenture, and
use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct
of his own affairs.
(b) No provision of this Indenture
shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to act, or its own willful
misconduct, except that:
(1) prior to the occurrence
of an Event of Default with respect to the Securities of a series and after the curing or waiving of all such Events of Default with respect
to that series that may have occurred: the duties and obligations of the Trustee shall with respect to the Securities of such series be
determined solely by the express provisions of this Indenture, and the Trustee shall not be liable with respect to the Securities of such
series except for the performance of such duties and obligations as are specifically set forth in this Indenture, and no implied covenants
or obligations shall be read into this Indenture against the Trustee; and in the absence of bad faith on the part of the Trustee, the
Trustee may with respect to the Securities of such series conclusively rely, as to the truth of the statements and the correctness of
the opinions expressed therein, upon any certificates or opinions furnished to the Trustee and conforming to the requirements of this
Indenture; but in the case of any such certificates or opinions that by any provision hereof are specifically required to be furnished
to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirement of this
Indenture;
(2) the Trustee shall not
be liable for any error of judgment made in good faith by a Responsible Officer or Responsible Officers of the Trustee, unless it shall
be proved that the Trustee, was negligent in ascertaining the pertinent facts;
(3) the Trustee shall not
be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders
of not less than a majority in principal amount of the Securities of any series at the time Outstanding relating to the time, method and
place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee
under this Indenture with respect to the Securities of that series; and
(4) this Subsection shall
not be construed to limit the effect of Subsection (c) of this Section 7.01.
(c) None of the provisions
contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur any financial liability in the
performance of any of its duties hereunder, or in the exercise of any of its rights or powers, it shall have reasonable grounds for believing
that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it.
(d) The Trustee shall not
be deemed to have notice of or be charged with having knowledge of any Default or Event of Default with respect to any series of Securities,
except Events of Default under Section 6.01(a)(1) or (a)(2), if and so long as it is acting as paying agent with respect to the Securities
of such series, unless written notice of such Default Event or Event of Default, as the case may be, is received by the Trustee at the
Corporate Trust Office of the Trustee from the Company or any Holder of Securities of such series, and such notice references the Securities
and this Indenture.
(e) Whether or not expressly
so provided, every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee
shall be subject to the provisions of this Section 7.01.
SECTION 7.02 NOTICE OF DEFAULTS.
If a Default occurs hereunder
with respect to Securities of any series and is known to a Responsible Officer of the Trustee, the Trustee shall give the Holders of Securities
of such series notice of such Default as and to the extent provided by the Trust Indenture Act; provided, however, that in the case of
any Default of the character specified in clause (3) of Section 6.01(a) with respect to Securities of such series, no such notice to Holders
shall be given until at least 30 days after the occurrence thereof.
SECTION 7.03 CERTAIN RIGHTS OF TRUSTEE.
Except as otherwise provided in Section 7.01:
(a) The Trustee may conclusively
rely and shall be fully protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion,
report, notice, request, consent, order, approval, bond, security or other paper or document believed by it to be genuine and to have
been signed or presented by the proper party or parties;
(b) Any request, direction,
order or demand of the Company mentioned herein shall be sufficiently evidenced by a Board Resolution or an instrument signed in the name
of the Company, by the President or any Vice President and by the Secretary or an Assistant Secretary or the Treasurer or an Assistant
Treasurer thereof (unless other evidence in respect thereof is specifically prescribed herein);
(c) The Trustee may consult
with counsel and the advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect
of any action taken or suffered or omitted hereunder in good faith and in reliance thereon;
(d) The Trustee shall be under
no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the
Securityholders, pursuant to the provisions of this Indenture, unless such Securityholders shall have offered to the Trustee reasonable
security or indemnity against the costs, expenses and liabilities that may be incurred therein or thereby; nothing contained herein shall,
however, relieve the Trustee of the obligation, upon the occurrence of an Event of Default with respect to a series of the Securities
(that has not been cured or waived) to exercise with respect to Securities of that series such of the rights and powers vested in it by
this Indenture, and to use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances
in the conduct of his own affairs;
(e) The Trustee shall not
be liable for any action taken or omitted to be taken by it in good faith and believed by it to be authorized or within the discretion
or rights or powers conferred upon it by this Indenture;
(f) The Trustee shall not
be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report,
notice, request, consent, order, approval, bond, security, or other papers or documents; and
(g) The Trustee may execute
any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys and the Trustee
shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder.
(h) whenever in the administration
of this Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any
action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may, in the absence of bad faith on its part,
conclusively rely upon an Officers’ Certificate;
(i) the rights, privileges,
protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to,
and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act
hereunder;
(j) the Trustee may request
that the Company deliver an Officers’ Certificate setting forth the names of individuals and/or titles of officers authorized at
such time to take specified actions pursuant to this Indenture;
(k) the permissive right of
the Trustee to take or refrain from taking any actions enumerated in this Indenture shall not be construed as a duty;
(l) anything in this Indenture
notwithstanding, in no event shall the Trustee be liable for special, indirect, punitive or consequential loss or damage of any kind whatsoever
(including but not limited to loss of profit), even if the Company or Guarantor has been advised as to the likelihood of such loss or
damage and regardless of the form of action;
(m) the Trustee shall not
be responsible or liable for any failure or delay in the performance of its obligations under this Indenture arising out of or caused,
directly or indirectly, by circumstances beyond its reasonable control, including, without limitation, acts of God; earthquakes; fire;
flood; terrorism; wars and other military disturbances; sabotage; epidemics; riots; interruptions; loss or malfunctions of utilities,
computer (hardware or software) or communication services; accidents; labor disputes; acts of civil or military authority and governmental
action.
SECTION 7.04 TRUSTEE NOT RESPONSIBLE FOR RECITALS OR ISSUANCE OR
SECURITIES.
(a) The recitals contained
herein and in the Securities shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness
of the same.
(b) The Trustee makes no representations
as to the validity or sufficiency of this Indenture or of the Securities.
(c) The Trustee shall not
be accountable for the use or application by the Company of any of the Securities or of the proceeds of such Securities, or for the use
or application of any moneys paid over by the Trustee in accordance with any provision of this Indenture or established pursuant to Section
2.01, or for the use or application of any moneys received by any paying agent other than the Trustee.
SECTION 7.05 MAY HOLD SECURITIES.
The Trustee or any paying
agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights
it would have if it were not Trustee, paying agent or Security Registrar.
SECTION 7.06 MONEYS HELD IN TRUST.
Subject to the provisions
of Section 11.05, all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes
for which they were received, but need not be segregated from other funds except to the extent required by law. The Trustee shall be under
no liability for interest on any moneys received by it hereunder except such as it may agree with the Company to pay thereon.
SECTION 7.07 COMPENSATION AND REIMBURSEMENT.
(a) The Company covenants
and agrees to pay to the Trustee, and the Trustee shall be entitled to, such reasonable compensation (which shall not be limited by any
provision of law in regard to the compensation of a trustee of an express trust), as the Company, and the Trustee may from time to time
agree in writing, for all services rendered by it in the execution of the trusts hereby created and in the exercise and performance of
any of the powers and duties hereunder of the Trustee, and, except as otherwise expressly provided herein, the Company will pay or reimburse
the Trustee upon its request for all reasonable expenses, disbursements and advances incurred or made by the Trustee in accordance with
any of the provisions of this Indenture (including the reasonable compensation and the expenses and disbursements of its counsel and of
all Persons not regularly in its employ) except any such expense, disbursement or advance as may arise from its gross negligence or willful
misconduct. The Company also covenants to indemnify the Trustee (and its officers, agents, directors and employees) for, and to hold it
harmless against, any loss, damage, claims liability or expense incurred without gross negligence or willful misconduct on the part of
the Trustee and arising out of or in connection with the acceptance or administration of this trust, including the costs and expenses
of defending itself against any claim whether asserted by the Company, any Securityholder or any other Person or liability including the
compensation and expense of counsel in connection with the exercise or performance of any of its powers or duties hereunder.
(b) The obligations of the
Company under this Section to compensate and indemnify the Trustee and to pay or reimburse the Trustee for expenses, disbursements and
advances shall constitute additional indebtedness hereunder. Such additional indebtedness shall be secured by a lien prior to that of
the Securities upon all property and funds held or collected by the Trustee as such, except funds held in trust for the benefit of the
Holders of particular Securities.
(c) To the extent permitted
by law, any compensation due or expense incurred by the Trustee after a default specified in or pursuant to Section 6.01 is intended to
constitute an expense of administration under any then applicable bankruptcy or insolvency law. “Trustee” for purposes of
this Section 7.07 shall include any predecessor Trustee but the negligence or bad faith of any Trustee shall not affect the rights of
any other Trustee under this Section 7.07.
(d) The provisions of this
Section 7.07 shall survive the satisfaction and discharge of this Indenture, the termination of this Indenture for any reason, or the
earlier resignation or removal of the Trustee and shall apply with equal force and effect to the Trustee in its capacity as Authenticating
Agent, Security Registrar or paying agent.
SECTION 7.08 RELIANCE ON OFFICERS’ CERTIFICATE.
Except as otherwise provided
in Section 7.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that
a matter be proved or established prior to taking or suffering or omitting to take any action hereunder, such matter (unless other evidence
in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be deemed
to be conclusively proved and established by an Officers’ Certificate delivered to the Trustee and such certificate, in the absence
of negligence or bad faith on the part of the Trustee, shall be full warranty to the Trustee for any action taken, suffered or omitted
to be taken by it under the provisions of this Indenture upon the faith thereof.
SECTION 7.09 DISQUALIFICATION; CONFLICTING INTERESTS.
If the Trustee has or shall
acquire any “conflicting interest” within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee and the Company
shall in all respects comply with the provisions of Section 310(b) of the Trust Indenture Act, subject to the penultimate paragraph thereof.
For purposes of Section 310(b)(i) of the Trust Indenture Act and to the extent permitted thereby, the Trustee, in its capacity as trustee
in respect of the Securities of any series, shall not be deemed to have a conflicting interest arising from its capacity as trustee in
respect of the Securities of any other series.
SECTION 7.10 CORPORATE TRUSTEE REQUIRED; ELIGIBILITY.
There shall at all times be
a Trustee with respect to the Securities issued hereunder which shall at all times be a corporation organized and doing business under
the laws of the United States of America or any State or Territory thereof or of the District of Columbia, or a corporation or other Person
permitted to act as trustee by the Commission, authorized under such laws to exercise corporate trust powers, having a combined capital
and surplus of at least fifty million U.S. dollars ($50,000,000), and subject to supervision or examination by federal, state, territorial,
or District of Columbia authority. If such corporation publishes reports of condition at least annually, pursuant to law or to the requirements
of the aforesaid supervising or examining authority, then for the purposes of this Section, the combined capital and surplus of such corporation
shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. The Company may
not, nor may any Person directly or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee.
In case at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall resign
immediately in the manner and with the effect specified in Section 7.11.
SECTION 7.11 RESIGNATION AND REMOVAL; APPOINTMENT OF SUCCESSOR.
(a) The Trustee or any successor
hereafter appointed, may at any time resign with respect to the Securities of one or more series by giving written notice thereof to the
Company and by transmitting notice of resignation by mail, first class postage prepaid, to the Securityholders of such series, as their
names and addresses appear upon the Security Register. Upon receiving such notice of resignation, the Company shall promptly appoint a
successor trustee with respect to Securities of such series by written instrument, in duplicate, executed by order of the Board of Directors,
one copy of which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee. If no successor trustee
shall have been so appointed and have accepted appointment within 30 days after the mailing of such notice of resignation, the resigning
Trustee may petition any court of competent jurisdiction for the appointment of a successor trustee with respect to Securities of such
series, or any Securityholder of that series who has been a bona fide Holder of a Security or Securities for at least six months may on
behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such court may
thereupon after such notice, if any, as it may deem proper and prescribe, appoint a successor trustee.
(b) In case at any time any one of the following
shall occur:
(1) the Trustee shall fail
to comply with the provisions of Section 7.09 after written request therefor by the Company or by any Securityholder who has been a bona
fide Holder of a Security or Securities for at least six months; or
(2) the Trustee shall cease
to be eligible in accordance with the provisions of Section 7.10 and shall fail to resign after written request therefor by the Company
or by any such Securityholder; or
(3) the Trustee shall become
incapable of acting, or shall be adjudged a bankrupt or insolvent, or commence a voluntary bankruptcy proceeding, or a receiver of the
Trustee or of its property shall be appointed or consented to, or any public officer shall take charge or control of the Trustee or of
its property or affairs for the purpose of rehabilitation, conservation or liquidation, then, in any such case, the Company may remove
the Trustee with respect to all Securities and appoint a successor trustee by written instrument, in duplicate, executed by order of the
Board of Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or,
unless, in the case of a failure to comply with Section 7.09, the Trustee’s duty to resign is stayed as provided in the penultimate
paragraph of Section 310(b) of the Trust Indenture Act, any Securityholder who has been a bona fide Holder of a Security or Securities
for at least six months may, on behalf of that Holder and all others similarly situated, petition any court of competent jurisdiction
for the removal of the Trustee and the appointment of a successor trustee. Such court may thereupon after such notice, if any, as it may
deem proper and prescribe, remove the Trustee and appoint a successor trustee.
(c) The Holders of a majority
in aggregate principal amount of the Securities of any series at the time Outstanding may at any time remove the Trustee with respect
to such series by so notifying the Trustee and the Company and may appoint a successor Trustee for such series with the consent of the
Company.
(d) Any resignation or removal
of the Trustee and appointment of a successor trustee with respect to the Securities of a series pursuant to any of the provisions of
this Section shall become effective upon acceptance of appointment by the successor trustee as provided in Section 7.12.
(e) Any successor trustee
appointed pursuant to this Section may be appointed with respect to the Securities of one or more series or all of such series, and at
any time there shall be only one Trustee with respect to the Securities of any particular series.
SECTION 7.12 ACCEPTANCE OF APPOINTMENT BY SUCCESSOR.
(a) In case of the appointment
hereunder of a successor trustee with respect to all Securities, every such successor trustee so appointed shall execute, acknowledge
and deliver to the Company and to the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal
of the retiring Trustee shall become effective and such successor trustee, without any further act, deed or conveyance, shall become vested
with all the rights, powers, trusts and duties of the retiring Trustee; but, on the request of the Company or the successor trustee, such
retiring Trustee shall, upon payment of its charges, execute and deliver an instrument transferring to such successor trustee all the
rights, powers, and trusts of the retiring Trustee and shall duly assign, transfer and deliver to such successor trustee all property
and money held by such retiring Trustee hereunder, subject nevertheless to the lien provided for in Section 7.07.
(b) In case of the appointment
hereunder of a successor trustee with respect to the Securities of one or more (but not all) series, the Company, the retiring Trustee
and each successor trustee with respect to the Securities of one or more series shall execute and deliver an indenture supplemental hereto
wherein each successor trustee shall accept such appointment and which
(1) shall contain such provisions
as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor trustee all the rights, powers, trusts and
duties of the retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor trustee
relates,
(2) shall contain such provisions
as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the retiring Trustee with respect
to the Securities of that or those series as to which the retiring Trustee is not retiring shall continue to be vested in the retiring
Trustee, and
(3) shall add to or change
any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder
by more than one Trustee, it being understood that nothing herein or in such supplemental indenture shall constitute such Trustees co-trustees
of the same trust, that each such Trustee shall be trustee of a trust or trusts hereunder separate and apart from any trust or trusts
hereunder administered by any other such Trustee and that no Trustee shall be responsible for any act or failure to act on the part of
any other Trustee hereunder; and upon the execution and delivery of such supplemental indenture the resignation or removal of the retiring
Trustee shall become effective to the extent provided therein, such retiring Trustee shall with respect to the Securities of that or those
series to which the appointment of such successor trustee relates have no further responsibility for the exercise of rights and powers
or for the performance of the duties and obligations vested in the Trustee under this Indenture, and each such successor trustee, without
any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee with respect
to the Securities of that or those series to which the appointment of such successor trustee relates; but, on request of the Company or
any successor trustee, such retiring Trustee shall duly assign, transfer and deliver to such successor trustee, to the extent contemplated
by such supplemental indenture, the property and money held by such retiring Trustee hereunder with respect to the Securities of that
or those series to which the appointment of such successor trustee relates, subject nevertheless to the lien provided for in Section 7.07.
(c) Upon request of any such
successor trustee, the Company shall execute any and all instruments for more fully and certainly vesting in and confirming to such successor
trustee all such rights, powers and trusts referred to in paragraph (a) or (b) of this Section, as the case may be.
(d) No successor trustee shall
accept its appointment unless at the time of such acceptance such successor trustee shall be qualified and eligible under this Article.
(e) Upon acceptance of appointment
by a successor trustee as provided in this Section, the Company shall transmit notice of the succession of such trustee hereunder by mail,
first class postage prepaid, to the Securityholders, as their names and addresses appear upon the Security Register. If the Company fails
to transmit such notice within ten days after acceptance of appointment by the successor trustee, the successor trustee shall cause such
notice to be transmitted at the expense of the Company.
SECTION 7.13 MERGER, CONVERSION, CONSOLIDATION OR SUCCESSION TO
BUSINESS.
Any Person into which the
Trustee may be merged or converted or with which it may be consolidated, or any Person resulting from any merger, conversion or consolidation
to which the Trustee shall be a party, or any Person succeeding to all or substantially all of the corporate trust business of the Trustee,
shall be the successor of the Trustee hereunder, provided that such Person shall be qualified under the provisions of Section 7.09 and
eligible under the provisions of Section 7.10, without the execution or filing of any paper or any further act on the part of any of the
parties hereto, anything herein to the contrary notwithstanding. In case any Securities shall have been authenticated, but not delivered,
by the Trustee then in office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such authentication
and deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities.
SECTION 7.14 PREFERENTIAL COLLECTION OF CLAIMS AGAINST THE COMPANY.
The Trustee shall comply with
Section 311(a) of the Trust Indenture Act, excluding any creditor relationship described in Section 311(b) of the Trust Indenture Act.
A Trustee who has resigned or been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent included therein.
ARTICLE VIII
CONCERNING THE SECURITYHOLDERS
SECTION 8.01 EVIDENCE OF ACTION BY SECURITYHOLDERS.
Whenever in this Indenture
it is provided that the Holders of a majority or specified percentage in aggregate principal amount of the Securities of a particular
series may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of
any other action), the fact that at the time of taking any such action the Holders of such majority or specified percentage of that series
have joined therein may be evidenced by any instrument or any number of instruments of similar tenor executed by such Holders of Securities
of that series in Person or by agent or proxy appointed in writing. If the Company shall solicit from the Securityholders of any series
any request, demand, authorization, direction, notice, consent, waiver or other action, the Company may, at its option, as evidenced by
an Officers’ Certificate, fix in advance a record date for such series for the determination of Securityholders entitled to give
such request, demand, authorization, direction, notice, consent, waiver or other action, but the Company shall have no obligation to do
so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or other action may be given
before or after the record date, but only the Securityholders of record at the close of business on the record date shall be deemed to
be Securityholders for the purposes of determining whether Securityholders of the requisite proportion of Outstanding Securities of that
series have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other action,
and for that purpose the Outstanding Securities of that series shall be computed as of the record date; provided, however, that no such
authorization, agreement or consent by such Securityholders on the record date shall be deemed effective unless it shall become effective
pursuant to the provisions of this Indenture not later than six months after the record date.
SECTION 8.02 PROOF OF EXECUTION BY SECURITYHOLDERS.
Subject to the provisions
of Section 7.01, proof of the execution of any instrument by a Securityholder (such proof will not require notarization) or his agent
or proxy and proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner:
(1) The fact and date of the
execution by any such Person of any instrument may be proved in any reasonable manner acceptable to the Trustee.
(2) The ownership of Securities
shall be proved by the Security Register of such Securities or by a certificate of the Security Registrar thereof.
(3) The Trustee may require
such additional proof of any matter referred to in this Section as it shall deem necessary.
SECTION 8.03 WHO MAY BE DEEMED OWNERS.
Prior to the due presentment
for registration of transfer of any Security, the Company, the Trustee, any paying agent and any Security Registrar may deem and treat
the Person in whose name such Security shall be registered upon the books of the Company as the absolute owner of such Security (whether
or not such Security shall be overdue and notwithstanding any notice of ownership or writing thereon made by anyone other than the Security
Registrar) for the purpose of receiving payment of or on account of the principal of (and premium, if any) and (subject to Section 2.03)
interest on such Security and for all other purposes; and neither the Company nor the Trustee nor any paying agent nor any Security Registrar
shall be affected by any notice to the contrary.
SECTION 8.04 CERTAIN SECURITIES OWNED BY COMPANY DISREGARDED.
In determining whether the
Holders of the requisite aggregate principal amount of Securities of a particular series have concurred in any direction, consent or waiver
under this Indenture, the Securities of that series that are owned by the Company or any other obligor on the Securities of that series
or by any Person directly or indirectly controlling or controlled by or under common control with the Company or any other obligor on
the Securities of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except
that for the purpose of determining whether the Trustee shall be protected in relying on any such direction, consent or waiver, only Securities
of such series that a Responsible Officer of the Trustee actually knows are so owned shall be so disregarded. The Securities so owned
that have been pledged in good faith may be regarded as Outstanding for the purposes of this Section, if the pledgee shall establish to
the satisfaction of the Trustee the pledgee’s right so to act with respect to such Securities and that the pledgee is not a Person
directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any such other obligor.
In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full protection to the Trustee.
SECTION 8.05 ACTIONS BINDING ON FUTURE SECURITYHOLDERS.
At any time prior to (but
not after) the evidencing to the Trustee, as provided in Section 8.01, of the taking of any action by the Holders of the majority or percentage
in aggregate principal amount of the Securities of a particular series specified in this Indenture in connection with such action, any
Holder of a Security of that series that is shown by the evidence to be included in the Securities the Holders of which have consented
to such action may, by filing written notice with the Trustee, and upon proof of holding as provided in Section 8.02, revoke such action
so far as concerns such Security. Except as aforesaid any such action taken by the Holder of any Security shall be conclusive and binding
upon such Holder and upon all future Holders and owners of such Security, and of any Security issued in exchange therefor, on registration
of transfer thereof or in place thereof, irrespective of whether or not any notation in regard thereto is made upon such Security. Any
action taken by the Holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified
in this Indenture in connection with such action shall be conclusively binding upon the Company, the Trustee and the Holders of all the
Securities of that series.
ARTICLE IX
SUPPLEMENTAL INDENTURES
SECTION 9.01 SUPPLEMENTAL INDENTURES WITHOUT THE CONSENT OF SECURITYHOLDERS.
In addition to any supplemental
indenture otherwise authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into an indenture
or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent
of the Securityholders, for one or more of the following purposes:
(1) to cure any ambiguity, defect, or inconsistency
herein, in the Securities of any series;
(2) to comply with Article X;
(3) to provide for uncertificated Securities in
addition to or in place of certificated Securities;
(4) to add to the covenants
of the Company for the benefit of the Holders of all or any series of Securities (and if such covenants are to be for the benefit of less
than all series of Securities, stating that such covenants are expressly being included solely for the benefit of such series) or to surrender
any right or power herein conferred upon the Company or to add any additional Events of Default for the benefit of the Holders of all
or any series of Securities (and if such additional Events of Default are to be for the benefit of less than all series of Securities,
stating that such additional Events of Default are expressly being included solely for the benefit of such series);
(5) to add to, delete from,
or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue, authentication, and delivery
of Securities (prior to the issuance thereof), as herein set forth;
(6) to make any change that
does not adversely affect the rights of any Securityholder in any material respect;
(7) to provide for the issuance
of and establish the form and terms and conditions of the Securities of any series as provided in Section 2.01, to establish the form
of any certifications required to be furnished pursuant to the terms of this Indenture or any series of Securities, or to add to the rights
of the Holders of any series of Securities; or
(8) to evidence and provide
for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more series and to add to
or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts
hereunder by more than one Trustee, pursuant to the requirements of Section 7.12.
The Trustee is hereby authorized
to join with the Company in the execution of any such supplemental indenture, and to make any further appropriate agreements and stipulations
that may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture that affects the Trustee’s
own rights, duties or immunities under this Indenture or otherwise.
Any supplemental indenture
authorized by the provisions of this Section may be executed by the Company and the Trustee without the consent of the Holders of any
of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 9.02.
SECTION 9.02 SUPPLEMENTAL INDENTURES WITH CONSENT OF SECURITYHOLDERS.
With the consent (evidenced
as provided in Section 8.01) of the Holders of not less than a majority in aggregate principal amount of the Securities of each series
affected by such supplemental indenture or indentures at the time Outstanding, the Company, when authorized by a Board Resolution, and
the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the
provisions of the Trust Indenture Act as then in effect) for the purpose of adding any provisions to or changing in any manner or eliminating
any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner not covered by Section 9.01 the
rights of the Holders of the Securities of such series under this Indenture; provided, however, that no such supplemental indenture shall,
without the consent of the Holders of each Security then Outstanding and affected thereby:
(1) change the maturity of
the principal of, or any installment of principal of or interest on, any Security, or reduce the principal amount thereof or the rate
of interest thereon or any premium payable upon the redemption thereof, or reduce the amount of the principal of an Original Issue Discount
Security or any other Security which would be due and payable upon a declaration of acceleration of the maturity thereof pursuant to Section
6.01 or change the coin or currency in which any Security or any premium or interest thereon is payable, or impair the right to institute
suit for the enforcement of any such payment on or after the maturity thereof (or, in the case of redemption, on or after the redemption
date), or
(2) reduce the percentage
in principal amount of the Outstanding Securities of any series, the consent of whose Holders is required for any such supplemental indenture,
or the consent of whose Holders is required for any waiver of certain defaults hereunder and their consequences provided for in this Indenture,
or
(3) modify any of the provisions
of this Section or Section 6.06 relating to waivers of default, except to increase any such percentage or to provide that certain other
provisions of this Indenture cannot be modified or waived without the consent of the Holder of each Outstanding Security affected thereby;
provided, however, that this clause shall not be deemed to require the consent of any Holder with respect to changes in the references
to “the Trustee” and concomitant changes in this Section, or the deletion of this proviso, in accordance with the requirements
of Sections 7.12 and 9.01(8).
A supplemental indenture which
changes or eliminates any covenant or other provision of this Indenture which has expressly been included solely for the benefit of one
or more particular series of Securities, or which modifies the rights of the Holders of Securities of such series with respect to such
covenant or other provision, shall be deemed not to affect the rights under this Indenture of the Holders of Securities of any other series.
It shall not be necessary for the consent of the Securityholders of any series affected thereby under this Section to approve the particular
form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof.
SECTION 9.03 EFFECT OF SUPPLEMENTAL INDENTURES.
Upon the execution of any
supplemental indenture pursuant to the provisions of this Article or of Section 10.01, this Indenture shall, with respect to such series,
be and be deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations, duties
and immunities under this Indenture of the Trustee, the Company and the Holders of Securities of the series affected thereby shall thereafter
be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions
of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.
SECTION 9.04 SECURITIES AFFECTED BY SUPPLEMENTAL INDENTURES.
Securities of any series,
affected by a supplemental indenture, authenticated and delivered after the execution of such supplemental indenture pursuant to the provisions
of this Article or of Section 10.01, may bear a notation in form approved by the Company, provided such form meets the requirements of
any exchange upon which such series may be listed, as to any matter provided for in such supplemental indenture. If the Company shall
so determine, new Securities of that series so modified as to conform, in the opinion of the Board of Directors of the Company, to any
modification of this Indenture contained in any such supplemental indenture may be prepared by the Company, authenticated by the Trustee
and delivered in exchange for the Securities of that series then Outstanding.
SECTION 9.05 EXECUTION OF SUPPLEMENTAL INDENTURES.
Upon the request of the Company,
accompanied by its Board Resolutions authorizing the execution of any supplemental indenture, and upon the filing with the Trustee of
evidence of any requisite consents of Securityholders required to consent thereto as aforesaid, the Trustee shall join with the Company
in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties or immunities
under this Indenture or otherwise, in which case the Trustee may in its discretion but shall not be obligated to enter into such supplemental
indenture. The Trustee, subject to the provisions of Section 7.01, shall be entitled to receive an Opinion of Counsel as conclusive evidence
that any supplemental indenture executed pursuant to this Article is authorized or permitted by, and conforms to, the terms of this Article
and that it is proper for the Trustee under the provisions of this Article to join in the execution thereof.
Promptly after the execution
by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Company shall transmit by
mail, first class postage prepaid, a notice, setting forth in general terms the substance of such supplemental indenture, to the Securityholders
of all series affected thereby as their names and addresses appear upon the Security Register. Any failure of the Company to mail such
notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.
ARTICLE X
SUCCESSOR ENTITY
SECTION 10.01 COMPANY MAY CONSOLIDATE, ETC.
Nothing contained in this
Indenture or in any of the Securities shall prevent any consolidation or merger of the Company with or into any other Person (whether
or not affiliated with the Company) or successive consolidations or mergers in which the Company or its successor or successors shall
be a party or parties, or shall prevent any sale, conveyance, transfer or other disposition of the property of the Company or its successor
or successors as an entirety, or substantially as an entirety, to any other Person (whether or not affiliated with the Company or its
successor or successors) authorized to acquire and operate the same; provided, however, the Company hereby covenants and agrees that,
upon any such consolidation or merger (in each case, if the Company is not the survivor of such transaction), sale, conveyance, transfer
or other disposition, the due and punctual payment of the principal of (and premium, if any) and interest on all of the Securities of
all series in accordance with the terms of each series, according to their tenor and the due and punctual performance and observance of
all the covenants and conditions of this Indenture or established with respect to each series of Securities pursuant to Section 2.01 to
be kept or performed by the Company shall be expressly assumed, by supplemental indenture (which shall conform to the provisions of the
Trust Indenture Act, as then in effect) satisfactory in form to the Trustee executed and delivered to the Trustee by the entity formed
by such consolidation, or into which the Company shall have been merged, or by the entity which shall have acquired such property.
SECTION 10.02 SUCCESSOR ENTITY SUBSTITUTED.
(a) In case of any such consolidation,
merger, sale, conveyance, transfer or other disposition and upon the assumption by any successor entity by supplemental indenture, executed
and delivered to the Trustee of the due and punctual payment of the principal of (and premium, if any) and interest on all of the Securities
of all series Outstanding and the due and punctual performance of all of the covenants and conditions of this Indenture or established
with respect to each series of the Securities pursuant to Section 2.01 to be performed by the Company, such successor entity shall succeed
to and be substituted for the Company with the same effect as if it had been named as the Company herein, and thereupon the predecessor
company, except in the case of a lease, shall be relieved of all obligations and covenants under this Indenture and the Securities.
(b) In case of any such consolidation,
merger, sale, conveyance, transfer or other disposition such changes in phraseology and form (but not in substance) may be made in the
Securities thereafter to be issued as may be appropriate.
(c) Nothing contained in this
Article shall require any action by the Company in the case of a consolidation or merger of any Person into the Company where the Company
is the survivor of such transaction, or the acquisition by the Company, by purchase or otherwise, of all or any part of the property of
any other Person (whether or not affiliated with the Company).
SECTION 10.03 EVIDENCE OF CONSOLIDATION, ETC. TO TRUSTEE.
The Trustee, subject to the
provisions of Section 7.01, shall be entitled to receive an Opinion of Counsel and an Officers’ Certificate as conclusive evidence
that any such consolidation, merger, sale, conveyance, transfer or other disposition, and any such assumption, comply with the provisions
of this Article.
ARTICLE XI
SATISFACTION AND DISCHARGE; DEFEASANCE
SECTION 11.01 SATISFACTION AND DISCHARGE.
This Indenture will be discharged
and will cease to be of further effect with respect to a series of Securities (except as to any surviving rights of registration of transfer
or exchange of such series of Securities herein expressly provided for), and the Trustee, at the expense of the Company, shall execute
proper instruments acknowledging satisfaction and discharge of this Indenture with respect to such series, when:
(1) either (A) all Securities
of that series theretofore authenticated and delivered (other than (i) any Securities that shall have been destroyed, lost or stolen and
that shall have been replaced or paid as provided in Section 2.07 and (ii) Securities for whose payment money or noncallable Governmental
Obligations have theretofore been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company
or discharged from such trust, as provided in Section 11.05) have been delivered to the Trustee for cancellation; or (B) all Securities
of such series not theretofore delivered to the Trustee for cancellation (i) have become due and payable, or (ii) will by their terms
become due and payable within one year, or (iii) are to be called for redemption within one year under arrangements satisfactory to the
Trustee for the giving of notice of redemption, and the Company shall deposit or cause to be deposited with the Trustee as trust funds
in trust for the purpose (x) moneys in an amount, or (y) noncallable Governmental Obligations the scheduled principal of and interest
on which in accordance with their terms will provide, not later than the due date of any payment, money in an amount, or (z) a combination
thereof, sufficient, in the case of (y) or (z), in the opinion of a nationally recognized firm of independent public accountants expressed
in a written certification thereof delivered to the Trustee, to pay and discharge, at maturity or upon redemption, all Securities of that
series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due or to become
due to such date of maturity or date fixed for redemption, as the case may be;
(2) the Company has paid or
caused to be paid all other sums payable hereunder with respect to such series by the Company; and
(3) the Company has delivered
to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all the conditions precedent herein provided
for relating to the satisfaction and discharge of this Indenture with respect to such series of Securities have been complied with. Notwithstanding
the satisfaction and discharge of this Indenture with respect to a series of Securities, the obligations of the Trustee under Section
7.07 and, if money shall have been deposited with the Trustee pursuant to subclause (y) of clause (1) of this Section, the obligations
of the Trustee under Sections 11.03 and 11.05 shall survive.
SECTION 11.02 DEFEASANCE.
The Company may, at its option
and at any time (including notwithstanding the exercise by the Company of a Covenant Defeasance (as defined herein)), elect to have its
obligations discharged with respect to a series of the Securities (“Legal Defeasance”). Such Legal Defeasance means that the
Company shall be deemed to have paid and discharged the entire indebtedness represented by such series of Securities, except for (a) the
rights of Holders to receive payments in respect of the principal of (and premium, if any) and interest on the Securities when such payments
are due solely from the trust fund described in this Section, (b) the Company’s obligations with respect to such series of Securities
concerning issuing temporary Securities, registration of transfer or exchange of such series of Securities, mutilated, destroyed, lost
or stolen Securities of such series and the maintenance of an office or agency for payments, (c) the rights, powers, trust, duties and
immunities of the Trustee and the Company’s obligations in connection therewith and (d) the Legal Defeasance provisions of this
Indenture. In addition, the Company may, at its option and at any time, elect to have the obligations of the Company released with respect
to covenants provided with respect to such series of Securities under Section 2.01(15), 9.01(4) and 9.01(7) of this Indenture (“Covenant
Defeasance”) and thereafter any omission to comply with such obligations shall not constitute a Default or Event of Default with
respect to such series of Securities. In the event of Covenant Defeasance, those events described under Section 6.01(a) with respect to
the foregoing covenants will no longer constitute an Event of Default with respect to such series of Securities.
In order to exercise either Legal Defeasance or
Covenant Defeasance:
(1) the Company must irrevocably
deposit with the Trustee, in trust, for the benefit of the Holders of such series, (A) moneys in an amount, or (B) noncallable Governmental
Obligations the scheduled principal of and interest on which in accordance with their terms will provide, not later than the due date
of any payment, money in an amount, or (C) a combination thereof, sufficient, in the case of (B) or (C), in the opinion of a nationally
recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge,
at maturity or upon redemption, the principal of (and premium, if any) and interest on such series of Securities on the stated date for
payment thereof or on the applicable redemption date, as the case may be;
(2) in the case of Legal
Defeasance, the Company shall have delivered to the Trustee an Opinion of Counsel confirming that (A) the Company has received from,
or there has been published by, the Internal Revenue Service a ruling or (B) since the date of this Indenture, there has been a change
in the applicable federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm
that, the Holders of such series of Securities will not recognize income, gain or loss for federal income tax purposes as a result of
such Legal Defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would
have been the case if such Legal Defeasance had not occurred;
(3) in the case of Covenant
Defeasance, the Company shall have delivered to the Trustee an Opinion of Counsel confirming that the Holders of such series of Securities
will not recognize income, gain or loss for federal income tax purposes as a result of such Covenant Defeasance and will be subject to
federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance
had not occurred;
(4) no Default or Event of
Default shall have occurred and be continuing on the date of such deposit or insofar as Events of Default under clauses (4) and (5) of
Section 6.01(a) with respect to the Securities of such series are concerned, at any time in the period ending on the 91st day after the
date of deposit;
(5) the Company shall have
delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent provided
for or relating to the Legal Defeasance or the Covenant Defeasance, as the case may be, have been complied with; and
(6) if such series of Securities
are to be redeemed prior to final maturity (other than from mandatory sinking fund payments or analogous payments), notice of such redemption
shall have been duly given pursuant to this Indenture or provision therefor satisfactory to the Trustee shall have been made.
SECTION 11.03 DEPOSITED MONEYS TO BE HELD IN TRUST.
All moneys or Governmental
Obligations deposited with the Trustee pursuant to Sections 11.01 or 11.02 shall be held in trust and shall be available for payment as
due, either directly or through any paying agent (including the Company acting as its own paying agent), to the Holders of the particular
series of Securities for the payment or redemption of which such moneys or Governmental Obligations have been deposited with the Trustee.
SECTION 11.04 PAYMENT OF MONEYS HELD BY PAYING AGENTS.
In connection with the satisfaction and discharge
of this Indenture all moneys or Governmental Obligations then held by any paying agent under the provisions of this Indenture shall, upon
demand of the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability with respect
to such moneys or Governmental Obligations.
SECTION 11.05 REPAYMENT TO COMPANY.
Any moneys or Governmental
Obligations deposited with any paying agent or the Trustee, or then held by the Company, in trust for payment of principal of (or premium,
if any) or interest on the Securities of a particular series that are not applied but remain unclaimed by the Holders of such Securities
for at least two years after the date upon which the principal of (and premium, if any) or interest on such Securities shall have respectively
become due and payable, shall be repaid to the Company on May 31 of each year or (if then held by the Company) shall be discharged from
such trust; and thereupon the paying agent and the Trustee shall be released from all further liability with respect to such moneys or
Governmental Obligations, and the Holder of any of the Securities entitled to receive such payment shall thereafter, as an unsecured general
creditor, look only to the Company for the payment thereof.
ARTICLE XII
IMMUNITY OF INCORPORATORS, SHAREHOLDERS, OFFICERS
AND DIRECTORS
SECTION 12.01 NO RECOURSE.
No recourse under or upon
any obligation, covenant or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof,
shall be had against any incorporator, shareholder, officer or director, past, present or future as such, of the Company or of any predecessor
or successor entity, either directly or through the Company or any such predecessor or successor entity, whether by virtue of any constitution,
statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Indenture
and the obligations issued hereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or
is or shall be incurred by, the incorporators, shareholders, officers or directors as such, of the Company or of any predecessor or successor
entity, or any of them, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants
or agreements contained in this Indenture or in any of the Securities or implied therefrom; and that any and all such personal liability
of every name and nature, either at common law or in equity or by constitution or statute, of, and any and all such rights and claims
against, every such incorporator, shareholder, officer or director as such, because of the creation of the indebtedness hereby authorized,
or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom,
are hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issuance
of such Securities.
ARTICLE XIII
MISCELLANEOUS PROVISIONS
SECTION 13.01 EFFECT ON SUCCESSORS AND ASSIGNS.
All the covenants, stipulations,
promises and agreements in this Indenture contained by or on behalf of the Company shall bind its successors and assigns, whether so expressed
or not.
SECTION 13.02 ACTIONS BY SUCCESSOR.
Any act or proceeding by any
provision of this Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and
may be done and performed with like force and effect by the corresponding board, committee or officer of any entity that shall at the
time be the lawful successor of the Company.
SECTION 13.03 SURRENDER OF COMPANY POWERS.
The Company by instrument
in writing executed by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to the
Company, and thereupon such power so surrendered shall terminate both as to the Company and as to any successor entity.
SECTION 13.04 NOTICES.
Except as otherwise expressly
provided herein, any notice or demand that by any provision of this Indenture is required or permitted to be given or served by the Trustee
or by the Holders of Securities to or on the Company may be given or served by being deposited first class postage prepaid in a post-office
letterbox addressed (until another address is filed in writing by the Company with the Trustee), as follows: 10 Earlsfort Terrace, Dublin
2, D02 T380, Ireland. Any notice, election, request or demand by the Company or any Securityholder to or upon the Trustee shall be deemed
to have been sufficiently given or made, for all purposes, if given or made in writing at the Corporate Trust Office of the Trustee.
SECTION 13.05 GOVERNING LAW; WAIVER OF TRIAL BY JURY.
This Indenture and each Security
shall be deemed to be a contract made under the internal laws of the State of [____________], and for all purposes shall be construed
in accordance with the laws of said State.
EACH PARTY HERETO, AND EACH
HOLDER OF A SECURITY BY ACCEPTANCE THEREOF, HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO
A TRIAL BY JURY IN RESPECT OF ANY LITIGATION RELATING TO THE TRUSTEE DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH
THIS INDENTURE
SECTION 13.06 TREATMENT OF SECURITIES AS DEBT.
It is intended that the Securities
will be treated as indebtedness and not as equity for federal income tax purposes. The provisions of this Indenture shall be interpreted
to further this intention.
SECTION 13.07 COMPLIANCE CERTIFICATES AND OPINIONS.
(a) Upon any application or
demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall furnish to the
Trustee an Officers’ Certificate stating that all conditions precedent provided for in this Indenture relating to the proposed action
have been complied with and an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been
complied with, except that in the case of any such application or demand as to which the furnishing of such documents is specifically
required by any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need
be furnished.
(b) Each certificate or opinion
provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or covenant in this Indenture
shall include
(1) a statement that the
Person making such certificate or opinion has read such covenant or condition;
(2) a brief statement as
to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion
are based;
(3) a statement that, in
the opinion of such Person, he has made such examination or investigation as is necessary to enable him to express an informed opinion
as to whether or not such covenant or condition has been complied with; and
(4) a statement as to whether
or not, in the opinion of such Person, such condition or covenant has been complied with.
SECTION 13.08 PAYMENTS ON BUSINESS DAYS.
Except as provided pursuant
to Section 2.01, by or pursuant to a Board Resolution, and as set forth in an Officers’ Certificate or established in one or more
indentures supplemental to this Indenture, in any case where the date of maturity of interest or principal of any Security or the date
of redemption of any Security shall not be a Business Day, then payment of interest or principal (and premium, if any) may be made on
the next succeeding Business Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest
shall accrue for the period after such nominal date.
SECTION 13.09 CONFLICT WITH TRUST INDENTURE ACT.
If and to the extent that
any provision of this Indenture limits, qualifies or conflicts with the duties imposed by Sections 310 to 317, inclusive, of the Trust
Indenture Act, such imposed duties shall control. If any provision of this Indenture modifies or excludes any provision of the Trust Indenture
Act which may be so modified or excluded, the latter provision shall be deemed to apply to this Indenture as so modified or to be excluded,
as the case may be.
SECTION 13.10 COUNTERPARTS.
This Indenture may be executed
in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same
instrument.
SECTION 13.11 SEPARABILITY.
In case any one or more of
the provisions contained in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable
in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Indenture or of such Securities,
but this Indenture and such Securities shall be construed as if such invalid or illegal or unenforceable provision had never been contained
herein or therein.
SECTION 13.12 ASSIGNMENT.
The Company will have the
right at all times to assign any of its rights or obligations under this Indenture to a direct or indirect wholly-owned Subsidiary of
the Company, provided that, in the event of any such assignment, the Company, will remain liable for all such obligations. Subject to
the foregoing, the Indenture is binding upon and inures to the benefit of the parties thereto and their respective successors and assigns.
This Indenture may not otherwise be assigned by the parties thereto.
[signature page follows]
IN WITNESS WHEREOF, the parties
hereto have caused this Indenture to be duly executed all as of the day and year first above written.
|
ADS-TEC ENERGY PLC |
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|
_______________, as Trustee |
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
Exhibit 4.21
ADS-TEC ENERGY PLC,
As Issuer,
AND
_______________,
As Trustee
INDENTURE
DATED AS OF [__________] [___], 20[__]
SUBORDINATED DEBT SECURITIES
CROSS-REFERENCE TABLE (1)1
Section of Trust Indenture Act of 1939, as Amended |
|
Indenture |
310(a) |
|
7.10 |
310(b) |
|
7.09; 7.11 |
310(c) |
|
Inapplicable |
311(a) |
|
7.14 |
311(b) |
|
7.14 |
311(c) |
|
Inapplicable |
312(a) |
|
5.02(a) |
312(b) |
|
5.02(c) |
312(c) |
|
Inapplicable |
313(a) |
|
5.04(a) |
313(b) |
|
5.04(b) |
313(c) |
|
5.04(a); 5.04(b) |
313(d) |
|
5.04(c) |
314(a) |
|
5.03; 4.06 |
314(b) |
|
Inapplicable |
314(c) |
|
13.07 |
314(d) |
|
Inapplicable |
314(e) |
|
13.07 |
314(f) |
|
Inapplicable |
315(a) |
|
7.01(a); 7.03 |
315(b) |
|
7.02 |
315(c) |
|
7.01 |
315(d) |
|
7.01(b) |
315(e) |
|
6.07; 7.07 |
316(a) |
|
6.06; 8.04 |
316(b) |
|
6.04 |
316(c) |
|
8.01 |
317(a) |
|
6.02 |
317(b) |
|
4.03 |
318(a) |
|
13.09 |
1 This Cross-Reference Table does not constitute part of
the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions
TABLE OF CONTENTS2
ARTICLE I DEFINITIONS |
1 |
|
|
SECTION 1.01 DEFINITIONS OF TERMS |
1 |
|
|
ARTICLE II ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES |
5 |
|
|
SECTION 2.01 DESIGNATION AND TERMS OF SECURITIES |
5 |
SECTION 2.02 FORM OF SECURITIES AND TRUSTEE’S CERTIFICATE |
6 |
SECTION 2.03 DENOMINATIONS: PROVISIONS FOR PAYMENT |
7 |
SECTION 2.04 EXECUTION AND AUTHENTICATION |
8 |
SECTION 2.05 REGISTRATION OF TRANSFER AND EXCHANGE |
8 |
SECTION 2.06 TEMPORARY SECURITIES |
9 |
SECTION 2.07 MUTILATED, DESTROYED, LOST OR STOLEN SECURITIES |
9 |
SECTION 2.08 CANCELLATION |
9 |
SECTION 2.09 BENEFITS OF INDENTURE |
10 |
SECTION 2.10 AUTHENTICATING AGENT |
10 |
SECTION 2.11 GLOBAL SECURITIES |
10 |
|
|
ARTICLE III REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS |
12 |
|
|
SECTION 3.01 REDEMPTION |
12 |
SECTION 3.02 NOTICE OF REDEMPTION |
12 |
SECTION 3.03 PAYMENT UPON REDEMPTION |
13 |
SECTION 3.04 SINKING FUND |
13 |
SECTION 3.05 SATISFACTION OF SINKING FUND PAYMENTS WITH SECURITIES |
13 |
SECTION 3.06 REDEMPTION OF SECURITIES FOR SINKING FUND |
13 |
|
|
ARTICLE IV COVENANTS |
14 |
|
|
SECTION 4.01 PAYMENT OF PRINCIPAL, PREMIUM AND INTEREST |
14 |
SECTION 4.02 MAINTENANCE OF OFFICE OR AGENCY |
14 |
SECTION 4.03 PAYING AGENTS |
14 |
SECTION 4.04 APPOINTMENT TO FILL VACANCY IN OFFICE OF TRUSTEE |
15 |
SECTION 4.05 COMPLIANCE WITH CONSOLIDATION PROVISIONS |
15 |
SECTION 4.06 STATEMENT BY OFFICERS AS TO DEFAULT |
15 |
|
|
ARTICLE V SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE |
15 |
|
|
SECTION 5.01 COMPANY TO FURNISH TRUSTEE NAMES AND ADDRESSES OF SECURITYHOLDERS |
15 |
SECTION 5.02 PRESERVATION OF INFORMATION; COMMUNICATIONS WITH SECURITYHOLDERS |
16 |
SECTION 5.03 REPORTS BY THE COMPANY |
16 |
SECTION 5.04 REPORTS BY THE TRUSTEE |
16 |
|
|
ARTICLE VI REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT |
17 |
|
|
SECTION 6.01 EVENTS OF DEFAULT |
17 |
SECTION 6.02 COLLECTION OF INDEBTEDNESS AND SUITS FOR ENFORCEMENT BY TRUSTEE |
18 |
SECTION 6.03 APPLICATION OF MONEYS COLLECTED |
19 |
SECTION 6.04 LIMITATION ON SUITS |
19 |
SECTION 6.05 RIGHTS AND REMEDIES CUMULATIVE; DELAY OR OMISSION NOT WAIVER |
20 |
SECTION 6.06 CONTROL BY SECURITYHOLDERS |
20 |
SECTION 6.07 UNDERTAKING TO PAY COSTS |
21 |
|
|
ARTICLE VII CONCERNING THE TRUSTEE |
21 |
|
|
SECTION 7.01 CERTAIN DUTIES AND RESPONSIBILITIES OF TRUSTEE |
21 |
SECTION 7.02 NOTICE OF DEFAULTS |
22 |
SECTION 7.03 CERTAIN RIGHTS OF TRUSTEE |
22 |
SECTION 7.04 TRUSTEE NOT RESPONSIBLE FOR RECITALS OR ISSUANCE OR SECURITIES |
23 |
SECTION 7.05 MAY HOLD SECURITIES |
24 |
SECTION 7.06 MONEYS HELD IN TRUST |
24 |
2 This Table of Contents does not constitute part of the Indenture and shall not have any bearing on
the interpretation of any of its terms or provisions.
SECTION 7.07 COMPENSATION AND REIMBURSEMENT |
24 |
SECTION 7.08 RELIANCE ON OFFICERS’ CERTIFICATE |
24 |
SECTION 7.09 DISQUALIFICATION; CONFLICTING INTERESTS |
25 |
SECTION 7.10 CORPORATE TRUSTEE REQUIRED; ELIGIBILITY |
25 |
SECTION 7.11 RESIGNATION AND REMOVAL; APPOINTMENT OF SUCCESSOR |
25 |
SECTION 7.12 ACCEPTANCE OF APPOINTMENT BY SUCCESSOR |
26 |
SECTION 7.13 MERGER, CONVERSION, CONSOLIDATION OR SUCCESSION TO BUSINESS |
27 |
SECTION 7.14 PREFERENTIAL COLLECTION OF CLAIMS AGAINST THE COMPANY |
27 |
|
|
ARTICLE VIII CONCERNING THE SECURITYHOLDERS |
27 |
|
|
SECTION 8.01 EVIDENCE OF ACTION BY SECURITYHOLDERS |
27 |
SECTION 8.02 PROOF OF EXECUTION BY SECURITYHOLDERS |
28 |
SECTION 8.03 WHO MAY BE DEEMED OWNERS |
28 |
SECTION 8.04 CERTAIN SECURITIES OWNED BY COMPANY DISREGARDED |
28 |
SECTION 8.05 ACTIONS BINDING ON FUTURE SECURITYHOLDERS |
28 |
|
|
ARTICLE IX SUPPLEMENTAL INDENTURES |
29 |
|
|
SECTION 9.01 SUPPLEMENTAL INDENTURES WITHOUT THE CONSENT OF SECURITYHOLDERS |
29 |
SECTION 9.02 SUPPLEMENTAL INDENTURES WITH CONSENT OF SECURITYHOLDERS |
30 |
SECTION 9.03 EFFECT OF SUPPLEMENTAL INDENTURES |
30 |
SECTION 9.04 SECURITIES AFFECTED BY SUPPLEMENTAL INDENTURES |
30 |
SECTION 9.05 EXECUTION OF SUPPLEMENTAL INDENTURES |
31 |
|
|
ARTICLE X SUCCESSOR ENTITY |
31 |
|
|
SECTION 10.01 COMPANY MAY CONSOLIDATE, ETC |
31 |
SECTION 10.02 SUCCESSOR ENTITY SUBSTITUTED |
31 |
SECTION 10.03 EVIDENCE OF CONSOLIDATION, ETC. TO TRUSTEE |
32 |
|
|
ARTICLE XI SATISFACTION AND DISCHARGE; DEFEASANCE |
32 |
|
|
SECTION 11.01 SATISFACTION AND DISCHARGE |
32 |
SECTION 11.02 DEFEASANCE |
33 |
SECTION 11.03 DEPOSITED MONEYS TO BE HELD IN TRUST |
34 |
SECTION 11.04 PAYMENT OF MONEYS HELD BY PAYING AGENTS |
34 |
SECTION 11.05 REPAYMENT TO COMPANY |
34 |
|
|
ARTICLE XII IMMUNITY OF INCORPORATORS, SHAREHOLDERS, OFFICERS AND DIRECTORS |
34 |
|
|
SECTION 12.01 NO RECOURSE |
34 |
|
|
ARTICLE XIII MISCELLANEOUS PROVISIONS |
35 |
|
|
SECTION 13.01 EFFECT ON SUCCESSORS AND ASSIGNS |
35 |
SECTION 13.02 ACTIONS BY SUCCESSOR |
35 |
SECTION 13.03 SURRENDER OF COMPANY POWERS |
35 |
SECTION 13.04 NOTICES |
35 |
SECTION 13.05 GOVERNING LAW; WAIVER OF TRIAL BY JURY |
35 |
SECTION 13.06 TREATMENT OF SECURITIES AS DEBT |
35 |
SECTION 13.07 COMPLIANCE CERTIFICATES AND OPINIONS |
35 |
SECTION 13.08 PAYMENTS ON BUSINESS DAYS |
36 |
SECTION 13.09 CONFLICT WITH TRUST INDENTURE ACT |
36 |
SECTION 13.10 COUNTERPARTS |
36 |
SECTION 13.11 SEPARABILITY |
36 |
SECTION 13.12 ASSIGNMENT |
36 |
|
|
ARTICLE XIV SUBORDINATION OF SECURITIES |
37 |
|
|
SECTION 14.01 SUBORDINATION TERMS |
37 |
|
|
|
INDENTURE, dated as of [__________]
[___], 20[__], between ADS-TEC Energy PLC, a public company incorporated in Ireland (the “Company”), and [_____________],
a [_____________], as trustee (the “Trustee”):
RECITALS OF THE COMPANY
WHEREAS, for its lawful corporate
purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of subordinated debt
securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time
to time in one or more series as provided in this Indenture, as registered Securities without coupons, to be authenticated by the certificate
of the Trustee;
WHEREAS, to provide the terms
and conditions upon which the Securities are to be authenticated, issued and delivered, the Company has duly authorized the execution
of this Indenture; and
WHEREAS, all things necessary
to make this Indenture a valid agreement of the Company, in accordance with its terms, have been done.
NOW, THEREFORE, in consideration
of the premises and the purchase of the Securities by the Holders thereof, it is mutually covenanted and agreed as follows for the equal
and ratable benefit of the Holders of Securities or of series thereof.
ARTICLE I
DEFINITIONS
SECTION 1.01 DEFINITIONS OF TERMS.
The terms defined in this
Section (except as in this Indenture otherwise expressly provided or unless the context otherwise requires) for all purposes of this Indenture
and of any indenture supplemental hereto shall have the respective meanings specified in this Section and shall include the plural as
well as the singular. All other terms used in this Indenture that are defined in the Trust Indenture Act, or that are by reference in
said Trust Indenture Act defined in the Securities Act (except as herein otherwise expressly provided or unless the context otherwise
requires), shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date
of the execution of this instrument.
“ARTICLE”, “SECTION”
or other subdivisions refer to Articles, Sections or other subdivisions of this Indenture.
“AUTHENTICATING AGENT”
means an authenticating agent with respect to all or any of the series of Securities appointed with respect to all or any series of the
Securities by the Trustee pursuant to Section 2.10.
“BANKRUPTCY LAW”
means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.
“BOARD OF DIRECTORS”
means the Board of Directors of the Company or any duly authorized committee of such Board.
“BOARD RESOLUTION”
means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board
of Directors and to be in full force and effect on the date of such certification.
“BUSINESS DAY”
means, with respect to any series of Securities, any day other than a Saturday or Sunday, or a day on which federal or state banking institutions
in [________], are authorized or obligated by law, executive order or regulation to close.
“CERTIFICATE”
means a certificate signed by the principal executive officer, the principal financial officer or the principal accounting officer of
the Company. The Certificate need not comply with the provisions of Section 13.07.
“COMMISSION” means
the Securities and Exchange Commission.
“COMPANY” means
ADS-TEC Energy PLC, a public company incorporated in Ireland, and its subsidiaries, and, subject to the provisions of Article X, shall
also include its successors and assigns.
“CORPORATE TRUST OFFICE”
means the office of the Trustee at which, at any particular time, its corporate trust business shall be principally administered, which
office at the date hereof is located at [________________________________].
“COVENANT DEFEASANCE”
has the meaning given in Section 11.02.
“CUSTODIAN” means
any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.
“DEFAULT” means
any event, act or condition that with notice or lapse of time, or both, would constitute an Event of Default.
“DEFAULTED INTEREST”
has the meaning given in Section 2.03.
“DEPOSITARY” means,
with respect to Securities of any series, for which the Company shall determine that such Securities will be issued as a Global Security,
[________], another clearing agency, or any successor registered as a clearing agency under the Exchange Act, or other applicable statute
or regulation, which, in each case, shall be designated by the Company pursuant to either Section 2.01 or 2.11.
“EVENT OF DEFAULT”
means, with respect to Securities of a particular series any event specified in Section 6.01, continued for the period of time, if any,
therein designated.
“EXCHANGE ACT”
means the Securities Exchange Act of 1934, as amended, or any successor statute or statutes thereto.
“GLOBAL SECURITY”
means, with respect to any series of Securities, a Security executed by the Company and delivered by the Trustee to the Depositary or
pursuant to the Depositary’s instruction, all in accordance with the Indenture, which shall be registered in the name of the Depositary
or its nominee.
“GOVERNMENTAL OBLIGATIONS”
means securities that are (i) direct obligations of the United States of America for the payment of which its full faith and credit is
pledged or (ii) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of
America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America that,
in either case, are not callable or redeemable at the option of the issuer thereof, and shall also include a depositary receipt issued
by a bank (as defined in Section 3(a)(2) of the Securities Act) as custodian with respect to any such Governmental Obligation or a specific
payment of principal of or interest on any such Governmental Obligation held by such custodian for the account of the Holder of such depositary
receipt; provided, however, that (except as required by law) such custodian is not authorized to make any deduction from the amount payable
to the Holder of such depositary receipt from any amount received by the custodian in respect of the Governmental Obligation or the specific
payment of principal of or interest on the Governmental Obligation evidenced by such depositary receipt.
“HEREIN”, “HEREOF”
and “HEREUNDER”, and other words of similar import, refer to this Indenture as a whole and not to any particular Article,
Section or other subdivision.
“INCLUDING”, unless
the context requires otherwise, means including without limitation.
“INDENTURE” means
this instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental
hereto entered into in accordance with the terms hereof, including, for all purposes of this instrument and any such supplemental indenture,
the provisions of the Trust Indenture Act that are deemed to be a part of and govern this instrument and any such supplemental indenture,
respectively. The term “Indenture” shall also include the terms of particular series of Securities established as contemplated
by Section 2.01.
“INTEREST PAYMENT DATE”,
when used with respect to any installment of interest on a Security of a particular series, means the date specified in such Security
or in a Board Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment
of interest with respect to Securities of that series is due and payable.
“LEGAL DEFEASANCE”
has the meaning given in Section 11.02.
“OFFICERS’ CERTIFICATE”
means a certificate signed by the Executive Chairman, Chief Executive Officer, President or a Vice President and by the Chief Financial
Officer, Treasurer or an Assistant Treasurer or the Controller or an Assistant Controller or the Secretary or an Assistant Secretary of
the Company that is delivered to the Trustee in accordance with the terms hereof. Each such certificate shall include the statements provided
for in Section 13.07, if and to the extent required by the provisions thereof.
“OPINION OF COUNSEL”
means an opinion in writing of legal counsel acceptable to the Trustee, who may be an employee of or counsel for the Company that is delivered
to the Trustee in accordance with the terms hereof. Each such opinion shall include the statements provided for in Section 13.07, if and
to the extent required by the provisions thereof.
“ORIGINAL ISSUE DISCOUNT
SECURITY” means any Security which provides for an amount less than the principal amount thereof to be due and payable upon a declaration
of acceleration of the maturity thereof pursuant to Section 6.01.
“OUTSTANDING”,
when used with reference to Securities of any series, means, subject to the provisions of Section 8.04, as of any particular time, all
Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except (a) Securities theretofore
canceled by the Trustee or any paying agent, or delivered to the Trustee or any paying agent for cancellation or that have previously
been canceled; (b) Securities or portions thereof for the payment or redemption of which moneys or Governmental Obligations in the necessary
amount shall have been deposited in trust with the Trustee or with any paying agent (other than the Company) or shall have been set aside
and segregated in trust by the Company (if the Company shall act as its own paying agent); provided, however, that if such Securities
or portions of such Securities are to be redeemed prior to the maturity thereof, notice of such redemption shall have been given as in
Article III; or provision satisfactory to the Trustee shall have been made for giving such notice; and (c) Securities in lieu of or in
substitution for which other Securities shall have been authenticated and delivered pursuant to the terms of Section 2.07; provided, however,
that in determining whether the Holders of the requisite principal amount of the Outstanding Securities have given, made or taken any
request, demand, authorization, direction, notice, consent, waiver or other action hereunder as of any date, the principal amount of an
Original Issue Discount Security which shall be deemed to be Outstanding shall be the amount of the principal thereof which would be due
and payable as of such date upon acceleration of the maturity thereof to such date pursuant to Section 6.01.
“PERSON” means
any individual, corporation, limited liability company, partnership, joint-venture, joint-stock company, unincorporated organization or
government or any agency or political subdivision thereof.
“PREDECESSOR SECURITY”
of any particular Security means every previous Security evidencing all or a portion of the same debt as that evidenced by such particular
Security; and, for the purposes of this definition, any Security authenticated and delivered under Section 2.07 in lieu of a lost, destroyed
or stolen Security shall be deemed to evidence the same debt as the lost, destroyed or stolen Security.
“RESPONSIBLE OFFICER”
when used with respect to the Trustee means any officer assigned to the [________________] [Division / Unit] (or any successor division
or unit) of the Trustee located at the Corporate Trust Office of the Trustee, who shall have direct responsibility for the administration
of this Indenture, and for the purposes of Section 7.01(b)(ii) and Section 315(b) of the Trust Indenture Act shall also include any other
officer of the Trustee to whom any corporate trust matter is referred because of his or her knowledge of and familiarity with the particular
subject.
“SECURITIES” means
the debt securities authenticated and delivered under this Indenture.
“SECURITIES ACT”
means the Securities Act of 1933, as amended, or any successor statute or statutes thereto.
“SECURITYHOLDER”,
“HOLDER of SECURITIES”, “REGISTERED HOLDER”, “HOLDER”, or other similar term, means the Person or
Persons in whose name or names a particular Security shall be registered on the books of the Company kept for that purpose in accordance
with the terms of this Indenture.
“SECURITY REGISTER”
has the meaning given in Section 2.05.
“SECURITY REGISTRAR”
has the meaning given in Section 2.05.
“SENIOR INDEBTEDNESS”
means the principal of (and premium, if any) and interest (including any interest accruing subsequent to the filing of a petition of bankruptcy
at the rate provided for in the documentation with respect thereto, whether or not such interest is an allowed claim under applicable
law) on any indebtedness of the Company, incurred or assumed, unless, in the case of any particular indebtedness, the instrument creating
or evidencing the same or pursuant to which the same is outstanding expressly provides that such indebtedness shall not be senior in right
of payment to the Securities. Notwithstanding the foregoing, “SENIOR INDEBTEDNESS” shall not include (i) any indebtedness
of the Company to a Subsidiary of the Company or any Affiliate of the Company or any of such Affiliate’s Subsidiaries, (ii) indebtedness
to, or guaranteed on behalf of, any shareholder, director, officer or employee of the Company or any Subsidiary of the Company (including,
without limitation, amounts owed for compensation), (iii) indebtedness to trade creditors and other amounts incurred in connection with
obtaining goods, materials or services, (iv) any liability for federal, state, local or other taxes owed or owing by the Company, (v)
that portion of any indebtedness incurred in violation of an incurrence test applicable to a series of the Securities, (vi) that portion
of any indebtedness which, when incurred and without respect to any election under Section 1111(b) of Title 11, United States Code, is
without recourse to the Company and (vii) that portion of any indebtedness which is, by its express terms, subordinated in right of payment
to the Securities.
“SUBSIDIARY” means,
with respect to any Person, (i) any corporation at least a majority of whose outstanding Voting Shares shall at the time be owned, directly
or indirectly, by such Person or by one or more of its Subsidiaries or by such Person and one or more of its Subsidiaries, (ii) any general
partnership, limited liability company, joint venture or similar entity, at least a majority of whose outstanding partnership or similar
interests shall at the time be owned by such Person, or by one or more of its Subsidiaries, or by such Person and one or more of its Subsidiaries
and (iii) any limited partnership of which such Person or any of its Subsidiaries is a general partner.
“TRUSTEE” means
[_____________] and, subject to the provisions of Article VII, shall also include its successors and assigns, and, if at any time there
is more than one Person acting in such capacity hereunder, “Trustee” shall mean each such Person. The term “Trustee”
as used with respect to a particular series of the Securities shall mean the trustee with respect to that series.
“TRUST INDENTURE ACT”
means the Trust Indenture Act of 1939, as amended, subject to the provisions of Sections 9.01, 9.02, and 10.01, as in effect at the date
of execution of this instrument.
“VOTING SHARES”,
as applied to shares of any Person, means shares, interests, participations or other equivalents in the equity interest (however designated)
in such Person having ordinary voting power for the election of a majority of the directors (or the equivalent) of such Person, other
than shares, interests, participations or other equivalents having such power only by reason of the occurrence of a contingency.
ARTICLE II
ISSUE, DESCRIPTION, TERMS, EXECUTION,
REGISTRATION AND EXCHANGE OF SECURITIES
SECTION 2.01 DESIGNATION AND TERMS OF SECURITIES.
The aggregate principal amount
of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or more series
up to the aggregate principal amount, if any, of Securities of that series from time to time authorized by or pursuant to a Board Resolution
or pursuant to one or more indentures supplemental hereto. Prior to the initial issuance of Securities of any series, there shall be established
in or pursuant to a Board Resolution, and set forth in an Officers’ Certificate, or established in one or more indentures supplemental
hereto:
(1) the title of the Security
of the series (which shall distinguish the Securities of the series from all other Securities);
(2) any limit upon the aggregate
principal amount of the Securities of that series that may be authenticated and delivered under this Indenture (except for Securities
authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of that series);
(3) the date or dates on which
the principal of the Securities of the series is payable, any original issue discount that may apply to the Securities of that series
upon their issuance, the principal amount due at maturity and the place(s) of payment;
(4) the rate or rates at which
the Securities of the series shall bear interest or the manner of calculation of such rate or rates, if any;
(5) the date or dates from
which such interest shall accrue, the Interest Payment Dates on which such interest will be payable or the manner of determination of
such Interest Payment Dates, the place(s) of payment, and the record date or other method for the determination of Holders to whom interest
is payable on any such Interest Payment Dates;
(6) the right, if any, to
extend the interest payment periods and the duration of such extension;
(7) the period or periods
within which, the price or prices at which and the terms and conditions upon which, Securities of the series may be redeemed, in whole
or in part, at the option of the Company;
(8) the obligation, if any,
of the Company to redeem or purchase Securities of the series pursuant to any sinking fund or analogous provisions (including payments
made in cash in satisfaction of future sinking fund obligations) or at the option of a Holder thereof and the period or periods within
which, the price or prices at which, and the terms and conditions upon which, Securities of the series shall be redeemed or purchased,
in whole or in part, pursuant to such obligation;
(9) any additional or different
subordination terms applicable to the Securities of the series;
(10) the form of the Securities
of the series, including the form of the Trustee’s certificate of authentication for such series;
(11) if other than denominations
of one thousand U.S. dollars ($1,000) or any integral multiple thereof, the denominations in which the Securities of the series shall
be issuable (including denominations of foreign currency);
(12) any and all other terms
with respect to such series (which terms shall not be inconsistent with the terms of this Indenture);
(13) whether the Securities
of the series are issuable as a Global Security and, in such case, the identity of the Depositary for such series and any other or different
terms in respect of such Global Security;
(14) whether the Securities
of the series will be convertible into ordinary shares or other securities of the Company and, if so, the terms and conditions upon which
such Securities will be so convertible, including the conversion price and the conversion period;
(15) if other than the principal
amount thereof, the portion of the principal amount of Securities of the series which shall be payable upon declaration of acceleration
of the maturity thereof pursuant to Section 6.01;
(16) any additional or different
Events of Default or restrictive covenants provided for with respect to the Securities of the series;
(17) if applicable, that the
Securities of the series, in whole or in specified part, shall be defeasible pursuant to Section 11.02 and, if other than by a Board Resolution,
the manner in which any election by the Company to defease such Securities shall be evidenced;
(18) if other than the currency
of the United States of America, the currency, currencies or currency units in which the principal of or any premium or interest on any
Securities of the series shall be payable and the manner of determining the equivalent thereof in the currency of the United States of
America for any purpose, including for purposes of the definition of “Outstanding” in Section 1.01, and/or the property, including
securities of the Company, in which the principal of or any premium or interest on any Securities of the series may be payable and the
terms and conditions of such payment in property, including whether at the option of the Company or the Securityholder; and
(19) the terms and conditions,
if any, upon which the Company shall pay amounts in addition to the stated interest, premium, if any and principal amounts of the Securities
of the series to any Securityholder that is not a “United States person” for federal tax purposes.
All Securities of any one
series shall be substantially identical except as to denomination and except as may otherwise be provided in or pursuant to any such Board
Resolution or in any indentures supplemental hereto. If any of the terms of the series are established by action taken pursuant to a Board
Resolution, a copy of an appropriate record of such action shall be certified by the Secretary or an Assistant Secretary of the Company
and delivered to the Trustee at or prior to the delivery of the Officers’ Certificate setting forth the terms of the series. Securities
of any particular series may be issued at various times, with different dates on which the principal or any installment of principal is
payable, with different rates of interest, if any, or different methods by which rates of interest may be determined, with different dates
on which such interest may be payable and with different redemption dates. Notwithstanding Section 2.01(2) and unless otherwise expressly
provided with respect to a series of Securities, the aggregate principal amount of a series of Securities may be increased and additional
Securities of such series may be issued up to the maximum aggregate principal amount authorized with respect to such series as increased.
SECTION 2.02 FORM OF SECURITIES AND TRUSTEE’S
CERTIFICATE.
The Securities of any series
and the Trustee’s certificate of authentication to be borne by such Securities shall be substantially of the tenor and purport as
set forth in one or more indentures supplemental hereto or as provided in or pursuant to a Board Resolution and as set forth in an Officers’
Certificate. The Securities may have such letters, numbers or other marks of identification or designation and such legends or endorsements
printed, lithographed or engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this
Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation
of any stock exchange on which Securities of that series may be listed, or to conform to usage.
SECTION 2.03 DENOMINATIONS: PROVISIONS FOR
PAYMENT.
The Securities shall be issuable
as registered Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, subject to Section
2.01(11). The Securities of a particular series shall bear interest payable on the dates and at the rates specified or provided for with
respect to that series. Except as contemplated by Section 2.01(18), the principal of and the interest on the Securities of any series,
as well as any premium thereon in case of redemption thereof prior to maturity, shall be payable in the coin or currency of the United
States of America that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for
that purpose in [_____________]; provided, however, that at the option of the Company payment of interest may be made by check mailed
to the address of the Person entitled thereto as such address shall appear in the Security Register. Each Security shall be dated the
date of its authentication by the Trustee. Except as contemplated by Section 2.01(4), interest on the Securities shall be computed on
the basis of a 360-day year composed of twelve 30-day months. Except as contemplated by Section 2.01(5), the interest installment on any
Security that is payable, and is punctually paid or duly provided for, on any Interest Payment Date for Securities of that series shall
be paid to the Person in whose name said Security (or one or more Predecessor Securities) is registered at the close of business on the
regular record date for such interest installment. In the event that any Security of a particular series or portion thereof is called
for redemption and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such
Interest Payment Date, interest on such Security will be paid upon presentation and surrender of such Security as provided in Section
3.03. Any interest on any Security that is payable, but is not punctually paid or duly provided for, on any Interest Payment Date for
Securities of the same series (herein called “Defaulted Interest”) shall forthwith cease to be payable to the registered Holder
on the relevant regular record date by virtue of having been such Holder; and such Defaulted Interest shall be paid by the Company, at
its election, as provided in clause (1) or clause (2) below:
(1) The Company may make payment
of any Defaulted Interest on Securities to the Persons in whose names such Securities (or their respective Predecessor Securities) are
registered at the close of business on a special record date for the payment of such Defaulted Interest, which shall be fixed in the following
manner: the Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such Security
and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the
aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for
such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled
to such Defaulted Interest as in this clause provided. Thereupon the Trustee shall fix a special record date for the payment of such Defaulted
Interest which shall not be more than 15 nor less than 10 days prior to the date of the proposed payment and not less than 10 days after
the receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the Company of such special record
date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Interest and the
special record date therefor to be mailed, first class postage prepaid, to each Securityholder at his or her address as it appears in
the Security Register (as hereinafter defined), not less than 10 days prior to such special record date. Notice of the proposed payment
of such Defaulted Interest and the special record date therefor having been mailed as aforesaid, such Defaulted Interest shall be paid
to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered on such special record date.
(2) The Company may make payment
of any Defaulted Interest on any Securities in any other lawful manner not inconsistent with the requirements of any securities exchange
on which such Securities may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company
to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee. Unless
otherwise set forth in a Board Resolution or one or more indentures supplemental hereto establishing the terms of any series of Securities
pursuant to Section 2.01 hereof, the term “regular record date” as used in this Section with respect to a series of Securities
with respect to any Interest Payment Date for such series shall mean either the fifteenth day of the month immediately preceding the month
in which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date
is the first day of a month, or the last day of the month immediately preceding the month in which an Interest Payment Date established
for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or
not such date is a Business Day. Subject to the foregoing provisions of this Section, each Security of a series delivered under this Indenture
upon transfer of or in exchange for or in lieu of any other Security of such series shall carry the rights to interest accrued and unpaid,
and to accrue, that were carried by such other Security.
SECTION 2.04 EXECUTION AND AUTHENTICATION.
The Securities shall be signed
on behalf of the Company by its President, or one of its Vice Presidents, or its Treasurer, or one of its Assistant Treasurers, attested
by its Secretary or one of its Assistant Secretaries. Signatures may be in the form of a manual or facsimile signature. The Company may
use the facsimile signature of any Person who shall have been a President or Vice President thereof, or of any Person who shall have been
the Treasurer, an Assistant Treasurer, the Secretary or an Assistant Secretary thereof, notwithstanding the fact that at the time the
Securities shall be authenticated and delivered or disposed of such Person shall have ceased to be the President or a Vice President,
or the Treasurer, an Assistant Treasurer, the Secretary or an Assistant Secretary, of the Company. The Securities may contain such notations,
legends or endorsements required by law, stock exchange rule or usage. A Security shall not be valid until authenticated manually by an
authorized signatory of the Trustee, or by an Authenticating Agent. Such signature shall be conclusive evidence and the only evidence
that the Security so authenticated has been duly authenticated and delivered hereunder and that the Holder is entitled to the benefits
of this Indenture. At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities
of any series executed by the Company to the Trustee for authentication, together with a written order of the Company for the authentication
and delivery of such Securities, signed by its President or any Vice President and its Secretary or any Assistant Secretary, and the Trustee
in accordance with such written order shall authenticate and deliver such Securities. In authenticating such Securities and accepting
the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive, and (subject
to Section 7.01) shall be fully protected in relying upon, an Opinion of Counsel stating that the form and terms thereof have been established
in conformity with the provisions of this Indenture and that such Securities, when authenticated and delivered by the Trustee and issued
by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute valid and legally binding
obligations of the Company enforceable in accordance with their terms, subject to any Bankruptcy Law or other insolvency, fraudulent transfer,
reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity
principles and to other customary exceptions. The Trustee shall not be required to authenticate such Securities if the issue of such Securities
pursuant to this Indenture will affect the Trustee’s own rights, duties or immunities under the Securities and this Indenture or
otherwise in a manner that is not reasonably acceptable to the Trustee.
SECTION 2.05 REGISTRATION OF TRANSFER AND EXCHANGE.
(a) Securities of any series
may be exchanged upon presentation thereof at the office or agency of the Company designated for such purpose in [_____________], for
other Securities of such series of authorized denominations, and for a like aggregate principal amount, upon payment of a sum sufficient
to cover any tax or other governmental charge in relation thereto, all as provided in this Section. In respect of any Securities so surrendered
for exchange, the Company shall execute, the Trustee shall authenticate and such office or agency shall deliver in exchange therefor the
Security or Securities of the same series that the Securityholder making the exchange shall be entitled to receive, bearing numbers not
contemporaneously outstanding.
(b) The Company shall keep,
or cause to be kept, at its office or agency designated for such purpose in [_____________], or such other location designated by the
Company a register or registers (herein referred to as the “Security Register”) in which, subject to such reasonable regulations
as it may prescribe, the Company shall register the Securities and the transfers of Securities as in this Article provided and which at
all reasonable times shall be open for inspection by the Trustee. The registrar for the purpose of registering Securities and transfer
of Securities as herein provided shall be appointed as authorized by Board Resolution (the “Security Registrar”). Upon surrender
for transfer of any Security at the office or agency of the Company designated for such purpose, the Company shall execute, the Trustee
shall authenticate and such office or agency shall deliver in the name of the transferee or transferees a new Security or Securities of
the same series as the Security presented for a like aggregate principal amount. All Securities presented or surrendered for exchange
or registration of transfer, as provided in this Section, shall be accompanied (if so required by the Company or the Security Registrar)
by a written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly executed by the
registered Holder or by such Holder’s duly authorized attorney in writing.
(c) No service charge shall
be made for any exchange or registration of transfer of Securities, or issue of new Securities in case of partial redemption of any series,
but the Company may require payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, other than
exchanges pursuant to Section 2.06, Section 3.03(b) and Section 9.04 not involving any transfer. The Company shall not be required (i)
to issue, exchange or register the transfer of any Securities during a period beginning at the opening of business 15 days before the
day of the mailing of a notice of redemption of less than all the Outstanding Securities of the same series and ending at the close of
business on the day of such mailing, nor (ii) to register the transfer of or exchange any Securities of any series or portions thereof
called for redemption. The provisions of this Section 2.05 are, with respect to any Global Security, subject to Section 2.11 hereof.
SECTION 2.06 TEMPORARY SECURITIES.
Pending the preparation of
definitive Securities of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities (printed,
lithographed or typewritten) of any authorized denomination. Such temporary Securities shall be substantially in the form of the definitive
Securities in lieu of which they are issued, but with such omissions, insertions and variations as may be appropriate for temporary Securities,
all as may be determined by the Company. Every temporary Security of any series shall be executed by the Company and be authenticated
by the Trustee upon the same conditions and in substantially the same manner, and with like effect, as the definitive Securities of such
series. Without unnecessary delay the Company will execute and will furnish definitive Securities of such series and thereupon any or
all temporary Securities of such series may be surrendered in exchange therefor (without charge to the Holders), at the office or agency
of the Company designated for the purpose in [_____________], and the Trustee shall authenticate and such office or agency shall deliver
in exchange for such temporary Securities an equal aggregate principal amount of definitive Securities of such series, unless the Company
advises the Trustee to the effect that definitive Securities need not be executed and furnished until further notice from the Company.
Until so exchanged, the temporary Securities of such series shall be entitled to the same benefits under this Indenture as definitive
Securities of such series authenticated and delivered hereunder.
SECTION 2.07 MUTILATED, DESTROYED, LOST OR
STOLEN SECURITIES.
In case any temporary or definitive
Security shall become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence) shall execute,
and upon the Company’s request the Trustee (subject as aforesaid) shall authenticate and deliver, a new Security of the same series,
bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated Security, or in lieu of and in substitution
for the Security so destroyed, lost or stolen. In every case the applicant for a substituted Security shall furnish to the Company and
the Trustee such security or indemnity as may be required by them to save each of them harmless, and, in every case of destruction, loss
or theft, the applicant shall also furnish to the Company and the Trustee evidence to their satisfaction of the destruction, loss or theft
of the applicant’s Security and of the ownership thereof. The Trustee may authenticate any such substituted Security and deliver
the same upon the written request or authorization of any officer of the Company. Upon the issuance of any substituted Security, the Company
may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and
any other expenses (including the fees and expenses of the Trustee) connected therewith. In case any Security that has matured or is about
to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security, pay or authorize
the payment of the same (without surrender thereof except in the case of a mutilated Security) if the applicant for such payment shall
furnish to the Company and the Trustee such security or indemnity as they may require to save them harmless, and, in case of destruction,
loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss or theft of such Security and of the
ownership thereof. Every replacement Security issued pursuant to the provisions of this Section shall constitute an additional contractual
obligation of the Company whether or not the mutilated, destroyed, lost or stolen Security shall be found at any time, or be enforceable
by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of
the same series duly issued hereunder. All Securities shall be held and owned upon the express condition that the foregoing provisions
are exclusive with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities, and shall preclude (to the
extent lawful) any and all other rights or remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary
with respect to the replacement or payment of negotiable instruments or other securities without their surrender.
SECTION 2.08 CANCELLATION.
All Securities surrendered
for the purpose of payment, redemption, exchange or registration of transfer shall, if surrendered to the Company or any paying agent,
be delivered to the Trustee for cancellation, or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be
issued in lieu thereof except as expressly required or permitted by any of the provisions of this Indenture. On request of the Company
at the time of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee. In the absence of such
request the Trustee may dispose of canceled Securities in accordance with its standard procedures and deliver a certificate of disposition
to the Company. If the Company shall otherwise acquire any of the Securities, however, such acquisition shall not operate as a redemption
or satisfaction of the indebtedness represented by such Securities unless and until the same are delivered to the Trustee for cancellation.
SECTION 2.09 BENEFITS OF INDENTURE.
Nothing in this Indenture
or in the Securities, express or implied, shall give or be construed to give to any Person, other than the parties hereto and the Holders
of the Securities (and, with respect to the provisions of Article XIV, the holders of Senior Indebtedness) any legal or equitable right,
remedy or claim under or in respect of this Indenture, or under any covenant, condition or provision herein contained; all such covenants,
conditions and provisions being for the sole benefit of the parties hereto and of the Holders of the Securities (and, with respect to
the provisions of Article XIV, the holder of Senior Indebtedness).
SECTION 2.10 AUTHENTICATING AGENT.
So long as any of the Securities
of any series remain Outstanding there may be an Authenticating Agent for any or all such series of Securities which the Trustee shall
have the right to appoint. Said Authenticating Agent shall be authorized to act on behalf of the Trustee to authenticate Securities of
such series issued upon exchange, transfer or partial redemption thereof, and Securities so authenticated shall be entitled to the benefits
of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder. All references in this
Indenture to the authentication of Securities by the Trustee shall be deemed to include authentication by an Authenticating Agent for
such series. Each Authenticating Agent shall be acceptable to the Company and shall be a corporation that has a combined capital and surplus,
as most recently reported or determined by it, sufficient under the laws of any jurisdiction under which it is organized or in which it
is doing business to conduct a trust business, and that is otherwise authorized under such laws to conduct such business and is subject
to supervision or examination by federal or state authorities. If at any time any Authenticating Agent shall cease to be eligible in accordance
with these provisions, it shall resign immediately. Any Authenticating Agent may at any time resign by giving written notice of resignation
to the Trustee and to the Company. The Trustee may at any time (and upon request by the Company shall) terminate the agency of any Authenticating
Agent by giving written notice of termination to such Authenticating Agent and to the Company. Upon resignation, termination or cessation
of eligibility of any Authenticating Agent, the Trustee may appoint an eligible successor Authenticating Agent acceptable to the Company.
Any successor Authenticating Agent, upon acceptance of its appointment hereunder, shall become vested with all the rights, powers and
duties of its predecessor hereunder as if originally named as an Authenticating Agent pursuant hereto. Any corporation into which an Authenticating
Agent may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation
to which such Authenticating Agent shall be a party, or any corporation succeeding to the corporate agency or corporate trust business
of an Authenticating Agent, shall continue to be an Authenticating Agent, provided that such corporation shall be otherwise eligible under
this Section, without the execution or filing of any paper or any further act on the part of the Trustee or the Authenticating Agent.
SECTION 2.11 GLOBAL SECURITIES.
(a) If the Company shall establish
pursuant to Section 2.01 that the Securities of a particular series are to be issued as a Global Security, then the Company shall execute
and the Trustee shall, in accordance with Section 2.04, authenticate and deliver, a Global Security that
(1) shall represent, and
shall be denominated in an amount equal to the aggregate principal amount of, all or a portion of the Outstanding Securities of such series,
(2) shall be registered in
the name of the Depositary or its nominee,
(3) shall be delivered by
the Trustee to the Depositary or pursuant to the Depositary’s instruction, and
(4) shall bear a legend substantially
to the following effect: “Except as otherwise provided in Section 2.11 of the Indenture, this Security may be transferred, in whole
but not in part, only to the Depositary, another nominee of the Depositary or to a successor Depositary or to a nominee of such successor
Depositary.”
(b) Notwithstanding the provisions
of Section 2.05, the Global Security of a series may be transferred, in whole but not in part and in the manner provided in Section 2.05,
only to the Depositary for such series, another nominee of the Depositary for such series, or to a successor Depositary for such series
selected or approved by the Company or to a nominee of such successor Depositary.
(c) If at any time the Depositary
for a series of the Securities notifies the Company that it is unwilling or unable to continue as Depositary for such series or if at
any time the Depositary for such series shall no longer be registered or in good standing under the Exchange Act, or other applicable
statute or regulation, and a successor Depositary for such series is not appointed by the Company within 90 days after the Company receives
such notice or becomes aware of such condition, as the case may be, this Section 2.11 shall no longer be applicable to the Securities
of such series and the Company will execute, and subject to Section 2.05, the Trustee will authenticate and deliver the Securities of
such series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal amount equal to
the principal amount of the Global Security of such series in exchange for such Global Security. In addition, the Company may at any time
determine that the Securities of any series shall no longer be represented by a Global Security and that the provisions of this Section
2.11 shall no longer apply to the Securities of such series. In such event the Company will execute and subject to Section 2.05, the Trustee,
upon receipt of an Officers’ Certificate evidencing such determination by the Company, will authenticate and deliver the Securities
of such series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal amount equal
to the principal amount of the Global Security of such series in exchange for such Global Security. Upon the exchange of the Global Security
for such Securities in definitive registered form without coupons, in authorized denominations, the Global Security shall be canceled
by the Trustee. Such Securities in definitive registered form issued in exchange for the Global Security pursuant to this Section 2.11(c)
shall be registered in such names and in such authorized denominations as the Depositary, pursuant to instructions from its direct or
indirect participants or otherwise, shall instruct the Trustee. The Trustee shall deliver such Securities to the Depositary for delivery
to the Persons in whose names such Securities are so registered.
(d) None of the Trustee, the
Security Registrar or any paying agent shall have any responsibility or obligation to any beneficial owner in a Global Security, a member
of, or a participant in the Depositary or other Person with respect to the accuracy of the records of the Depositary or its nominee or
of any participant or member thereof, with respect to any ownership interest in the Securities or with respect to the delivery to any
participant, member, beneficial owner or other Person (other than the Depositary) of any notice (including any notice of redemption) or
the payment of any amount, under or with respect to such Securities. All notices and communications to be given to the Securityholders
and all payments to be made to Securityholders under the Securities and this Indenture shall be given or made only to or upon the order
of the registered holders (which shall be the Depositary or its nominee in the case of the Global Security). The rights of beneficial
owners in the Global Security shall be exercised only through the Depositary subject to the applicable procedures. The Trustee, the Security
Registrar and any paying agent shall be entitled to rely and shall be fully protected in relying upon information furnished by the Depositary
with respect to its members, participants and any beneficial owners. The Trustee, the Security Registrar and any paying agent shall be
entitled to deal with any depositary (including the Depositary), and any nominee thereof, that is the registered holder of any Global
Security for all purposes of this Indenture relating to such Global Security (including the payment of principal, premium, if any, and
interest and additional amounts, if any, and the giving of instructions or directions by or to the owner or holder of a beneficial ownership
interest in such Global Security) as the sole holder of such Global Security and shall have no obligations to the beneficial owners thereof.
None of the Trustee, the Security Registrar or any paying agent shall have any responsibility or liability for any acts or omissions of
any such depositary with respect to such Global Security, for the records of any such depositary, including records in respect of beneficial
ownership interests in respect of any such Global Security, for any transactions between such depositary and any participant in such depositary
or between or among any such depositary, any such participant and/or any holder or owner of a beneficial interest in such Global Security,
or for any transfers of beneficial interests in any such Global Security.
Notwithstanding the foregoing,
with respect to any Global Security, nothing herein shall prevent the Company, the Trustee, the Security Registrar, any paying agent,
or any other agent of the Company or any agent of the Trustee, from giving effect to any written certification, proxy or other authorization
furnished by any depositary (including the Depositary), as a Securityholder, with respect to such Global Security or impair, as between
such depositary and owners of beneficial interests in such Global Security, the operation of customary practices governing the exercise
of the rights of such depositary (or its nominee) as Holder of such Global Security.
ARTICLE III
REDEMPTION OF SECURITIES AND SINKING FUND
PROVISIONS
SECTION 3.01 REDEMPTION.
The Company may redeem the
Securities of any series issued hereunder on and after the dates and in accordance with the terms established for such series pursuant
to Section 2.01 hereof.
SECTION 3.02 NOTICE OF REDEMPTION.
(a) In case the Company shall
desire to exercise such right to redeem all or, as the case may be, a portion of the Securities of any series in accordance with the right
reserved so to do, the Company shall (upon five Business Days prior notice to the Trustee, unless a shorter notice period shall be acceptable
to the Trustee), or shall cause the Trustee to, give notice of such redemption to Holders of the Securities of such series to be redeemed
by mailing, first class postage prepaid, a notice of such redemption not less than 30 days and not more than 90 days before the date fixed
for redemption of that series to such Holders at their last addresses as they shall appear upon the Security Register unless a shorter
period is specified in the Securities to be redeemed. Any notice that is mailed in the manner herein provided shall be conclusively presumed
to have been duly given, whether or not the registered Holder receives the notice. In any case, failure duly to give such notice to the
Holder of any Security of any series designated for redemption in whole or in part, or any defect in the notice, shall not affect the
validity of the proceedings for the redemption of any other Securities of such series or any other series. In the case of any redemption
of Securities prior to the expiration of any restriction on such redemption provided in the terms of such Securities or elsewhere in this
Indenture, the Company shall furnish the Trustee with an Officers’ Certificate evidencing compliance with any such restriction.
Each such notice of redemption shall specify the date fixed for redemption and the redemption price at which Securities of that series
are to be redeemed, and shall state that payment of the redemption price of such Securities to be redeemed will be made at the office
or agency of the Company in [_____________], upon presentation and surrender of such Securities, that interest accrued to the date fixed
for redemption will be paid as specified in said notice, that from and after said date interest will cease to accrue and that the redemption
is for a sinking fund, if such is the case. If less than all the Securities of a series are to be redeemed, the notice to the Holders
of Securities of that series to be redeemed in whole or in part shall specify the particular Securities to be so redeemed. In case any
Security is to be redeemed in part only, the notice that relates to such Security shall state the portion of the principal amount thereof
to be redeemed, and shall state that on and after the redemption date, upon surrender of such Security, a new Security or Securities of
such series in principal amount equal to the unredeemed portion thereof will be issued.
(b) If less than all the Securities
of a series are to be redeemed, the Company shall give the Trustee at least 45 days’ notice in advance of the date fixed for redemption
as to the aggregate principal amount of Securities of the series to be redeemed, and thereupon the Trustee shall select, by lot or in
such other manner as it shall deem appropriate and fair in its discretion and that may provide for the selection of a portion or portions
(equal to one thousand U.S. dollars ($1,000) or any integral multiple thereof) of the principal amount of such Securities of a denomination
larger than $1,000, the Securities to be redeemed and shall thereafter promptly notify the Company in writing of the numbers of the Securities
to be redeemed, in whole or in part. The Company may, if and whenever it shall so elect, by delivery of instructions signed on its behalf
by its President or any Vice President, instruct the Trustee or any paying agent to call all or any part of the Securities of a particular
series for redemption and to give notice of redemption in the manner set forth in this Section, such notice to be in the name of the Company
or its own name as the Trustee or such paying agent as it may deem advisable. In any case in which notice of redemption is to be given
by the Trustee or any such paying agent, the Company shall deliver or cause to be delivered to, or permit to remain with, the Trustee
or such paying agent, as the case may be, such Security Register, transfer books or other records, or suitable copies or extracts therefrom,
sufficient to enable the Trustee or such paying agent to give any notice by mail that may be required under the provisions of this Section.
SECTION 3.03 PAYMENT UPON REDEMPTION.
(a) If the giving of notice
of redemption shall have been completed as above provided, the Securities or portions of Securities of the series to be redeemed specified
in such notice shall become due and payable on the date and at the place stated in such notice at the applicable redemption price, together
with interest accrued to the date fixed for redemption and interest on such Securities or portions of Securities shall cease to accrue
on and after the date fixed for redemption, unless the Company shall default in the payment of such redemption price and accrued interest
with respect to any such Security or portion thereof. On presentation and surrender of such Securities on or after the date fixed for
redemption at the place of payment specified in the notice, said Securities shall be paid and redeemed at the applicable redemption price
for such series, together with interest accrued thereon to the date fixed for redemption (but if the date fixed for redemption is an Interest
Payment Date, the interest installment payable on such date shall be payable to the registered Holder at the close of business on the
applicable record date pursuant to Section 2.03).
(b) Upon presentation of any
Security of such series that is to be redeemed in part only, the Company shall execute and the Trustee shall authenticate and the office
or agency where the Security is presented shall deliver to the Holder thereof, at the expense of the Company, a new Security of the same
series of authorized denominations in principal amount equal to the unredeemed portion of the Security so presented.
SECTION 3.04 SINKING FUND.
The provisions of Sections
3.04, 3.05 and 3.06 shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified
as contemplated by Section 2.01 for Securities of such series. The minimum amount of any sinking fund payment provided for by the terms
of Securities of any series is herein referred to as a “mandatory sinking fund payment,” and any payment in excess of such
minimum amount provided for by the terms of Securities of any series is herein referred to as an “optional sinking fund payment”.
If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided
in Section 3.05. Each sinking fund payment shall be applied to the redemption of Securities of any series as provided for by the terms
of Securities of such series.
SECTION 3.05 SATISFACTION OF SINKING FUND PAYMENTS
WITH SECURITIES.
The Company,
(1) may deliver Outstanding
Securities of a series (other than any Securities previously called for redemption) and
(2) may apply as a credit
Securities of a series that have been redeemed either at the election of the Company pursuant to the terms of such Securities or through
the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of
all or any part of any sinking fund payment with respect to the Securities of such series required to be made pursuant to the terms of
such Securities as provided for by the terms of such series, provided that such Securities have not been previously so credited. Such
Securities shall be received and credited for such purpose by the Trustee at the redemption price specified in such Securities for redemption
through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly.
SECTION 3.06 REDEMPTION OF SECURITIES FOR SINKING
FUND.
Not less than 45 days prior
to each sinking fund payment date for any series of Securities, the Company will deliver to the Trustee an Officers’ Certificate
specifying the amount of the next ensuing sinking fund payment for that series pursuant to the terms of the series, the portion thereof,
if any, that is to be satisfied by delivering and crediting Securities of that series pursuant to Section 3.05 and the basis for such
credit and will, together with such Officers’ Certificate, deliver to the Trustee any Securities to be so delivered. Not less than
30 days before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund payment
date in the manner specified in Section 3.02 and cause notice of the redemption thereof to be given in the name of and at the expense
of the Company in the manner provided in Section 3.02. Such notice having been duly given, the redemption of such Securities shall be
made upon the terms and in the manner stated in Section 3.03.
ARTICLE IV
COVENANTS
SECTION 4.01 PAYMENT OF PRINCIPAL, PREMIUM
AND INTEREST.
The Company will duly and
punctually pay or cause to be paid the principal of (and premium, if any) and interest on the Securities of each series at the time and
place and in the manner provided herein and established with respect to such Securities.
SECTION 4.02 MAINTENANCE OF OFFICE OR AGENCY.
So long as any series of the
Securities remain Outstanding, the Company agrees to maintain an office or agency in [_____________], with respect to each such series
and at such other location or locations as may be designated as provided in this Section 4.02, where (i) Securities of that series may
be presented for payment, (ii) Securities of that series may be presented as herein above authorized for registration of transfer and
exchange, and (iii) notices and demands to or upon the Company in respect of the Securities of that series and this Indenture may be given
or served, such designation to continue with respect to such office or agency until the Company shall, by written notice signed by its
President or a Vice President and delivered to the Trustee, designate some other office or agency in [_____________] for such purposes
or any of them. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee
with the address thereof, such presentations, notices and demands may be made or served at the Corporate Trust Office of the Trustee,
and the Company hereby appoints the Trustee as its agent to receive all such presentations, notices and demands.
The Company may also from
time to time designate one or more other offices or agencies where the Securities of one or more series may be presented or surrendered
for any or all such purposes and may from time to time rescind such designations; provided, however, that no such designation or rescission
shall in any manner relieve the Company of its obligation to maintain an office or agency in [_____________] for Securities of any series
for such purposes. The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change
in the location of any such other office or agency.
SECTION 4.03 PAYING AGENTS.
(a) If the Company shall appoint
one or more paying agents for all or any series of the Securities, other than the Trustee, the Company will cause each such paying agent
to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this
Section:
(1) that it will hold all
sums held by it as such agent for the payment of the principal of (and premium, if any) or interest on the Securities of that series (whether
such sums have been paid to it by the Company or by any other obligor of such Securities) in trust for the benefit of the Persons entitled
thereto;
(2) that it will give the
Trustee notice of any failure by the Company (or by any other obligor of such Securities) to make any payment of the principal of (and
premium, if any) or interest on the Securities of that series when the same shall be due and payable;
(3) that it will, at any
time during the continuance of any failure referred to in the preceding paragraph (a)(2) above, upon the written request of the Trustee,
forthwith pay to the Trustee all sums so held in trust by such paying agent; and
(4) that it will perform
all other duties of paying agent as set forth in this Indenture.
(b) If the Company shall act
as its own paying agent with respect to any series of the Securities, it will on or before each due date of the principal of (and premium,
if any) or interest on Securities of that series, set aside, segregate and hold in trust for the benefit of the Persons entitled thereto
a sum sufficient to pay such principal (and premium, if any) or interest so becoming due on Securities of that series until such sums
shall be paid to such Persons or otherwise disposed of as herein provided and will promptly notify the Trustee of such action, or any
failure (by it or any other obligor on such Securities) to take such action. Whenever the Company shall have one or more paying agents
for any series of Securities, it will, prior to each due date of the principal of (and premium, if any) or interest on any Securities
of that series, deposit with the paying agent a sum sufficient to pay the principal (and premium, if any) or interest so becoming due,
such sum to be held in trust for the benefit of the Persons entitled to such principal, premium or interest, and (unless such paying agent
is the Trustee) the Company will promptly notify the Trustee of this action or failure so to act.
(c) Notwithstanding anything
in this Section to the contrary,
(1) the agreement to hold
sums in trust as provided in this Section is subject to the provisions of Section 11.05, and
(2) the Company may at any
time, for the purpose of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or direct any paying
agent to pay, to the Trustee all sums held in trust by the Company or such paying agent, such sums to be held by the Trustee upon the
same terms and conditions as those upon which such sums were held by the Company or such paying agent; and, upon such payment by any paying
agent to the Trustee, such paying agent shall be released from all further liability with respect to such money.
SECTION 4.04 APPOINTMENT TO FILL VACANCY IN
OFFICE OF TRUSTEE.
The Company, whenever necessary
to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 7.11, a Trustee, so that there shall
at all times be a Trustee hereunder.
SECTION 4.05 COMPLIANCE WITH CONSOLIDATION
PROVISIONS.
The Company will not, while
any of the Securities remain Outstanding, consolidate with or merge into any other Person, in either case where the Company is not the
survivor of such transaction, or sell, convey, transfer or otherwise dispose of its property as an entirety or substantially as an entirety,
to any other Person unless the provisions of Article X hereof are complied with.
SECTION 4.06 STATEMENT BY OFFICERS AS TO DEFAULT.
The Company will deliver to
the Trustee, within 120 days after the end of each fiscal year of the Company, an Officers’ Certificate, stating whether or not
to the best knowledge of the signer thereof the Company is in default in the performance and observance of any of the terms, provisions
and conditions of this Indenture (without regard to any period of grace or requirement of notice provided hereunder) and, if the Company
shall be in default, specifying all such defaults and the nature and status thereof of which such signer may have knowledge.
ARTICLE V
SECURITYHOLDERS’ LISTS AND REPORTS BY
THE COMPANY AND THE TRUSTEE
SECTION 5.01 COMPANY TO FURNISH TRUSTEE NAMES
AND ADDRESSES OF SECURITYHOLDERS.
The Company will furnish or
cause to be furnished to the Trustee:
(1) not more than 15 days
after each regular record date (as defined in Section 2.03) a list, in such form as the Trustee may reasonably require, of the names and
addresses of the Holders of each series of Securities as of such regular record date, provided that the Company shall not be obligated
to furnish or cause to furnish such list at any time that the list shall not differ in any respect from the most recent list furnished
to the Trustee by the Company; and
(2) at such other times as
the Trustee may request in writing within 30 days after the receipt by the Company of any such request, a list of similar form and content
as of a date not more than 15 days prior to the time such list is furnished; provided, however, that, in either case, no such list need
be furnished for any series for which the Trustee shall be the Security Registrar.
SECTION 5.02 PRESERVATION OF INFORMATION; COMMUNICATIONS
WITH SECURITYHOLDERS.
(a) The Trustee shall preserve,
in as current a form as is reasonably practicable, all information as to the names and addresses of the Holders of Securities contained
in the most recent list furnished to it as provided in Section 5.01 and as to the names and addresses of Holders of Securities received
by the Trustee in its capacity as Security Registrar (if acting in such capacity).
(b) The Trustee may destroy
any list furnished to it as provided in Section 5.01 upon receipt of a new list so furnished.
(c) Securityholders may communicate
as provided in Section 312(b) of the Trust Indenture Act with other Securityholders with respect to their rights under this Indenture
or under the Securities.
SECTION 5.03 REPORTS BY THE COMPANY.
(a) The Company covenants
and agrees to file with the Trustee, within 15 days after the Company has filed the same with the Commission, copies of the annual reports
and of the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time
to time by rules and regulations prescribe) that the Company may be required to file with the Commission pursuant to Section 13 or Section
15(d) of the Exchange Act; or, if the Company is not required to file information, documents or reports pursuant to either of such sections,
then to file with the Trustee and the Commission, in accordance with the rules and regulations prescribed from time to time by the Commission,
such of the supplementary and periodic information, documents and reports that may be required pursuant to Section 13 of the Exchange
Act, in respect of a security listed and registered on a national securities exchange as may be prescribed from time to time in such rules
and regulations.
(b) The Company covenants
and agrees to file with the Trustee and the Commission, in accordance with the rules and regulations prescribed from to time by the Commission,
such additional information, documents and reports with respect to compliance by the Company with the conditions and covenants provided
for in this Indenture as may be required from time to time by such rules and regulations.
(c) The Company covenants
and agrees to transmit by mail, first class postage prepaid, or reputable overnight delivery service that provides for evidence of receipt,
to the Securityholders, as their names and addresses appear upon the Security Register, within 30 days after the filing thereof with the
Trustee, such summaries of any information, documents and reports required to be filed by the Company pursuant to subsections (a) and
(b) of this Section as may be required by rules and regulations prescribed from time to time by the Commission.
(d) Delivery of reports, information
and documents to the Trustee under this Section 5.03 is for informational purposes only and the Trustee’s receipt of the foregoing
shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including
the Company’s compliance with any of its respective covenants hereunder (as to which the Trustee is entitled to rely exclusively
on Officers’ Certificates, except as otherwise provided herein).
SECTION 5.04 REPORTS BY THE TRUSTEE.
(a) On or before July 15 in
each year in which any of the Securities are Outstanding, the Trustee shall transmit by mail, first class postage prepaid, to the Securityholders,
as their names and addresses appear upon the Security Register, a brief report dated as of the preceding May 15, if and to the extent
required under Section 313(a) of the Trust Indenture Act.
(b) The Trustee shall comply
with Section 313(b) and 313(c) of the Trust Indenture Act.
(c) A copy of each such report
shall, at the time of such transmission to Securityholders, be filed by the Trustee with the Company, with each stock exchange upon which
any Securities are listed (if so listed) and also with the Commission. The Company agrees to notify the Trustee when any Securities become
listed on any stock exchange.
ARTICLE VI
REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS
ON
EVENT OF DEFAULT
SECTION 6.01 EVENTS OF DEFAULT.
(a) Whenever used herein with
respect to Securities of a particular series, “Event of Default” means any one or more of the following events that has occurred
and is continuing (whatever the reason for such Event of Default and whether it shall be occasioned by the subordination provisions of
Article XIV or other subordination provisions applicable to a series of Securities or be voluntary or involuntary or be effected by operation
of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental
body):
(1) the Company defaults
in the payment of any installment of interest upon any of the Securities of that series, as and when the same shall become due and payable,
and continuance of such default for a period of 90 days; provided, however, that a valid extension of an interest payment period by the
Company in accordance with the terms of any indenture supplemental hereto shall not constitute a default in the payment of interest for
this purpose;
(2) the Company defaults
in the payment of the principal of (or premium, if any, on) any of the Securities of that series as and when the same shall become due
and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment required by any sinking or analogous
fund established with respect to that series; provided, however, that a valid extension of the maturity of such Securities in accordance
with the terms of any indenture supplemental hereto shall not constitute a default in the payment of principal or premium, if any;
(3) the Company fails to
observe or perform any other of its covenants or agreements with respect to that series contained in this Indenture or otherwise established
with respect to that series of Securities pursuant to Section 2.01 hereof (other than a covenant or agreement that has been expressly
included in this Indenture solely for the benefit of one or more series of Securities other than such series) for a period of 90 days
after the date on which written notice of such failure, requiring the same to be remedied and stating that such notice is a “Notice
of Default” hereunder, shall have been given to the Company by the Trustee, by registered or certified mail, or to the Company and
the Trustee by the Holders of at least 25% in principal amount of the Securities of that series at the time Outstanding;
(4) the Company pursuant
to or within the meaning of any Bankruptcy Law
|
(i) |
commences a voluntary case, |
|
|
|
|
(ii) |
consents to the entry of an order for relief against it in an involuntary case, |
|
|
|
|
(iii) |
consents to the appointment of a Custodian of it or for all or substantially all of its property, or |
|
|
|
|
(iv) |
makes a general assignment for the benefit of its creditors; or |
(5) a court of competent jurisdiction
enters an order under any Bankruptcy Law that
|
(i) |
is for relief against the Company in an involuntary case, |
|
|
|
|
(ii) |
appoints a Custodian of the Company for all or substantially all of its property, or |
|
|
|
|
(iii) |
orders the liquidation of the Company, and the order remains unstayed and in effect for 90 days. |
(b) In each and every such
case, unless the principal of all the Securities of that series shall have already become due and payable, either the Trustee or the Holders
of not less than 25% in aggregate principal amount of the Securities of that series then Outstanding hereunder, by notice in writing to
the Company (and to the Trustee if given by such Securityholders), may declare the principal of all the Securities of that series to be
due and payable immediately, and upon any such declaration the same shall become and shall be immediately due and payable, notwithstanding
anything contained in this Indenture or in the Securities of that series or established with respect to that series pursuant to Section
2.01 to the contrary.
(c) At any time after the
principal of the Securities of that series shall have been so declared due and payable, and before any judgment or decree for the payment
of the moneys due shall have been obtained or entered as hereinafter provided, the Holders of a majority in aggregate principal amount
of the Securities of that series then Outstanding hereunder, by written notice to the Company and the Trustee, may rescind and annul such
declaration and its consequences if:
(1) the Company has paid
or deposited with the Trustee a sum sufficient to pay all matured installments of interest upon all the Securities of that series and
the principal of (and premium, if any, on) any and all Securities of that series that shall have become due otherwise than by acceleration
(with interest upon such principal and premium, if any, and, to the extent that such payment is enforceable under applicable law, upon
overdue installments of interest, at the rate per annum expressed in the Securities of that series to the date of such payment or deposit)
and the amount payable to the Trustee under Section 7.07, and
(2) any and all Events of
Default under the Indenture with respect to such series, other than the nonpayment of principal on Securities of that series that shall
not have become due by their terms, shall have been remedied or waived as provided in Section 6.06. No such rescission and annulment shall
extend to or shall affect any subsequent default or impair any right consequent thereon.
(d) In case the Trustee shall
have proceeded to enforce any right with respect to Securities of that series under this Indenture and such proceedings shall have been
discontinued or abandoned because of such rescission or annulment or for any other reason or shall have been determined adversely to the
Trustee, then and in every such case, subject to any determination in such proceedings, the Company, and the Trustee shall be restored
respectively to their former positions and rights hereunder, and all rights, remedies and powers of the Company and the Trustee shall
continue as though no such proceedings had been taken.
SECTION 6.02 COLLECTION OF INDEBTEDNESS AND
SUITS FOR ENFORCEMENT BY TRUSTEE.
(a) The Company covenants
that
(1) in case it shall default
in the payment of any installment of interest on any of the Securities of a series, as and when the same shall have become due and payable,
and such default shall have continued for a period of 90 days, or
(2) in case it shall default
in the payment of the principal of (or premium, if any, on) any of the Securities of a series when the same shall have become due and
payable, whether upon maturity of the Securities of a series or upon redemption or upon declaration, pursuant to any sinking or analogous
fund established with respect to that series or otherwise, then, upon demand of the Trustee, the Company will pay to the Trustee, for
the benefit of the Holders of the Securities of that series, the whole amount that then shall have been become due and payable on all
such Securities for principal (and premium, if any) or interest, or both, as the case may be, with interest upon the overdue principal
(and premium, if any) and (to the extent that payment of such interest is enforceable under applicable law) upon overdue installments
of interest at the rate per annum expressed in the Securities of that series; and, in addition thereto, such further amount as shall be
sufficient to cover the costs and expenses of collection, and the amount payable to the Trustee under Section 7.07.
(b) If the Company shall fail
to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be entitled and
empowered to institute any action or proceedings at law or in equity for the collection of the sums so due and unpaid, and may prosecute
any such action or proceeding to judgment or final decree, and may enforce any such judgment or final decree against the Company or other
obligor upon the Securities of that series and collect the moneys adjudged or decreed to be payable in the manner provided by law out
of the property of the Company or other obligor upon the Securities of that series, wherever situated.
(c) In case of any receivership,
insolvency, liquidation, bankruptcy, reorganization, readjustment, arrangement, composition or judicial proceedings affecting the Company,
or its creditors or property, the Trustee shall have power to intervene in such proceedings and take any action therein that may be permitted
by the court and shall (except as may be otherwise provided by law) be entitled to file such proofs of claim and other papers and documents
as may be necessary or advisable in order to have the claims of the Trustee and of the Holders of Securities of such series allowed for
the entire amount due and payable by the Company under the Indenture at the date of institution of such proceedings and for any additional
amount that may become due and payable by the Company after such date, and to collect and receive any moneys or other property payable
or deliverable on any such claim, and to distribute the same after the deduction of the amount payable to the Trustee under Section 7.07;
and any receiver, assignee or trustee in bankruptcy or reorganization is hereby authorized by each of the Holders of Securities of such
series to make such payments to the Trustee, and, in the event that the Trustee shall consent to the making of such payments directly
to such Securityholders, to pay to the Trustee any amount due it under Section 7.07.
(d) All rights of action and
of asserting claims under this Indenture, or under any of the terms established with respect to Securities of that series, may be enforced
by the Trustee without the possession of any of such Securities, or the production thereof at any trial or other proceeding relative thereto,
and any such suit or proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery
of judgment shall, after provision for payment to the Trustee of any amounts due under Section 7.07, be for the ratable benefit of the
Holders of the Securities of such series. In case of an Event of Default hereunder, the Trustee may in its discretion proceed to protect
and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as the Trustee shall deem most effectual
to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise, whether for the specific enforcement
of any covenant or agreement contained in the Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce
any other legal or equitable right vested in the Trustee by this Indenture or by law. Nothing contained herein shall be deemed to authorize
the Trustee to authorize or consent to or accept or adopt on behalf of any Securityholder any plan of reorganization, arrangement, adjustment
or composition affecting the Securities of that series or the rights of any Holder thereof or to authorize the Trustee to vote in respect
of the claim of any Securityholder in any such proceeding.
SECTION 6.03 APPLICATION OF MONEYS COLLECTED.
Any moneys collected by the
Trustee pursuant to this Article with respect to a particular series of Securities and any money or other property distributable in respect
of the company’s obligations under this Indenture after an Event of Default shall be applied in the following order, at the date
or dates fixed by the Trustee and, in case of the distribution of such moneys on account of principal (or premium, if any) or interest,
upon presentation of the Securities of that series, and notation thereon of the payment, if only partially paid, and upon surrender thereof
if fully paid:
FIRST: To the payment of costs
and expenses of collection and of all amounts payable to the Trustee (including any predecessor Trustee) under Section 7.07;
SECOND: To the payment of
all Senior Indebtedness of the Company if and to the extent required by Article XIV or other subordination provisions applicable with
respect to such series; and
THIRD: To the payment of the
amounts then due and unpaid upon Securities of such series for principal (and premium, if any) and interest, in respect of which or for
the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due
and payable on such Securities for principal (and premium, if any) and interest, respectively.
SECTION 6.04 LIMITATION ON SUITS.
No Holder of any Security
of any series shall have any right by virtue or by availing of any provision of this Indenture to institute any suit, action or proceeding
in equity or at law upon or under or with respect to this Indenture or for the appointment of a receiver or trustee, or for any other
remedy hereunder, unless
(1) such Holder previously
shall have given to the Trustee written notice of an Event of Default and of the continuance thereof with respect to the Securities of
such series specifying such Event of Default, as hereinbefore provided;
(2) the Holders of not less
than 25% in aggregate principal amount of the Securities of such series then Outstanding shall have made written request upon the Trustee
to institute such action, suit or proceeding in its own name as trustee hereunder;
(3) such Holder or Holders
shall have offered to the Trustee such reasonable indemnity as it may require against the costs, expenses and liabilities to be incurred
therein or thereby; and
(4) the Trustee for 60 days
after its receipt of such notice, request and offer of indemnity, shall have failed to institute any such action, suit or proceeding and
(5) during such 60-day period,
the Holders of a majority in principal amount of the Securities of that series do not give the Trustee a direction inconsistent with the
request.
Notwithstanding anything contained
herein to the contrary, the right of any Holder of any Security to receive payment of the principal of (and premium, if any) and interest
on such Security, as therein provided, on the respective due dates expressed in such Security (or in the case of redemption, on the redemption
date), or to institute suit for the enforcement of any such payment on or after such respective dates or redemption date, shall not be
impaired or affected without the consent of such Holder and by accepting a Security hereunder it is expressly understood, intended and
covenanted by the taker and Holder of every Security of such series with every other such taker and Holder and the Trustee, that no one
or more Holders of Securities of such series shall have any right in any manner whatsoever by virtue or by availing of any provision of
this Indenture to affect, disturb or prejudice the rights of the Holders of any other of such Securities, or to obtain or seek to obtain
priority over or preference to any other such Holder, or to enforce any right under this Indenture, except in the manner herein provided
and for the equal, ratable and common benefit of all Holders of Securities of such series. For the protection and enforcement of the provisions
of this Section, each and every Securityholder and the Trustee shall be entitled to such relief as can be given either at law or in equity.
SECTION 6.05 RIGHTS AND REMEDIES CUMULATIVE;
DELAY OR OMISSION NOT WAIVER.
(a) Except as otherwise provided
in Section 2.07, all powers and remedies given by this Article to the Trustee or to the Securityholders shall, to the extent permitted
by law, be deemed cumulative and not exclusive of any other powers and remedies available to the Trustee or the Holders of the Securities,
by judicial proceedings or otherwise, to enforce the performance or observance of the covenants and agreements contained in this Indenture
or otherwise established with respect to such Securities.
(b) No delay or omission of
the Trustee or of any Holder of any of the Securities to exercise any right or power accruing upon any Event of Default occurring and
continuing as aforesaid shall impair any such right or power, or shall be construed to be a waiver of any such default or on acquiescence
therein; and, subject to the provisions of Section 6.04, every power and remedy given by this Article or by law to the Trustee or the
Securityholders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Securityholders.
SECTION 6.06 CONTROL BY SECURITYHOLDERS.
The Holders of a majority
in aggregate principal amount of the Securities of any series at the time Outstanding, determined in accordance with Section 8.01, shall
have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising
any trust or power conferred on the Trustee with respect to such series; provided, however, that such direction shall not be in conflict
with any rule of law or with this Indenture or be unduly prejudicial to the rights of Holders of Securities of any other series at the
time Outstanding determined in accordance with Section 8.01. Subject to the provisions of Section 7.01, the Trustee shall have the right
to decline to follow any such direction if the Trustee in good faith shall, by a Responsible Officer or Officers of the Trustee, determine
that the proceeding so directed would involve the Trustee in personal liability. The Holders of a majority in aggregate principal amount
of the Securities of any series at the time Outstanding affected thereby, determined in accordance with Section 8.01, may on behalf of
the holders of all of the Securities of such series waive any past default in the performance of any of the covenants contained herein
or established pursuant to Section 2.01 with respect to such series and its consequences, except a default in the payment of the principal
of (or premium, if any) or interest on, any of the Securities of that series as and when the same shall become due by the terms of such
Securities otherwise than by acceleration (unless such default has been cured and a sum sufficient to pay all matured installments of
interest and principal and any premium has been deposited with the Trustee (in accordance with Section 6.01(c)) or in respect of a covenant
or provision hereof which under Article IX cannot be modified or amended without the consent of the Holder of each Outstanding Security
affected. Upon any such waiver, the default covered thereby shall be deemed to be cured for all purposes of this Indenture and the Company,
the Trustee and the Holders of the Securities of such series shall be restored to their former positions and rights hereunder, respectively;
but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon.
SECTION 6.07 UNDERTAKING TO PAY COSTS.
All parties to this Indenture
agree, and each Holder of any Securities by such Holder’s acceptance thereof shall be deemed to have agreed, that any court may
in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee
for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of
such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees, against any
party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but
the provisions of this Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder, or
group of Securityholders, holding more than 10% in aggregate principal amount of the Outstanding Securities of any series, or to any suit
instituted by any Securityholder for the enforcement of the payment of the principal of (or premium, if any) or interest on any Security
of such series, on or after the respective due dates expressed in such Security or established pursuant to this Indenture.
ARTICLE VII
CONCERNING THE TRUSTEE
SECTION 7.01 CERTAIN DUTIES AND RESPONSIBILITIES
OF TRUSTEE.
(a) The Trustee, prior to
the occurrence of an Event of Default with respect to the Securities of a series and after the curing of all Events of Default with respect
to the Securities of that series that may have occurred, shall undertake to perform with respect to the Securities of such series such
duties and only such duties as are specifically set forth in this Indenture, and no implied covenants shall be read into this Indenture
against the Trustee. In case an Event of Default with respect to the Securities of a series has occurred (that has not been cured or waived),
the Trustee shall exercise with respect to Securities of that series such of the rights and powers vested in it by this Indenture, and
use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct
of his own affairs.
(b) No provision of this Indenture
shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to act, or its own willful
misconduct, except that:
(1) prior to the occurrence
of an Event of Default with respect to the Securities of a series and after the curing or waiving of all such Events of Default with respect
to that series that may have occurred: the duties and obligations of the Trustee shall with respect to the Securities of such series be
determined solely by the express provisions of this Indenture, and the Trustee shall not be liable with respect to the Securities of such
series except for the performance of such duties and obligations as are specifically set forth in this Indenture, and no implied covenants
or obligations shall be read into this Indenture against the Trustee; and in the absence of bad faith on the part of the Trustee, the
Trustee may with respect to the Securities of such series conclusively rely, as to the truth of the statements and the correctness of
the opinions expressed therein, upon any certificates or opinions furnished to the Trustee and conforming to the requirements of this
Indenture; but in the case of any such certificates or opinions that by any provision hereof are specifically required to be furnished
to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirement of this
Indenture;
(2) the Trustee shall not
be liable for any error of judgment made in good faith by a Responsible Officer or Responsible Officers of the Trustee, unless it shall
be proved that the Trustee, was negligent in ascertaining the pertinent facts;
(3) the Trustee shall not
be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders
of not less than a majority in principal amount of the Securities of any series at the time Outstanding relating to the time, method and
place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee
under this Indenture with respect to the Securities of that series; and
(4) this Subsection shall
not be construed to limit the effect of Subsection (c) of this Section 7.01.
(c) None of the provisions
contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur any financial liability in the
performance of any of its duties hereunder, or in the exercise of any of its rights or powers, it shall have reasonable grounds for believing
that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it.
(d) The Trustee shall not
be deemed to have notice of or be charged with having knowledge of any Default or Event of Default with respect to any series of Securities,
except Events of Default under Section 6.01(a)(1) or (a)(2), if and so long as it is acting as paying agent with respect to the Securities
of such series, unless written notice of such Default Event or Event of Default, as the case may be, is received by the Trustee at the
Corporate Trust Office of the Trustee from the Company or any Holder of Securities of such series, and such notice references the Securities
and this Indenture.
(e) Whether or not expressly
so provided, every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee
shall be subject to the provisions of this Section 7.01.
SECTION 7.02 NOTICE OF DEFAULTS.
If a Default occurs hereunder
with respect to Securities of any series and is known to a Responsible Officer of the Trustee, the Trustee shall give the Holders of Securities
of such series notice of such Default as and to the extent provided by the Trust Indenture Act; provided, however, that in the case of
any Default of the character specified in clause (3) of Section 6.01(a) with respect to Securities of such series, no such notice to Holders
shall be given until at least 30 days after the occurrence thereof.
SECTION 7.03 CERTAIN RIGHTS OF TRUSTEE.
Except as otherwise provided
in Section 7.01:
(a) The Trustee may conclusively
rely and shall be fully protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion,
report, notice, request, consent, order, approval, bond, security or other paper or document believed by it to be genuine and to have
been signed or presented by the proper party or parties;
(b) Any request, direction,
order or demand of the Company mentioned herein shall be sufficiently evidenced by a Board Resolution or an instrument signed in the name
of the Company, by the President or any Vice President and by the Secretary or an Assistant Secretary or the Treasurer or an Assistant
Treasurer thereof (unless other evidence in respect thereof is specifically prescribed herein);
(c) The Trustee may consult
with counsel and the advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect
of any action taken or suffered or omitted hereunder in good faith and in reliance thereon;
(d) The Trustee shall be under
no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the
Securityholders, pursuant to the provisions of this Indenture, unless such Securityholders shall have offered to the Trustee reasonable
security or indemnity against the costs, expenses and liabilities that may be incurred therein or thereby; nothing contained herein shall,
however, relieve the Trustee of the obligation, upon the occurrence of an Event of Default with respect to a series of the Securities
(that has not been cured or waived) to exercise with respect to Securities of that series such of the rights and powers vested in it by
this Indenture, and to use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances
in the conduct of his own affairs;
(e) The Trustee shall not
be liable for any action taken or omitted to be taken by it in good faith and believed by it to be authorized or within the discretion
or rights or powers conferred upon it by this Indenture;
(f) The Trustee shall not
be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report,
notice, request, consent, order, approval, bond, security, or other papers or documents; and
(g) The Trustee may execute
any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys and the Trustee
shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder.
(h) whenever in the administration
of this Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any
action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may, in the absence of bad faith on its part,
conclusively rely upon an Officers’ Certificate;
(i) the rights, privileges,
protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to,
and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act
hereunder;
(j) the Trustee may request
that the Company deliver an Officers’ Certificate setting forth the names of individuals and/or titles of officers authorized at
such time to take specified actions pursuant to this Indenture;
(k) the permissive right of
the Trustee to take or refrain from taking any actions enumerated in this Indenture shall not be construed as a duty;
(l) anything in this Indenture
notwithstanding, in no event shall the Trustee be liable for special, indirect, punitive or consequential loss or damage of any kind whatsoever
(including but not limited to loss of profit), even if the Company or Guarantor has been advised as to the likelihood of such loss or
damage and regardless of the form of action;
(m) the Trustee shall not
be responsible or liable for any failure or delay in the performance of its obligations under this Indenture arising out of or caused,
directly or indirectly, by circumstances beyond its reasonable control, including, without limitation, acts of God; earthquakes; fire;
flood; terrorism; wars and other military disturbances; sabotage; epidemics; riots; interruptions; loss or malfunctions of utilities,
computer (hardware or software) or communication services; accidents; labor disputes; acts of civil or military authority and governmental
action.
SECTION 7.04 TRUSTEE NOT RESPONSIBLE FOR RECITALS
OR ISSUANCE OR SECURITIES.
(a) The recitals contained
herein and in the Securities shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness
of the same.
(b) The Trustee makes no representations
as to the validity or sufficiency of this Indenture or of the Securities.
(c) The Trustee shall not
be accountable for the use or application by the Company of any of the Securities or of the proceeds of such Securities, or for the use
or application of any moneys paid over by the Trustee in accordance with any provision of this Indenture or established pursuant to Section
2.01, or for the use or application of any moneys received by any paying agent other than the Trustee.
SECTION 7.05 MAY HOLD SECURITIES.
The Trustee or any paying
agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights
it would have if it were not Trustee, paying agent or Security Registrar.
SECTION 7.06 MONEYS HELD IN TRUST.
Subject to the provisions
of Section 11.05, all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes
for which they were received, but need not be segregated from other funds except to the extent required by law. The Trustee shall be under
no liability for interest on any moneys received by it hereunder except such as it may agree with the Company to pay thereon.
SECTION 7.07 COMPENSATION AND REIMBURSEMENT.
(a) The Company covenants
and agrees to pay to the Trustee, and the Trustee shall be entitled to, such reasonable compensation (which shall not be limited by any
provision of law in regard to the compensation of a trustee of an express trust), as the Company, and the Trustee may from time to time
agree in writing, for all services rendered by it in the execution of the trusts hereby created and in the exercise and performance of
any of the powers and duties hereunder of the Trustee, and, except as otherwise expressly provided herein, the Company will pay or reimburse
the Trustee upon its request for all reasonable expenses, disbursements and advances incurred or made by the Trustee in accordance with
any of the provisions of this Indenture (including the reasonable compensation and the expenses and disbursements of its counsel and of
all Persons not regularly in its employ) except any such expense, disbursement or advance as may arise from its gross negligence or willful
misconduct. The Company also covenants to indemnify the Trustee (and its officers, agents, directors and employees) for, and to hold it
harmless against, any loss, damage, claims liability or expense incurred without gross negligence or willful misconduct on the part of
the Trustee and arising out of or in connection with the acceptance or administration of this trust, including the costs and expenses
of defending itself against any claim whether asserted by the Company, any Securityholder or any other Person or liability including the
compensation and expense of counsel in connection with the exercise or performance of any of its powers or duties hereunder.
(b) The obligations of the
Company under this Section to compensate and indemnify the Trustee and to pay or reimburse the Trustee for expenses, disbursements and
advances shall constitute additional indebtedness hereunder. Such additional indebtedness shall be secured by a lien prior to that of
the Securities upon all property and funds held or collected by the Trustee as such, except funds held in trust for the benefit of the
Holders of particular Securities.
(c) To the extent permitted
by law, any compensation due or expense incurred by the Trustee after a default specified in or pursuant to Section 6.01 is intended to
constitute an expense of administration under any then applicable bankruptcy or insolvency law. “Trustee” for purposes of
this Section 7.07 shall include any predecessor Trustee but the negligence or bad faith of any Trustee shall not affect the rights of
any other Trustee under this Section 7.07.
(d) The provisions of this
Section 7.07 shall survive the satisfaction and discharge of this Indenture, the termination of this Indenture for any reason, or the
earlier resignation or removal of the Trustee and shall apply with equal force and effect to the Trustee in its capacity as Authenticating
Agent, Security Registrar or paying agent.
SECTION 7.08 RELIANCE ON OFFICERS’ CERTIFICATE.
Except as otherwise provided
in Section 7.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that
a matter be proved or established prior to taking or suffering or omitting to take any action hereunder, such matter (unless other evidence
in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be deemed
to be conclusively proved and established by an Officers’ Certificate delivered to the Trustee and such certificate, in the absence
of negligence or bad faith on the part of the Trustee, shall be full warranty to the Trustee for any action taken, suffered or omitted
to be taken by it under the provisions of this Indenture upon the faith thereof.
SECTION 7.09 DISQUALIFICATION; CONFLICTING
INTERESTS.
If the Trustee has or shall
acquire any “conflicting interest” within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee and the Company
shall in all respects comply with the provisions of Section 310(b) of the Trust Indenture Act, subject to the penultimate paragraph thereof.
For purposes of Section 310(b)(i) of the Trust Indenture Act and to the extent permitted thereby, the Trustee, in its capacity as trustee
in respect of the Securities of any series, shall not be deemed to have a conflicting interest arising from its capacity as trustee in
respect of the Securities of any other series.
SECTION 7.10 CORPORATE TRUSTEE REQUIRED; ELIGIBILITY.
There shall at all times be
a Trustee with respect to the Securities issued hereunder which shall at all times be a corporation organized and doing business under
the laws of the United States of America or any State or Territory thereof or of the District of Columbia, or a corporation or other Person
permitted to act as trustee by the Commission, authorized under such laws to exercise corporate trust powers, having a combined capital
and surplus of at least fifty million U.S. dollars ($50,000,000), and subject to supervision or examination by federal, state, territorial,
or District of Columbia authority. If such corporation publishes reports of condition at least annually, pursuant to law or to the requirements
of the aforesaid supervising or examining authority, then for the purposes of this Section, the combined capital and surplus of such corporation
shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. The Company may
not, nor may any Person directly or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee.
In case at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall resign
immediately in the manner and with the effect specified in Section 7.11.
SECTION 7.11 RESIGNATION AND REMOVAL; APPOINTMENT
OF SUCCESSOR.
(a) The Trustee or any successor
hereafter appointed, may at any time resign with respect to the Securities of one or more series by giving written notice thereof to the
Company and by transmitting notice of resignation by mail, first class postage prepaid, to the Securityholders of such series, as their
names and addresses appear upon the Security Register. Upon receiving such notice of resignation, the Company shall promptly appoint a
successor trustee with respect to Securities of such series by written instrument, in duplicate, executed by order of the Board of Directors,
one copy of which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee. If no successor trustee
shall have been so appointed and have accepted appointment within 30 days after the mailing of such notice of resignation, the resigning
Trustee may petition any court of competent jurisdiction for the appointment of a successor trustee with respect to Securities of such
series, or any Securityholder of that series who has been a bona fide Holder of a Security or Securities for at least six months may on
behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such court may
thereupon after such notice, if any, as it may deem proper and prescribe, appoint a successor trustee.
(b) In case at any time any
one of the following shall occur:
(1) the Trustee shall fail
to comply with the provisions of Section 7.09 after written request therefor by the Company or by any Securityholder who has been a bona
fide Holder of a Security or Securities for at least six months; or
(2) the Trustee shall cease
to be eligible in accordance with the provisions of Section 7.10 and shall fail to resign after written request therefor by the Company
or by any such Securityholder; or
(3) the Trustee shall become
incapable of acting, or shall be adjudged a bankrupt or insolvent, or commence a voluntary bankruptcy proceeding, or a receiver of the
Trustee or of its property shall be appointed or consented to, or any public officer shall take charge or control of the Trustee or of
its property or affairs for the purpose of rehabilitation, conservation or liquidation, then, in any such case, the Company may remove
the Trustee with respect to all Securities and appoint a successor trustee by written instrument, in duplicate, executed by order of the
Board of Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or,
unless, in the case of a failure to comply with Section 7.09, the Trustee’s duty to resign is stayed as provided in the penultimate
paragraph of Section 310(b) of the Trust Indenture Act, any Securityholder who has been a bona fide Holder of a Security or Securities
for at least six months may, on behalf of that Holder and all others similarly situated, petition any court of competent jurisdiction
for the removal of the Trustee and the appointment of a successor trustee. Such court may thereupon after such notice, if any, as it may
deem proper and prescribe, remove the Trustee and appoint a successor trustee.
(c) The Holders of a majority
in aggregate principal amount of the Securities of any series at the time Outstanding may at any time remove the Trustee with respect
to such series by so notifying the Trustee and the Company and may appoint a successor Trustee for such series with the consent of the
Company.
(d) Any resignation or removal
of the Trustee and appointment of a successor trustee with respect to the Securities of a series pursuant to any of the provisions of
this Section shall become effective upon acceptance of appointment by the successor trustee as provided in Section 7.12.
(e) Any successor trustee
appointed pursuant to this Section may be appointed with respect to the Securities of one or more series or all of such series, and at
any time there shall be only one Trustee with respect to the Securities of any particular series.
SECTION 7.12 ACCEPTANCE OF APPOINTMENT BY SUCCESSOR.
(a) In case of the appointment
hereunder of a successor trustee with respect to all Securities, every such successor trustee so appointed shall execute, acknowledge
and deliver to the Company and to the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal
of the retiring Trustee shall become effective and such successor trustee, without any further act, deed or conveyance, shall become vested
with all the rights, powers, trusts and duties of the retiring Trustee; but, on the request of the Company or the successor trustee, such
retiring Trustee shall, upon payment of its charges, execute and deliver an instrument transferring to such successor trustee all the
rights, powers, and trusts of the retiring Trustee and shall duly assign, transfer and deliver to such successor trustee all property
and money held by such retiring Trustee hereunder, subject nevertheless to the lien provided for in Section 7.07.
(b) In case of the appointment
hereunder of a successor trustee with respect to the Securities of one or more (but not all) series, the Company, the retiring Trustee
and each successor trustee with respect to the Securities of one or more series shall execute and deliver an indenture supplemental hereto
wherein each successor trustee shall accept such appointment and which
(1) shall contain such provisions
as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor trustee all the rights, powers, trusts and
duties of the retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor trustee
relates,
(2) shall contain such provisions
as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the retiring Trustee with respect
to the Securities of that or those series as to which the retiring Trustee is not retiring shall continue to be vested in the retiring
Trustee, and
(3) shall add to or change
any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder
by more than one Trustee, it being understood that nothing herein or in such supplemental indenture shall constitute such Trustees co-trustees
of the same trust, that each such Trustee shall be trustee of a trust or trusts hereunder separate and apart from any trust or trusts
hereunder administered by any other such Trustee and that no Trustee shall be responsible for any act or failure to act on the part of
any other Trustee hereunder; and upon the execution and delivery of such supplemental indenture the resignation or removal of the retiring
Trustee shall become effective to the extent provided therein, such retiring Trustee shall with respect to the Securities of that or those
series to which the appointment of such successor trustee relates have no further responsibility for the exercise of rights and powers
or for the performance of the duties and obligations vested in the Trustee under this Indenture, and each such successor trustee, without
any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee with respect
to the Securities of that or those series to which the appointment of such successor trustee relates; but, on request of the Company or
any successor trustee, such retiring Trustee shall duly assign, transfer and deliver to such successor trustee, to the extent contemplated
by such supplemental indenture, the property and money held by such retiring Trustee hereunder with respect to the Securities of that
or those series to which the appointment of such successor trustee relates, subject nevertheless to the lien provided for in Section 7.07.
(c) Upon request of any such
successor trustee, the Company shall execute any and all instruments for more fully and certainly vesting in and confirming to such successor
trustee all such rights, powers and trusts referred to in paragraph (a) or (b) of this Section, as the case may be.
(d) No successor trustee shall
accept its appointment unless at the time of such acceptance such successor trustee shall be qualified and eligible under this Article.
(e) Upon acceptance of appointment
by a successor trustee as provided in this Section, the Company shall transmit notice of the succession of such trustee hereunder by mail,
first class postage prepaid, to the Securityholders, as their names and addresses appear upon the Security Register. If the Company fails
to transmit such notice within ten days after acceptance of appointment by the successor trustee, the successor trustee shall cause such
notice to be transmitted at the expense of the Company.
SECTION 7.13 MERGER, CONVERSION, CONSOLIDATION
OR SUCCESSION TO BUSINESS.
Any Person into which the
Trustee may be merged or converted or with which it may be consolidated, or any Person resulting from any merger, conversion or consolidation
to which the Trustee shall be a party, or any Person succeeding to all or substantially all of the corporate trust business of the Trustee,
shall be the successor of the Trustee hereunder, provided that such Person shall be qualified under the provisions of Section 7.09 and
eligible under the provisions of Section 7.10, without the execution or filing of any paper or any further act on the part of any of the
parties hereto, anything herein to the contrary notwithstanding. In case any Securities shall have been authenticated, but not delivered,
by the Trustee then in office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such authentication
and deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities.
SECTION 7.14 PREFERENTIAL COLLECTION OF CLAIMS
AGAINST THE COMPANY.
The Trustee shall comply with
Section 311(a) of the Trust Indenture Act, excluding any creditor relationship described in Section 311(b) of the Trust Indenture Act.
A Trustee who has resigned or been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent included therein.
ARTICLE VIII
CONCERNING THE SECURITYHOLDERS
SECTION 8.01 EVIDENCE OF ACTION BY SECURITYHOLDERS.
Whenever in this Indenture
it is provided that the Holders of a majority or specified percentage in aggregate principal amount of the Securities of a particular
series may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of
any other action), the fact that at the time of taking any such action the Holders of such majority or specified percentage of that series
have joined therein may be evidenced by any instrument or any number of instruments of similar tenor executed by such Holders of Securities
of that series in Person or by agent or proxy appointed in writing. If the Company shall solicit from the Securityholders of any series
any request, demand, authorization, direction, notice, consent, waiver or other action, the Company may, at its option, as evidenced by
an Officers’ Certificate, fix in advance a record date for such series for the determination of Securityholders entitled to give
such request, demand, authorization, direction, notice, consent, waiver or other action, but the Company shall have no obligation to do
so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or other action may be given
before or after the record date, but only the Securityholders of record at the close of business on the record date shall be deemed to
be Securityholders for the purposes of determining whether Securityholders of the requisite proportion of Outstanding Securities of that
series have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other action,
and for that purpose the Outstanding Securities of that series shall be computed as of the record date; provided, however, that no such
authorization, agreement or consent by such Securityholders on the record date shall be deemed effective unless it shall become effective
pursuant to the provisions of this Indenture not later than six months after the record date.
SECTION 8.02 PROOF OF EXECUTION BY SECURITYHOLDERS.
Subject to the provisions
of Section 7.01, proof of the execution of any instrument by a Securityholder (such proof will not require notarization) or his agent
or proxy and proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner:
(a) The fact and date of the
execution by any such Person of any instrument may be proved in any reasonable manner acceptable to the Trustee.
(b) The ownership of Securities
shall be proved by the Security Register of such Securities or by a certificate of the Security Registrar thereof.
(c) The Trustee may require
such additional proof of any matter referred to in this Section as it shall deem necessary.
SECTION 8.03 WHO MAY BE DEEMED OWNERS.
Prior to the due presentment
for registration of transfer of any Security, the Company, the Trustee, any paying agent and any Security Registrar may deem and treat
the Person in whose name such Security shall be registered upon the books of the Company as the absolute owner of such Security (whether
or not such Security shall be overdue and notwithstanding any notice of ownership or writing thereon made by anyone other than the Security
Registrar) for the purpose of receiving payment of or on account of the principal of (and premium, if any) and (subject to Section 2.03)
interest on such Security and for all other purposes; and neither the Company nor the Trustee nor any paying agent nor any Security Registrar
shall be affected by any notice to the contrary.
SECTION 8.04 CERTAIN SECURITIES OWNED BY COMPANY
DISREGARDED.
In determining whether the
Holders of the requisite aggregate principal amount of Securities of a particular series have concurred in any direction, consent or waiver
under this Indenture, the Securities of that series that are owned by the Company or any other obligor on the Securities of that series
or by any Person directly or indirectly controlling or controlled by or under common control with the Company or any other obligor on
the Securities of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except
that for the purpose of determining whether the Trustee shall be protected in relying on any such direction, consent or waiver, only Securities
of such series that a Responsible Officer of the Trustee actually knows are so owned shall be so disregarded. The Securities so owned
that have been pledged in good faith may be regarded as Outstanding for the purposes of this Section, if the pledgee shall establish to
the satisfaction of the Trustee the pledgee’s right so to act with respect to such Securities and that the pledgee is not a Person
directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any such other obligor.
In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full protection to the Trustee.
SECTION 8.05 ACTIONS BINDING ON FUTURE SECURITYHOLDERS.
At any time prior to (but
not after) the evidencing to the Trustee, as provided in Section 8.01, of the taking of any action by the Holders of the majority or percentage
in aggregate principal amount of the Securities of a particular series specified in this Indenture in connection with such action, any
Holder of a Security of that series that is shown by the evidence to be included in the Securities the Holders of which have consented
to such action may, by filing written notice with the Trustee, and upon proof of holding as provided in Section 8.02, revoke such action
so far as concerns such Security. Except as aforesaid any such action taken by the Holder of any Security shall be conclusive and binding
upon such Holder and upon all future Holders and owners of such Security, and of any Security issued in exchange therefor, on registration
of transfer thereof or in place thereof, irrespective of whether or not any notation in regard thereto is made upon such Security. Any
action taken by the Holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified
in this Indenture in connection with such action shall be conclusively binding upon the Company, the Trustee and the Holders of all the
Securities of that series.
ARTICLE IX
SUPPLEMENTAL INDENTURES
SECTION 9.01 SUPPLEMENTAL INDENTURES WITHOUT
THE CONSENT OF SECURITYHOLDERS.
In addition to any supplemental
indenture otherwise authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into an indenture
or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent
of the Securityholders, for one or more of the following purposes:
(1) to cure any ambiguity,
defect, or inconsistency herein, in the Securities of any series;
(2) to comply with Article
X;
(3) to provide for uncertificated
Securities in addition to or in place of certificated Securities;
(4) to add to the covenants
of the Company for the benefit of the Holders of all or any series of Securities (and if such covenants are to be for the benefit of less
than all series of Securities, stating that such covenants are expressly being included solely for the benefit of such series) or to surrender
any right or power herein conferred upon the Company or to add any additional Events of Default for the benefit of the Holders of all
or any series of Securities (and if such additional Events of Default are to be for the benefit of less than all series of Securities,
stating that such additional Events of Default are expressly being included solely for the benefit of such series);
(5) to add to, delete from,
or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue, authentication, and delivery
of Securities (prior to the issuance thereof), as herein set forth;
(6) to make any change that
does not adversely affect the rights of any Securityholder in any material respect;
(7) to provide for the issuance
of and establish the form and terms and conditions of the Securities of any series as provided in Section 2.01, to establish the form
of any certifications required to be furnished pursuant to the terms of this Indenture or any series of Securities, or to add to the rights
of the Holders of any series of Securities; or
(8) to evidence and provide
for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more series and to add to
or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts
hereunder by more than one Trustee, pursuant to the requirements of Section 7.12.
The Trustee is hereby authorized
to join with the Company in the execution of any such supplemental indenture, and to make any further appropriate agreements and stipulations
that may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture that affects the Trustee’s
own rights, duties or immunities under this Indenture or otherwise.
Any supplemental indenture
authorized by the provisions of this Section may be executed by the Company and the Trustee without the consent of the Holders of any
of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 9.02.
SECTION 9.02 SUPPLEMENTAL INDENTURES WITH CONSENT
OF SECURITYHOLDERS.
With the consent (evidenced
as provided in Section 8.01) of the Holders of not less than a majority in aggregate principal amount of the Securities of each series
affected by such supplemental indenture or indentures at the time Outstanding, the Company, when authorized by a Board Resolution, and
the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the
provisions of the Trust Indenture Act as then in effect) for the purpose of adding any provisions to or changing in any manner or eliminating
any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner not covered by Section 9.01 the
rights of the Holders of the Securities of such series under this Indenture; provided, however, that no such supplemental indenture shall,
without the consent of the Holders of each Security then Outstanding and affected thereby:
(1) change the maturity of
the principal of, or any installment of principal of or interest on, any Security, or reduce the principal amount thereof or the rate
of interest thereon or any premium payable upon the redemption thereof, or reduce the amount of the principal of an Original Issue Discount
Security or any other Security which would be due and payable upon a declaration of acceleration of the maturity thereof pursuant to Section
6.01 or change the coin or currency in which any Security or any premium or interest thereon is payable, or impair the right to institute
suit for the enforcement of any such payment on or after the maturity thereof (or, in the case of redemption, on or after the redemption
date); or
(2) reduce the percentage
in principal amount of the Outstanding Securities of any series, the consent of whose Holders is required for any such supplemental indenture,
or the consent of whose Holders is required for any waiver of certain defaults hereunder and their consequences provided for in this Indenture;
(3) modify any of the provisions
of this Section or Section 6.06 relating to waivers of default, except to increase any such percentage or to provide that certain other
provisions of this Indenture cannot be modified or waived without the consent of the Holder of each Outstanding Security affected thereby;
provided, however, that this clause shall not be deemed to require the consent of any Holder with respect to changes in the references
to “the Trustee” and concomitant changes in this Section, or the deletion of this proviso, in accordance with the requirements
of Sections 7.12 and 9.01(8); or
(4) modify the provisions
of this Indenture with respect to the subordination of such Security in a manner adverse to the holder thereof.
A supplemental indenture which
changes or eliminates any covenant or other provision of this Indenture which has expressly been included solely for the benefit of one
or more particular series of Securities, or which modifies the rights of the Holders of Securities of such series with respect to such
covenant or other provision, shall be deemed not to affect the rights under this Indenture of the Holders of Securities of any other series.
It shall not be necessary for the consent of the Securityholders of any series affected thereby under this Section to approve the particular
form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof.
SECTION 9.03 EFFECT OF SUPPLEMENTAL INDENTURES.
Upon the execution of any
supplemental indenture pursuant to the provisions of this Article or of Section 10.01, this Indenture shall, with respect to such series,
be and be deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations, duties
and immunities under this Indenture of the Trustee, the Company and the Holders of Securities of the series affected thereby shall thereafter
be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions
of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.
SECTION 9.04 SECURITIES AFFECTED BY SUPPLEMENTAL
INDENTURES.
Securities of any series,
affected by a supplemental indenture, authenticated and delivered after the execution of such supplemental indenture pursuant to the provisions
of this Article or of Section 10.01, may bear a notation in form approved by the Company, provided such form meets the requirements of
any exchange upon which such series may be listed, as to any matter provided for in such supplemental indenture. If the Company shall
so determine, new Securities of that series so modified as to conform, in the opinion of the Board of Directors of the Company, to any
modification of this Indenture contained in any such supplemental indenture may be prepared by the Company, authenticated by the Trustee
and delivered in exchange for the Securities of that series then Outstanding.
SECTION 9.05 EXECUTION OF SUPPLEMENTAL INDENTURES.
Upon the request of the Company,
accompanied by its Board Resolutions authorizing the execution of any supplemental indenture, and upon the filing with the Trustee of
evidence of any requisite consents of Securityholders required to consent thereto as aforesaid, the Trustee shall join with the Company
in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties or immunities
under this Indenture or otherwise, in which case the Trustee may in its discretion but shall not be obligated to enter into such supplemental
indenture. The Trustee, subject to the provisions of Section 7.01, shall be entitled to receive an Opinion of Counsel as conclusive evidence
that any supplemental indenture executed pursuant to this Article is authorized or permitted by, and conforms to, the terms of this Article
and that it is proper for the Trustee under the provisions of this Article to join in the execution thereof.
Promptly after the execution
by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Company shall transmit by
mail, first class postage prepaid, a notice, setting forth in general terms the substance of such supplemental indenture, to the Securityholders
of all series affected thereby as their names and addresses appear upon the Security Register. Any failure of the Company to mail such
notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.
ARTICLE X
SUCCESSOR ENTITY
SECTION 10.01 COMPANY MAY CONSOLIDATE, ETC.
Nothing contained in this
Indenture or in any of the Securities shall prevent any consolidation or merger of the Company with or into any other Person (whether
or not affiliated with the Company) or successive consolidations or mergers in which the Company or its successor or successors shall
be a party or parties, or shall prevent any sale, conveyance, transfer or other disposition of the property of the Company or its successor
or successors as an entirety, or substantially as an entirety, to any other Person (whether or not affiliated with the Company or its
successor or successors) authorized to acquire and operate the same; provided, however, the Company hereby covenants and agrees that,
upon any such consolidation or merger (in each case, if the Company is not the survivor of such transaction), sale, conveyance, transfer
or other disposition, the due and punctual payment of the principal of (and premium, if any) and interest on all of the Securities of
all series in accordance with the terms of each series, according to their tenor and the due and punctual performance and observance of
all the covenants and conditions of this Indenture or established with respect to each series of Securities pursuant to Section 2.01 to
be kept or performed by the Company shall be expressly assumed, by supplemental indenture (which shall conform to the provisions of the
Trust Indenture Act, as then in effect) satisfactory in form to the Trustee executed and delivered to the Trustee by the entity formed
by such consolidation, or into which the Company shall have been merged, or by the entity which shall have acquired such property.
SECTION 10.02 SUCCESSOR ENTITY SUBSTITUTED.
(a) In case of any such consolidation,
merger, sale, conveyance, transfer or other disposition and upon the assumption by any successor entity by supplemental indenture, executed
and delivered to the Trustee of the due and punctual payment of the principal of (and premium, if any) and interest on all of the Securities
of all series Outstanding and the due and punctual performance of all of the covenants and conditions of this Indenture or established
with respect to each series of the Securities pursuant to Section 2.01 to be performed by the Company, such successor entity shall succeed
to and be substituted for the Company with the same effect as if it had been named as the Company herein, and thereupon the predecessor
company, except in the case of a lease, shall be relieved of all obligations and covenants under this Indenture and the Securities.
(b) In case of any such consolidation,
merger, sale, conveyance, transfer or other disposition such changes in phraseology and form (but not in substance) may be made in the
Securities thereafter to be issued as may be appropriate.
(c) Nothing contained in this
Article shall require any action by the Company in the case of a consolidation or merger of any Person into the Company where the Company
is the survivor of such transaction, or the acquisition by the Company, by purchase or otherwise, of all or any part of the property of
any other Person (whether or not affiliated with the Company).
SECTION 10.03 EVIDENCE OF CONSOLIDATION, ETC.
TO TRUSTEE.
The Trustee, subject to the
provisions of Section 7.01, shall be entitled to receive an Opinion of Counsel and an Officers’ Certificate as conclusive evidence
that any such consolidation, merger, sale, conveyance, transfer or other disposition, and any such assumption, comply with the provisions
of this Article.
ARTICLE XI
SATISFACTION AND DISCHARGE; DEFEASANCE
SECTION 11.01 SATISFACTION AND DISCHARGE.
This Indenture will be discharged
and will cease to be of further effect with respect to a series of Securities (except as to any surviving rights of registration of transfer
or exchange of such series of Securities herein expressly provided for), and the Trustee, at the expense of the Company, shall execute
proper instruments acknowledging satisfaction and discharge of this Indenture with respect to such series, when:
(1) either (A) all Securities
of that series theretofore authenticated and delivered (other than (i) any Securities that shall have been destroyed, lost or stolen and
that shall have been replaced or paid as provided in Section 2.07 and (ii) Securities for whose payment money or noncallable Governmental
Obligations have theretofore been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company
or discharged from such trust, as provided in Section 11.05) have been delivered to the Trustee for cancellation; or (B) all Securities
of such series not theretofore delivered to the Trustee for cancellation (i) have become due and payable, or (ii) will by their terms
become due and payable within one year, or (iii) are to be called for redemption within one year under arrangements satisfactory to the
Trustee for the giving of notice of redemption, and the Company shall deposit or cause to be deposited with the Trustee as trust funds
in trust for the purpose (x) moneys in an amount, or (y) noncallable Governmental Obligations the scheduled principal of and interest
on which in accordance with their terms will provide, not later than the due date of any payment, money in an amount, or (z) a combination
thereof, sufficient, in the case of (y) or (z), in the opinion of a nationally recognized firm of independent public accountants expressed
in a written certification thereof delivered to the Trustee, to pay and discharge, at maturity or upon redemption, all Securities of that
series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due or to become
due to such date of maturity or date fixed for redemption, as the case may be;
(2) the Company has paid or
caused to be paid all other sums payable hereunder with respect to such series by the Company; and
(3) the Company has delivered
to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all the conditions precedent herein provided
for relating to the satisfaction and discharge of this Indenture with respect to such series of Securities have been complied with. Notwithstanding
the satisfaction and discharge of this Indenture with respect to a series of Securities, the obligations of the Trustee under Section
7.07 and, if money shall have been deposited with the Trustee pursuant to subclause (y) of clause (1) of this Section, the obligations
of the Trustee under Sections 11.03 and 11.05 shall survive.
SECTION 11.02 DEFEASANCE.
The Company may, at its option
and at any time (including notwithstanding the exercise by the Company of a Covenant Defeasance (as defined herein)), elect to have its
obligations discharged with respect to a series of the Securities (“Legal Defeasance”). Such Legal Defeasance means that the
Company shall be deemed to have paid and discharged the entire indebtedness represented by such series of Securities, except for (a) the
rights of Holders to receive payments in respect of the principal of (and premium, if any) and interest on the Securities when such payments
are due solely from the trust fund described in this Section, (b) the Company’s obligations with respect to such series of Securities
concerning issuing temporary Securities, registration of transfer or exchange of such series of Securities, mutilated, destroyed, lost
or stolen Securities of such series and the maintenance of an office or agency for payments, (c) the rights, powers, trust, duties and
immunities of the Trustee and the Company’s obligations in connection therewith and (d) the Legal Defeasance provisions of this
Indenture. In addition, the Company may, at its option and at any time, elect to have the obligations of the Company released with respect
to covenants provided with respect to such series of Securities under Section 2.01(16), 9.01(4) and 9.01(7) of this Indenture (“Covenant
Defeasance”) and thereafter any omission to comply with such obligations shall not constitute a Default or Event of Default with
respect to such series of Securities. In the event of Covenant Defeasance, those events described under Section 6.01(a) with respect to
the foregoing covenants will no longer constitute an Event of Default with respect to such series of Securities.
In order to exercise either
Legal Defeasance or Covenant Defeasance:
(1) the Company must irrevocably
deposit with the Trustee, in trust, for the benefit of the Holders of such series, (A) moneys in an amount, or (B) noncallable Governmental
Obligations the scheduled principal of and interest on which in accordance with their terms will provide, not later than the due date
of any payment, money in an amount, or (C) a combination thereof, sufficient, in the case of (B) or (C), in the opinion of a nationally
recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge,
at maturity or upon redemption, the principal of (and premium, if any) and interest on such series of Securities on the stated date for
payment thereof or on the applicable redemption date, as the case may be;
(2) in the case of Legal Defeasance,
the Company shall have delivered to the Trustee an Opinion of Counsel confirming that (A) the Company has received from, or there has
been published by, the Internal Revenue Service a ruling or (B) since the date of this Indenture, there has been a change in the applicable
federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of
such series of Securities will not recognize income, gain or loss for federal income tax purposes as a result of such Legal Defeasance
and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if
such Legal Defeasance had not occurred;
(3) in the case of Covenant
Defeasance, the Company shall have delivered to the Trustee an Opinion of Counsel confirming that the Holders of such series of Securities
will not recognize income, gain or loss for federal income tax purposes as a result of such Covenant Defeasance and will be subject to
federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance
had not occurred;
(4) no Default or Event of
Default shall have occurred and be continuing on the date of such deposit or insofar as Events of Default under clauses (4) and (5) of
Section 6.01(a) with respect to the Securities of such series are concerned, at any time in the period ending on the 91st day after the
date of deposit;
(5) the Company shall have
delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent provided
for or relating to the Legal Defeasance or the Covenant Defeasance, as the case may be, have been complied with; and
(6) if such series of Securities
are to be redeemed prior to final maturity (other than from mandatory sinking fund payments or analogous payments), notice of such redemption
shall have been duly given pursuant to this Indenture or provision therefor satisfactory to the Trustee shall have been made.
SECTION 11.03 DEPOSITED MONEYS TO BE HELD
IN TRUST.
All moneys or Governmental
Obligations deposited with the Trustee pursuant to Sections 11.01 or 11.02 shall be held in trust and shall be available for payment as
due, either directly or through any paying agent (including the Company acting as its own paying agent), to the Holders of the particular
series of Securities for the payment or redemption of which such moneys or Governmental Obligations have been deposited with the Trustee.
Funds held pursuant to this Section with respect to any series of Securities shall not be subject to the claims of the holders of Senior
Indebtedness with respect to such series, provided, that at the time of the deposit of such funds with the Trustee under this Article,
no event had occurred that would, under the subordination provisions related to such series, require that any payment to be made to the
holders of such Securities be paid or paid over to the holders of such Senior Indebtedness.
SECTION 11.04 PAYMENT OF MONEYS HELD BY PAYING
AGENTS.
In connection with the satisfaction
and discharge of this Indenture all moneys or Governmental Obligations then held by any paying agent under the provisions of this Indenture
shall, upon demand of the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability
with respect to such moneys or Governmental Obligations.
SECTION 11.05 REPAYMENT TO COMPANY.
Any moneys or Governmental
Obligations deposited with any paying agent or the Trustee, or then held by the Company, in trust for payment of principal of (or premium,
if any) or interest on the Securities of a particular series that are not applied but remain unclaimed by the Holders of such Securities
for at least two years after the date upon which the principal of (and premium, if any) or interest on such Securities shall have respectively
become due and payable, shall be repaid to the Company on May 31 of each year or (if then held by the Company) shall be discharged from
such trust; and thereupon the paying agent and the Trustee shall be released from all further liability with respect to such moneys or
Governmental Obligations, and the Holder of any of the Securities entitled to receive such payment shall thereafter, as an unsecured general
creditor, look only to the Company for the payment thereof.
ARTICLE XII
IMMUNITY OF INCORPORATORS, SHAREHOLDERS,
OFFICERS AND DIRECTORS
SECTION 12.01 NO RECOURSE.
No recourse under or upon
any obligation, covenant or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof,
shall be had against any incorporator, shareholder, officer or director, past, present or future as such, of the Company or of any predecessor
or successor entity, either directly or through the Company or any such predecessor or successor entity, whether by virtue of any constitution,
statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Indenture
and the obligations issued hereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or
is or shall be incurred by, the incorporators, shareholders, officers or directors as such, of the Company or of any predecessor or successor
entity, or any of them, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants
or agreements contained in this Indenture or in any of the Securities or implied therefrom; and that any and all such personal liability
of every name and nature, either at common law or in equity or by constitution or statute, of, and any and all such rights and claims
against, every such incorporator, shareholder, officer or director as such, because of the creation of the indebtedness hereby authorized,
or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom,
are hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issuance
of such Securities.
ARTICLE XIII
MISCELLANEOUS PROVISIONS
SECTION 13.01 EFFECT ON SUCCESSORS AND ASSIGNS.
All the covenants, stipulations,
promises and agreements in this Indenture contained by or on behalf of the Company shall bind its successors and assigns, whether so expressed
or not.
SECTION 13.02 ACTIONS BY SUCCESSOR.
Any act or proceeding by any
provision of this Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and
may be done and performed with like force and effect by the corresponding board, committee or officer of any entity that shall at the
time be the lawful successor of the Company.
SECTION 13.03 SURRENDER OF COMPANY POWERS.
The Company by instrument in
writing executed by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to the Company,
and thereupon such power so surrendered shall terminate both as to the Company and as to any successor entity.
SECTION 13.04 NOTICES.
Except as otherwise expressly
provided herein, any notice or demand that by any provision of this Indenture is required or permitted to be given or served by the Trustee
or by the Holders of Securities to or on the Company may be given or served by being deposited first class postage prepaid in a post-office
letterbox addressed (until another address is filed in writing by the Company with the Trustee), as follows: 10 Earlsfort Terrace, Dublin
2, D02 T380, Ireland. Any notice, election, request or demand by the Company or any Securityholder to or upon the Trustee shall be deemed
to have been sufficiently given or made, for all purposes, if given or made in writing at the Corporate Trust Office of the Trustee.
SECTION 13.05 GOVERNING LAW; WAIVER OF TRIAL
BY JURY.
This Indenture and each Security
shall be deemed to be a contract made under the internal laws of the State of [____________], and for all purposes shall be construed
in accordance with the laws of said State.
EACH PARTY HERETO, AND EACH
HOLDER OF A SECURITY BY ACCEPTANCE THEREOF, HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO
A TRIAL BY JURY IN RESPECT OF ANY LITIGATION RELATING TO THE TRUSTEE DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH
THIS INDENTURE
SECTION 13.06 TREATMENT OF SECURITIES AS DEBT.
It is intended that the Securities
will be treated as indebtedness and not as equity for federal income tax purposes. The provisions of this Indenture shall be interpreted
to further this intention.
SECTION 13.07 COMPLIANCE CERTIFICATES AND OPINIONS.
(a) Upon any application or
demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall furnish to the
Trustee an Officers’ Certificate stating that all conditions precedent provided for in this Indenture relating to the proposed action
have been complied with and an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been
complied with, except that in the case of any such application or demand as to which the furnishing of such documents is specifically
required by any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need
be furnished.
(b) Each certificate or opinion
provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or covenant in this Indenture
shall include
(1) a statement that the
Person making such certificate or opinion has read such covenant or condition;
(2) a brief statement as
to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion
are based;
(3) a statement that, in
the opinion of such Person, he has made such examination or investigation as is necessary to enable him to express an informed opinion
as to whether or not such covenant or condition has been complied with; and
(4) a statement as to whether
or not, in the opinion of such Person, such condition or covenant has been complied with.
SECTION 13.08 PAYMENTS ON BUSINESS DAYS.
Except as provided pursuant
to Section 2.01, by or pursuant to a Board Resolution, and as set forth in an Officers’ Certificate or established in one or more
indentures supplemental to this Indenture, in any case where the date of maturity of interest or principal of any Security or the date
of redemption of any Security shall not be a Business Day, then payment of interest or principal (and premium, if any) may be made on
the next succeeding Business Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest
shall accrue for the period after such nominal date.
SECTION 13.09 CONFLICT WITH TRUST INDENTURE
ACT.
If and to the extent that
any provision of this Indenture limits, qualifies or conflicts with the duties imposed by Sections 310 to 317, inclusive, of the Trust
Indenture Act, such imposed duties shall control. If any provision of this Indenture modifies or excludes any provision of the Trust Indenture
Act which may be so modified or excluded, the latter provision shall be deemed to apply to this Indenture as so modified or to be excluded,
as the case may be.
SECTION 13.10 COUNTERPARTS.
This Indenture may be executed
in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same
instrument.
SECTION 13.11 SEPARABILITY.
In case any one or more of
the provisions contained in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable
in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Indenture or of such Securities,
but this Indenture and such Securities shall be construed as if such invalid or illegal or unenforceable provision had never been contained
herein or therein.
SECTION 13.12 ASSIGNMENT.
The Company will have the
right at all times to assign any of its rights or obligations under this Indenture to a direct or indirect wholly-owned Subsidiary of
the Company, provided that, in the event of any such assignment, the Company, will remain liable for all such obligations. Subject to
the foregoing, the Indenture is binding upon and inures to the benefit of the parties thereto and their respective successors and assigns.
This Indenture may not otherwise be assigned by the parties thereto.
ARTICLE XIV
SUBORDINATION OF SECURITIES
SECTION 14.01 SUBORDINATION TERMS.
The payment by the Company
of the principal of, premium, if any, and interest on any series of Securities issued hereunder shall be subordinated to the extent set
forth in an indenture supplemental hereto relating to such securities.
[signature page follows]
IN WITNESS WHEREOF, the parties
hereto have caused this Indenture to be duly executed all as of the day and year first above written.
|
ADS-TEC ENERGY PLC |
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
|
|
|
_______________, as Trustee |
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
Exhibit 5.1
Our Reference: AD107-031
11 February 2025
PRIVATE AND CONFIDENTIAL
To: |
The Directors
ads-tec Energy plc (the “Company”)
10 Earlsfort Terrace
Dublin 2
D02 T380
Ireland |
Dear Sirs,
| 1.1 | We have acted as solicitors in Ireland for the Company, a public limited company organised under the laws
of Ireland with registration number 669283 in connection with the preparation of a registration statement on Form F-3 in the form of a
“shelf” registration (the “Registration Statement”) and the prospectuses contained therein filed by the
Company with the United States Securities and Exchange Commission (the “SEC”) under the Securities Act 1933, as amended
(the “Securities Act”) relating to the registration by the Company of (i) up to US$250,000,000 of an indeterminate
number of ordinary shares of $0.0001 each in the capital of the Company (“Ordinary Shares”), preferred shares of $0.0001
each in the capital of the Company (the “Preferred Shares”), senior and subordinated debt securities to be issued in
one or more series under a senior indenture or subordinated indenture, each in the forms filed as exhibits to the Registration Statement,
as the same may be supplemented from time to time, (the “Debt Securities”),warrants to purchase Ordinary Shares or
any of the securities offered by the Registration Statement (the “Warrants”), rights to purchase Ordinary Shares, Preferred
Shares, and/or Debt Securities (the “Rights”), purchase contracts in respect of a specific or variable number of Ordinary
Shares, Preferred Shares, Debts Securities, Warrants or Rights (the “Purchase Contracts”) (the “Shelf Securities”,
of which any shares being the “Shelf Shares”), and units comprised of any combination of the foregoing for sale from
time to time in one or more offerings (the “Units” and together with the Ordinary Shares, the Preferred Shares, the
Warrants, the Debt Securities, the Rights, and the Purchase Contracts, the “Shelf Securities”) and, (ii) the offer
and sale of up to 10,516,670 ordinary shares in the capital of the Company issuable upon the exercise by certain third parties of certain
warrants (the “Second Prospectus Warrants”) to purchase ordinary shares in the Company (the “Warrant Shares”
collectively, with the Shelf Securities, the “Securities”). |
| 1.2 | This opinion is solely for the benefit of the addressee of this Opinion and may not be relied upon, used,
transmitted, referred to, quoted from, circulated, copied, filed with any governmental agency or authority, disseminated or disclosed
by or to any other person or entity for any purpose(s) without our prior written consent. However, we hereby consent to the filing of
this Opinion as an exhibit to the Registration Statement. In giving this consent, we do not hereby admit that we are within the category
of persons whose consent is required within Section 7 of the Act or the rules and requisitions of the SEC thereunder. |
| 1.3 | This Opinion is given on the basis that our client is the Company. For the purposes of giving this Opinion,
we have taken instructions solely from that client. |
| 1.4 | This Opinion is confined to and given in all respects of the basis of the laws of Ireland (meaning Ireland
exclusive of Northern Ireland) in force as at the date hereof as currently applied by the courts of Ireland. |
| 1.5 | We have made no investigations of and we express no opinion as to the laws of any other jurisdiction or
the effect thereof. In particular, we express no opinion on the laws of the European Union as they affect any jurisdiction other than
Ireland. We have assumed without investigation that insofar as the laws of any jurisdiction other than Ireland are relevant, such laws
do not prohibit and are not inconsistent with any of obligations or rights expressed in the Registration Statement or the transactions
contemplated thereby. |
| 1.6 | This Opinion is strictly confined to: |
| (a) | the matters expressly stated herein and is not to read as extending by implication or otherwise to any
other matter; and |
| (b) | the Registration Statement (and no other document whatsoever) and the searches listed in paragraph 1.10
below (the “Searches”) (and no other searches whatsoever), |
and is subject to the assumptions and
qualifications set out below.
| 1.7 | We express no opinion and make no representation or warranty, as to any matter of fact or in respect of
any documents which may exist in relation to the filing of the Registration Statement. |
| 1.8 | In giving this Opinion, we have relied upon the Corporate Certificate and the Searches and we give this
Opinion expressly on the terms that no further investigation or diligence in respect of any matter referred to in the Corporate Certificate
or the Searches is required of us. |
| 1.9 | For the purposes of this Opinion, we have reviewed: |
| (a) | a corporate certificate dated 10 February 2025, executed for and on behalf of the Company (the “Corporate
Certificate”); |
| (b) | a copy of the resolutions of the board of directors of the dated 10 February 2025; |
| (d) | a draft of the Registration Statement (excluding exhibits save for the form of Indentures) sent to us
by email by a representative of Reed Smith LLP on 11 February 2025. |
| 1.10 | For the purpose of giving this Opinion, we have caused to be made the following legal searches against
the Company on 11 February 2025: |
| (a) | on the file of the Company maintained by the Registrar of Companies in the CRO for mortgages, debentures
or similar charges or notices thereof and for the appointment of any receiver, examiner or liquidator; |
| (b) | in the Judgments Office of the High Court for unsatisfied judgments, orders, decrees and the like for
the twelve years immediately preceding the date of the search; |
| (c) | in the Central Office of the High Court for any proceedings or petitions filed in respect of the Company
in the last two years; and |
| (d) | on the register of persons disqualified or restricted from acting as directors of companies incorporated
in Ireland which is maintained by the Registrar of Companies in the CRO against the names of the current directors and secretary of the
Company as identified in the search results referred to in paragraph (a) above. |
| 1.11 | This Opinion is governed by and is to be construed in accordance with the laws of Ireland (as interpreted
by the courts of Ireland at the date hereof) and anyone seeking to rely on this Opinion agrees, for our benefit, that the Courts of Ireland
shall have exclusive jurisdiction to settle any dispute arising out of, or in connection with, this Opinion. This Opinion speaks only
as of its date. We assume no obligation to update this Opinion at any time or to advise the addressee of this Opinion of any change in
law or change in interpretation of law which may occur after the date of this Opinion. |
| 1.12 | No opinion is expressed on the taxation consequences of the Registration Statement and any of the matters
contemplated thereby. |
Subject to the assumptions and qualifications
set out in this Opinion, we are of the opinion that:
| 2.1 | The Company is a public limited company and is duly incorporated and validly existing under the laws of
Ireland and as such is required as a matter of Irish company law to maintain its registered office in Ireland. |
| 2.2 | The Shelf Shares, when (a) issued and allotted in accordance with all necessary corporate action of the
Company, (b) issued, sold and paid for as contemplated in the Registration Statement, Prospectus Supplement (as defined below) and any
applicable Securities Agreement (as defined below), and (c)registered in the register of members of the Company, shall be validly issued,
fully paid up and non-assessable (which term means that no further sums are required to be paid to the holders thereof in connection with
the issuance of such Shelf Shares). |
| 2.3 | The Debt Securities, Warrants, Rights, Purchase Contracts and Units, when (a) issued in accordance with
all necessary corporate action of the Company, (b) issued, sold and paid for as contemplated in the Registration Statement, Prospectus
Supplement (as defined below) and any applicable Securities Agreement (as defined below), (c) if appropriate, authenticated in the manner
set forth in the applicable Securities Agreement, and (d) the applicable Securities Agreement has been duly authorised, executed and delivered
by the Company and the other parties thereto, will be duly authorised and validly issued. |
| 2.4 | The Company has the requisite corporate capacity to issue the Shelf Securities. |
| 2.5 | The Warrant Shares have been duly authorised and upon payment in full being made therefor and, upon the
exercise of the Second Prospectus Warrants, any such Warrant Shares being entered as fully paid on the register of members of the Company,
will be validly issued, fully paid or credited as fully paid, and non-assessable (which term means that no further sums are required to
be paid by the holders thereof in connection with the issue of the Warrant Shares). |
| 2.6 | The Company has the requisite corporate authority to issue the Second Prospectus Warrants to purchase
the Warrant Shares and therefore has the requisite authority to be the issuer of the Second Prospectus Warrants. |
For the purpose of giving this Opinion
we assume the following, without any responsibility on our part if any assumption proves to have been untrue as we have not verified independently
any assumption:
Authenticity and bona fides
| 3.1 | The truth, completeness, accuracy and authenticity of all copy letters, resolutions, certificates, permissions,
minutes, authorisations and all other documents of any kind submitted to us as originals or copies of originals, and (in the case of copies)
conformity to the originals of copy documents, the genuineness of all signatures (electronic or otherwise), stamps and seals thereon,
that any signatures (electronic or otherwise) are the signatures of the persons who they purport to be, that each witness to a signature
actually witnessed that signature, and that each original was executed in the manner appearing on the copy. |
| 3.2 | That the register of members of the Company is up to date and has been correctly completed in accordance
with the Constitution and the Companies Act 2014 (the “2014 Act”). That, where an incomplete Registration Statement
has been submitted to us, the original of such Registration Statement corresponds in all respects with the last or final draft of the
complete Registration Statement submitted to us. |
| 3.3 | That the copies produced to us of minutes of meetings and/or of resolutions correctly record the proceedings
at such meetings and/or the subject matter which they purport to record and that any meetings referred to in such copies were duly convened,
duly quorate and held, that those present at any such meetings were entitled to attend and vote at the meeting and acted bona fide throughout
and that no further resolutions have been passed or corporate or other action taken which would or might alter the effectiveness thereof
and that such resolutions (whether passed at a meeting or by way of written resolution) have not been amended or rescinded and are in
full force and effect. |
| 3.4 | That each director of the Company has disclosed any interest which he may have in the transactions contemplated
by the Registration Statement in accordance with the provisions of the 2014 Act and the Constitution and none of the directors of the
Company has any interest in such transactions except to the extent permitted by the Constitution. |
| 3.5 | The absence of fraud, coercion, duress or undue influence and lack of bad faith on the part of the parties
to the documents and their respective officers, employees, agents and (with the exception of Arthur Cox LLP) advisers. |
Restrictions and Disqualifications
| 3.6 | That, based only on the Searches, no person who has been appointed or acts in any way, whether directly
or indirectly, as a director or secretary of, or who has been concerned in or taken part in the promotion of, the Company has: |
| (a) | been the subject of any declaration, order or deemed order for disqualification or restriction under the
2014 Act (including Part 14, Chapters 3 and 4 thereof) or any analogous legislation; or |
| (b) | received any notice under the 2014 Act (including Part 14, Chapter 5 thereof) or any analogous legislation
regarding a disqualification or restriction undertaking. |
Accuracy of Searches and the Corporate
Certificate
| 3.7 | The accuracy and completeness of the information disclosed in the Searches and that such information is
accurate as of the date of this Opinion and has not since the time of such Search been altered. In this connection, it should be noted
that: |
| (a) | the matters disclosed in the Searches may not present a complete summary of the actual position on the
matters we have caused searches to be conducted for; |
| (b) | the position reflected by the Searches may not be fully up-to-date; and |
| (c) | searches at the CRO do not necessarily reveal whether or not a prior charge has been created or a resolution
has been passed or a petition presented or any other action taken for the winding-up of, or the appointment of a receiver or an examiner
to, the Company or its assets. |
| 3.8 | The truth, completeness and accuracy of all representations and statements as to factual matters contained
in the Corporate Certificate at the time they were made and at all times thereafter. |
No other information and compliance
| 3.9 | That the Registration Statement and the documents contemplated therein and the forms attached as exhibits
thereto relating to the issuance and sale of the Securities are the only documents relating to the subject matter of this transaction
and that there are no agreements or arrangements in existence between the parties to the documents contemplated by the Registration Statement
which in any way amend or vary the terms of the Registration Statement or in any way bear upon or are inconsistent with the opinions stated
herein. |
Authority, Capacity, Execution and
Enforceability
| 3.10 | The filing of the Registration Statement and the issuance and sale of the Securities (i) does and will
not contravene the laws of any jurisdiction outside Ireland; (ii) does not and will not result in any breach of any agreement, instrument
and obligation to which any party thereto is a party and (iii) will not be illegal or unenforceable by virtue of the laws of that jurisdiction. |
| 3.11 | That the Securities will be issued and sold in the manner contemplated in the Registration Statement. |
| 3.12 | That, at the time of the issuance and sale of any of the Securities, the effectiveness of the Registration
Statement (including any post-effective amendments) shall not have been terminated or rescinded. |
| 3.13 | That the Company will deliver and file an appropriate prospectus supplement with respect to an offering
of the Shelf Securities in compliance with the Act and the applicable rules and regulations (the “Prospectus Supplement”). |
| 3.14 | That any document recording the authorisation of the transactions contemplated by the Registration Statement,
including any issue of Shelf Shares or Warrant Shares, is a true, complete and accurate record of an authorisation which is valid in all
respects. |
| 3.15 | That all authorisations, approvals or licences required under any law for any party (other than the Company)
to enter into or to perform any of its obligations under a transaction contemplated by the Registration Statement have been obtained,
remain valid and subsisting and have been complied with. |
| 3.16 | That no law or official directive of any jurisdiction, other than the laws of Ireland, affects any of
the opinions expressed. |
| 3.17 | That, insofar as any obligation under any document examined is to be performed in any jurisdiction other
than Ireland, its performance will not be illegal or unenforceable under the law of that jurisdiction. |
| 3.18 | That he formalities for execution required by the law of the place of execution of each document examined
have or will be complied with. |
| 3.19 | That the Company will comply with its obligations under, and the representations and warranties contained
in the documents referred to in, the Registration Statement. |
Shares
| 3.20 | That the rights attaching to the Shelf Shares or Warrant Shares will be validly determined prior to their
issue in accordance with the Constitution and the 2014 Act. |
| 3.21 | That the board of directors of the Company will approve the allotment and issue of the Shelf Shares or
Warrant Shares in accordance with the Constitution and the 2014 Act and such Shelf Shares or Warrant Shares will be issued in compliance
with the Constitution and the 2014 Act. |
| 3.22 | That at the time of the execution and delivery of any definitive purchase, underwriting or similar agreement
between the Company and any third party under which any Shelf Securities may be issued (the “Securities Agreement”),
the Securities Agreement will be the valid and legally binding obligation of such third party, enforceable against such third party in
accordance with its terms. That, upon issue, each holder of Shelf Securities and the Shelf Shares will have fully paid the amount payable
to the Company for their Shelf Securities and the Shelf Shares. |
| 3.23 | That, upon issue, the Shelf Shares or Warrant Shares will be duly registered and will continue to be registered
in the Company’s register of members. |
| 3.24 | That any issue of the Shelf Shares or Warrant Shares will be in compliance with the 2014 Act, the Takeover
Panel Act, 1997, Takeover Rules, 2013 of Ireland (as may be amended), and all other applicable Irish company, takeover, securities, market
abuse, insider dealing laws and other rules and regulations. |
Solvency and Insolvency
| (a) | the Company was not unable to pay its debts within the meaning of Sections 509(3) and 570 of the 2014
Act or any analogous provisions under any applicable laws immediately after the filing of the Registration Statement; and |
| (b) | the Company will not as a consequence of doing any act or thing which the Registration Statement contemplates,
permits or requires the relevant party to do, be unable to pay its debts within the meaning of such Sections or any analogous provision
under any applicable laws. |
| 3.26 | That, upon the opening of any insolvency proceedings pursuant to Regulation (EU) 2015/848 of the European
Parliament and of the Council of 20 May 2015 on insolvency proceedings (recast) (the “Recast EU Insolvency Regulation”),
the Company will have its “centre of main interests” (as that term is used in Article 3(1) of the Recast EU Insolvency Regulation)
in Ireland being the jurisdiction in which the Company has its registered office and will not have an “establishment” (being
any place of operations where a debtor carries out or has carried out in the 3-month period prior to the request to open main insolvency
proceedings a non-transitory economic activity with human means and assets) as defined in Article 2(10) of the Recast EU Insolvency Regulation
outside Ireland. |
The opinions set out in this Opinion
are subject to the following reservations:
Enforcement and binding effect
| 4.1 | The description of obligations in this Opinion as “enforceable” refers to the legal character
of the obligations assumed by the relevant party under the relevant instrument. It implies no more than the obligations are of a character
which the laws of Ireland recognise and will in certain circumstances enforce. In particular, it does not mean or imply that the relevant
instrument will be enforced in all circumstances in accordance with its terms or by or against third parties or that any particular remedy
will be available. In particular (without limiting the foregoing): |
| (a) | the binding effect and enforceability of the obligations of the Company contemplated under any of the
Securities may be limited by liquidation, insolvency, bankruptcy, receivership, court protection, examinership, moratoria, reorganisation,
reconstruction, company voluntary arrangements, fraud of creditors, fraudulent preference of creditors or similar laws whether in Ireland
or elsewhere affecting creditors’ rights generally; |
| (b) | the binding effect and enforceability of the obligations of the Company under any of the Securities may
also be limited as a result of the provisions of the laws of Ireland applicable to contracts held to have become frustrated by events
happening after their execution, and any breach of the terms of any document by the party seeking to enforce such document; |
| (c) | enforcement may be limited by general principles of equity. In particular, equitable remedies are not
available where damages are considered to be an adequate remedy; the remedy of specific performance is discretionary and will not normally
be ordered in respect of a monetary obligation; and injunctions are granted only on a discretionary basis and accordingly we express no
opinion on such matters; |
| (d) | claims may become barred under the Statute of Limitations 1957 or may be or become subject to the defence
of set-off or counterclaim; |
| (e) | enforcement will be subject to, netting, claims and attachment and any other rights of another party to
a contract; and |
| (f) | enforcement may be limited by reason of fraud. |
| 4.2 | Where any obligations of any person are to be performed in jurisdictions outside Ireland, such obligations
may not be enforceable under Irish law to the extent that performance thereof would be illegal under the laws of any such jurisdiction
or contrary to public policy under the laws of any such jurisdiction and an Irish court may take into account the law of the place of
performance in relation to the manner of performance and to the steps to be taken in the event of defective performance. |
| 4.3 | Where a judgment creditor seeks to enforce his judgment, he can only do so in accordance with the applicable
rules of Irish courts. The making of an execution order against particular assets, such as a charging order over land or a beneficial
interest therein or most types of investment or a third party debt order over a bank account or certain other debts, is a matter for the
Court’s discretion. |
General Matters
| 4.4 | A determination or a certificate as to any matter provided for in any of the Securities may be held by
an Irish court not to be final, conclusive or binding if such determination or certificate could be shown to have an unreasonable, incorrect
or arbitrary basis or not to have been given or made in good faith. |
| 4.5 | Where a party to any of the Securities is vested with a discretion or may determine a matter in its opinion,
Irish law may require that such discretion is exercised reasonably or that such opinion is based upon reasonable grounds. |
| 4.6 | A particular course of dealing among the parties or an oral amendment, variation or waiver may result
in an Irish court finding that the terms of any of the Securities have been amended, varied or waived even if such course of dealing or
oral amendment, variation or waiver is not reflected in writing among the parties. |
| 4.7 | The effectiveness of the provisions any of the Securities excusing a party from a liability or duty otherwise
owed are limited by Irish law, particularly in relation to a fundamental breach of the contract. |
| 4.8 | We express no opinion as to any obligation which any of the Securities may purport to establish in favour
of any person who is not a party thereto. |
| 4.9 | Any provision of any of the Securities which constitutes, or purports to constitute, a restriction on
the exercise of any statutory power by any party thereto or any other person may be ineffective. |
| 4.10 | To the extent that any matter is expressly to be determined by future agreement or negotiation, the relevant
provision may be unenforceable or void for uncertainty. |
Yours faithfully,
/s/ Arthur Cox LLP
ARTHUR COX LLP
8
Exhibit
5.2

|
Reed
Smith LLP |
599 Lexington
Avenue |
New York,
NY 10022 |
+212 521
5400 |
Fax +1 212
521 5450 |
reedsmith.com |
February
11, 2025
ADS-TEC Energy
PLC
10 Earlsford
Terrace
Dublin 2,
D02 T380, Ireland
Re: Registration
Statement on Form F-3
Ladies and
Gentlemen:
We
have acted as special counsel for ADS-TEC Energy PLC, a public company limited by shares (the “Company”), in connection
with the Company’s filing with the Securities and Exchange Commission of a Registration Statement on Form F-3 (as amended, the
“Registration Statement”) for the purpose of registering under the Securities Act of 1933, as amended (the
“Securities Act”), (a) ordinary shares, nominal value $0.0001 per share, of the Company (the “Ordinary
Shares”); (b) preferred shares, nominal value $0.0001 per share, of the Company (the “Preferred Shares”); (c)
senior debt securities and subordinated debt securities of the Company (collectively, the “Debt Securities”), which may
be issued under one or more senior debt indentures (each, a “Senior Indenture”), between the Company and the trustee to
be named therein (the “Senior Debt Trustee”), and a subordinated debt indenture (each, a “Subordinated
Indenture” and, together with the Senior Indentures, the “Indentures”), between the Company and the trustee to be
named therein (the “Subordinated Debt Trustee” and, together with the Senior Debt Trustee, the “Trustees”);
(d) warrants of the Company (the “Warrants”), which may be issued under one or more warrant agreements (each, a
“Warrant Agreement”), between the Company and the warrant agent to be named therein (the “Warrant Agent”);
(e) rights to purchase Ordinary Shares, Preferred Shares and/or Debt Securities (the “Rights”), which may be issued
under one or more rights agreements (each, a “Rights Agreement”), between the Company and the rights agent to be named
therein (the “Rights Agent”); (f) purchase contracts of the Company (the “Purchase Contracts”), which may be
issued under one or more purchase contract agreements (each, a “Purchase Contract Agreement”), between the Company and
the purchase contract agent to be named therein (the “Purchase Contract Agent”); and (g) units of the Company (the
“Units”), which may be issued under one or more unit agreements (each, a “Unit Agreement”), by and among the
Company, a bank or trust company, as unit agent to be named therein (the “Unit Agent”), and the holders from time to
time of the Units. This opinion letter is furnished to you at your request to enable you to fulfill the requirements of Item 601(b)(5) of Regulation S-K,
17 C.F.R. Sec. 229.601(b)(5), in connection with the Registration Statement.
We,
as your counsel, have examined originals or copies of such documents, corporate records, certificates of public officials and other instruments
as we have deemed necessary or advisable for the purpose of rendering this opinion.
In
rendering the opinions expressed herein, we have, without independent inquiry or investigation, assumed that (i) all documents submitted
to us as originals are authentic and complete, (ii) all documents submitted to us as copies conform to authentic, complete originals,
(iii) all documents filed as exhibits to the Registration Statement that have not been executed will conform to the forms thereof, (iv)
all signatures on all documents that we reviewed are genuine, (v) all natural persons executing documents had and have the legal capacity
to do so, (vi) all statements in certificates of public officials and officers of the Company that we reviewed were and are accurate
and (vii) all representations made by the Company as to matters of fact in the documents that we reviewed were and are accurate.
ABU
DHABI ♦ ASTANA ♦ ATHENS ♦ AUSTIN ♦ BEIJING ♦ BRUSSELS ♦ CENTURY CITY ♦ CHICAGO ♦ DALLAS
♦ DUBAI ♦ FRANKFURT ♦ HONG KONG
HOUSTON ♦ LONDON ♦ LOS ANGELES ♦ MIAMI ♦ MUNICH ♦
NEW YORK ♦ ORANGE COUNTY ♦ PARIS ♦ PHILADELPHIA ♦ PITTSBURGH
PRINCETON ♦ RICHMOND ♦ SAN FRANCISCO
♦ SHANGHAI ♦ SILICON VALLEY ♦ SINGAPORE ♦ TYSONS ♦ WASHINGTON, D.C. ♦ WILMINGTON
ADS-TEC Energy
PLC
February
11, 2025
Page 2
Based
upon the foregoing, and subject to the additional assumptions and qualifications set forth below, we advise you that, in our opinion:
|
1. |
When the applicable Indenture
and any supplemental indenture to be entered into in connection with the issuance of any Debt Securities has been duly authorized,
executed and delivered by the applicable Trustee and the Company; the specific terms of a particular series of Debt Securities have
been duly authorized and established in accordance with such Indenture; and such Debt Securities have been duly authorized, executed,
authenticated, issued and delivered in accordance with the Indenture and the applicable underwriting or other agreement against payment
therefor, such Debt Securities will constitute valid and binding obligations of the Company, enforceable in accordance with their
terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness
and equitable principles of general applicability, provided that we express no opinion as to (w) the enforceability of any waiver
of rights under any usury or stay law, (x) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable
law on the conclusions expressed above, (y) the validity, legally binding effect or enforceability of any section of the applicable
Indenture that requires or relates to adjustments to the conversion rate at a rate or in an amount that a court would determine in
the circumstances under applicable law to be commercially unreasonable or a penalty or forfeiture or (z) the validity, legally binding
effect or enforceability of any provision that permits holders to collect any portion of stated principal amount upon acceleration
of the Debt Securities to the extent determined to constitute unearned interest. |
|
2. |
When the Warrant Agreement
to be entered into in connection with the issuance of any Warrants has been duly authorized, executed and delivered by the Warrant
Agent and the Company; the specific terms of the Warrants have been duly authorized and established in accordance with the Warrant
Agreement; and such Warrants have been duly authorized, executed, issued and delivered in accordance with the Warrant Agreement and
the applicable underwriting or other agreement against payment therefor, such Warrants will constitute valid and binding obligations
of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting
creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability. |
|
3. |
When the Purchase Contract
Agreement to be entered into in connection with the issuance of any Purchase Contracts has been duly authorized, executed and delivered
by the Purchase Contract Agent and the Company; the specific terms of the Purchase Contracts have been duly authorized and established
in accordance with the Purchase Contract Agreement; and such Purchase Contracts have been duly authorized, executed, issued and delivered
in accordance with the Purchase Contract Agreement and the applicable underwriting or other agreement against payment therefor, such
Purchase Contracts will constitute valid and binding obligations of the Company, enforceable in accordance with their terms, subject
to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and
equitable principles of general applicability. |
|
4. |
When the Unit Agreement
to be entered into in connection with the issuance of any Units has been duly authorized, executed and delivered by the Unit Agent
and the Company; the specific terms of the Units have been duly authorized and established in accordance with the Unit Agreement;
and such Units have been duly authorized, executed, issued and delivered in accordance with the Unit Agreement and the applicable
underwriting or other agreement against payment therefor, such Units will constitute valid and binding obligations of the Company,
enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’
rights generally, concepts of reasonableness and equitable principles of general applicability. |
In
connection with the opinions expressed above, we have assumed that, at or prior to the time of the delivery of any such security, (i)
the Board of Directors of the Company, as required under Irish law, shall have duly established the terms of such security (and that
such security is governed by the laws of the State of New York) and duly authorized the issuance and sale of such security and such authorization
shall not have been modified or rescinded; (ii) the Company is, and shall remain, validly existing as a corporation in good standing
(to the extent such concept exists) under the laws of Ireland; (iii) the Registration Statement shall have been declared effective and
such effectiveness shall not have been terminated or rescinded; (iv) the applicable Indenture, Debt Securities, Warrant Agreement, Purchase
Contract Agreement, and Unit Agreement are each valid, binding and enforceable agreements of each party thereto (other than as expressly
covered above in respect of the Company); and (v) there shall not have occurred any change in law affecting the validity or enforceability
of such security. We have also assumed that the execution, delivery and performance by the Company of any Debt Security whose terms are
established subsequent to the date hereof (a) are within its corporate powers, (b) do not contravene, or constitute a default under,
the articles of association or other constitutive documents of the Company, (c) require no action by or in respect of, or filing with,
any governmental body, agency or official and (d) do not contravene, or constitute a default under public policy, any provision of applicable
law or regulation or any judgment, injunction, order or decree or any agreement or other instrument binding upon the Company.
ADS-TEC Energy
PLC
February
11, 2025
Page 3
We
are members of the Bar of the State of New York and the foregoing opinion is limited to the laws of the State of New York. Insofar as
the foregoing opinion involves matters governed by the laws of Ireland, we have relied, without independent inquiry or investigation,
on the opinion of Arthur Cox delivered to you today.
We
hereby consent to the filing of this opinion as an exhibit to the Registration Statement referred to above and further consent to the
reference to our name under the caption “Legal Matters” in the prospectus, which is a part of the Registration Statement.
In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities
Act.
|
Very truly yours, |
|
|
|
REED SMITH LLP |
|
|
|
REED SMITH LLP |
|
a Limited Liability Partnership |
Exhibit 23.2
Ads-Tec Energy PLC
10 Earlsfort Terrace
Dublin 2, D02 T380
Ireland
Consent of Independent Registered Public
Accounting Firm
We hereby consent to the incorporation by
reference in the Prospectus constituting a part of this Registration Statement of our report dated April 30, 2024, relating to the consolidated
financial statements of Ads-Tec Energy PLC (the Company) appearing in the Company’s Annual Report on Form 20-F for the year ended
December 31, 2023. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the
caption “Experts” in the Prospectus.
Very truly yours,
/s/ BDO AG Wirtschaftsprüfungsgesellschaft
BDO AG Wirtschaftsprüfungsgesellschaft
Frankfurt am Main, Germany
February 11, 2025
Chairman
of the Supervisory Board: Dr. Holger Otte ● Executive Board: WP StB Andrea Bruckner and RA Parwäz Rafiqpoor (Chairpersons)
● WP StB Roland Schulz ● WP Dr. Jens Freiberg
Registered
Office: Hamburg (District Court of Hamburg HR B 1981)
Berlin
● Bielefeld ● Bonn ● Bremen ● Chemnitz ● Cologne ● Dortmund ● Dresden ● Dusseldorf ●
Erfurt ● Essen ● Flensburg ● Frankfurt am Main ● Freiburg ● Hamburg ● Hannover ● Kassel ●
Kiel ● Leer ● Leipzig ● Lubeck ● Mainz ● Munich ● Munster ● Nuremberg ● Oldenburg ●
Rostock ● Stuttgart
BDO
AG Wirtschaftsprüfungsgesellschaft, a German company limited by shares, is a member of BDO International Limited, a UK company limited
by guarantee, and forms part of the international BDO network of independent member firms.
BDO
is the brand name for the BDO network and for each of the BDO Member Firms. © BDO 2025
Exhibit 107
Calculation of Filing Fee Table
Form F-3
(Form Type)
ads-tec Energy PLC
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward
Securities
|
|
Security
Type |
|
Security
Class Title |
|
Fee
Calculation or Carry Forward Rule |
|
|
Amount
Registered (1) |
|
|
Proposed
Maximum Offering Price Per Share |
|
|
Maximum
Aggregate Offering Price |
|
|
Fee
Rate |
|
|
Amount
of Registration Fee |
|
|
Carry
Forward Form Type |
|
|
Carry
Forward File Number |
|
|
Carry
Forward Initial Effective date |
|
|
Filing
Fee Previously Paid In Connection with Unsold Securities to be Carried Forward |
|
Newly
Registered Securities |
Fees
to Be Paid |
|
Equity |
|
Ordinary
Shares |
|
|
457(o) |
|
|
|
|
(2) |
|
|
|
(2) |
|
|
|
(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
Preferred
Shares |
|
|
457(o) |
|
|
|
|
(2) |
|
|
|
(2) |
|
|
|
(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
Warrants |
|
|
457(o) |
|
|
|
|
(2) |
|
|
|
(2) |
|
|
|
(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt |
|
Debt
Securities |
|
|
457(o) |
|
|
|
|
(2) |
|
|
|
(2) |
|
|
|
(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
Rights |
|
|
457(o) |
|
|
|
|
(2) |
|
|
|
(2) |
|
|
|
(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
Purchase
Contracts |
|
|
457(o) |
|
|
|
|
(2) |
|
|
|
(2) |
|
|
|
(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
Units |
|
|
457(o) |
|
|
|
|
(2) |
|
|
|
(2) |
|
|
|
(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated
(Universal) Shelf |
|
- |
|
|
457(o) |
|
|
|
|
(2) |
|
|
|
(2) |
|
$ |
250,000,000 |
|
|
|
0.00015310 |
|
|
$ |
38,275 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Secondary
Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
Ordinary
Shares |
|
|
457(c) |
|
|
|
10,516,670 |
(3) |
|
$ |
14.43 |
(4) |
|
$ |
151,755,549 |
|
|
|
0.00015310 |
|
|
$ |
23,234 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carry
Forward Securities |
Carry
Forward Securities |
|
- |
|
- |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
Total Offering
Amounts |
|
|
$ |
401,755,549 |
|
|
|
|
|
|
$ |
61,509 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fees
Previously Paid |
|
|
|
|
|
|
|
|
|
|
$ |
-- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
Fee Offsets |
|
|
|
|
|
|
|
|
|
|
|
-- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Fee Due |
|
|
|
|
|
|
|
|
|
|
$ |
61,509 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
(2) |
Omitted pursuant to General Instruction II.C of Form F-3 and Rule 457(o) promulgated under the Securities Act. The proposed amount to be registered, maximum offering price per unit and maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder. There are being registered hereunder such indeterminate number of ordinary shares, such indeterminate number of preferred shares, such indeterminate principal amount of debt securities, such indeterminate number of warrants, rights and purchase contracts to purchase ordinary shares, preferred shares or debt securities, and such indeterminate number of units, as shall have an aggregate initial offering price not to exceed $250,000,000. If any debt securities are issued at an original issue discount, then the offering price of such debt securities shall be in such greater principal amount as shall result in an aggregate initial offering price not to exceed $250,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. The proposed maximum initial offering price per unit will be determined, from time to time, by the registrant in connection with the issuance by the registrant of the securities registered hereunder. The securities registered also include such indeterminate number of ordinary shares and preferred shares as may be issued upon conversion or exchange of convertible or exchangeable securities being registered hereunder or pursuant to the anti-dilution provisions of any such securities. |
|
|
(3) |
Represents up to 10,516,670 Ordinary Shares, which consists of up to (i) 1,716,667 Ordinary Shares issuable upon exercise of the warrants to purchase Ordinary Shares at an exercise price of $3.00 per share pursuant to those warrants dated May 5, 2023, (ii) 4,000,001 Ordinary Shares issuable upon exercise of the warrants to purchase Ordinary Shares at an exercise price of $6.20 per share pursuant to those warrants dated August 18, 2023, and (iii) 4,800,002 Ordinary Shares issuable upon exercise of the warrants to purchase Ordinary Shares at an exercise price of $6.20 per share pursuant to those warrants dated August 26, 2024. |
(4) |
Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Ordinary Shares on the Nasdaq Stock Market LLC on February 7, 2025 ($14.43 per share), in accordance with Rule 457(c) of the Securities Act. |
ADD TEC Energy (NASDAQ:ADSEW)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
ADD TEC Energy (NASDAQ:ADSEW)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025